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1. OVERVIEW 
 
In a modern, fast-developing world, where epidemics, incurable diseases and narrow resources still 
remain as unsolved problems, mankind relies on the synthetic skills of eager chemists, who develop new 
pharmaceutical agents and technical materials to face the needs of our population and their future 
generation. Most notably, scientific discoveries in organic chemistry are of crucial importance, since 
carbon-atom derived molecules are the basis of all life and are responsible for a huge variety of 
phenomena like natural colors (pigments), poisonous animals (venoms) or antibacterial mould (peni-
cillins). The class of heterocyclic compounds constitute one of the largest and most varied family of 
organic molecules. They are widely distributed in nature and their structures can be found in herbicides, 
pesticides, insecticides, dyes and copolymers.1 By understanding their role in biological processes,2 
heterocycles from natural products can be targeted for pharmacologically purposes with many of them 
already being used in clinical routine. In particularly, the determination of the biological active site in a 
natural product is essential for the development of new drugs. In order to optimize the biological activity, 
it is indispensable to create libraries of molecules of the same scaffolds, but with different functional 
groups.3 To prepare such functionalized heterocycles, chemists have developed a broad variety of 
synthetic methods. A very common method is to create the backbone of a heterocycle and to introduce 
the desired functional groups before the cyclization process is initiated. Alternatively, a more modern 
approach is to introduce or replace substituents in an existing heterocycle.1a This offers a higher 
flexibility, since there is a greater choice of substituents that can be easily introduced and there is less 
necessity of tedious protection/deprotection cycles. In this context, organometallic chemistry is a 
versatile tool for the functionalization of heterocycles. There are a plenty of useful metalorganic 
compounds with various metals, providing different reactivities for distinct purposes.4 Their application 
in organic synthesis include traditional aromatic substitutions,5 oxidative metal-insertions,6 halogen-
metal exchange reactions,7 directed metalations8 and cross-coupling reactions.9 Especially cross-
coupling reactions became very popular for their facile carbon-carbon bond formation, rewarding 
Heck,10 Suzuki11 and Negishi12 with the Nobel prize in chemistry in 2010. 
 
                                                 
1 (a) Comprehensive Heterocyclic Chemistry III, Vol. 1 (Eds.: A. R. Katritzky, C. A. Ramsden, E. F. V. Scriven, R. J. K. 
Taylor), Elsevier, Oxford, United Kingdom, 2008 (b) Heterocycles in Live and Society (Eds.: A. F. Pozharskii, A. T. 
Soldatenkov, A. R. Katrinzky), John Wiley & Sons, Chichester, United Kingdom, 2011. 
2 Medicinal Natural Products, 3. Edition (Ed.: P. M. Dewick), John Wiley & Sons, United Kingdom, 2009, 1. 
3 N. A. Meanwell, J. Med. Chem. 2011, 54, 2529. 
4(a) A. Boudier, L. O. Bromm, M. Lotz, P. Knochel, Angew. Chem. Int. Ed. 2000, 39, 4414. (b) Handbook of Functionalized 
Oganometallics (Ed.: P. Knochel), Wiley-VCH, Weinheim, 2005. (c) The Organometallic Chemistry of the Transition Metals 
(Ed.: R. H. Crabtree), Wiley & Sons, 2014.  
5 Organometallic Chemisty, Vol. 38 (Eds.: I. J. S. Fairlamb, J. N. Lynam), RSC, 2012.  
6 (a) A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 6040. (b) F. M. Piller, P. 
Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 6802. 
7 P. Knochel, W. Dohle, N. Gommermann, F. F. Kneisel, F. Kopp, T. Korn, I. Sapountzis, V. A., Angew. Chem. Int. Ed. 2003, 
42, 4302. 
8 (a) V. Snieckus, Chem. Rev. 1990, 90, 879. (b) E. Bergin, Nat. Chem. 2015, 7, 8. (c) H. Gilman, R. L. Bebb, J. Am. Chem. 
Soc. 1939, 61, 109.  
9 Metal-Catalyzed Cross-Coupling Reactions, 2nd Ed. (Eds.: A. de Meijere, F. Diederich), Wiley-VCH, Weinheim, 2004. 
10 Palladium Reagents in Organic Synthesis (Best Synthetic Methods), Ed. Richard F. Heck, Academic Press Inc, 1985. 
11 A. Suzuki, Angew. Chem. Int. Ed. 2011, (50), 6722. 
12 E.-i. Negishi, Organometallics in Organic Synthesis, Wiley-VCH, Weinheim, 1980.  
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2. ORGANOMETALLIC CHEMISTRY 
 
2.1 Historical background 
 
The first organometallic compound can be traced back to 1760, where Cadet de Gassicourt produced 
As2Me4 from potassium acetate with arsenic trioxide, trying to prepare invisible ink.13 The next reported 
organometallic compounds have been “Zeise’s salt” and “Frankland’s diethyl zinc”.14 Almost 150 years 
above from “Cadet’s fuming liquid“, at the beginning of the 20th century, Grignard, set a milestone in 
the history of organometallic chemistry by the preparation of the first organomagnesium compound.15 
Therefore, in 1912 he was rewarded with the Nobel prize and many laureates followed for their expertise 
in metalorganic research: Ziegler and Natta (1963), Wilkinson and Fischer (1973), Brown and Wittig 
(1989), Knowles, Noyori and Sharpless (2001), Chauvin, Grubbs and Schrock (2005), and as already 
mentioned Heck, Negishi and Suzuki (2010). Nowadays, there exists a vast number of organometallic 
species, which find broad application in both industry and academia.16  
The reactivity of an organometallic compound is characterized by the polarization of its carbon-metal 
bond. In general, the reactivity increases with the ionic character of the respective bond (Figure 1).17,4b 
 
 
 
 
 
 
 
 
 
Figure 1: Polarity of organometallic reagents versus functional group tolerance and reactivity.18 
 
Organometallics, such as organolithium, -sodium or -potassium reagents are highly reactive towards 
many electrophiles, but are incompatible with sensitive functional groups.19 However, using reagents 
with a very covalent carbon-metal bond like organoboron, -silicon, -indium or -tin species, functional 
group tolerance is maintained.20,4b But their mild reactivity often requires harsh conditions or special 
catalysts in order to react with electrophiles. Organoaluminium, -magnesium and -zinc reagents are a 
                                                 
13 D. Seyferth, Organometallics 2001, 20, 1488. 
14 (a) E. Frankland, Liebigs Ann. Chem. 1848, 71, 171. (b) E. Frankland, J. Chem. Soc. 1848, 2, 263. 
15 V. Grignard, Compt. Rend. Acad. Sc. Paris 1900, 130, 1322. 
16 (a) Organomagnesium Compounds (Eds.: Z. Rappoport, I. Marek), John Wiley & Sons, Chichester, United Kingdom, 2006. 
(b) Main Group Metals in Organic Synthesis (Eds. H. Yamamoto, K. Oshima), VCH, Wiley, Weinheim, Germany, 2004. (c) 
Organometallics, 3rd edition, Ed.: C. Elschenbroich, Wiley-VCH, 2003. (d) Organometallic Reagents in Synthesis, 3rd issue of 
Oxford Chemistry Primers, Ed. P. R. Jenkins, Oxford University Press, 1992.  
17 (a) Organometallics in Organic Synthesis (Ed.: N. Negishi), VCH, Wiley, Weinheim, Germany, 1996. (b) Applications of 
Organometallic Compounds (Ed.: I. Omae), VCH, Wiley, Chichester, United Kingdom, 1998. (c) The Chemistry of Organo-
metallic Compounds (Eds.: E. G. Rochow, D. T. Hurd, R. N. Lewis), VCH, Wiley, New York, United States 1957. (d) Principle 
of Organometallic Chemistry (Ed.: Powell), Chapman and Hall, London, United Kingdom, 1988. 
18 B. Haag, M. Mosrin, H. Ila, V. Malakhov, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9794. 
19 J. Clayden, Organolithiums: Selectivity for Synthesis (Ed. J. E. Baldwin), Pergamon Press, Oxford, 2002. 
20 Boronic Acids: Preparation and Applications in Organic Synthesis, Medicine and Materials (Ed. D.G. Hall), Wiley-VCH, 
Weinheim, 2011. 
4 
 
good compromise between the two extremes, since they provide enough reactivity and show a very 
suitable group tolerance.  
 
 
2.2 Oxidative Insertion 
 
One of the oldest and today still very convenient method to prepare organometallic reagents, is the direct 
oxidative insertion of elemental metal into a carbon-halogen bond. In 1849, Frankland was the first 
chemist who discovered this method by preparing dialkylzinc reagents by treating alkyliodides with 
zinc.14 Further experiments were done by Hallwachs and Schaferik, who investigated the reaction 
between ethyl-/methyl iodide with aluminium.21 The final breakthrough however was made by Grignard 
in 1900, who generated the first organomagnesium reagents via insertion of elemental magnesium into 
a carbon halide bond.15 Originally, Barbier developed a one pot synthesis for the preparation of 
functional alcohols starting from alkyl halides, magnesium metal and carbonyl compounds,22 but it was 
Grignard, who separately prepared organomagnesium reagents in ethereal solvents before the addition 
of carbonyl compounds. Nowadays, so-called “Grignard-reagents” play a very important role in organic 
synthesis. 
However, the first magnesium insertions had some major drawbacks. First of all, refluxing conditions 
were required, which limited functional group tolerance. Furthermore, those insertions have a certain 
induction period, making sudden exothermic reactions unpredictable for large scale productions. In      
addition only very less alkyl or aryl halides react with magnesium metal because of its passivized layer 
of magnesium oxide/magnesium hydroxide. To overcome these problems, Rieke developed highly 
reactive metal powders by reduction of an anhydrous metal chloride with an alkali metal such as lithium, 
sodium or potassium. This method allowed the preparation of Grignard reagents at very low                   
temperatures, increasing functional group tolerance, for instance tolerating groups such as tert-butyl-
ester or nitriles. Furthermore, “Rieke metals” proved to be so powerful that even relatively unreactive               
organohalides, such as fluorides can be transformed into the corresponding magnesium species     
(Scheme 1).23  
A major drawback of “Rieke metals” is the circumstance that they always have to be freshly prepared 
and that the functional group tolerance is still limited. In recent times, Knochel and co-workers 
developed a mild and efficient method for the preparation of highly functionalized Grignard reagents. 
Starting from aromatic or heteroaromatic halides, they inserted commercially available zinc and 
magnesium turnings in the presence of lithium chloride (Scheme 2).24  
                                                 
21 W. Hallwachs, A. Schaferik, Ann. Chem.1859, 109, 206. 
22 P. Barbier, C. R. Hebd. Séances Acad. Sci.1899, 128, 110.  
23 (a) R. D. Rieke, L.-C. Chao, Syn. React. Inorg. Metal-Org. Chem. 1974, 4, 101. (b) R. D. Rieke, Acc. Chem. Res. 1977, 10, 
301. (c) R. D. Rieke, Science 1989, 246, 1260. (d) L. Zhu, R. M. Wehmeyer, R. D. Rieke, J. Org. Chem. 1991, 56, 1445. (e) 
R. D. Rieke, M. V. Hanson, Tetrahedron 1997, 53, 1925. (f) R. D. Rieke, Aldrichim. Acta 2000, 33, 52. (g) J. Lee, R. Velarde-
Ortiz, A. Guijarro, J. R. Wurst, R. D. Rieke, J. Org. Chem. 2000, 65, 5428.  
24 (a) F. M. Piller, P. Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 6802. (b) F. M. 
Piller, A. Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. Eur. J. 2009, 15, 7192. (c) A. Krasovskiy, 
V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 6040. (d) N. Boudet, S. Sase, P. Sinha, C.-Y. Liu, 
A. Krasovskiy, P. Knochel, J. Am. Chem. Soc. 2007, 129, 12358.   
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Scheme 1: Preparation and reaction of functionalized Grignard reagents using “Rieke magnesium“. 
 
Several studies showed that lithium chloride enhances the reaction rate of the metal insertion by 
lowering the energy of the transition state.25 Furthermore, lithium chloride improves the solubility of 
the organometallic reagent by forming an “ate”-species of the general formula RMetXCl-Li+ (R = alkyl, 
aryl; Met = Mg, Zn, X = Cl, Br, I).26 
 
 
Scheme 2: Preparation of organomagnesium and organozinc reagents in the presence of LiCl. 
 
However, in some cases the zinc insertion is still very slow and the generated zinc reagents are                  
inert towards many electrophiles. This problem can be solved by performing a lithium chloride promoted         
magnesium insertion in the presence of zinc chloride. Thus, the Grignard reagent is still formed fast and  
                                                 
25 C.-Y. Liu, X. Wang, T. Furuyama, S. Yasuike, A. Muranaka, K. Morokuma, M. Uchiyama, Chem. Eur. J. 2010, 16, 1780. 
26 (a) A. Krasovskiy, B. F. Straub, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 159. (b) K. Koszinowski, P. Böhrer, 
Organometallics 2009, 28, 771. (c) J. E. Fleckenstein, K. Koszinowski, Organometallics 2011, 30, 5018. 
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then transmetalated to zinc, creating an organozinc species of the formula RZnCl·MgXCl·LiCl (X = Cl, 
Br, I). These zinc species react easily with aldehydes, ketones and carbon dioxide, whereas normal zinc 
species without MgXCl salt often do not undergo these reactions.27 When using Zn(OPiv)2·2LiCl instead 
of ZnCl2·2LiCl, the magnesium insertion rate is even much faster. Furthermore, this method provides 
solid and thus easy to handle organozinc compounds, which show air stability for a period of time.28 
Knochel and co-workers also demonstrated many examples of lithium chloride promoted zinc insertions 
into benzylic chlorides (Scheme 3).29 
 
 
Scheme 3: LiCl-mediated preparation of functionalized benzylic organozinc reagents. 
 
For more versatility, Knochel and co-workers extended the insertion into benzylic halides with indium,30 
manganese,31 and aluminum32 metal, tolerating a large variety of functional groups. 
 
 
2.3 Halogen-Metal Exchange 
 
Another, even more practical method to prepare an organomagnesium species is the halogen-magnesium 
exchange. Prévost was the first scientist who discovered this methodology in 1931 by reaction of          
cinnamyl bromide with ethylmagnesium bromide (Scheme 4).33 
 
 
Scheme 4: First example of a halogen-magnesium exchange. 
                                                 
27 A. Metzger, S. Bernhardt, G. Manolikakes, P. Knochel, Angew. Chem. Int. Ed. 2010, 49, 4665. 
28 (a) S. Bernhardt, G. Manolikakes, T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9205. (b) C. I. Stathakis, S. 
Bernhardt, V. Quint, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 9428. (c) M. Ellwart, P. Knochel, Angew. Chem. Int. Ed. 
2015, 54, 10662. (d) M. S. Hofmayer, J. M. Hammann, F. H. Lutter, P. Knochel, Synthesis 2017, in print. (e) J. M. Hammann, 
F. H. Lutter, D. Haas, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 1082.  
29 (a) A. Metzger, M. A. Schade, P. Knochel, Org. Lett. 2008, 10, 1107. (b) M. A. Schade, A. Metzger, S. Hug, P. Knochel,  
Chem. Comm. 2008, 3046. (c) A. Metzger, M. A. Schade, G. Manolikakes, P. Knochel, Chem. Asian J. 2008, 3, 1678. (d) A. 
Metzger, F. Piller, P. Knochel, Chem. Comm. 2008, 5824. (e) A. Metzger, C. Argyo, P. Knochel, Synthesis 2010, 882. 
30 (a) Y.-H. Chen, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 7648. (b) Y.-H. Chen, M. Sun, P. Knochel, Angew. Chem. Int. 
Ed. 2009, 48, 2236. (s) S. Bernhardt, Z. -L. Shen, P. Knochel, Chem. Eur. J. 2013, 19, 828. 
31 (a) Z. Peng, P. Knochel, Org. Lett. 2011, 13, 3198. (b) P. Quinio, A. D. Benischke, A. Moyeux, G. Cahiez, P. Knochel, Synlett 
2015, 26, 514-518. 
32 T. D. Blümke, K. Groll, K. Karaghiosoff, P. Knochel, Org. Lett. 2011, 6440. 
33 C. Prévost, Bull. Soc. Chim. Fr. 1931, 1372. 
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Further discoveries in this field followed by Urion34 in 1934 and Wittig and Gilman35 in 1938. In contrast 
to insertion reactions, halogen-metal exchange can be mostly performed under very mild conditions, 
improving the functional group tolerance. Also, this method gives access to organometallic reagents, 
like carbenoids, which are difficult to prepare by direct metal insertion.36  
The halogen/metal exchange is considered to be an equilibrium in which the formation of the most stable 
organometallic species is formed according to its hybridization (sp > sp2vinyl > sp2aryl > sp3prim > sp3sec). 
Thus, the formed organometallic compound has a higher thermodynamic stability than the exchange 
reagent itself.37 Even though, the exact mechanism of such an exchange reaction is still not known, a 
halogen ate complex is assumed to be an intermediate in this process.38 The reaction rate is enhanced in 
the presence of electronegative substituents on the aryl halide, thus generating a more stable organo-
metallic compound. Not to neglect are the electronic properties of the halogen and the organic substrate 
itself. 
Until today, the halogen/magnesium exchange has become the most versatile method among all                
exchange reactions. In 1998, Knochel and co-workers further extended this method by describing 
iodine/magnesium exchange reactions using PhMgCl and iPrMgBr at low temperatures.39 This protocol 
enables the use of substrates bearing sensitive functionalities like ester- or nitrogroups (Scheme 5). 
 
 
Scheme 5: Preparation of polyfunctional Grignard reagents starting from aryl iodides using iPrMgBr/PhMgCl. 
 
Knochel could further improve the halogen/magnesium exchange by development of the reagent 
iPrMgCl·LiCl (1).40 This so called “Turbo-Grignard” is obtained by the stoichiometric addition of 
lithium chloride to iPrMgCl. 
 
                                                 
34 E. Urion, C. R. Hebd. Séances Acad. Sci.1934, 198, 1244.  
35 (a) G. Wittig, U. Pockels, H. Dröge, Chem. Ber. 1938, 71, 1903. (b) R. G. Jones, H. Gilman, Org. React. 1951, 6, 339 (c) H. 
Gilman, W. Langham, A. L. Jacoby, J. Am. Chem. Soc. 1939, 61, 106.  
36 (a) J. Villiéras, Bull. Soc. Chim. Fr. 1967, 1520. (b) J. Villiéras, B. Kirschleger, R. Tarhouni, M. Rambaud, Bull. Soc. Chim. 
Fr. 1986, 470. (c) C. Tamborski, G. J. Moore, J. Organomet. Chem. 1971, 26, 153. (d) N. Furukawa, T. Shibutani, H. Fujihara,  
Tetrahedron Lett. 1987, 28, 5845. (e) D. J. Burton, Z.-Y. Yang, Tetrahedron 1992, 48, 189. (f) G. Cahiez, D. Bernard, J. F. 
Normant, J. Organomet. Chem. 1976, 113, 107. (g) C. Bolm, D. Pupowicz, Tetrahedron Lett. 1997, 38, 7349.  
37 D. Hauk, S. Lang, A. Murso, Org. Process Res. Dev. 2006, 10, 733.  
38 (a) R. W. Hoffmann, M. Bönstrup, M. Müller, Org. Lett. 2003, 5, 313. (b) V. P. W. Böhm, V. Schulze, M. Bönstrup, M. 
Müller, R. W. Hoffmann, Organometallics 2003, 22, 2925.  
39 (a) L. Boymond, M. Rottländer, G. Cahiez, P. Knochel, Angew. Chem. Int. Ed. 1998, 37, 1701. (b) I. Sapountzis, P. Knochel,  
Angew. Chem. Int. Ed. 2002, 41, 1610. (c) A. E. Jensen, W. Dohle, I. Sapountzis, D. M. Lindsay, V. A. Vu, P. Knochel, 
Synthesis 2002, 565.  
40 (a) A. Krasovskiy, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 3333. (b) A. Krasovskiy, B. F. Straub, P. Knochel, Angew. 
Chem. Int. Ed. 2006, 45, 159. (c) H. Ren, P. Knochel, Chem. Commun. 2006, 726. (d) C.-Y. Liu, P. Knochel, Org. Lett. 2005, 
7, 2543. (e) F. Kopp, A. Krasovskiy, P. Knochel, Chem. Commun. 2004, 2288. 
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It shows a remarkably high reactivity which is caused by the breakup of iPrMgCl aggregates and the 
formation of magnesium-lithium ate complexes (Scheme 6). 
 
 
Scheme 6: Formation of lithium-ate complex through addition of LiCl to iPrMgCl. 
 
Where iPrMgBr/PhMgCl lacked in reactivity, iPrMgCl·LiCl (1) enables facile bromine/magnesium 
exchange reactions. Thus, a broad range of aromatic and heteroaromatic bromides were converted into 
their corresponding organomagnesium reagents (Scheme 7). 
 
 
Scheme 7: iPrMgCl·LiCl (1) as reagent for bromine/magnesium exchange reactions. 
 
However, in case of electron-rich arenes, iPrMgCl·LiCl (1) fails to react with these compounds. 
Therefore, bis-magnesium reagents of type R2Mg·LiCl with an increased ate-character have been 
established. Thus, the Grignard reagents sBu2Mg·LiCl and iPr2Mg·LiCl could be successfully em-
ployed in exchange reactions with unreactive aryl bromides and iodides (Scheme 8).41 
 
 
Scheme 8: Grignard reagents sBu2Mg·LiCl and iPr2Mg·LiCl as exchange reagents for electron-rich aromatics. 
 
Iodine-zinc exchange reactions have also been reported. For instance, various iodinated aromatic and 
heteroaromatic substrates can be zincated using iPr2Zn in the presence of Li(acac).42  
 
                                                 
41 A. Krasovskiy, B. F. Straub, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 159. 
42 F. F. Kneisel, M. Dochnahl, P. Knochel, Angew. Chem. Int. Ed.2004, 43, 1017. 
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2.4 Metalation 
 
Besides the halogen-metal exchange and the oxidative insertion, the metalation offers a third possibility 
to generate an organometallic species. The huge advantage is, that there is no need for a halogen 
precursor. For metalation, the respective (hetero-)arene has to have a carbon-hydrogen-bond with a 
relative acidic proton, which can be deprotonated using alkyl metals or metal amide bases.  
Through the pioneering work of Gilman,43 Wittig 44 and Snieckus 45, it became possible to regio-
selectively functionalize aromatic and heteroaromatic systems in ortho-position to a directing group 
(directed ortho-metallation, DoM). Such a directing group or DMG (directing metalation group) usually 
contains a heteroatom with a free electron pair that can coordinate to the lithium reagent and thus leads 
the deprotonation in ortho-position. Very common DMGs are carbamates, amides, methoxy or cyano 
groups.  
For the first directed ortho-metalations, organolithium compounds like nBuLi or PhLi were used. Due 
to nucleophilic side reactions, more sterically hindered lithium bases such as LDA46 (lithium diiso-
propylamide) or TMPLi (2)47 (2,2,6,6-tetramethylpiperidyl lithium) have been developed. Many further 
developments in the field of DoM and organolithium chemistry have been made. For example, variation 
of the used lithium bases allows DoM on different ortho-metalation sites (Figure 2). 
 
 
Figure 2: Regioselective ortho-metalation of ortho- and meta-anisic acid depending on used lithium base.48  
 
However, alkyllithium reagents as well as lithium amides show such a high reactivity, that undesired 
side reactions, e. g. Chichibabin addition49 or an attack on the functional group can occur. Furthermore, 
they have to be prepared in situ since their stability in THF is limited and most lithiations require very 
low temperatures (-78 to -100 °C). As an alternative, especially when dealing with sensitive functional 
groups, magnesium amide bases have been developed. In 1947, based on Meunier’s original dis-          
coveries50 Hauser and coworkers established the magnesium amide bases of type R2NMgX and                           
                                                 
43 H. Gilman, R. L. Bebb, J. Am. Chem. Soc.1939, 61, 109. 
44 G. Wittig, G. Fuhrmann, Ber. Dtsch. Chem. Ges.1940, 73, 1197. 
45 (a) V. Snieckus, Pure & Appl. Chem. 1990, 62, 2047 (b) T. K. Macklin, J. Panteleev, V. Snieckus, Angew. Chem. Int. Ed. 
2008, 47, 2097. (c) V. Snieckus, Chem. Rev. 1990, 90, 879.  
46 M. Hamell, R. Levine, J. Org. Chem. 1950, 15, 162.  
47 (a) C. L. Kissel, B. Rickborn, J. Org. Chem. 1972, 37, 2060. (b) M. W. Rathke, R. Kow, J. Am. Chem. Soc. 1972, 94, 6854.  
48 T.-H.Nguyen , N. T. T. Chau , A.-S.Castanet, K. P. P. Nguyen , J. Mortier, J. Org. Chem. 2007, 72, 3419. 
49 A. E. Chichibabin, O. A. Zeide, J. Russ. Phys. Chem. Soc. 1914, 46, 1216.  
50 L. Meunier, C. R. Hebd. Seances Acad. Sci. 1903, 136, 758.  
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(R2N)2Mg.51 Several decades later, Eaton52 and then Mulzer53 applied sterically more demanding amide 
bases of the kind TMPMgX and TMP2Mg (TMP = 2,2,6,6-Tetramethylpiperidyl) for the directed ortho-
magnesiation of aromatic compounds. However, these magnesium amides are in an aggregated state, 
leading to low kinetic basicity and low solubility. As a consequence, a large excess of the used 
magnesium amide (up to 10 equiv) and the electrophile were necessary to overcome these drawbacks. 
A huge improvement was achieved in 2006, when Knochel and coworkers developed the highly active 
mixed Mg/Li-base TMPMgCl·LiCl (3) (Scheme 9).54  
                              
 
Scheme 9: Preparation and crystal structure of TMPMgCl·LiCl (3) 
 
The outstanding advantages of this new base are not only its excellent kinetic basicity and the very good 
solubility, but also the high thermal stability in THF-solutions, giving the ability to long term storage. 
TMPMgCl·LiCl (3) has proven to be a suitable reagent for the deprotonation of a wide range of activated 
aromatics and heterocycles with excellent regio- and chemoselectivity at moderate temperatures 
(Scheme 10).55 
 
Scheme 10: TMPMgCl·LiCl (3) as suitable reagent for the magnesiation of (hetero-)aromatics. 
 
Ever since, several lithium chloride solubilized TMP-bases have been developed by the Knochel group, 
all of them showing different reactivity, thus making them suitable for different substrates. Among     
                                                 
51 (a) C. R. Hauser, H. G. Walker, J. Am. Chem. Soc. 1947, 69, 295. (b) C. R. Hauser, F. C. Frostick, J. Am. Chem. Soc. 1949, 
71, 1350.  
52 (a) P. E. Eaton, C.-H. Lee, Y. Xiong, J. Am. Chem. Soc. 1989, 111, 8016. (b) M.-X. Zhang, P. E. Eaton, Angew. Chem. Int. 
Ed. 2002, 41, 2169. (c) P. E. Eaton, K. A. Lukin, J. Am. Chem. Soc. 1993, 115, 11375. (d) Y. Kondo, A. Yoshida, T. Sakamoto,  
J. Chem. Soc., Perkin Trans 1, 1996, 2331.  
53 (a) W. Schlecker, A. Huth, E. Ottow, J. Mulzer, J. Org. Chem. 1995, 60, 8414. (b) W. Schlecker, A. Huth, E. Ottow, J. 
Mulzer, Liebigs Ann. 1995, 1441. (c) W. Schlecker, A. Huth, E. Ottow, J. Mulzer, Synthesis, 1995, 1225. 
54 A. Krasovskiy, V. Krasovskaya, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 2958.  
55 For a review see: B. Haag, M. Mosrin, H. Ila, V. Malakhov, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9794.  
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them, the most practical and most used are TMPMgCl·LiCl (3), TMP2Mg·2LiCl (4)56, TMPZnCl·LiCl 
(5)57and TMP2Zn·2MgCl2·2LiCl (6)58 (Figure 3). 
 
 
 
                                                                                 selectivity 
       Reactivity 
Figure 3: TMP-magnesium and zinc bases 3-5; reactivity vs. selectivity. 
 
Where TMPMgCl·LiCl (3) lacks in reactivity, TMP2Mg·2LiCl (4) is strong enough to easily magnesiate 
substrates bearing electron-donating substituents or weakly electron-accepting substituents. However, 
for the metalation of substrates with very sensitive groups (e.g. -NO2, -CHO), TMPZnCl·LiCl (5) is a 
suitable reagent. Until today, the chemistry of TMP amide bases has been widely extended by Knochel 
et al. using different metals for finetuning of reactivity. Thus, TMP3Al·3LiCl, (tBu)NCH(iPr)-
(tBu)]3Al·3LiCl,59 TMP2Mn·2LiCl,60 TMP2Fe·4LiCl,61 TMP4Zr·6LiCl62 and TMP3La·5LiCl63 have 
found broad application for the metalation of rigid substrates. 
Besides DoM, the regioselective metalation of heterocycles has become pronounced interest in recent 
years. Especially, the functionalization of pyridines and quinolines is a major synthetic goal, since these 
heterocycles show vast biological properties64 and are of interest for new functional materials.65 Due to 
Chichibabin-type dimerizations66, the stoichiometric lithiation of unactivated pyridines is complicated. 
However, Kessar et al. showed that the complexation of pyridine with BF3 enables a low-temperature 
lithiation in α-position.67  
                                                 
56 (a) G. C. Clososki, C. J. Rohbogner, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7681. (b) C. J. Rohbogner, G. C. Clososki, 
P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 1503. (c) C. J. Rohbogner, A. J. Wagner, G. C. Clososki, P. Knochel, Org. Synth. 
2009, 86, 374.  
57 (a) M. Mosrin, P. Knochel, Org. Lett. 2009, 11, 1837. (b) M. Mosrin, T. Bresser, P. Knochel, Org. Lett. 2009, 11, 3406. (c) 
M. Mosrin, G. Monzon, T. Bresser, P. Knochel, Chem. Commun. 2009, 5615. 
58 (a) S. H. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7685. (b) S. H. Wunderlich, P. Knochel, Org. Lett. 2008, 
10, 4705.  
59 S. H. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2009, 48, 1501. 
60 S. H. Wunderlich, M. Kienle, P. Knochel, Angew. Chem Int. Ed. 2010, 49, 4157. 
61 S. H. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2009, 48, 9717. 
62 M. Jeganmohan, P. Knochel, Angew. Chem. Int. Ed. 2010, 49, 8520. 
63 S. H. Wunderlich, P. Knochel, Chem Eur. J. 2010, 16, 3304. 
64 (a) K. C. Nicolaou, R. Scarpelli, B. Bollbuck, B. Werschkun, M. M. A. Pereira, M. Wartmann, K.-H. Altmann, D. Zaharevitz, 
R. Gussio, P. Giannakakou, Chem. Biol. 2000, 7, 593. (b) B. Oliva, K. Miller, N. Caggiano, A. J. O`Neill, G. D. Cuny, M. Z. 
Hoemann, J. R. Hauske, I. Chopra, Antimicrob. Agents Chemother. 2003, 47, 458. (c) A. Bouillon, A. S. Voisin, A. Robic, J.-
C. Lancelot, V. Collot, S. Rault, J. Org. Chem. 2003, 68, 10178. (d) E. M. Nolan, J. Jaworski, K.-I. Okamoto, Y. Hayashi, M. 
Sheng, S. J. Lippard, J. Am. Chem. Soc. 2005, 127, 16812. (e) A. Hayashi, M. Arai, M. Fujita, M. Kobayashi, Biol. Pharm. 
Bull. 2009, 32, 1261. (f) J. Quiroga, J. Trilleras, B. Insuasty, R. Abonia M. Nogueras, A. Marchal, J. Cobo, Tetrahedron Lett. 
2010, 51, 1107. 
65 (a) A. Yokoyama, I. Nishiyama, A. Yoshizawa, Ferroelectrics 1993, 148, 139. (b) Y. G. Skrypnik, T. F. Doroshenko, Mater. 
Sci. 1996, 32, 537. (c) H. Tsutsumi, K. Okada, T. Oishi, Electrochim. Acta 1996, 41, 2657. (d) C. G. Bangcuyo, M. E. Rampey-
Vaughn, L. T. Quan, S. M. Angel, M. D. Smith, U. H. F. Bunz, Macromolecules 2002, 35, 1563. (e) M. Vetrichelvan, S. 
Valiyaveetti, Chem. Eur. J. 2005, 11, 5889. 
66 (a) A. J. Clarke, S. McNamara, O. Meth-Cohn, Tetrahedron Lett. 1974, 15, 2373. (b) P. Gros, Y. Fort, P. Caubère, J. Chem. 
Soc. Perkin Trans. 1 1997, 3597. 
67 S. V. Kessar, P. Singh, K. N. Singh, M. Dutt, J. Chem. Soc. Chem. Commun. 1991, 570. 
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Furthermore, Michl and co-workers demonstrated the metalation of 3-alkylpyridines with BF3·OEt2 and 
lithium tmp zincates.68 For a convenient and smooth metalation of pyridines Knochel and co-workers 
demonstrated that a two-step metalation by prior complexation with BF3·OEt2 and subsequent addition 
of TMPMgCl·LiCl (3), TMP2Zn·2MgCl2·2LiCl (6) or (tBu)NCH(iPr)-(tBu)]3Al·3LiCl results in 
magnesiated, zincated or aluminated pyridines with high yield.69 They also realized that the presence or 
absence of BF3·OEt2 during metalation leads to a complete switch in regioselectivity for some cases 
(Scheme 11). 
 
Scheme 11: Switchable, regioselective metalation of 3-fluoropyridine in the presence or absence of BF3·OEt2. 
 
The Knochel group futher extended the concept of switchable, regioselective Lewis acid controlled 
metalation to more complex heterocycles like pyrimidines or cinnolines (Scheme 12).70,71 
 
 
Scheme 12: Switchable, regioselective metalation of 4,6-dimethoxypyrimidine and cinnoline  
in the presence or absence of BF3·OEt2. 
 
 
                                                 
68 (a) P. Schwab, F. Fleischer, J. Michl, J. Org. Chem. 2002, 67, 443. (b) Y. Kondo, M. Shilai, M. Uchiyama, T. Sakamoto, 
J. Am. Chem. Soc. 1999, 121, 3539. 
69 (a) M. Jaric, B. A. Haag, A. Unsinn, K. Karaghiosoff, P. Knochel, Angew. Chem. Int. Ed. 2010, 49, 5451. (b) M. Jaric, B. A. 
Haag, S. M. Manolikakes, P. Knochel, Org. Lett. 2011, 2306. 
70 (a) K. Groll, S. M. Manolikakes, X. M. du Jourdin, M. Jaric, A. Bredihhin, K. Karaghiosoff, T. Carell, P. Knochel, Angew. 
Chem. Int. Ed. 2013, 52, 6776. (b) K. Groll, S. M. Manolikakes, X. Mollat du Jourdin, M. Jaric, A. Bredihhin, K. Karaghiosoff, 
T. Carell, P. Knochel, Angew. Chem. Int. Ed. 2013, 52, 6776. 
71 T. Klatt, D. S. Roman, T. Leόn, P. Knochel, Org. Lett. 2014, 16, 1232. 
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2.5 Transition Metal Catalyzed Cross-Couplings with Iron and Cobalt 
 
Transition-metal catalyzed cross-coupling reactions are the most common methods in metalorganic 
chemistry to form carbon-carbon bonds. Industries from all over the world use this powerful method for 
the synthesis of pharmaceutical, agrochemical and technical products. The utilization of cross-couplings 
has increased exponentially within the last ten years and there exists a vast number of variations for   
each type of cross-coupling. The most famous cross-couplings in organic synthesis are the Suzuki-, 
Negishi-, Kumada-, Heck-, Stille- and Sonogashira-coupling. However, these types of cross-couplings 
require expensive and toxic palladium- and nickel-salts.72 In addition, catalytic systems with both 
palladium and nickel usually require the addition of structurally complex and costly ligands. Due to 
these ecological and economical disadvantages, organic research is focused on the applicability of low-
cost and low-toxic transition metals for cross-coupling.    
Recently, iron salts have received increased interest, since they represent ideal alternative precatalysts.  
There is an enormous availability of iron, being the most abundant metal in the universe and the second-
most abundant metal in the earth’s crust. Moreover, iron is an essential metal in the human body (4g/ 
person). Its low toxicity makes iron-catalysts suitable for health-care related chemistry. The environ-
mental properties and the moderate price reveal iron as the promising catalyst of the future. In the field 
of iron-catalyzed cross-coupling, alkyl-aryl,73 alkyl-alkenyl,74 aryl-alkenyl,73b,73c,73k,75 as well as alkenyl-
                                                 
72 (a) Handbook of the Toxikology of Metals; L. Friberg, G. F. Nordberg, V. B. Vouk, Eds.; Elsevier, Amsterdam, 1986. (b) M. 
N. Hughes, Compr. Coord. Chem. 1987, 67, 643. (c) Nickel and the Skin: Absorption, Immunology, Epidermology, and 
Metallurgy; J. J. Hostynek, H. I. Maibach, Eds. CRC Press, Boca Raton, 2002. 
73 (a) A. Fürstner, A. Leitner, Angew. Chem. Int. Ed. 2002, 41, 609. (b) A. Fürstner, A. Leitner, M. Méndez, H. Krause, H.        
J. Am. Chem. Soc. 2002, 124, 13856. (c) R. Martin, A. Fürstner, Angew. Chem. Int. Ed. 2004, 43, 3955. (d) T. Nagano, T. 
Hayashi, Org. Lett. 2004, 6, 1297. (e) M. Nakamura, S. Ito, K. Matsuo, E. Nakamura, J. Am. Chem. Soc. 2004, 126, 3686. (f) 
R. B. Bedford, D. W. Bruce, R. M. Frost, J. W. Goodby, M. Hird, Chem. Commun. 2004, 40, 2822. (g) M. Nakamura, S. Ito, 
K. Matsuo, E. Nakamura, Synlett 2005, 11, 1794. (h) R. B. Bedford, M. Betham, D. W. Bruce, A. A. Danopoulos, R. M. Frost, 
M. Hird, J. Org. Chem. 2006, 71, 1104. (i) G. Cahiez, V. Habiak, C. Duplais, A. Moyeux, Angew. Chem. Int. Ed. 2007, 46, 
4364. (j) A. Fürstner, R. Martin, H. Krause, G. Seidel, R. Goddard, C. W. Lehmann, J. Am. Chem. Soc. 2008, 130, 8773. (k) 
W. M. Czaplik, M. Mayer, A. Jacobi von Wangelin, Angew. Chem. Int. Ed. 2009, 48, 607. (l) R. B. Bedford, M. Huwe, M. C. 
Wilkinson, Chem. Commun. 2009, 45, 600. (m) G. Cahiez, L. Foulgoc, A. Moyeux, Angew. Chem. Int. Ed. 2009, 48, 2969. (n) 
D. Noda, Y. Sunada, T. Hatakeyama, M. Nakamura, H. J. Nagashima, J. Am. Chem. Soc. 2009, 131, 6078. (o) S. Ito, Y.-i. 
Fujiwara, E. Nakamura, M. Nakamura, Org. Lett. 2009, 11, 4306. (p)T. M. Gøgsig, A. T. Lindhardt, T. Skrydstrup, Org. Lett. 
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alkynyl76 coupling reactions are well investigated and their utilization to different substrates is still 
improved.  
In 2013 Malhotra impressively showed that chemoselective iron-catalyzed sp2-sp3 cross-couplings in a 
one-pot system are feasible.77 By the initial treatment of 1,3-dichloroisoquinoline with MeMgBr in the 
presence of Fe(acac)3 followed by additional iron-catalyst and EtMgBr selectively furnished a 
differentially substituted 1,3-isoquinoline in high yield. (Scheme 13).  
 
 
Scheme 13: One-pot selective iron-catalyzed dialkyl cross-coupling and mechanistic aspects. 
 
This result indicates that the chemoselective incorporation of the alkyl groups strongly depends upon 
the different ability of the C-X bonds in dihaloaromatic compounds to undergo an insertion. While the 
aromaticity in intermediate B is retained, the aromaticity in intermediate A is lost when the first metal 
insertion takes place in position 3 of 1,3-dichloroquinoline (Scheme 13).78  
Stereoselectivity also often plays an important role, when it comes to the production of bioactive 
substances with certain stereoinformation. In 2011, Knochel and co-workers developed a highly dia-            
stereoselective iron-mediated sp2-sp3 cross coupling between aryl Grignard reagents and cyclic iodo-
hydrine derivatives (Scheme 14).79 
 
 
Scheme 14: Iron-mediated cross-coupling of TBS-protected iodohydrine with aryl magnesium reagents. 
 
                                                 
76 (a) T. Hatakeyama, Y. Yoshimoto, T. Gabriel, M. Nakamura, Org. Lett. 2008, 10, 5341. (b) W. M. Czaplik, M. Mayer, A. 
Jacobi von Wangelin, ChemCatChem 2011, 3, 135. (c) T. Hatakeyama, Y. Okada, Y. Yoshimoto, M. Nakamura, Angew. Chem. 
Int. Ed. 2011, 50, 10973. 
77 S. Malhotra, P. S. Seng, S. G. König, A. J. Deese, K. A. Ford, Org. Lett. 2013, 15, 3698. 
78 A. K. Steib, O. M. Kuzmina, S. Fernandez, S. Malhotra, P. Knochel, Chem. Eur. J. 2015, 21, 1961. 
79 A. K. Steib, T. Thaler, K. Komeyama, P. Mayer, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 3303. 
15 
 
In all cases the aryl magnesium reagents were coupled efficiently with high diastereoselectivity, giving 
the thermodynamically favored trans-1,2-disubstituted cyclohexanols. 
In organic synthesis aryl-aryl cross-couplings belong to the utmost important ones. However, iron-          
catalyzed aryl-aryl couplings remained as a challenging task for a long time due to insufficient catalytic 
activity of the iron-catalyst and due to undesired homo-coupling side-reaction of the organometallic 
species.80 In 2002, Fürstner reported unsymmetrical biaryl-formation mediated by an iron catalyst 
(Scheme 15).73b 
 
Scheme 15: Iron-catalyzed aryl-aryl bond-formation reported by Fürstner et al. 
 
Heteroaromatic chlorides were treated with non-functionalized (hetero)aryl Grignard reagents              
(2.3 equiv) at low temperatures (-30 °C) in the presence of 5 mol% of Fe(acac)3 in THF. Within only    
10 min reaction time, the reaction reached full conversion, showing the activity of the iron-catalyst. 
However, the large formation of homo-coupling byproduct made the use of excess Grignard reagent 
indespensible. Further investigations by Figadère81 and Plé82 unveiled Fürstner’s conditions for iron 
catalyzed cross-couplings to still be the best.  
In 2007, Nakamura et al. made a huge improvement by suppressing the undesired homo-coupling           
reaction significantly. They introduced a novel catalytic system based on FeF3·3H2O and N-heterocyclic 
carbene ligands.83 The active iron-species is produceed by treatment of FeF3·3H2O and the carbene      
ligand precursor SiPr·HCl (1,3-bis-(2,6-diisopropylphenyl)-4,5-dihydroimidazolium chloride) with 
EtMgBr. Subsequently, the electrophile and the desired Grignard reagent have to be added and the 
reaction mixture has to be stirred at 60-120 °C for 24 h to produce the biaryl coupling product (Scheme 
16).  
                                                 
80 For Fe-catalyzed homo-coupling reactions, see: (a) M. S. Kharasch, E. K. Fields, J. Am. Chem. Soc. 1941, 63, 2316. (b) H. 
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C. Chaboche, F. Mahuteau-Betzer, M. Ahr, Org. Lett. 2005, 7, 1943. (e) X. Xu, D. Cheng, W. Pei, J. Org. Chem. 2006, 71, 
6637. (f) W. Liu, A. Lei, Tetrahedron Lett. 2007, 49, 610. (g) G. Cahiez, A. Moyeux, J. Buendia, C. Duplais, J. Am. Chem. 
Soc. 2007, 129, 13788. (h) G. Kiefer, L. Jeanbourquin, K. Severin, Angew. Chem. Int. Ed. 2013, 52, 6302. (i) D. Toummini, F. 
Ouzzani, M. Taillefer, Org. Lett. 2013, 15, 4690. 
81 J. Quintin, X. Franck, R. Hocquemiller, B. Fidagère, Tetrahedron Lett. 2002, 43, 3547. 
82 L. Boully, M. Darabantu, A. Turck, N. Plé, J. Heterocycl. Chem. 2005, 42, 1423. 
83 (a) T. Hatakeyama, M. Nakamura, J. Am. Chem. Soc. 2007, 129, 9844. (b) T. Hatakeyama, S. Hashimoto, K. Ishizuka, M. 
Nakamura, J. Am. Chem. Soc. 2009, 131, 11949.  
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Scheme 16: Unsymmetrical biaryl cross-coupling with iron-carbene catalyst. 
 
However, carbene ligands are quite expensive and iron fluoride salts are very toxic. Furthermore, the 
reaction requires high temperatures up to 120 °C and long reaction times to complete the coupling 
reaction. Above all, the scope of this method is quite limited. So, there was still a need for more 
convenient reaction conditions with easy accessible ligands for iron-catalysis. 
In 2012, Knochel et al. found that tBuOMe as a cosolvent hampers homocoupling side-reactions in iron-
catalyzed cross-couplings between N-heterocyclic chlorides/bromides with various electron-rich or poor 
arylmagnesium reagents.84 The authors used FeBr3 (3 mol%) as catalyst at ambient temperature and 
achieved high yields with this smooth method. But in their scope, they still encountered slow reaction 
rates in some cases. During further investigations,85 they noted that the reaction of 1-chloroisoquinoline 
and PhMgCl in the presence of 3% FeBr3 in the solvent mixture tBuOMe/THF takes only 5 min and 
provides the cross-coupled product, 1-phenylisoquinoline in 90% yield, whereas the cross-coupling of 
2-chloropyridine under the same conditions requires 1.5 h for completion and gives 2-phenylpyridine in 
82% yield (Scheme 17). 
 
Scheme 17: Ligand accelerated iron-catalyzed cross-couplings of 1-chloroisoquinoline and 2-chloropyridine with PhMgCl. 
 
                                                 
84 O. M. Kuzmina, A. K. Steib, D. Flubacher, P. Knochel, Org. Lett. 2012, 14, 4818. 
85 O. M. Kuzmina, A. K. Steib, S. Fernandez, W. Boudot, J. T. Markiewicz, P. Knochel, Chem. Eur. J. 2015, 21, 8242. 
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The reactivity difference of these substrates led to the assumption that the catalytically active iron         
species, generated in situ, may contain an isoquinoline fragment as a ligand. This hypothesis was 
checked by the reaction of 2-chloropyridine and PhMgCl in the presence of 7% isoquinoline.                     
Interestingly, the arylated pyridine formed much faster (within 15 min) with an increased isolated yield 
of 89%. Above all these improvements, it has to be mentioned that iron salts are restricted to a very 
small number of certain ligands and the reaction scope is still limited.86 An alternative display cobalt-
salts, which have a similar reactivity to iron, but show a higher catalytic activity in many cases as well 
as a lower tendency to form homocoupling byproducts. 
 
The first cobalt-catalyzed synthesis of unsymmetrical byaryls was described by Uemura via reaction of 
diaryltellurides with aromatic organomagnesium reagents (Scheme 18).87 
 
 
Scheme 18: Cobalt-catalyzed cross-coupling reaction between diaryltelurides and aromatic Grignard reagents. 
 
Knochel and Cahiez found that heteroaromatic halides can be coupled with Grignard reagents in the 
presence of catalytic amounts of CoCl2. Under the described conditions, it is even possible to react 
sterically hindered Grignard reagents like mesitylmagnesium bromide (Scheme 19).88 
 
 
Scheme 19: CoCl2-catalyzed cross-coupling reactions between heteroaryl chlorides and aromatic Grignard reagents. 
 
Nakamura showed that his method using N-heterocyclic carbene ligands for aryl-aryl cross-coupling 
can also be applied using cobalt fluoride salt.83b This method provides even better results when aromatic 
iodides or bromides are used, whereas iron fluoride provides better yields in case of aryl chlorides.89 
A further interesting cobalt-catalyzed cross-coupling method was invented by Gosmini, who showed 
that the use of manganese metal as reducing agent allows an efficient cross-coupling between chloro- 
or bromo-styrenes and various aryl bromides (Scheme 20).90 
                                                 
86 (a) I. Bauer, H.-J. Knölker, Chem. Rev. 2015, 115, 3170. (b) T. L. Mako, J. A. Byers, Inorg. Chem. Front. 2016, 3, 766.  
87 (a) S. Uemura, S.-I. Fukuzawa, Tetrahedron Lett. 1982, 23, 1181. (b) S. Uemura, S.-I. Fukuzawa, S. R. Path, J. 
Organomet. Chem. 1983, 243, 9. 
88 T. Korn, G. Cahiez, P. Knochel, Synlett 2003, 1892.  
89 G. Cahiez, A. Moyeux, Chem. Rev. 2010, 110, 1435.  
90 A. Moncomble, P. Le Floch, A. Lledos, C. Gosmini, J. Org. Chem. 2012, 77, 5056. 
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Scheme 20: Stereoselective cobalt-catalyzed alkenylation. 
 
This protocol allows the smooth formation of functionalized stilbenes with the total retention of the 
double bond using triphenylphosphine as ligand. 
Similar to iron-catalysis our group showed that using isoquinoline as ligand can accelerate the reaction-
rate of cobalt-catalyzed cross-couplings between N-heteroaryl halides and aryl magnesium                         
reagents.85, 91 Thus, the cross-coupling of 3-N,N-dimethylaminophenylmagnesium bromide with methyl 
2-chloro-nicotinate in the presence of CoCl2 (3 mol%) and isoquinoline (10 mol%) furnishes the desired 
product in 71% yield within just 10 min at 25 °C, whereas the absence of isoquinoline leads to only     
10% yield within the same reaction time (Scheme 21). 
 
 
Scheme 21: Isoquinoline accelerated cobalt-catalyzed cross-coupling. 
 
Above the superior scope and reactivity, cobalt-catalysis can also enhance the chemoselectivity. Alkynes 
prone to undergo carbometallation with Fe-catalysis, e. g. the coupling of 2-bromo-4-((trimethylsilyl)-
ethynyl)pyridine with (4-methoxyphenyl)magnesium bromide gives only 38% yield of the desired 
bisaryl species. However, using CoCl2 instead of FeBr3 improves the yield drastically, furnishing 62% 
of isolated product (Scheme 22).91 
 
 
Scheme 22: Chemoselective cross-coupling of acetylene containing bromo-pyridine. 
 
                                                 
91 O. M. Kuzmina, A. K. Steib, J. T. Markiewicz, D. Flubacher, P. Knochel, Angew. Chem. Int. Ed. 2013, 52, 4945. 
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As shown on previous pages, cobalt-catalyzed cross-coupling with magnesium reagents are well 
investigated and optimized. However, when using (hetero)aryl substrates with sensitive functionalities 
like esters, mild reaction conditions with less reactive organozinc are inevitable. For that reason, Knochel 
and coworkers developed a new methodology for a mild cobalt-catalyzed Negishi cross-coupling of 
(hetero)arylzinc reagents with (hetero)aryl halides.92 The authors used CoCl2·2LiCl as catalyst system, 
which is conveniently soluble in THF. Sodium formate was found to be a suitable and cheap ligand, 
considerably suppressing side reactions and thus improving the yield. This protocol easily allows to 
react the corresponding zinc reagents with (hetero)aryls bearing sensitive groups like ketones, esters or 
nitriles under convenient conditions (Scheme 23). 
 
Scheme 23: Mild cobalt-catalyzed Negishi cross-coupling of (hetero)arylzinc reagents with aryl halides. 
 
 
 
 
 
 
 
 
 
 
 
                                                 
92 D. Haas, J. M. Hammann, F. H. Lutter, P. Knochel, Angew. Chem. Int. Ed. 2016, 55, 3809. 
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3. NAPHTHYRIDINES 
 
Naphthyridines93 are a class of bicyclic heterocycles consisting of two fused pyridine rings in which the 
two nitrogen atoms do not occupy a bridgehead position. Through alternating of the two nitrogen atoms, 
six constitutional isomers can be drawn (Figure 4). All naphthyridine isomers are crystalline. The 
planarity of naphthyridines is based on their aromatic delocalization. Only 1,8-naphthyridine is non-
planar due to the repulsion of nitrogen lonepair electrons.94 
 
 
Figure 4: The six isomers of the naphthyridine class. 
 
In 1893, Reissert synthesized the first naphthyridine derivative (octahydro-1,8-naphthyridine), where-
upon he suggested the name naphthyridine for this kind of heterocycle. However, it lasted more than 
three decades until the first unsubstituted and unsaturated naphthyridines were prepared in 1927 by 
Bobranski95 (1,5-naphthyridine) and Koller96 (1,8-naphthyridine). The next isomers were synthesized    
by Ikekawa97 (1,6-, 1,7-, and 2,6- naphthyridine) in 1958 and independently by Albert98 (1,6- and 1,7-
naphthyridine) in 1960. The last isomer (2,6-naphthyridine) was prepared by Giacomello99 and Tan and 
Taurnis100 in 1965. Ever since, the research in the chemistry of naphthyridines has sharply increased    
and 6080 publications and 2006 patents have appeared in the literature.101 The strong interest in 
naphthyridines is due to their exceptionally broad spectrum of biological activities102 and their 
physicochemical properties103 (Figure 5).  
                                                 
93 (a) V. P. Litinov, S. V. Roman, V. D. Dyachenko, Russ. Chem. Rev. 2000, 69, 201. (b) W. W. Paudler, T. J. Kress, Adv. 
Heterocycl. Chem. 2001, 80, 123. (c) P.-W. Puan, M. C. Kozlowski, Science of Synthesis 2005, 15, 947. (d) V. P. Litinov, Adv. 
Heterocycl. Chem. 2006, 91, 189.  
94 (a) W. Czuba, Wiad. Chem. 1981, 35, 441; Chem Abstr. 1982, 96, 52192. (b) A. Clearfield, M. J. Sims, P. Singh, Acta 
Crytallogr., Sect. B 1972, 350. 
95 B. Bobranski, E. Sucharda, Ber. Dtsch. Chem. Ges. 1927, 60, 1081. 
96 G. Koller, Ber. Dtsch Chem Gesl. 1927, 60, 1918. 
97 N. Ikekawa, Chem. Pharm. Bull. 1958, 6, 263. 
98 A. Albert, J. Chem. Soc. 1960, 1790. 
99 G. Giacomello, F. Gualtieri, F. M. Riccieri, M. L. Stein, Tetraedron Lett. 1965, 1117. 
100 R. Tan, A. Taurins, Tetrahedron Lett. 1965, 2737. 
101 SciFinder search results 26.06.17. 
102 (a) X. Z. Zhao, et al., ACS Chemical Biology 2016, 11, 1074. (b) B. A. Johns, J. G. Weatherhead, S. H. Allen, J. B. Thompson, 
E. P. Garvey, S. A. Foster, J. L. Jeffrey, W. H. Miller, Bioorg. Med. Chem. 2009, 19, 1807. (c) K. Schiemann, et al., Novel 
naphthryidines and isoquinolines and their use as CDK8/19 inhibitors. WO2016009076, Jan 21, 2016. (d) A. Madaan, R. 
Verma, V. Kumar, A. T. Singh, S. K. Jain, M. Jaggi, Arch. Pharm. Chem. Life Sci. 2015, 348, 837. 
103 (a) Y.-Y. Wu, Y. Chen, G.-Z. Gou, W.-H. Mu, X.-J. Lv, M.-L. Du, W. F. Fu, Org. Lett. 2012, 14, 5226. (b) J. S. Vincent, 
Chem. Phys. Lett. 1971, 8, 37. (c) J. Zhang, F. Chen, Y.-M. He, Q.-H. Fan, Angew. Chem. Int. Ed. 2015, 54, 4622. (d) P. Pyykkö, 
P. Zaleski-Ejgierd, Phys. Chem. Chem. Phys., 2008, 10, 114.  
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Nowadays naphthyridines already find application in diagnostics and therapy of human diseases 
including AIDS,102a antibacterial and antiparasitic agents,104 OLEDs and semiconductor materials105 and 
as ligands in analytical chemistry.106 
  
Figure 5: Anti-HIV agent102a and fluorescent push-pull BF2 complexes103a based on the 1,8 naphthyridine scaffold. 
 
Noteworthy, many publications on naphthyridines describe complicated functionalization procedures 
and there is only little known about the straightforward functionalization of naphthyridines using 
organometallic chemistry, especially metalation. In the following, two important discoveries will be 
described: In 2015, Bracher and co-workers used Knochel’s TMPMgCl·LiCl (3) for their final 
cyclization step to gain access to the alkaloid sampangine and other analogues. Ring-closure was 
achieved through a directed remote ring metalation, followed by intramolecular trapping of the ester 
group (Scheme 24).107  
 
 
Scheme 24: Suzuki cross-coupling of 1-bromo-2,7-naphthyridine, followed by TMPMgCl·LiCl (3) mediated ring closure. 
 
In 2010, Voight et al. from GlaxoSmithKline described an efficient enantioselective total synthesis of 
the potent antibiotic GSK966587. Besides two innovative Heck reactions, also a directed ortho-
metalation using a highly selective zincate base was involved (Scheme 25).108 
 
                                                 
104 (a) A. Tejería , Y. Pérez-Pertejo, R. M. Reguera, R. Balaña-Fouce, C. Alonso, M. Fuertes, M. González , G. Rubiales, F. 
Palacios, Eur. J. Med. Chem. 2016, 124, 740. (b) J. M. Quintela, C. Peinador, L. González, R. Iglesias, A. Paramá, F. Álvarez, 
M. L. Sanmartı́n,  R. Riguera, Eur. J. Med. Chem. 2003, 38, 265. (c)  J. P. Sanchez, J. M. Domagala, S. E. Hagen, C. L. Heifetz, 
M. P. Hutt, J. B. Nichols, A. K. Trehan, J. Med. Chem. 1988, 31, 983. (d) A. K. Parhi, Y. Zhang, K. W. Saionz, P. Pradhan, M. 
Kaul, K. Trivedi, D. S. Pilch, E. J. LaVoie, Bioorg. Med. Chem. Lett. 2013, 23, 4968. 
105 (a) C. H. Chen, J. Shi, Coord. Chem. Rev. 1998, 171, 161. (b) S.-W. Liu, C.-C. Lee, C.-F. Lin, J.-C. Huang, C.-T. Chen , J.-
H. Lee, J. Mater. Chem. 2010, 20, 7800. (c) K.-Y. Wang, C. Chen., J.-F. Liu, Q. Wang, J. Chang, H.-J. Zhu, C. Li, Org. Biomol. 
Chem. 2012, 10, 6693. 
106 X. Li, J. Yang, M. C. Kozlowski, Org. Lett. 2011, 3, 1137.  
107 A. Plodek, M. König, F. Bracher, Eur. J. Org. Chem. 2015, 1302. 
108 E. A. Voight, H. Yin, S. V. Downing, S. A. Calad, H. Matsuhashi, I. Giodano, A. J. Hennessy, R. M. Goodman, J. L. Wood, 
Org. Lett. 2010, 12, 3422 
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Scheme 25: Directed ortho-metalation and iodination as important step in the synthesis of antibacterial drug GSK966587. 
 
These two examples show how important organometallic chemistry is for the functionalization of 
complex heterocycles like naphthyridines. However, very less is known about the direct metalation of 
naphthyridines. Thus, a detailed research in this area is desirable.  
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4. 1,8-NAPHTHALIMIDES 
 
Like Naphthyridines, 1,8-Naphthalimides are heterocyclic compounds. Their systematic name is derived 
from the benzoisoquinoline backbone they have. Hundreds of published articles describe their use in 
various biological and photophysical settings. For instance, the development of new drugs includes 
Hepatitis C and Influenza A inhibitors. 1,8-Naphthalimides are also well acknowledged for their high 
stability in combination with high fluorescence quantum yields and solvatochromic effects (Figure 6).109 
 
 
Figure 6: Examples of 4-amino-substituted 1,8-naphthalimides and their wide areas of application. 
 
Especially 1,8-naphtalimides bearing electron-rich substituents in the peri-position110 display very 
strong fluorescence. Among countless inventions, derivatives with acylamino or alkoxy substituents 
found application as optical brighteners111 in textile industries, whereas 1,8-naphthalimides with a di- or 
tri-phenylamine substituent in the 4-position are investigated as OLED hole transporting materials112 or 
as sensitizers in DSCs.113 Furthermore, by the introduction of various functional groups, 1,8-naphtal-
imides have been extensively utilized as chemosensors for the detection of toxic metal ions.114 
 
                                                 
109 T. Kindahl, E. and E. Chorell, Eur. J. Org. Chem. 2014, 6175. 
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113 X. Huang, Y. Fang, X. Li, Y. Xie, W. Zhu, Dyes Pigment. 2011, 90, 297. 
114 (a) Y. Yu, X. Cheng, H. Zhang, S. Hu, X. Li, A. Zhang, J. Polym. Sci. Pol. Chem. 2013, 51, 4592. (b) M. Shahid, P. Srivastava, 
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5. OBJECTIVES 
 
As previously described, there is only little reported about the organometallic functionalization of 
naphythyridines. Due to the potential applications of such N-heterocycles in medical chemistry and 
material science, it is utmost important to find convenient methods for the modification of such 
molecules. Therefore, we planned to functionalize the 1,5- and 2,7-naphthyridine scaffold by metalation 
and cross-coupling reactions using methods developed in our group. In spite of the probability that 
modifications will occur simultaneously on both rings, we envisioned to regioselectively functionalize 
both naphthyridines gaining access to unsymmetrically substituted rings systems (Scheme 26).115 
 
 
Scheme 26: Regioselective organometallic functionalization off the 1,5- and 2,7 -naphthyridines. 
 
1,8-Naphtalimides with substituents in peri-position are well known fluorescent dyes which find       
broad applications like in OLEDs or WLEDs. Naphthalimides with donor groups in position 4 such as 
4-aminonaphthalene-1,8-dicarboximides and 4-alkoxynaphthalene-1,8-carboximides are of special 
interest since comparably large Stokes shifts and positive solvatochromism of the fluorescence are ob-
served. In another project, we aimed for the preparation of new, highly soluble donor-substituted 1,8-
naphthalimides with aryl groups as conjugating spacers between the donor group and the naphtalimide 
acceptor group. Thus, the fluorescent solvatochromism is expected to increase with the photo-induced 
dipole moment depending on the distance of the separated charges (Figure 7).116 
 
 
 
Figure 7: New push-pull 1,8-naphthalimides with aryl spacer for pronounced solvatochromism. 
 
 
 
 
 
 
                                                 
115 This project was carried out in cooperation with Dr. Romain Blanc, Dorothée Ziegler, Denise Cibu and Moritz Balkenhohl. 
116 This project was carried out in cooperation with Dr. Dominik Zgela, Dr. Thorben Schlücker and Prof. Langhals. 
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1. REGIOSELECTIVE METALATION OF THE 2,7-NAPHTHYRIDINE SCAFFOLD 
 
1.1 Introduction 
 
Nitrogen-containing heterocycles are present in numerous natural products, pharmaceuticals and 
agrochemicals.117 Among them, the naphthyridines have been extensively studied in the last decade. Of      
particular interest for this thesis is the 2,7-naphthyridine scaffold, which was originally synthesized by 
Ikekawa.97 In terms of pharmaceutical drug development, this kind of naphthyridine is still underre-
presented. However, countless alkaloids with a 2,7-naphthyridine structure have been found in natural 
products (Figure 8).93d 
 
Figure 8: Bioactive 2,7-naphthyridine derivatives. 
 
By synthetic efforts some of the known 2,7-naphthyridine alkaloids have already become accessible via 
total synthesis.118 Despite the fact that many methods for the general construction of this scaffold exist,93 
almost nothing is reported about the direct metalation of naphthyridines. In 2009, Yang reported a facile 
synthesis of 1,3,4-trisubstituted isoquinolines by lithiation and subsequent trapping with electrophiles 
(Scheme 27).119 
 
Scheme 27: Synthesis of 4-substituted-1,3-dichloroisoquinolines via lithiation and electrophilic trapping. 
 
 
                                                 
117 T. Eicher, S. Hauptmann, A. Speicher, in The Chemistry of Heterocycles 2nd Ed., Wiley-VCH, Weinheim, 2003. 
118 (a) A. Zhang, C. Ding, C. Cheng, Q. Yao, J. Comb. Chem. 2007, 9, 916. (b) M. Lotter, J. Schilling, E. Reimann, F. Bracher, 
Arch. Pham. Chem. Life. Sci. 2006, 339, 677. (c) F. Bracher, K. Mink, Liebigs Ann. 1995, 645. (d) A. Plodek, S. Raeder, F. 
Bracher; Tetrahedron 2012, 68, 4693; Tetrahedron 2013, 69, 9857. (e) W. Disadee, P. Polypradith, T. Aree, N. Chaichit, S. 
Ruchirawat, Tetrahedron Lett. 2011, 52, 6142. (f) E. Barbu, J. J. Wolff, I. Bolocan, F. Cuiban, Het. Comm. 2000, 6, 25. (g) S. 
Vijayalakshmi, S. P. Raijendran, Oppi Briefs, 1998, 30, 356. 
119 H. Yang, Tetrahedron Lett. 2009, 50, 3081. 
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Regarding Yang’s discoveries, we have chosen the similar 1,3,6,8-tetrachloro-2,7-naphthyridine (7) as 
convenient starting material for our metalation experiments. Compound 7 can be easily obtained by 
Knoevenagel condensation of diethylacetonedicarboxylate with malonitrile, followed by chlorination 
(Scheme 28).120 
 
Scheme 28: Synthetic route to 1,3,6,8-tetrachloro-2,7-naphthyridine (7). 
 
Furthermore, we also decided to examine 2,7-naphthyridin-1(2H)-one (8) upon metalation since this 
structure is widely represented in natural products118,121 and its analogues are investigated as enzyme 
inhibitors.122 Compound 8 can be produced in a multiple step procedure starting by the condensation of 
ethyl acetoacetate and cyanoacetamide. Chlorination and reduction gives rise of 4-methyl-3-cyano-
pyridine. Further treatment with DMF-DMA leads to the corresponding enamine, which can be cyclized 
to the desired naphtyridone 8 under acidic conditions (Scheme 29).118a 
 
 
Scheme 29: Synthetic route to 2,7-naphthyridin-1(2H)-one (8). 
 
 
 
 
 
 
                                                 
120 (a) J. P. Plante, P. D. Jones, D. R. Powell, T. E. Glass, Chem. Comm. 2003, 336. (b) B. M. Ferrier, N. J. Campbell, Chem. 
Soc. 1960, 3513. (c) W. W.  Paudler, S. J. Cornrich, J. Heterocyclic Chem. 1970, 7, 419. 
121 (a) G. Duvey, F. Nivoliers, P. Rocca, A. Godard, F. Marsais, G. Quéguiner, J. Heterocyclic Chem. 2001, 38, 1039. (b) H. 
Gross, D. E. Goeger, P. Hills, S. L. Mooberry, D. L. Ballantine, T. F. Murray, F. A. Valeriote, W. H. Gerwick, J. Nat. Prod. 
2006, 69, 640. 
122 (a) Y. Zhang, B. Illarionov, A. Bacher, M. Fischer, G. I. Georg, Q.-Z. Ye, D. V. Velde, P. E. Fanwick, Y. Song, M. Cushman, 
J. Org. Chem. 2007, 72, 2769. (b) K. Kumpan, A. Nathubhai, C. Zhang, P. J. Wood, M. D. Lloyd, A. S. Thompson, T. 
Haikarainen, L. Lehtiö, M. D. Threadgill, Bioorg. Med. Chem. 2015, 23, 3013. (c) J. Y. L. Chung, R. J. Cvetovich, M. 
McLaughlin, J. Amato , F.-R. Tsay, M. Jensen, S. Weissman, D. Zewge, J. Org. Chem., 2006, 71, 8602. 
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1.2 Metalation of 2,7-Naphthyridines in Position 4 
 
In several preliminary experiments, we noticed that the tetrachloro-2,7-naphthyridine 7 cannot be 
cleanly lithiated with various lithium bases or magnesiated using TMPMgCl·LiCl (3). Therefore, we 
converted 7 by nucleophilic substitution, using alkoxides120a and alkylthiolates, into the corresponding 
derivatives 9a-d (42-82% yield, Scheme 30).  
 
 
Scheme 30: Preparation of alkoxy- and thioalkyl- naphthyridines 9a-d. 
 
The reason for this substitution pattern can be explained by the formation of the most stable intermediate. 
While the aromaticity in intermediate A is retained according to Hückel’s rule, aromaticity is lost in 
intermediate B.78 To give evidence of this hypothesis we recorded a crystal structure of 9c (Figure 9). 
 
 
 
 
Figure 9: Mechanistic aspects of thioalkylation (left) and crystal structure of 9c (right); thermal 
ellipsoids are drawn at 50% probability level. 
 
Except derivative 9d, which bears no alkyl residues, all other naphthyridines 9a-c are greatly soluble    
in all common organic solvents, making them accessible to metalation. Since our naphthyridines have a 
C-Cl bond next to a nitrogen atom, strong bases like nBuLi, which prone to undergo nucleophilic 
substitution as side reaction, were not desirable. However, the sterically hindered bases TMPZnCl·LiCl 
(5) and TMPMgCl·LiCl (3) were not satisfactory for the metalation of 9a-c, whereby a stronger, 
sterically hindered base was required. Thus, we found that TMPLi (2, 1.2 equiv, THF, -40 °C, 0.5 h) 
allows a smooth lithiation of the naphthyridines 9a-c in position 4, leading to the lithiated 2,7-naphthy-
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ridines 10a-c. After iodolysis, the corresponding 4-iodo-2,7-naphthyridines 11a-c were obtained in 67-
90% yield (Scheme 31). 
  
Scheme 31: Lithiation of naphthyridines 9a-c followed by iodolysis. 
 
Furthermore, quenching of lithiated 10b with TMSCl provided the desired trimethylsilyl derivative 11d 
in 69% yield. A crystal structure of 11d clearly gives evidence about the regioselectivity upon the 
metalation of unsymmetrically 9b. It can be clearly recognized that metalation takes place at C4 (Figure 
10). This seems to be logical, since the ring moiety with two chlorine atoms is more electron deficient. 
                                             
Figure 10: DIAMOND view of the molecular structure of compound 11d in the crystal; thermal 
ellipsoids are drawn at 50% probability level. 
 
Since the thiobutyl-substituted naphthyridine 9c has an excellent solubility in organic solvents such as 
THF and gives the best yield upon iodolysis (11c: 90%), we have examined its lithiation and quenching 
with a range of other electrophiles (Table 1). Thus, the bromination of 10c with bromine (1.2 equiv,              
-40 °C, 2 h) and the cyanation using tosyl cyanide (1.2 equiv, - 40 °C, 2 h) provides the 4-bromo-
naphthyridine 12a and the nitrile 12b, respectively in both in 63% yield (Table 1, entries 1-2). Quenching 
of 10c with Me3SiCl (1.5 equiv, -78 °C, 1 h) gives the expected trimethylsilyl derivative 12c in 73% 
yield (entry 3). The addidion of S-phenyl benzenethiosulfonate to 10c (1.2 equiv, -40 °C, 2 h) gave the 
thioether 12d in 80% yield (entry 4). Aminomethylation was achieved using Eschenmoser’s salt123 (1.2 
equiv, -40 °C, 2 h) leading to the dimethylaminomethyl derivative 12e in 81% yield (entry 5). Also, the 
introduction of a carbethoxy substituent was achieved by the transmetalation of lithiated naphthyridine  
 
 
                                                 
123 (a) N. Gommermann, C. Koradin, P. Knochel, Synthesis 2002, 2143. (b) J. Saczewski, M. Gdaniec, Tetrahedron Lett. 2007, 
48, 7624. (c) F. A. Carey, R. J. Sundberg, Advanced Organic Chemistry: Part B Reaction and Synthesis 2007, 140, Springer. 
(d) N. M. Barl, E. Sansiaume-Dagousset, G. Monzón, A. J. Wagner, P. Knochel, Org. Lett. 2014, 16, 2422. (e) V. Werner, M. 
Ellwart, A. J. Wagner, P. Knochel, Org. Lett. 2015, 17, 2016. 
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10c with MgCl2 and subsequent quenching with ethyl chloroformate (1.1 equiv, -30 °C, 6 h) affording 
the 2,7-naphthyridine ethylester 12f in 84% yield (entry 6). Copper(I)-mediated allylation124 with allyl  
 
Table 1: Preparation of C(4)-substituted naphthyridines 12a-j by quenching of 10c with various electrophiles. 
 
Entry Electrophile Product Yield[a] [%] 
1 
2 
3 
4 
5 
6 
Br2 
p-TolCN 
TMSCl 
PhSSO2Ph 
H2CN(CH3)2+ I- 
ClCO2Et 
 
12a: E = Br; 63% 
12b: E = CN; 63% 
12c: E = TMS; 73% 
12d: E = SPh; 80% 
12e: E = CH2NMe2; 81% 
12f: E = CO2Et; 84%[c] 
7  
 
12g: 93%[b] 
8 
 
 
12h: 95%[b] 
9  
 
12i: 84%[d] 
10 
 
 
12j: 72%[c] 
    [a] Isolated yields of analytically pure product. [b] Allylation was performed using 1 M CuCN·2LiCl  
    (20 mol%). [c] A transmetalation with MgCl2 (1.2 equiv) was performed. [d] A transmetalation with  
    1 M ZnCl2 (1.1 equiv) was performed followed by the addition of 1 M CuCN·2LiCl (20 mol%). 
 
                                                 
124 P. Knochel, M. C. P. Yeh, S. C. Berk, J. Talbert, J. Org. Chem. 1988, 53, 2390. 
31 
 
bromide or 3-bromocyclohexene gave the allylated 2,7-naphthyridines 12g-h in 93-95% (entries 7-8). 
Moreover, a copper(I)-catalyzed alkynylation of the corresponding zinc derivative of 10c with ethyl 3-
bromo-propiolate (1.2 equiv, -40 °C, 12 h) provided the functionalized acetylene 12g in 84 % yield 
(entry 9). Finally, sulfinylation of the magnesium derivative of 10c using 4-methoxy-3,5-dimethyl-
benzene-sulfinyl chloride gave the sulfoxide 12j in 72% yield (entry 10). Thus, we have demonstrated 
lithiation of the naphthyridine 9c in 4-position and subsequent trapping with a variety of electrophiles, 
furnishing new naphthyridines 12a-j in good yields. However, further experiments to carry out classic 
Negishi-type cross-couplings with the zinc species of 10c or with the naphthyridines 11c and 12a 
completely failed. Also, we could not achieve metalation of the naphthyridines 12 in position 5 with 
Mg- and Li-bases under various conditions. Solving this problem might give rise of new electron-rich 
and highly soluble 2,7-naphtyridineimides (Scheme 32).125 
 
Scheme 32: Hypothetic pathway to new 2,7-naphthyridineimides. 
 
 
1.3 Metalation of 2,7-Naphthyridone in Position 3  
 
In order to functionalize the 2,7-naphthyridone 8 it is crucial to protect the free amine. Furthermore, the 
introduction of a DMG would give the opportunity of a regioselective metalation. Ziegler et al. found 
that a MEM-protecting group in 2-pyridones can serve as a DMG. Thus, the treatment of 1-((2-methoxy-
ethoxy)methyl)pyridin-2(1H)-one with TMP2Zn·2MgCl2·2LiCl (6) at -10 °C proved to give the best 
results upon metalation. Subsequent trapping with electrophiles led to functionalized 2-pyridones in      
60-90% yield (Scheme 33).  
 
Scheme 33: Metalation of MEM-protected 2-pyridones and subsequent trapping with electrophiles. 
 
Following this reaction protocol, we first protected naphthyridone 8 with 2-methoxyethoxymethyl ether 
(MEM) by a standard method 126 (Scheme 34). 
 
                                                 
125 T. L. Andrew, B. V. Veller, T. M. Swager, Synlett 2010, 22, 3045. 
126 A. B. Smith, Org. Lett. 2005, 7, 315-318. 
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Scheme 34: MEM-protection of naphthyridone 8. 
 
For metalation, TMP2Zn·2MgCl2·2LiCl (6) at -10 °C also proved to give the best results, since we en-
countered solubility problems with TMPMgCl·LiCl (3) at temperatures below -20 °C, what makes the 
application of stronger bases at low temperatures impossible.  
Interestingly, 0.6 equiv of the zinc-base (6) are not enough to completely metalate 13 and upon 
quenching with iodine only 36% of analytically pure product could be obtained.127 This could indicate 
a complexation of 6 by the MEM-protected naphthyridone 13 leading to partial zincation only. To over-
come this problem, we raised the amount of base to 1.2 equiv, leading to full conversion upon iodolysis 
after 72 h reaction time (Scheme 35). 
 
 
Scheme 35: Zincation of naphthyridone 13, followed by iodolysis. 
 
The X-ray structure of compound 15 reveals iodination exclusively in position 3 (Figure 11). Thus, we 
give evidence for the ortho-directing effect of the MEM-protecting group in naphthyridone 13. 
                                                     
Figure 11: Molecular structure of naphthyridone 15 in the crystal, DIAMOND representation; thermal ellipsoids 
 are drawn at 50 % probability level.  
 
Using this method for the regioselective functionalization of naphthyridone 13, we could successfully 
prepare a range of new interesting compounds by palladium-catalyzed arylations. For the most cross-
coupling reactions of 14 with para-substituted iodo-benzenes, Pd(dba)2 and P(o-furyl)3 was used as 
catalyst system. Thus, 4-iodoanisole and 4-iodotoluene reacted smoothly with zincated naphthyridone 
14 giving the desired products 16a-b in both 83% yield (Table 2, entry 1 and 2). Also, 1-chloro-4-
iodobenzene reacted easily with 14, furnishing the corresponding chloro-naphthyridone 16c in 86% 
yield (entry 3). The cross-coupling of 14 with electron-poor 4-iodobenzonitrile provided 16d in 74% 
yield (entry 4). However, using 1-iodo-4-(trifluoromethyl)benzene as electrophile led to a decreased 
                                                 
127 S. H. Wunderlich, P. Knochel, Chem. Commun. 2008, 6387. 
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yield of only 46% of compound 16e (entry 5). For the coupling of 5-bromobenzo[d]-[1,3]dioxole 
PEPPSI-iPr was used as a standard catalyst, giving 16f in 79 % yield (entry 6). In case of the coupling 
of 4-iodoaniline, a special method from Manolikakes128 was used, since the electrophile bears acidic 
protons, which can easily react with the zinc species. Therefore, zincated naphthyridone 14 was added 
very slowly over 1 h via syringe pump to the electrophile, enabling a smooth cross-coupling and 
furnishing the desired amino-naphthyridone 16g in 76% yield (entry 7). 
 
Table 2: Zincation of naphthyridone 13 and subsequent Pd-catalyzed arylations (*MgCl2 and LiCl are omitted 
 for sake of claritiy). 
 
Entry Electrophile Product Yield[a] 
1 
2 
3 
4 
5 
 
4-OMe-iodobenzene 
4-Me-iodobenzene 
4-Cl-iodobenzene 
4-CN-iodobenzene 
4-CF3-iodobenzene 
 
 
16a: X = OMe; 83%[b] 
16b: X = Me; 83%[b] 
16c: X = Cl; 86%[b] 
16d: X = CN; 74%[b] 
16e: X = CF3; 46%[b] 
6 
 
 
 
16f: 79%[c] 
7 
 
 
16g: 76%[d] 
      [a] Isolated yield of analytically pure product. [b] Pd(dba)2 (4 mol%) and P(o-furyl)3 (8 mol%) was  
      used; 12 h reaction time at 25 °C. [c] PEPPSI-iPr (4 mol%) was used; 12 h reaction time at 60 °C.  
      [d] reversed addition of zinc species to electrophile via syringe pump within 1 h; Pd(OAc)2 (4 mol%)  
      and S-Phos (8 mol%) was used; 12 h reaction time at 25°C. 
 
 
Unfortunately, several experiments to react 14 with nitrogen containing heterocycles failed. We then 
further tried to do copper(I)-mediated acylation reactions with 14 using stoichiometric amounts of 
CuCN·2LiCl (Scheme 36). Thus, the reaction of the copper derivative of 14 with thiophene-2-carbonyl 
chloride and benzoyl chloride only gave 17a in 51% and 17b in 30% yield respectively. This 
circumstance is due to many by-products, that form during the reaction decreasing the yield. 
                                                 
128 (a) G. Manolikakes, M. A. Schade, C. Munoz Hernandez, H. Mayr, P. Knochel, Org. Lett. 2008, 10, 2765. (b) G. 
Manolikakes, C. Munoz Hernandez, M. A. Schade, A. Metzger, P. Knochel, J. Org. Chem. 2008, 73, 8422. 
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Scheme 36: Copper(I)-mediated acylation reactions of naphthyridone 14. 
 
The allylation of 14 with allyl bromide nether worked with catalytic amounts nor with stoichiometric 
amounts of CuCN·2LiCl. Also, we could not convert 14 with simple electrophiles like PhSSO2Ph, 
indicating that the zinc species is too unreactive. Therefore, we accessed the more reactive Mg-species 
18 by reacting iodinated naphthyridone 15 with iPrMgCl·LiCl (1). Subsequent trapping with 
electrophiles gave the desired products 19a-c. (Scheme 37). 
 
 
Scheme 37: Zinc-magnesium exchange of 15, followed by quenching with electrophiles. 
 
Thus, quenching 18 with PhSSO2Ph (3.0 equiv) furnished the corresponding naphthyridone-thiophenyl-
ether 19a in 71% yield. Cyanation with 4-methylbenzenesulfonyl cyanide (1.5 equiv) gave 19b in 62% 
yield. Nucleophilic substitution using 1,2-dibromo-1,1,2,2-tetrachloroethane (2.0 equiv) generated the 
bromo-naphthyridone 19c in 58% yield. Finally, we demonstrated that we can remove the MEM-group 
after functionalization. The treatment of protected naphthyridone 16b with 37% HCl in EtOH generated 
the free amine 20 in 95% yield (Scheme 38). 
 
 
Scheme 38: Deprotection of MEM-protected naphthyridone 16b. 
 
In summary, we could generate a range of new functionalized naphthyridones by regioselective, MEM-
directed metalation and subsequent conversion with aryl and acyl electrophiles. Also, we showed how 
to access the more reactive Mg-species of naphthyridone by I/Mg-exchange, which can be quenched 
with simple electrophiles. Finally, we demonstrated a simple method to remove the protecting group 
after functionalization. 
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2. FURTHER FUNCTIONALIZATION OF 2,7-NAPHTHYRIDINES AND SYNTHESIS OF 
NATURAL PRODUCTS LOPHOCLADINE A & B 
 
We further envisioned the manifold functionalization of our new established 2,7-naphthyridines. In a 
vast number of experiments, we encountered many side reactions preventing us from the isolation of 
clean products. However, we could achieve some further modifications, which are presented in the 
following.  
Benzylic groups are widespread scaffolds in biological active compounds and pharmaceuticals. Often 
benzylic chlorides are used as precursors. Therefore, we converted the naphthyridine-amine 12d with 
ClCO2Et producing the corresponding chloromethyl derivative 21 in 82% yield (Scheme 39).129 
 
 
Scheme 39: Conversion of naphthyridine 12e into the chloromethyl-derivative 21. 
 
In order to do cross-couplings selectively in position 3 and 6 (CHAPTER B.4), we targeted to convert the 
two thiobutyl groups of 9c into unreactive alkyl substituents, since thioethers can also undergo cross-
couplings reactions.130 Thus, we found that the thiobutyl groups of 9c can be easily converted into methyl 
groups by using Me2CuLi131 (3.0 equiv, THF, -40 °C, 2 h), furnishing 22 in very good yield (Scheme 
40). 
 
Scheme 40: Functionalization of naphthyridine 9c by Sonogashira coupling and methylation with subsequent allylation. 
 
                                                 
129 (a) F. A. Carey, R. J. Sundberg, Advanced Organic Chemistry: Part B Reaction and Synthesis 2007, 140, Springer. (b) C. R. 
Nevill, P. L. Fuchs, Synth Commun. 1990, 20,761. (c) F. Stiemke, M. Gjikaj, D. E. Kaufmann, J. Organomet. Chem. 2009, 694, 
5. 
130 A.  Metzger, L. Melzig, C. Despotopoulou and P. Knochel, Org. Lett. 2009, 11, 4228. 
131 J. F. Normant, Synthesis 1972, 63. (b) N. Krause, Modern Organocopper Chemistry, Wiley-VCH, Weinheim, 2002. (c) C. 
Piazza, P. Knochel, Angew. Chem, Int. Ed. 2002, 41, 3263. 
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Furthermore, the methyl groups in 22 could then be allylated with allyl bromide using TMPZnCl·LiCl 
(5, 3.0 equiv, 25 °C, 2 h), producing the new 2,7-naphthyridine 23 in 60% yield (Scheme 40).132 
Interestingly, the dithiobutylnaphthyridine 9c undergoes a selective thioalkyl-substitution with 
trimethylsilylacetylene (3.0 equiv) under typical Sonogashira reaction conditions133 leading to the             
1-butyl-thio-8-alkynylnaphthyridine 24 in 48% yield (Scheme 40). 
Besides the metalation of the dimethyl-dichloro-naphthyridine 22, a Pd-catalyzed cross-coupling with 
bis-trimethylsilylmethylmagnesium bromide was achieved, leading to the mono-coupled product 25       
in 58% yield. We found that the bis-trimethylsilylmethyl group can facilitate regioselective bromination 
with NBS, furnishing the bromo-naphthyridine 26 in 98% yield (Scheme 41). 
 
 
Scheme 41: Pd-catalyzed cross-coupling of 22 follwed by regioselective bromination. 
 
To proof the generality of this discovery, we converted 2-bromo-6-methylpyridine (27) with bis-
trimethylsilylmethylmagnesium bromide to the pyridine derivative 28. Similar to the bromination of 25, 
the reaction of 28 with NBS proceeded smoothly, furnishing 2-(bis(trimethylsilyl)methyl)-6-methyl-
pyridine (29) in 72% yield. (Scheme 42).  
 
 
Scheme 42: Pd-catalyzed cross-coupling of 27 followed by regioselective bromination. 
 
In the transition state, the inductive effect of the methyl group as well as of the bistrimethylsilylmethyl 
group stabilizes the positive charge. However, the presence of both groups seems to be essential for the 
bromination. Thus, further bromination experiments with 2-methylpyridine or 2-(bis(trimethylsilyl)-
methyl)pyridine completely failed. 
                                                 
132 (a) S. Duez, A. K. Steib, S. M. Manolikakes, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 7686. (b) S. Duez, A. K. Steib, P. 
Knochel, Org. Lett. 2012, 14, 1951.  
133 (a) K. Sonogashira, J. Organomet. Chem. 2002, 653, 46. (b) R. Chinchilla, C. Najera, Chem. Soc. Rev. 2011, 40, 5084. (c) 
M. Schilz, H. Plenio, J. Org. Chem. 2012, 77, 2798. 
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We also targeted further functionalization of the naphthyridone 8 (Scheme 43). Therefore, we 
chlorinated 8 according to the literature.125 By using lithium butane-1-thiolate we further converted 1-
chloro-2,7-naphthyridine (30) into 1-(butylthio)-2,7-naphthyridine (31).  
 
 
Scheme 43: Further functionalization of 2,7-naphthyridin-1(2H)-one (8). 
 
A Pd-catalyzed cross-coupling of the thioether 31 with 4-cyanopropylzinc iodide provided the alkylated 
naphthyridine 32 in 74% yield. The treatment of compound 31 with NBS directs the bromine in para-
position to the butyl-thio group, furnishing the halogenated naphthyridine 33 in 51% yield.  
In Chapter B 1.2, we demonstrated a new method to introduce an iodide in position 3 of naphthyridone 
8. We then realized that an iodide in position 4 would give us access to the natural products Lophocladine 
A & B. By using a method from the literature for the iodination of pyridin-2(1H)-one,134 we efficiently 
produced 4-iodo-2,7-naphthyridin-1(2H)-one (34) in 79% yield (Scheme 44). A careful Negishi cross-
coupling by the slow addition of phenylzinc chloride via syringe pump to acidic naphthyridone 34 
furnished natural product Lophocladine A (35) in 41% yield. Furthermore, the reaction of 34 with POCl3 
afforded the 1-chloro-4-iodo-2,7-naphthyridine (36) in very good yield. Subsequent Negishi cross-
coupling with PhZnCl gave the phenylated chloro-naphthyridine 37 in 86% yield (Scheme 44).  
 
                                                 
134 Y. Koseki, T. Sugimura, K. Ogawa, R. Suzuki, H. Yamada, N. Suzuki, Y. Masuyama, Y. Y. Lin, T. Usuki, Eur. J. Org. Chem. 
2015, 4024. 
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Scheme 44: Synthesis of natural products Lophocladine A (35) & B (38). 
 
Previous work by Disadee et al. revealed that a direct amination of 37 does not work. Instead they used 
phenylmethaneamine for amination and subsequently cleaved of the benzyl group with concentrated 
sulfuric acid, furnishing Lophpcladine B in 48% yield. We could improve the amination by a method 
from Buchwald,135 employing a Pd-catalyzed reaction of 37 with LiHMDS as ammonia surrogate. Acid 
promoted deprotection witch HCl provided the desired Lophocladine B (38) in quantitative yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
135 X. Huang, S. L. Buchwald, Org. Lett. 2001, 3, 3417. 
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3. REGIOSELECTIVE METALATION OF THE 1,5-NAPHTHYRIDINE SCAFFOLD 
 
3.1 Introduction 
 
Heterocyclic ring structures are ubiquitous in pharmaceutical and agrochemical research, and the 
discovery of new medicinal targets requires the functionalization of always less common hetero-
cycles.136 Naphthyridines certainly belong to the heterocycles of the future137 and their functionalization 
via metalation is still in its infancy.107,108 Especially 1,5-naphthyridines have been identified as suitable 
candidates for antimalarial,138 antibacterial,93c,139 anticancer140 and anti-HIV141 drugs (Figure 12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: 1,5-Naphthyridines as medical drugs. 
 
                                                 
136 (a) E. Vitaku, D. T. Smith, J. T. Njardarson, J. Med. Chem. 2014, 57, 10257. (b) P. Martins, J. Jesus, S. Santos, L. Raposo, 
C. Roma- Rodrigues, P. Baptista, A. Fernandes, Molecules 2015, 20, 16852. (c) A. Gomtsyan, Chem. Heterocycl. Comp. 
2012, 48, 7. (d) S. Sharma, P. K. Sharma, N. Kumar, R. Dudhe, Biomed. Pharmacother. 2011, 65, 244- 251.  
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Also, their applicability as photosensitizers142 and OLED materials105c has been proven (Figure 13). In 
order to give access to a convenient functionalization of the 1,5-naphthyridine scaffold, our target was  
 
 
 
Figure 13: 1,5-Naphthyridines as photosensitizer and OLED materials. 
 
to find was find a method for the regioselective metalation of this N-heterocycle. We also wanted to 
prove if we can enhance the metalation rate or change the regioselectivity by using Lewis acids such as 
BF3·OEt2. 1,5-Naphthyridine (39) could be easily synthesized from 3-aminopyridine via Skraup-                     
reaction (Scheme 45).143 
 
 
Scheme 45: Preparation of 1,5-naphthyridine via Skraup-reaction. 
 
 
3.2 Metalation of the 1,5-Naphthyridine Scaffold in Position 4 
 
In several screening experiments, it was found that the magnesium amide base TMP2Mg·2LiCl (4) is 
most suitable for the metalation of 1,5-naphthyridine (39). Thus, it was found that the precom-
plexation144 of 39 with TMP2Mg·2LiCl (4; 1.1 equiv) at - 78 °C in THF induces a magnesiation within 
5 min, leading to the magnesiated heterocycle 40, which, after quenching with D2O reveals metalation 
at position C(4) in 1H-NMR spectra (Scheme 46). We then examined the quenching of 40 with several 
electrophiles, leading to novel 4-substituted 1,5-naphthyridines 42a-i (Table 3). When the magnesium 
species 40 was treated with iodine and 1,2-dibromotetrachloroethane the 4-halo-1,5-naphthyridines 42a-
b were isolated in 49-62% yield (Table 3, entries 1-2). Transmetalation of 40 with ZnCl2 and subsequent 
acylation with pivaloyl chloride in the presence of 5 mol % Pd(PPh3)4 gave the 4-acyl-1,5-naphthyridine  
42c in 63% yield (entry 3). The reaction of 40 with PhSSO2Ph provided the 4-thiophenyl-1,5- 
naphthyridine in 38 % yield (entry 4). Transmetalation of 40 to the corresponding copper derivative 
                                                 
142 Ger. Pat. 4105386; Chem. Abstr. 1993, 118, 82835. 
143 K. C. Chunavala, S. Adimurthy, Synth. Commun. 2011, 41, 1843. 
144 M. C. Whisler, S. MacNeil, V. Snieckus, P. Beak, Angew. Chem. Int. Ed. 2004, 43, 2206. 
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using CuCN·2LiCl124 and reaction with 3-bromocyclohexene or Villieras’ allylic bromide145 provided 
the allylated 1,5- naphthyridines 42e-f in 53-60% yield (entries 5-6). 
 
           
Scheme 46: Metalation of 1,5-naphthyridine (39) (top) and NMR-studies of 1,5-naphthyridine-4-d (41) (bottom). 
 
Arylation of the magnesium species 40 was performed by transmetalation with ZnCl2 and Negishi cross-
coupling with electron-rich and poor aryl iodides in the presence of 3 mol% Pd(dba)2 and 6 mol% tfp 
leading to the novel 1,5-naphthyridines 42g-j in 40-75% yield (entries 7-10, Figure 14). 
 
Table 3: Metalation and functionalization of 1,5-naphthyridine (39) in the C(4) position using TMP2Mg·2LiCl (4). 
 
Entry Electrophile Product Yield[a]  
1 
2 
3 
4 
I2 
(BrCCl2)2 
tBuCOCl 
PhSSO2Ph  
42a: X = I; 62% 
42b: X = Br; 49% 
42c: X = COtBu; 63%[b] 
42d: X = SPh; 38% 
5 
 
 
42e: 60%[c] 
                                                 
145 J. Villieras, M. Rambaud, Org. Synth. 1988, 66, 220. 
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6 
 
            
42f: 53%[c] 
7 
8 
9 
 
 
42g: X = OMe; 75%[d] 
42h: X = CN; 48%[d] 
42i: X = CO2Et; 40%[d] 
10 
 
 
42j: 41%[d] 
[a] Isolated yields of analytically pure product. [b] Acylation was performed with 5 mol% Pd(PPh3)4 after 
transmetalation with 1 M ZnCl2 (1.2 equiv). [c] Allylation was performed after transmetalation with 1 M 
CuCN·2LiCl (1.2 equiv). [d] The cross-coupling was performed with 3 mol% Pd(dba)2 and 6 mol% tfp  
after transmetalation with 1 M ZnCl2 (1.2 equiv). 
 
 
Figure 14: Molecular structure of 1,5-naphthyridine 42j in the crystal, DIAMOND representation; thermal ellipsoids 
 are drawn at 50 % probability level.  
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Thus, we could easily prepare a range of new 4-functionalized 1,5-naphthyridines. However, the pre-
addition of BF3·OEt2 before the addition of TMP2Mg·2LiCl (4) did not influence the metalation rate or 
lead to a change in regioselectivity, since decomposition of 39 occurs. Simultaneously, a new method 
for the preparation of 1,5-naphthyridines has been developed in our group (Scheme 47 and Figure 15). 
 
 
Scheme 47: Preparation of novel 3-chloro-1,5-naphthyridines 45a-b by intramolecular imine formation. 
 
 
Figure 15: Crystal structure of 45a in DIAMOND representation; thermal ellipsoids are drawn at 50 % probability level.  
 
Therefore, the TBS/TMS-protected alkenyl zinc reagents 43a-b have been cross-coupled with 2-bromo-
5-chloro-3-nitropyridine, providing the alkenylated nitroarenes 44a-b in 63-69% yield. After indium-
mediated reduction and acidic acetal cleavage, the novel 3-chloro-1,5-naphthyridines 45a-b could be 
obtained in 60-62% yield. 
With these new derivatives in our hand, we have been also highly encouraged to metalate 45a-b in           
4-position. It was found that 45a-b can be easily magnesiated at -40 °C within 1 h using TMPMgCl·LiCl 
(3). Subsequent quenching with electrophiles (E-X) led to the new 4-substituted-3-chloro-napht-
hyridines 47a-e (Table 4). Thus, the treatment of magnesiated 46 with iodine or PhSSO2Ph gave the 
corresponding 4-iodo- and 4-phenylthio-1,5-naphthyridine (47a-b) in 82-92% yield (Table 4, entries      
1-2). Negishi cross-coupling of 46 with ethyl 3-iodobenzoate or 4-iodo-1,2-dimethylbenzene furnished 
the desired arylated 1,5-naphthyridines 47c-d in 72-78% yield (entries 3-4). A Cu(I)-mediated acylation 
of 46 with 4-chlorobenzoyl chloride led to the 1,5-naphthyridine-ketone 47e in 86% yield (entry 5). 
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Table 4:  Metalation and functionalization of 3-chloro-1,5-naphthyridines (45a-b) in the C(4) position                                                   
using TMPMgCl·LiCl (3). 
 
Entry Electrophile Product Yield[a]  
1 
2 
I2 
PhSSO2Ph 
 
47a: R = tBu; X = I; 82% 
47b: R = Me; X = SPh; 92% 
3 
 
4  
 
47c: R = Me; X = m-CO2Et; 
72%[b] 
47d: R = tBu; X = p-, m-
CH3; 78%[b] 
5 
 
 
47e: R = tBu; 86%[c] 
 [a] Isolated yields of analytically pure product. [b] The cross-coupling was performed with 3 mol% Pd(dba)2 
 and 6 mol% tfp after transmetalation with 1 M ZnCl2 (1.2 equiv). [c] Acylation was performed using 1 M     
 CuCN·2LiCl (1.1 equiv). 
 
By using a standard procedure, we further demonstrated the removal of the TBS-protecting group in 
47e, affording (3-chloro-1,5-naphthyridin-4-yl)-(4-chlorophenyl)methanone (48) in 82% yield (Scheme 
48). 
 
Scheme 48: Removal of TBS-protecting group in 47e. 
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3.3 Metalation of 1,5-Naphthyridines in Position 8 
 
The presence of a substituent in naphthyridines 42 at position C(4) prevents further complexation of a 
metallic amide at N(5) and thus leads to precomplexation of the base at N(1). This favors a directed 
metalation at C(8). We proved this issue by the reaction of 42a with TMPMgCl·LiCl (3) leading to 
magnesiated 49, which, upon quenching with D2O gave 4-iodo-1,5-naphthyridine-8-d (50). The inco-
operation of deuterium at C(8) can be clearly noticed in 1H-NMR-spectra (Scheme 49). 
 
 
   
Scheme 49: Metalation of 4-iodo-1,5-naphthyridine (42a) (top) and NMR-studies of 4-iodo-1,5-naphthyridine-8-d (50) 
(bottom). 
 
We then investigated the 1,5-naphthyridines 42b-c for the metalation with amide bases. By quenching 
of the corresponding metal species with several electrophiles, we could obtain some novel regio-
selectively defined 4,8-functionalized 1,5-naphthyridines 52a-g (Table 5). Thus, the naphthyridine 42b 
reacted with TMPMgCl·LiCl (3, 1.1 equiv, -40 °C, 1 h) to give the magnesiated species 51a. Quenching 
of 51a with S-phenyl benzenethiosulfonate gave the naphthyridine thioether 52a in 54% yield (Table 5, 
entry 1). Chlorination of 51a with 1,1,2-trichlorotrifluoroethane gave the 4,8-dihalogenated 1,5-naph-
thyridine 52b in 53% yield (entry 2). Reaction of the magnesium species 51a after transmetalation to 
zinc with 1-chloro-4-iodobenzene under standard Negishi cross-coupling conditions resulted in the 
arylated bromo-1,5-naphthyridine 52c in 60% yield (entry 3). Zincation of the naphthyridine 42c with 
TMPZnCl·LiCl (5, 1.5 equiv, 25 °C, 1 h) led to the formation of the heteroaryl zinc species 51b which 
reacted with iodine to give compound 52d in 71% yield (entry 4). Cross-coupling of 51b with 1-iodo-
4-trifluoromethylbenzene and 1-(3-iodophenyl)-2-methylpropan-1-one furnished the 4,8-functionalized 
1,5-naphthyridines 52e-f in 97-98% yield (entries 5-6). After transmetalation of the zinc species 51b 
with CuCN·2LiCl, the reaction with allyl bromide provided the allylated naphthyridine 52g in 80% yield 
(entry 7). 
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Table 5:  Metalation of 4-substituted 1,5-naphthyridines in C(8)-position and quenching with electrophiles. 
 
 
Entry Substrate Electrophile Product, Yield[a] 
 
 
 
 
 
1 
2 
42b 
42b 
PhSSO2Ph 
ClCF2CCl2F 
52a: X = SPh; 54%[b] 
52b: X = Cl; 53%[b] 
3 42b 
 
 
   52c: 60%[b][c] 
4 
 
I2 
 
 42c  52d: 71%[d] 
  
 
 
5 42c X = p-CF3 52e: 98%[c][d] 
6 42c X = COiPr 52f: 97%[c][d] 
7 42c  
 
   52g: 80%[d][e] 
[a] Isolated yields of analytically pure product. [b] TMPMgCl·LiCl (3, 1.1 equiv, -40 °C, 1 h) was used.  
[c] The cross-coupling was performed using 3 mol% Pd(dba)2 and 6 mol% tfp after transmetalation with 
1 M ZnCl2 (1.2 equiv). [d] TMPZnCl·LiCl (5, 1.5 equiv, 25 °C, 1 h) was used. [e] Allylation was performed 
after transmetalation with 1 M CuCN·2LiCl (1.2 equiv). 
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Crystal structures of compounds 52a, 52c, 52e and 52g reveal a functionalization of naphthyridines 42b 
and 42c exclusively at C(8) (Figure 16). 
   
          
Figure 16: Molecular structure of naphthyridines 52a (top left), 52c (top right), 52e (bottom left), 52g (bottom right), in the 
crystal, DIAMOND representation; thermal ellipsoids are drawn at 50 % probability level.  
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3.4 Metalation of 1,5-Napthyridines in Position 2 
 
Alternatively, the naphthyridines 42 can be treated with the Lewis acid BF3·OEt2 which has two con-
sequences: (1) BF3 hampers the metalation at position C(8), since no efficient complexation of the 
magnesium base (3) at N(1) is possible; (2) the BF3-complexation dramatically enhances the acidity at 
C(2). This results in a regioselective magnesiation at C(2) using TMPMgCl·LiCl (3). Once more, we 
proved this by the reaction of 42a with BF3·OEt3 and TMPMgCl·LiCl (3) leading to magnesiated             
53, which, upon quenching with D2O gave 4-iodo-1,5-naphthyridine-2-d (54). The incooperation of 
deuterium at C(2) can be clearly noticed in 1H-NMR-spectra (Scheme 50). 
 
    
Scheme 50: Metalation of 4-iodo-1,5-naphthyridine (42a) (top) and NMR-studies of 4-iodo-1,5-naphthyridine-2-d (54) 
(bottom). 
 
We then investigated the 1,5-naphthyridines 42a and 42g for the Lewis-acid directed metalation with 
TMPMgCl·LiCl (3). By quenching of the corresponding metal species 53 and 55 with electrophiles we 
could obtain some novel regioselectively defined 2,4-functionalized 1,5-naphthyridines 56a-e (Table 6). 
Thus, quenching of 53 with iodine or 1,2-dibromotetrachloroethane furnished the 2,4-bishalogenated 
1,5-naphthyridines 56a-b in 72-74% yield (Table 6, entries 1-2). A copper(I)-mediated acylation of 53 
with benzoyl chloride provided the 4-iodo-2-benzoyl-1,5-naphthyridine 56c in 53% yield (entry 3). 
Using this reaction protocol, we also achieved a copper(I)-mediated acylation of 55 with thiophene-2-
carbonyl chloride affording the desired heteroaryl compound 56d in 70% yield (entry 4). Finally, a 
standard Negishi cross-coupling of 55 with 4-iodotoluene gave the 2,4-bisarylated 1,5-naphthyridine 
56e in 56% yield (entry 5, Figure 17). 
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Table 6:  Metalation of 4-substituted 1,5-naphthyridines in C(2)-position and quenching with electrophiles. 
 
Entry Substrate Electrophile Product, Yield[a] 
 
 
 
 
 
1 
2 
3 
42a 
42a 
42a 
I2 
(BrCCl2)2 
PhCOCl 
56a: X = I; 74% 
56b: X = Br; 72% 
56c: X = PhCO; 53%[b] 
4 
 
 
 
 42g  56d: 70%[b] 
5 42g 
 
 
   56e: 56%[c] 
[a] Isolated yields of analytically pure product. [b] Acylation was performed with 1 M CuCN·2LiCl  
(1.2 equiv). [c] The cross-coupling was performed with 3 mol% Pd(dba)2 and 6 mol% tfp after trans- 
metalation with 1 M ZnCl2 (1.2 equiv). 
 
 
Figure 17. Molecular structure of compound 56c in the crystal, DIAMOND representation; thermal ellipsoids are drawn at 
50 % probability level. 
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4. ALTERNATIVE METAL-CATALYZED CROSS-COUPLINGS OF NAPHTHYRIDINES 
 
4.1 Introduction 
 
N-heterocyclic scaffolds are ubiquitous building blocks for pharmaceuticals, agrochemicals and material 
science. There is a need for new N-heterocyclic structures since such ring systems may display novel 
useful biological or physical properties. The functionalization of naphthyridines was found to be 
especially difficult and no general methods are available.  
In the last chapters, we could already demonstrate the regioselective metalation of 2,7- and 1,5-
naphthyridines by using the sterically hindered TMP-amide bases 2, 3, 5, 6. However, standard Pd-
catalyzed Kumada or Negishi cross-couplings with halogenated nahthyridines turned out to be quite 
challenging. 
In chapter A 2.5 we shortly described methods from us and other groups for the functionalization of       
N-heterocycles like pyridines or quinolines using the alternative metals iron and cobalt. In the following, 
we will describe the functionalization of several halogenated naphthyridines using such methods. 
 
 
4.2 Iron- and Cobalt-Catalyzed C(sp2)-C(sp3) Cross-Couplings   
 
We screened several of our naphthyridines and found that the chloro-naphthyridines 22, 30 and 57 are 
suitable substrates for iron- and cobalt-catalyzed C(sp2)-C(sp3) cross-couplings (Table 7). In preliminary 
experiments, we treated the 3,6-dichloro-1,8-dimethyl-2,7 naphthyridine (22) with various alkyl-
magnesium reagents using 5 mol% Fe(acac)3 according to a procedure from Malhotra.77  
 
Table 7: Iron- and cobalt-catalyzed cross-couplings of chloro-naphthyridines. 
 
 
 
 
Entry Naphthyridine Magnesium Reagent Product, Yield[a] 
 
 
 
 
1 
2 
3 
4 
5 
6 
 
 
 
 
 
22 
22 
22 
22 
22 
22 
EtMgCl 
iPrMgCl·LiCl (2) 
cHexMgBr·LiCl 
cPropMgBr·LiCl 
Ph(CH2)2MgBr·LiCl 
Ph(CH2)2MgBr·LiCl 
 
 
 
58a: X = Et; 69%[b] 
58b: X = iPr; 41%[c] 
58c: X = cHex; 78%[c] 
58d: X = H, cProp; 62%[c] 
58e: X = (CH2)2Ph; 83%[c] 
58f: X = H, (CH2)2Ph; 80%[d] 
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7 
8 
9 
30 
30 
30 
Ph(CH2)2MgBr·LiCl 
MeMgCl 
sBuMgCl 
 
58g: X = (CH2)2Ph; 82%[d] 
58h: X = Me; 98%[d] 
58i: X = sBu; 54%[d] 
 
 
 
 
10 
11 
57 
57 
BuMgCl 
cPropMgBr·LiCl 
 
58j: X = Bu; 69%[d] 
58k: X = cProp; 52%[d] 
[a] Isolated yield of analytically pure product. [b] 5 mol% Fe(acac)3 was used; 2 h reaction time. [c] 5 mol% 
Fe(acac)3 was used; 30 min reaction time. [d] 5 mol% CoCl2 was used; 20 min reaction time. 
 
Thus, the reaction of 22 with EtMgCl (2.4 equiv) in the presence of 5 mol% Fe(acac)3 in THF furnished 
the 3,6-diethyl-2,7-naphthyridine (58a) in 69% yield (Table 7, entry 1). iPrMgCl·LiCl (2.4 equiv) 
reacted smoothly with 22 providing the bis-alklylated naphythyridine 58b in 41% yield (entry 2). 
Treating the dimethylnaphthyridine (22) with cHexMgBr·LiCl (2.4 equiv) gave the corresponding 
naphthyridine 58c in 78% yield (entry 3). The use of cyclopropylmagnesium bromide (2.4 equiv) allows 
to perform a mono-alkylation whereupon the 3-chloro-6-cyclopropyl-2,7-naphthyridine (58d) was 
isolated in 62% yield (entry 4). The reaction of 2-phenylethylmagnesium bromide (2.4 equiv) with 22 
gave the expected bis-alkylated naphthyridine (58e) in 83% yield (entry 5). 
Similarly, reacting 2-phenylethylmagnesium bromide (1.1 equiv) with 22 using 5 mol% CoCl2 provided 
the mono-alkylated naphthyridine (58f) in 80% yield (entry 6). Also, the chloro-naphthyridines 30 and 
57 can be easily alkylated using 5 mol% CoCl2. Thus, also 2-phenylethyl-magnesium bromide (1.1 
equiv) reacted smoothly with 30, providing the 1-alkylated-2,7-naphthyridine (58g) in 82% yield (entry 
7). The treatment of 30 with MeMgCl gave the corresponding 1-methyl-2,7-naphthyridine (58h) in 98% 
yield (entry 8). Furthermore, sterically hindered sBuMgCl reacted with 30 to afford 1-(sbutyl)-2,7-
naphthyridine (58i) in 54% yield (entry 9). The cobalt-catalyzed alkylation of 5-chloro-2-(trifluoro-
methyl)-1,6-naphthyridine (57) with BuMgCl provided the desired 5-butyl-2-(trifluoromethyl)-1,6-
naphthyridine (58j) in 69% yield (entry 10). Additionally, the reaction of the chloro-1,6-naphthyridine 
(57) with cyclopropylmagnesium bromide afforded 5-cyclopropyl-2-(tri-fluoromethyl)-1,6-naph-
thyridine (58k) in 52% yield (entry 6). 
Also, we further functionalized the bis-trimethylsilylmethyl-2,7-naphthyridine (25) via iron-catalyzed 
cross-coupling with nBuMgCl (1.1 equiv) providing the unsymmetrically, bis-alkylated naphthyridine 
59 in 56% yield. Subsequent Peterson-olefination146 of 59 with benzaldehyde (1.2 equiv) in the presence 
of 10 mol% TBAF gave the expected styryl-derivative 60 in 85% yield (Scheme 51). 
 
                                                 
146 L. F. Van Staden, D. Gravestock, D. J. Ager, Chem. Soc. Rev. 2002, 31, 195. 
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Scheme 51: Iron-catalyzed alkylation of 25, followed by Peterson-olefination. 
 
Next, we targeted C(sp2)-C(sp2) couplings of the 3,6-dichloro-1,8-dimethyl-2,7 naphthyridine (22). By 
using a method from our group,84 we treated 22 with PhMgCl (4.0 equiv, THF/t-BuOMe, 25 °C, 15 min) 
in the presence of 5 mol% FeBr3 (Scheme 52). 
 
 
Scheme 52: Iron-catalyzed cross-coupling of 22 with PhMgCl. 
 
However, the 3,6-phenylated-2,7-naphthyridine (61) could be obtained in only 41% yield. Interestingly, 
the addition of isoquinoline as ligand led to strong precipitation, preventing a clean reaction. Also, it 
remains unclear if the 2,7-naphthyridines act as ligands themselves in such reactions. 
 
 
4.3 Cobalt-Catalyzed C(sp2)-C(sp2) Cross-Couplings 
 
For the reaction of the 3,6-dichloro-1,8-dimethyl-2,7 naphthyridine (22) with aryl Grignard reagents, 
we found a difference in reactivity by using CoCl2 instead of FeBr3. Thus, compound 22 can be easily 
bis-arylated using 5 mol% CoCl2, providing the novel naphthyridines 62a-d in good yield (Scheme 53). 
 
 
Scheme 53: Cobalt-catalyzed bis-arylation of naphthyridine 22 with various arylmagnesium reagents. 
 
The reaction of 22 with 4-(trimethylsilyl)phenylmagnesium bromide provided at -40 °C within 4 h        
the bis(trimethylsilyl)phenylnaphthyridine (62a) in 62% yield. Similarly, 4-N,N-dimethylamino-
phenylmagnesium bromide and 4-methoxyphenylmagnesium bromide underwent such smooth cobalt-
catalyzed cross-couplings (-40 °C, 4-12 h) with the dichloronaphthyridine 22 leading to the desired 3,6-
substituted naphthyridines (62b-c) in 60-73% yield. However, the sterically hindered mesitylmagnesium 
bromide reacted with the 3,6-dichloro-naphthyridine 22 only at 25 °C within 4 h, furnishing the desired 
53 
 
2,6-mesityl-1,8-naphthyridine (62d) in 93% yield. By the treatment of compound 62a with iodine 
monochloride, we could obtain the corresponding bis-iodophenyl-2,7-naphthyridine 63 in quantitative 
yield, which is not accessible by cobalt-catalyzed cross-coupling of 22 with 4-iodophenylmagnesium 
chloride147 (Scheme 54). 
 
 
Scheme 54: Conversion of 62a into bis-iodophenyl-2,7-naphthyridine 63. 
 
During the course of our investigations, we noticed that C(sp2)-C(sp2) cross-couplings of naphthyridines 
30 and 57 with PhMgCl using 5 mol% CoCl2 led to diminished yields (< 30%). This problem could be 
solved by replacing the arylmagnesium reagents with the corresponding zinc reagents and using 
HCO2Na as ligand.92 Thus, 1-chloro-2,7-naphthyridine (30) reacted smoothly with PhMgCl or [1,1'-
biphenyl]-4-ylzinc chloride within 12 h at 25 °C, furnishing the corresponding arylated naphthyridines 
63a-b in 80-82% yield (Table 8, entry 1-2).  
 
Table 8: Cobalt-catalyzed arylations of arylzinc reagents with chloro-naphthyridines 30 and 57. 
 
 
 
 
 
 
Entry Naphthyridine Zinc Reagent Product, Yield[a] 
 
 
 
 
1 
2 
3 
4 
5 
 
 
 
 
 
 
30 
30 
30 
30 
30 
X = H 
X = p-Ph 
X = p-CF3 
X = p-OTBS 
X = p-CN, m-F 
 
 
 
63a: 80% 
63b: 82%[b] 
63c: 69% 
63d: 72%[b] 
63e: 74% 
 
                                                 
147 F. Kopp, I. Sapountzis, P. Knochel, Synlett 2003, 6, 885. 
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6 
 
 
30  
 
 
 
 
 
 
 
 
63f: 79% 
 
7 
 
 
30  
 
   63g: 60% 
8 
 
 
 
 57  63h: 74% 
 
 
 
 
 
 
9 57 X = p-OBn 63i: 83% 
 10 57 X = p-OTIPS 63j: 61% 
[a] Isolated yield of analytically pure product. [b] Reaction was performed by D. Ziegler 
 
Furthermore, a range of arylzinc reagents bearing various functional groups underwent such cobalt-
catalyzed Negishi cross-couplings with chloro-naphthyridine 30, providing the expected products 63c-f 
in 69-79% yield (entries 3-6). Heteroaryl-heteroaryl cross-couplings are utmost challenging due to 
catalyst deactivation when Pd or Ni is used.148 However, in the presence of THF-soluble CoCl2·2LiCl (5 
mol%) and sodium formate (50 mol%), the cross-coupling of 1-chloronaphthyridine (30) with thiophen-
2-ylzinc chloride afforded the thiophenyl-naphthyridine 63g in 60% yield (entry 7). We further 
demonstrate, that 5-chloro-2-(trifluoromethyl)-1,6-naphthyridine (57) can also be easily arylated under 
these conditions. Thus, the cobalt-catalyzed reaction of 57 with 4-methoxy-3,5-dimethylphenylzinc 
chloride and 4-(benzyloxy)phenylzinc chloride provided the new 1,6-naph-thyridines 63h-i in 74-83% 
yield (entries 8-9). Interestingly, the cobalt-catalyzed arylation of 57 with 2-((triisopropylsilyl)oxy)-
phenylzinc chloride only succeeded at elevated temperature (60 °C, 12 h) to give the desired protected 
naphthyridine alcohol 63j in 61% yield (entry 10).  
                                                 
148 (a) C. Kaes, A. Katz, M. W. Hosseini, Chem. Rev. 2000, 100, 3533. (b) S. Bedel, G. Ulrich, C. Picard, P. Tisnès, Synthesis 2002, 
1564. (c) Comprehensive Coordination Chemistry II, Vol 1; J. A. McCleverty, T. J. Meyer, Eds.; Elsevier, Oxford, 2004, 1. (d) M. A. 
Düfert, K. L. Billingsley, S. L. Buchwald, J. Am. Chem. Soc. 2013, 135, 12877.  
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Since we observed that iodo-substituted naphthyridines prone to undergo I/Mg-exchange with aryl 
Grignards, we also employed our mild cobalt-catalyzed Negishi cross-coupling method for the reaction 
of iodonaphthyridines with arylzinc reagents (Table 9). 
 
Table 9: Cobalt-catalyzed arylations of arylzinc reagents with iodo-naphthyridines 42a, 52d, 56a and 65. 
 
 
 
 
 
 
 
Entry Naphthyridine Zinc Reagent Product, Yield[a] 
 
 
 
 
1 
2 
3 
 
 
 
 
 
 
 
 
42a 
42a 
42a 
 
X = m-SMe 
X = p-OMe 
X = p-CN 
 
 
 
64a: 80% 
64b: 78% 
64c: 83% 
 
 
4 
 
 
 
42a 
 
 
 
 
 
 
 
 
64d: 73% 
 
 
 
5 
 
 
 
42a 
 
 
   64e: 47% 
6 
 
 
 
 52d  64f: 86% 
56 
 
7 
  
 
 56a  64g: 75% 
8 
 
 
 
 65  64h: 48%[b] 
9 
 
 
 
 
 
 65  64i: 65%
[b] 
 
[a] Isolated yield of analytically pure product. [b] 3.0 equiv of the zinc reagent was necessary for a 
complete conversion. 
 
Thus, the coupling of 3-(methylthio)phenylzinc chloride and 4-methoxyphenyl)zinc chloride with           
4-iodo-1,5-naphthyridine (42a) afforded the naphthyridines 64a-b in 78-80% yield (Table 9, entries        
1-2). Similarly, the reaction of the electron-deficient arylzinc reagent p-NCC6H4ZnCl with iodo-
naphthyridine 42a led to the desired product 64c in 83% yield (entry 3). Furthermore, (1-methyl-1H-
indol-5-yl)zinc chloride reacted smoothly with 42a to afford the naphthyridine-indol derivative 64d in 
73% yield (entry 4).  
Remarkably, also the sterically demanding (4-methoxynaphthalen-1-yl)zinc chloride could be converted 
with 4-iodo-1,5-naphthyridine (42a) to give the new 1,5-naphthyridine 64e in 47% yield (entry 5). This 
mild method also allows the coupling of sensitive iodo-naphthyridines. Thus, the coupling of the aryl 
zinc reagent p-Me2NC6H4ZnCl with 4-iodo-8-keto-naphthyridine (52d) provided the corresponding 4,8-
functionalized 1,5-naphthyridine 64f in 86% yield (entry 6). Similar to the bis-arylation of dichloro-
naphthyridine 22 (Scheme 53), we also examined the cobalt-catalyzed reaction of 2,4-diiodo-1,5-
naphthyridine (56a) with p-MeOC6H4ZnCl and could afford the corresponding bis-anisyl-naphthy-
ridine (64g) in 75% yield (entry 7). Finally, we could do a cobalt-catalyzed cross-coupling of the 
sterically hindered 8-iodo-7-phenyl-1,6-naphthyridine (65)149 with p-MeOC6H4ZnCl and p-Me2N-
C6H4ZnCl to give the 7,8-bisarylated-1,6-naphthyridines 64h-i in 48-65% yield (entry 8-9, Figure 18).       
 
 
                                                 
149 Q. Huang , J. A. Hunter, R. C. Larock, Org. Lett. 2001, 3, 2973. 
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Figure 17: Molecular structure of naphthyridine 64h in the crystal, DIAMOND representation; thermal ellipsoids 
are drawn at 50 % probability level.  
 
Additionally, we have examined benzylic cross-couplings of our naphthyridine substrates using CoCl2 
and found that 4-iodo-1,5-naphthyridine (42a) reacts smoothly with benzylic zinc reagents. Thus, the 
coupling of 42a with 3-(ethoxycarbonyl)benzylzinc chloride or 3-fluorobenzylzinc chloride  provided 
the benzylic naphthyridines 66a in 62% yield and 66b in 75% yield, respectively (Scheme 54).  
 
 
Scheme 54: Cobalt-catalyzed cross-coupling of 4-iodo-1,5-naphthyridine (42a) with benzylic zinc reagents. 
 
In terms of differentially halogenated naphthyridines, we found that 1-chloro-4-iodo-2,7-naphthyridine 
(67) can be regioselectively functionalized by successive cross-coupling using Pd- and Co-catalysis 
(Scheme 55).  
 
Scheme 55: Regioselective Pd- and Co-catalyzed cross-coupling of 1-chloro-4-iodo-2,7-naphthyridine 67. 
 
Thus, a standard Pd-catalyzed Negishi cross-coupling of 67 with PhZnCl selectively furnished the 1-
chloro-4-phenyl-2,7-naphthyridine (68) in 82% yield. Subsequent Co-catalyzed Negishi cross-coupling 
with (3,4,5-trimethoxyphenyl)zinc chloride gave the desired bis-arylated naphthyridine 69 in 91% yield. 
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4.4 Fluorescent Naphthyridines 
 
Naphthyridine derivatives have previously been applied as fluorescent probes105c,125,150 or as ligands for 
fluorescent complexes.103a,105a,151 The newly prepared naphthyridines 62b and 64i are highly fluorescent 
in various organic solvents and display strong solvatochromism (Figure 19). 
 
 
Figure 19: (a,b) PL spectra of compounds 62b and 64i, respectively, dissolved in heptane (blue), Et2O (purple), CHCl3 (red), 
and THF (orange). The excitation wavelengths are 360 and 390 nm, respectively. Insets, photographs of the solutions under 
UV illumination. (c,d) Time-correlated single-photon counting (TCSPC) traces of 62b and 64i in CHCl3, measured at the peaks 
of the PL spectra (hollow symbols). Solid lines represent a mono-exponential fit. 
 
While the absolute photoluminescence quantum efficiencies (PLQEs) of 62b in various solvents are 
about 20%, the PLQE of 64i is almost quantitative in non-polar solvents (toluene: 95±5%, cyclohexane: 
93±5%) and drops only slightly in more polar solvents (CHCl3: 81±5%, 1,4-dioxane: 80±5%, THF: 
71±5%). These high emission efficiencies are accompanied by very long excited lifetimes of 3.8 ns and 
12.0 ns for 62b and 64i, respectively (Figure 19). Compounds 62b and 64i also reveal considerable 
Stokes shifts, particularly in polar solvents like THF (Figure 20). 
 
                                                 
150 (a) Y.-Y. Sun, J.-H. Liao, J.-M. Fang, P.-T. Chou, C.-H. Shen, C.-W. Hsu, L.-C. Chen, Org. Lett. 2006, 8, 3713. (b) L. Xiao,  
X. Xing, Z. Chen, B. Qu, H. Lan, Q. Gong, J. Kido, Adv. Funct. Mater. 2013, 23, 1323.      
151 (a) J.-H. Liao, C.-T. Chen, H.-C. Chou, C.-C. Cheng, P.-T. Chou, J.-M. Fang, Z. Slanina, T. J. Chow, Org. Lett. 2002, 4, 
3107. (b) H.-J. Li, W.-F. Fu, L. Li, X. Gan, W.-H. Mu, W.-Q. Chen, X.-M. Duan, H.-B. Song, Org. Lett. 2010, 12, 2924. (c) 
Krämer, C.; Leingang, S.; Hübner, O.; Kaifer, E.; Wadepohl, H.; Himmel, H.-J. Dalton Trans. 2016, 45, 16966.  
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Figure 20: Normalized UV-Vis and PL spectra of 62b and 64i in heptane (grey) and THF (black) 
with corresponding Stokes shifts. 
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5. FLUORESCENT ARYL NAPHTHALENE DICARBOXIMIDES WITH LARGE STOKES 
SHIFTS AND STRONG SOLVATOCHROMISM CONTROLLED BY DYNAMICS AND 
MOLECULAR GEOMETRY 
 
5.1 Introduction 
 
Rigid aromatic systems are preferred as basic structures for the development of highly fluorescent 
materials.152 Small Stokes shifts are generally observed for such fluorophores because the electronic 
excitation does not induce significant geometric alterations and the conditions are similar in the 
electronic transitions both for absorption and fluorescence, respectively. Fluorophores with rotational 
freedom mostly reveal large Stokes shifts, but intramolecular dynamic processes usually prevent high 
fluorescence quantum yields. However, by specifically designing new fluorescent structures with 
limited freedom of intramolecular motions, highly fluorescent molecules with large Stokes shifts can    
be created. 
In this context Langhals and co-workers investigated C-C coupled perylene dichromophores and 
oligothiophenes regarding conformational changes upon excitation with light153 (Figure 21). For the S0 
ground state, they estimated that steric effects will force the perylene dichromophores to be nearly 
orthogonal, whereas the oligothiophenes are slightly twisted with dihedral angels between 3°-9°. Light 
absorption leads to a fast, vertical electronic transition to the S1 state, preserving the initial geometry.  
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Schematic process causing increased Stokes shifts in linked 
perylenedicarboximides (top left) and adamantyl substituted oligothiophenes 
(top right): i) Vertical transition by light absorption (hν) from the electronic 
ground state S0 to reach the electronically excited state S1. ii) Relaxation to 
a geometrically more favourable, energetically lower excited state S1’. iii) 
Bathochromically shifted fluorescence (-hν’) from S1’ to S0’. iv) Relaxation 
to the energetically more favoured initial state from S0’ to S0. Schematic  
energy diagram (bottom right) of electronic transitions and relaxation  
processes; overlaying vibronic processes are omitted for sake of clearness. 
 
                                                 
152 (a) H. Zollinger, Color Chemistry. Syntheses, Properties and Applications of Organic Dyes and Pigments, 2nd ed.; Wein-
heim, 1991; ISBN 3-527-28352-8. (b) O. S. Wolfbeis, Fluorescence Spectroscopy, Methods and Applications; Springer Verlag: 
Berlin, 1993; ISBN 978-3-642-77372-3. 
153 (a) H. Langhals, A. Hofer, J. Org. Chem. 2012, 77, 9585. (b) T. Schlücker, V. Dhayalan, H. Langhals, C. Sämann, P. Knochel, 
Asian J. Org. Chem. 2015, 4, 763. 
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The subsequent relaxation to the S1’ state is fast enough to not affect the electronic excitation, but leads 
to a more planar conformation as a result of stronger conjugation between the single units (assigned by 
DFT calculations). Bathochromically shifted fluorescence proceeds as a vertical electronic transition to 
the electronic ground state S0′ where a further relaxation closes the circle to the initial state S0. 
A relatively new fluorescence phenomenon, namely Twisted Intramolecluar Charge Transfer (TICT),154 
is observed in molecules that consist of a donor D and an acceptor A linked by a single bond. In polar 
environments, such fluorophores undergo fast intramolecular electron transfer from the donor to the 
acceptor part of the molecule. This electron transfer is accompanied by intramolecular D–A twisting 
around the single bond and produces a relaxed perpendicular structure (Figure 22). This is a result of a 
one electron-excitation from the HOMO to the LUMO. The resulting singlet diradical having one 
unpaired electron in the HOMO and one electron in the LUMO stabilizes itself by rotation around the 
single bond (minimization of Coulomb interaction). The geometric relaxation results in large Stokes 
shifts of the TICT fluorescence. Since TICT represents a state with strong polarization, the most 
characteristic feature of TICT fluorescence is the solvatochromism, i. e., the fluorescence wavelength is 
sensitive to the polarity of the environment. 
The equilibration between a relaxed perpendicular conformer and a coplanar conformer often results in 
dual fluorescence, i.e., from a high energy band through relaxation of the locally excited (LE) state and 
from a lower energy band due to emission from the TICT state (Figure 22). For the design of novel 
functional materials, the relaxation pathways can be modulated by substituents, local polarity and steric 
restrictions. 
 
Figure 22: Twisted Intramolecular Charge Transfer (TICT): Upon excitation from the ground state (GS), the locally excited 
state (LE) equilibrates rapidly with the TICT state after fast charge transfer. Fluorescence from LE is strong with small Stokes 
shift whereas fluorescence from TICT is weak due to non-radiative relaxations, but accompanied with enhanced Stokes shift. 
 
 
                                                 
154 S. Sasaki, G. P. C. Drummen, G.-i. Konishi, J. Mater. Chem. C 2016, 4, 2731. 
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Relatively unexplored molecules with D-A moieties are naphthalimides with donor groups in position 
4 such as 4-aminonaphthalene-1,8-dicarboximides155 and 4-alkoxynaphthalenecarboximides.156 Here, a 
photo-induced shift of electron density from the donor to the carboximide is responsible for inducing a 
large dipole moment. Lowering of the energy of the excited state by solvation with polar solvents causes 
a bathochromic shift of the fluorescence. This process corresponds to the positive solvatochromism of 
4-amino-N-methylphthalimide applied for Zelinski’s solvent polarity S scale.157 An even more pro-
nounced solvatochromism of naphthalimides should be obtained through the introduction of extended 
electrone rich aryl moieties. 
Based on the aforementioned mechanistic aspects, we targeted the synthesis and investigation of new 
extended naphthalimides with aryldonor groups in position 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
155 (a) I. G. Farbenindustrie AG, Brit. Patent GB 402309 (Mar 24, 1933); Chem. Abstr. 1934, 28, 27267. (b) Gevaert Photo-
Producten N. V. (inv. W. K. Koerber, F. L. Schouteden) Ger. Patent DE 1108560 (June 6, 1957); Chem. Abstr. 1962, 56, 
32447. (c) B. M. Krasovitskii, D. G. Pereyaslova, E. G. Yushko, G. V. Tatsii, Monokrist., Stsintill. Org. Lyuminafory 1967, 1, 
92; Chem. Abstr. 1968, 69, 60030. 
156 (a) W. Bradley, F. W. Pexton, J. Chem. Soc. 1954, 4432. (b) I. Grabtchev, Tz. Philipova, Dyes Pigments, 1995, 27, 321. (c) 
A. Pardo, J. M. L. Poyato, E. Martin, J. J. Camacho, D. Reyman, M. F. Brana, J. M. Castellano, Photochem. Photobiol. A: 
Chemistry 1989, 46, 323. (d) V. Wintgens, P. Valat, J. Kossanyi, A. Demeter, L. Biczok, T. Berces, New J. Chem. 1996, 20, 
1149. (e) X. Qian, Y. Zhang, K. Chen, Z. Tao, Y. Shen, Dyes Pigments 1996, 32, 229. (f) G. J.-F. Demets, E. R. Triboni, E. B. 
Alvarez, G. M. Arantes, P. B. Filho, M. J. Politi, Spectrochim. Acta Mol. Biomol. Spectrosc. 2006, 63, 220. 
157 (a) I. A. Zhmyreva, V. V. Zelinskii, V. P. Kolobkov, N. D. Krasnitskaya, Dokl. Akad. Nauk SSSR 1959, 129, 1089; Chem. 
Abstr. 1961, 55, 141336. (b) K. Schwetlick, Kinetic methods for studying reaction mechanisms, p. 165, VEB Deut. Verlag 
Wiss., Berlin 1971; Chem. Abstr. 1972, 77, 79990. (c) C. Reichardt, T. Welton, Solvents and Solvent Effects in Organic 
Chemistry; 4th ed.; Wiley-VCH: Weinheim 2011; ISBN 3-527-26805-7. 
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5.2 Preparation of Aryl Naphthalene Dicarboximides and Discussion of Optical 
Measurements 
 
The fluorescent solvatochromism is expected to increase with the photo-induced dipole moment 
depending on the distance of the separated charges. Therefore, we inserted aryl groups as conjugating 
spacers between the donor groups and the naphthalimide acceptor moiety to achieve such a prolongation. 
To obtain highly soluble dyes, we started with a condensation of readily available 4-bromonaphthalic 
anhydride 71 with tridecan-7-amine giving the highly soluble key intermediate 72 in 90% yield. 
(Scheme 56). The Suzuki cross-coupling reaction of 72 with various aryl dioxaborolanes gave the 
corresponding arylated derivatives 73a-d and 73g-j, in 25-94% yield, respectively. 
 
 
Scheme 56: Synthesis of highly soluble arylated naphthalene carboximides. (*4-(Trimethylsilyl)phenylboronic acid 
 and 4-cyanophenylboronic acid were used for the preparation). 
 
Substitution with the sterically hindered 2,6-dimethyl phenyl boronate failed where synthesis could be 
alternatively realized by stepwise peripheral introduction of the sterically demanding methyl groups. 
Thus, the easily accessible trimethoxy derivative 73d was brominated with N-bromosuccinimide to give 
73e in 69% yield and then further treated with methylzinc chloride under typical Negishi cross-coupling 
conditions to provide 73f in 74 % yield (Scheme 57). Since also the borylation of more complex aryl 
halides proved to be difficult, we converted the trimethylsilyl derivative 73i, using iodine monochloride, 
into the corresponding aryl iodide 73k in order to extend the conjugated system. A typical Negishi cross-
coupling of 73k with p-anisylzinc chloride (prepared from the reaction of 4-iodoanisole with                        
iPrMgCl·LiCl, followed by ZnCl2) gave the methoxy biphenyl derivative 73l in 89% yield. Further, the 
cyanation of 73k with K4Fe(CN)6 led to the corresponding arylnaphthyl cyanide 73j in an improved 
yield (Scheme 57). 
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Scheme 57: Bromination of 73d and subsequent cross-coupling with MeZnCl giving 73f (top);  
cyanation and Negishi cross-coupling of 73k leading to 73j and 73l respectively (bottom). 
 
Fluorescence measurements reveal that the new dyes 73 are strongly solvatochromic in fluorescence 
(Figure 23), whereas compounds 73 are only moderately solvatochromic in absorbance. This indicates 
an optical excitation-induced increase of the dipole moment and was subject of further investigations. 
The molar energies of fluorescence light of various carboximides were calculated by means of equation 
(1) where λmax is the fluorescence maximum of the individual dye in the tested solvent (ET values are in 
kcal·mol-1 for comparison with previously reported values in the literature to avoid confusion; these may 
be multiplied by 4.2 to obtain SI units). The solvatochromism of the carboximides was analysed 
according to various theoretical approaches. Those of Kawski,158 Abboud159 or Catalán160 fitted our 
experimental results well (see supporting information161). 
 
ET = 28591/λmax     (1) 
 
ET = a·ET(30) + b     (2) 
 
 
 
 
                                                 
158 A. Kawski, P. Bojarski and B. Kukliński, Chem. Phys. Lett. 2008, 463, 410. 
159 J.-L. M. Abboud, R. W. Taft, J. Kamlet, J. Chem. Soc., Perkin Trans. 2 1985, 815. 
160 J. Catalán, J. Phys. Chem. B, 2009, 113, 5951. 
161 R. Greiner, T. Schlücker, D. Zgela, H. Langhals, J. Mater. Chem. C 2016, 4, 11244. 
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73a    73b    73c 
 
 
 
 
 
 
73d     73g     73h 
 
 
 
 
 
 
73i    73j    73l 
 
 
 
  
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: (A) Fluorescence spectra in various solvents: n-hexane (red), n-tetradecane (blue), toluene (grey), chloroform 
(black), 1-undecanol (turquoise), 1-butanol (green), DMF (yellow). (B) Aryl naphthalene carboximides in CHCl3 solutions 
under UV-light (366 nm).  
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Furthermore, we investigated the fluorescent solvatochromism in more detail using the concepts of 
Brooker’s χR scale162 and Dimroth & Reichardt’s ET(30) polarity scale163 which delivered the best  
results. The first represents mainly the polarisability of the solvent whereas the second indicates mostly 
for the effect of dynamic solvation. The spectroscopic data of dyes 73 were compared to reported data 
to evaluate the solvent sensitivity of the fluorescence. The highly solvatochromic 4-amino-N-methyl-
phthalimide (74) as the basis of Zelinski’s universal solvent polarity S scale served as reference as well 
as the simple donor substituted 4-amino-N-methylnaphthalimide (75) (Figure 24). The ET values of 74 
were calculated from literature data for various solvents. A linear free energy relation (LFER)164 of these 
ET values with the ET(30) polarity scale according to equation (2) gave appreciably better results 
(correlation number r = 0.95 for n = 14 solvents) than with Brooker’s χR scale (r = 0.90 for n = 14 
solvents). 
 
Figure 24: 4-Amino-N-methylphthalimide (74) and 4-methoxy-N-methylnaphthalimide (75) 
as reference for fluorescence data comparison. 
 
Similar results were obtained for the solvatochromism of the fluorescence of 73a-j (Table 10). As a 
consequence, we conclude that the solvent effects by polar dynamic orientation of the solvent molecules 
dominate for the reported carboximides and agreed with the ET(30) scale as most appropriate com-
parison. We investigated the solvents tetradecane, hexane, toluene, chloroform, N,N-dimethyl form-
amide (DMF), 1-undecanol and 1-butanol for an overview of solvent effects where the two protic 
solvents were applied for studying the influence of hydrogen bonds. Linear correlations of the ET values 
with the ET(30) values were obtained. Larger deviations to higher ET were observed for hydrogen bond-
donating solvents such as 1-butanol and 1-undecanol indicating the specific influence of such 
interactions; the solvent viscosity seems to have a minor influence (compare hexane with tetradecane 
and 1-butanol with 1-decanol) and large Stokes shifts are even observed in a solid glassy matrix of 
PMMA. As a consequence, the further discussion was concentrated on the non-hydrogen bond-donating 
solvents for better comparability between the dyes 73-75. A slope α of -0.60 is found for 4-amino-N-
methylphthalimide (dye 74, Table 10) and characterizes the sensitivity of this highly solvatochromic 
fluorescent dye to polar solvent effects. In comparison, this interaction is appreciably lower for the 
methoxynaphthalimide 75 (α = -0.27) and indicates a smaller alteration of the molecular dipole moment 
with optical excitation. 
 
 
 
                                                 
162 L. G. S. Brooker, A. C. Craig, D. W. Heseltine, P. W. Jenkins, L. L. Lincoln, J. Am. Chem. Soc. 1965, 87, 2443. 
163 (a) K. Dimroth, C. Reichardt, T. Siepmann, F. Bohlmann, Liebigs Ann. Chem. 1963, 661, 1. (b) C. Reichardt, Angew. Chem., 
Int. Ed. 1965, 4, 29. (c) C. Reichardt, R. Müller, Liebigs Ann. Chem. 1976, 1937. (d) C. Reichardt, Pure Appl. Chem. 2008, 80, 
1415. (e) V. G. Machado, R. I. Stock, C. Reichardt, Chem. Rev. 2014, 114, 10429. (f) J. P. Cerón-Carrasco, D. Jacquemin, C. 
Laurence, A. Planchat, C. Reichardt, K. Sraïdi, J. Phys. Org. Chem. 2014, 27, 512. 
164 N. B. Chapman, J. Shorter (Eds.), Correlation Analysis in Chemistry - Recent Advances, Plenum Press: New York, 
London, 1978; ISBN 0-306-31068-6. 
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Table 10: Solvatochromism of the fluorescence of the carboximides 73, 74 and 75. 
Dye Φ[a] τ[b] α[c] r[d] 
74   -0.60 -0.95 
75   -0.27 -0.89 
73a 0.78 3.21 -0.34 -0.99 
73b 0.83 4.11 -0.74 -0.99 
73c 0.64 6.99 -1.49 -0.96 
73d 0.65 6.62 -1.43 -0.98 
73f < 0.05    
73g 0.39 4.07 -1.36 -0.98 
73h 0.40 4.14 -1.37 -0.99 
73i 0.79 3.08 -0.34 -0.99 
73j 0.54 1.34 -0.80 -0.99 
73l 0.67 2.93 -1.33 -0.98 
Applied solvents: tetradecane, hexane, toluene, chloroform, dimethylformamide (DMF);  
[a] fluorescence quantum yieldΦ in chloroform. [b] fluorescence lifetime τ in ns in chloroform;  
[c] slope α of the linear regression. [d] coefficient r of correlation for applications of equation (2) 
 
 
An extension of the conjugated system of the naphthalimide with a phenyl group in 73a increases the 
slope slightly to α = - 0.34. Further introduction of a donor group into the p-position of the phenyl 
substituent to obtain 73b establishes a D-A system between the methoxy- and the carbonyl groups and 
enhances the sensitivity (α = -0.74) to exceed the solvatochromism of 74 by far. The dimethylamino 
group of derivative 73c causes an even higher sensitivity towards solvents, however, the fluorescence 
quantum yield strongly decreases in polar solvents. Multiple donor groups as in 73d also display a 
remarkably high solvatochromism with comparably high fluorescence quantum yields; even though 
weak fluorescence was still observed in polar DMF. A substitution with larger aryl groups like the 4-
methoxynaphthyl moiety leads to 73g which displays a very distinct solvatochromism (α = -1.36) while 
still exhibiting high fluorescence quantum yields in polar solvents. Further extension of the conjugated 
framework to the methoxybiphenyl derivative 73l also induces such a pronounced fluorescent 
solvatochromism (α = -1.33) exceeding that of the anisyl-substituted species 73b. Finally, the effect of 
the donor acceptor motif in 73b, was further tested with 73j where the electron donating methoxy group 
was exchanged by an electron withdrawing cyano moiety. There is still a comparably high sensitivity to 
solvent polarity, but as expected, the effect of the donor-substituted derivatives was not reached (Table 
10). The electronic properties of the 4-methoxynaphthyl derivative 73g are comparable to those of 
compound 73b. However, the slope parameter α is found to be nearly twice as much. This observation 
made us focusing more intensely on the geometrical arrangement of the chromophores and prompted us 
to investigate the influence of steric hindrance on mesomerism. In comparison, the optical properties of 
73g and its methylated analogue 73h are only slightly different from each other (Figure 25). This 
indicates a similar intramolecular geometry. 
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Figure 25: Comparison of absorption- (left) and fluorescence-spectra (right) 73g (black) and 73h (red). 
 
A skew arrangement of the aromatic systems seems to be mainly influenced by peri-hydrogen atoms of 
the naphthalene subunits. These findings were further confirmed by quantumchemical DFT-calculations 
(B3LYP 6-311**G) as shown in Table 11 and Figure 26. Hence, the steric influence of the methyl group 
in 73h is only subordinated (dihedral angle 75.38°) and does not affect the geometry significantly 
(71.60° for 73g). Comparison of the 3,4,5-trimethoxyphenyl naphthalimides 73d (57.34°) and 73f               
(87.42°) exhibits much more pronounced effects. The steric repulsion of the methyl groups in 73f 
arranges the two aromatic systems statically fixed. The nearly orthogonal geometry results in low fluo-
rescence quantum yield of less than 0.05. 
 
Table 11: Optimized structures and calculated dipole moments of 73 (DFT B3LYP 6-311**G). 
Dye ϑ[a] ϑex[b] dipole[c] dipoleE1[d] 
73a 57.80 39.64 5.52 7.75 
73b 55.61 35.86 6.40 9.82 
73c 51.35 31.43 9.20 14.86 
73d 57.34 35.67 6.77 9.22 
73f 87.42 89.36 6.08 7.22 
73g 71.60 43.34 6.47 12.21 
73h 75.38 44.94 6.03 12.20 
73i 57.31 36.39 6.01 8.53 
73j 57.95 36.57 0.47 1.66 
73l 56.66 32.24 6.94 11.26 
 39.56[e] 31.92[e]   
74   5.20 8.92 
75   6.29 7.96 
Applied solvents: tetradecane, hexane, toluene, chloroform, dimethylformamide (DMF). 
[a] Calculated dihedral angle ϑ in ground state. [b] Calculated dihedral angle ϑ in the first 
electronically excited. [c] Dipole moment in electronic ground state in Debye. [d] Dipole  
moment in the first electronically excited state in Debye. [e] dihedral angle between phenyl 
moieties. 
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Figure 26: Quantumchemical calculations. From bottom to top: lowest energy structures (ground state,  
B3LYP 6-311**G), HOMO (middle) and LUMO (top) orbitals. Left to right: 75, 73b, 73f, 73g. 
 
A twisted geometry between the donor and the acceptor promotes charge transfer causing strong 
solvatochromism in fluorescence and large Stokes shifts. Moderate angles below 80° preserve high 
fluorescence quantum yields. A complete orthogonalisation (73f) quenches fluorescence where an ob-
viously essential residual orbital overlap is lacking. We further confirmed this concept by heating a 
solution of 73f in diethylene glycol diethyl ether to 200 °C where the very weak fluorescence reversibly 
becomes intensified by a factor of 2 (Figure 27).165 
 
 
Figure 27: Temperature dependent fluorescent spectra of 73f in diethylene glycol diethyl ether. 
Room temperature (blue), approx. 100 °C (yellow), approx. 200 °C (red). 
 
This is attributed to thermally induced vibronic perturbation of the nearly orthogonal arrangement 
enabling fluorescence. The proposed geometrical requirements for a distinct charge transfer are related 
to the TICT theory. However, our results imply that orthogonal arrangements between donor and 
acceptor completely quench the fluorescence. Significant fluorescence is attributed to skew con-
formations which tend to more planar arrangements in the excited state allowing significant orbital 
overlap. Thus, the optical properties, particularly the fluorescent solvatochromism is not the result of a 
twist-induced charge transfer. It is rather the result of an interplay of conformational change and 
                                                 
165 C. Cao, X. Liu, Q. Qiao, M. Zhao, W. Yin, D. Mao, H. Zhang, Z. Xu, Chem. Commun. 2014, 50, 15811. 
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electronic charge transfer depending on the dipole moment. By tuning the molecular geometry, we could 
obtain a series of chromophores with adjustable fluorescence and quantum yields up to more than 80%. 
Since fluorescent nanoparticles166 are obtaining increased interest for basic research and applications, 
we also targeted the grafting of 73g on silica HDK T40. Therfore, 4-bromonaphthalic anhydride 71 was 
condensed with allyl amine to obtain 76 in 92% yield,167 which was subsequently reacted in a Suzuki 
cross-coupling with 2-(4-methoxynaphthalen-1-yl)-4,4,5,5-tetra-methyl-1,3,2-dioxaborolane to give 77 
(Scheme 58). By using the Karstedt catalyst, 77 was hydrosilylated with triethoxysilane, providing the 
triethoxysilyl derivative 78 in 67% yield. 
 
 
Scheme 58: Preparation of triethoxysilyl derivative 78 for grafting on HDK T40. 
 
Finally, by reacting 78 with HDK T40 (anhydrous) for 16 h in CHCl3, highly fluorescent covalently 
grafted silica was obtained, from which the coloration could not be removed by washing with any 
common solvent (Figure 28). 
 
 
clear supernatant 
            grafted nanoparticles 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: UV/Vis absorption (left) and fluorescence (right) spectra of dye 73g in CHCl3 solution (solid black lines) and of 
78 grafted on silica as a suspension in CHCl3 (dashed black lines). Inset fotograph: Grafted nanoparticles in EtOH. 
 
                                                 
166 (a) H. Langhals, A. J. Esterbauer, Chem. Eur. J. 2009, 15, 4793. (b) H. Langhals, A. J. Esterbauer, S. Kinzel, New J. Chem. 
2009, 33, 1829. 
167 A. Schulz, J. Wotschadlo, T. Heinze, G. J. Mohr, J. Mater. Chem. 2010, 20, 1475. 
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6. SUMMARY 
 
6.1 Regioselective Organometallic Functionalization of 1,5- and 2,7-
Naphthyridines 
 
6.1.1 Regioselective Metalation of Naphthyridines 
 
Whereas many publications report about the regioselective metalation of pyridines, only less is known 
about the metalation of naphthyridines. In this work, 2,7- and 1,5-naphthyridines have been regio-
selectively metalated using various TMP-bases.  
Due to diminished solubility of readily available 1,3,6,8-tetrachloro-2,7-naphthyridine (7) in organic 
solvents, we converted 7 into the highly soluble thioalkyl-naphtyridine derivative 9c. The use of TMPLi, 
followed by trapping with electrophiles allowed the functionalization of 9c in position 4. Thus, a range 
of polyfunctional 1,3,4,6,8-substituted-2,7-naphthyridines 12 could be prepared (Scheme 59).  
 
 
Scheme 59: Preparation of 1,3,4,6,8-functionalized 2,7-naphthyridines 12. 
 
Many alkaloids have a naphthyridone scaffold and thus it is desirable to develop a method for the 
functionalization of such structures. It was found that a MEM-protecting group in pyridones can act        
as a DMG. Therefore, MEM-protected 2,7-naphthyridin-1(2H)-one (13) was metalated using 
TMP2Zn·2MgCl2·2LiCl (6). Subsequent iodination, Pd-catalyzed cross-coupling or copper-mediated 
acylation gave rise of several in 3-position functionalized 2,7-naphthyridones 15, 16a-g and 17a-b 
(Scheme 60). Where the zinc species 14 lacks in reactivity for the reaction with certain electrophiles, 
the corresponding magnesium species 18 (which is not accessible by direct magnesiation of 8) could be 
generated by a facile I/Mg-exchange with iPrMgCl·LiCl (1). Quenching of 18 with the desired 
electrophiles gave the corresponding 2,7-naphthyridones 19a-c (Scheme 61). 
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Scheme 60: DoM of MEM-protected 2,7-naphthyridone (13) and subsequent functionalization. 
 
 
 
Scheme 61: Preparation of magnesiated 2,7-naphthyridone (18) and subsequent quenching with electrophiles. 
 
A new general method was developed for the regioselective metalation of 1,5-naphthyridine (39). By 
using TMP2Mg·2LiCl (4) the 1,5-naphthyridine scaffold can be selectively metalated within 5 min at     
-78 °C. Subsequent treatment with electrophiles provided a range of novel 4-substituted 1,5-naphthy-
ridines 42a-i (Scheme 62). 
 
Scheme 62: Preparation of 4-substituted 1,5-naphthyridines 42a-i by metalation with TMP2Mg·2LiCl (4). 
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Also the new 3-chloro-8-TBS/TMS-1,5-naphtyhridines 45a-b can be selectively metalated in position 4 
using TMPMgCl·LiCl (3) and be further treated with electrophiles. For instance, a copper(I)-mediated 
acylation of magnesiated 45a furnished the expected product 47e in 86% yield. After cleavage of the 
TBS-group by treatment of 47e with TBAF, the desired 3-chloro-4-keto-1,5-naphthyridine 48 was 
obtained in 82% yield. 
 
 
Scheme 63: Preparation of 3,4-substituted 1,5-naphthyridine 48. 
 
Regarding further metalation on 4-susbtituted 1,5-naphthyridines 42, we found that regioselectivity can 
be switched by the prescence or absence of the Lewis acid BF3·OEt2. The substituent E1 in 42 at position 
C(4) prevents further complexation of a metallic amide at N(5) and thus favors precomplexation of the 
TMP base at N(1), providing metalation at C(8). The pre-addition of BF3·OEt2 also leads to a com-
plexation at N(1), which in turn increases the acidity of the proton at C(2), resulting in a magnesiation 
in this position. The quenching of 51 or 53 with electrophiles furnished a range of new 4,8- and 2,4-
functionalized 1,5-naphthyridines 52a-g and 56a-e respectively (Scheme 64).  
 
 
Scheme 64: Regioselective metalation of 42 in the prescence/absence of BF3·OEt2. 
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6.1.2 Iron- and Cobalt-Catalyzed Cross-Coupling of Naphthyridines 
 
In preliminary experiments, we found that chloro-naphthyridines easily undergo C(sp3)-C(sp2) cross-
couplings using 5 mol% Fe(acac)3 or CoCl2 (Scheme 65). 
 
 
Scheme 65: Iron- and cobalt-catalyzed C(sp3)-C(sp2) cross-couplings. 
 
As we encountered low yields carrying out iron-catalyzed C(sp2)-C(sp2) cross-couplings with halo-
genated naphthyridines, we found that the 3,6-dichloro-2,7-naphthyridine (22) smoothly reacts with 
arylmagnesium reagents using 5 mol% CoCl2 (Scheme 66). 
 
 
Scheme 66: Cobalt-catalyzed bis-arylation of dichloronaphthyridine 22. 
 
However, the cross-coupling of other chloronaphthyridines (30 and 57) with arylmagnesium reagents 
using CoCl2 also led to diminished yields. This problem was solved by replacing the arylmagnesium 
reagents with the corresponding zinc reagents and using HCO2Na as ligand. This method even enabled 
us to do cobalt-catalyzed C(sp2)-C(sp2) cross-couplings with iodo-naphthyridines (Scheme 67). We 
further found that 4-iodo-1,5-naphthyridine 42a smoothly reacts with benzylic zinc reagents in 
prescence of 5 mol% CoCl2 without using any additives. Finally, we envisioned regiosoelctive cross-
coupling depending on the nature of the halogen and found that 1-chloro-4-iodo-2,7-naphthyridine (67) 
can be differntially bisarylated by utilizing successive Pd- and Co-catalysis leading to the 1,4-substituted 
2,7-naphthyridine 69. Beyond synthetic efforts, we noticed that the functionalized naphthyridines 62b 
and 64i are highly fluorescent in various organic solvents and display strong solvatochromism. 
Compound 64i reaches quantum efficiencies up to 95% and a long excited state lifetime of up to 12 ns. 
These interesting molecules should be investigated in the future to find out wether the TICT or PICT 
mechanism dominates intramolecular dynamics under excitation with light. 
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Scheme 67: Mild cobalt-catalyzed Negishi-type cross-couplings of halogenated naphthyridines with arylzinc reagents. 
 
 
6.2 Preparation of New Fluorescent Aryl Naphthalene Dicarboximides with Large 
Stokes Shifts and Strong Solvatochromism 
 
In summary, we have reported new, readily soluble and highly fluorescent derivatives of naphthalene-
1,8-dicarboximides that have been obtained by Pd-catalyzed arylation in position 4. These compounds 
display a pronounced solvatochromic fluorescence. The sensitivity of the substituted naphthalimides 
towards solvent polarity was evaluated according to several theoretical approaches. A photo-induced 
charge transfer from the electron rich aryl moiety to the naphthalimide is enhanced in polar solvents and 
causes a bathochromic shift of the fluorescence. Furthermore, the electronic effects are accompanied by 
molecular dynamics. The intramolecular arrangement influences the intensity of the charge transfer. A 
skew geometry between donor and acceptor allows planarization in the first electronically excited state. 
This allows high fluorescent quantum yields and still favors a pronounced charge transfer resulting in 
both, distinct solvatochromism and large Stokes shifts. In contrast to basic TICT-theory, no orthogo-
nalization occurs and rectangular orientation leads to strongly quenched fluorescence. The presented 
synergy of electronic and geometric effects results in highly fluorescent compounds such as 73b and 
73g with easily adjustable emission spectra controlled by medium effects. This provides very large 
Stokes shifts exceeding 200 nm (approx. 1.6 eV) being of interest for various applications such as for 
frequency converters, fluorescence optical fibers and highly tunable light sources. For purposes like 
bioimaging we further demonstrated the synthesis of triethoxysilyl derivative 78, an analogue to 73g, 
which can be easily grafted on silica nanoparticles like HDK T40. 
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C. EXPERIMENTAL SECTION 
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1. GENERAL CONSIDERATIONS 
 
If not otherwise stated, all reactions have been carried out using standard Schlenk-techniques in flame-
dried glassware under nitrogen or argon. Prior to use, syringes and needles have been purged with the 
respective inert gas. 
 
 
1.1 Solvents 
 
Solvents were dried according to standard procedures by distillation over drying agents and stored under 
argon. 
 
CH2Cl2 was predried over CaCl2 and distilled from CaH2. 
CHCl3 was predried over CaCl2 and distilled from CaH2. 
tBuOMe was predried over CaCl2 and distilled from CaH2.  
CH3CN was heated to reflux for 14 h over CaH2 and distilled from CaH2.  
DMF was heated to reflux for 14 h over CaH2 and distilled from CaH2.  
NMP was heated to reflux for 14 h over CaH2 and distilled from CaH2.  
THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen 
and stored over 4 Å molecular sieve under an argon atmosphere. 
Toluene was predried over CaCl2, distilled from CaH2 and stored over 4 Å molecular sieve under an 
argon atmosphere. 
NEt3 was dried over KOH and distilled. 
MeOH, EtOH and BuOH were purchased in p. A. quality and used without further purification. 
 
Solvents for reaction workup and for column chromatography were distilled on a rotary evaporator prior 
to use. 
 
 
1.2 Reagents 
 
All reagents were obtained from commercial sources and used without further purification unless 
otherwise stated. Liquid reagents were distilled prior to use.  
 
TMPH was distilled under argon prior to use. 
iPrMgCl·LiCl solution in THF was purchased from Rockwood Lithium. 
nBuLi solution in hexane was purchased from Rockwood Lithium. 
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Preparation of CuCN·2LiCl solution:124 
CuCN·2LiCl solution (1.0 M in THF) was prepared by drying CuCN (7.17 g, 80 mmol) and LiCl (6.77 g, 
160 mmol) in a Schlenk-tube under high vacuum at 140 °C for 5 h. After cooling to rt, dry THF (80 mL) 
was added and stirring was continued until all salts were dissolved. 
 
Preparation of ZnCl2 solution: 
ZnCl2 solution (1.0 M in THF) was prepared by drying ZnCl2 (13.63 g, 100 mmol) in a Schlenk-flask 
under high vacuum at 140 °C for 5 h. After cooling ro rt, dry THF (100 mL) was added and stirring was 
continued until all salts were dissolved. 
 
Preparation of MgCl2 solution: 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirrer and a septum was charged with 
Mg turnings (2.55 g, 105 mmol) and THF (200 mL). 1,2-Dichloroethane (9.90 g, 100 mmol, 7.92 mL) 
was added dropwise over 1 h. The reaction mixture was stirred at rt until the gas evolution vanished. 
 
Preparation of TMPLi (2):47 
TMPLi solution was prepared by slow addition of nBuLi (2.17 mL, 5.0 mmol, 2.3 M in hexane) to a 
solution of TMPH (706 mg, 0.85 mL, 5.0 mmol) in THF (5 mL) at -40 °C. The mixture was stirred for 
30 min at -40 °C before being titrated. 
 
Preparation of TMPMgCl·LiCl (3):54 
In a dry and argon-flushed Schlenk-flask TMPH (2,2,6,6-tetramethylpiperidine, 14.8 g, 105 mmol) was 
added to iPrMgCl·LiCl (1; 71.4 mL, 1.40 M in THF, 100 mmol) at rt and the mixture was stirred for        
3 days at this temperature before being titrated.  
 
Preparation of TMP2MgCl·LiCl (4):56 
In a dry, argon-flushed Schlenk-flask, 2,2,6,6-tetramethylpiperidine (TMPH, 5.07 mL, 30 mmol) was 
dissolved in dry THF (30 mL). This solution was cooled to –40 °C and nBuLi (2.4 M in hexane, 12.5 
mL, 30 mmol) was added dropwise. After the addition was complete, the reaction mixture was warmed 
to 0 °C and stirred at this temperature for 30 min. Freshly titrated TMPMgCl·LiCl (1.45 M in THF, 20.7 
mL, 30 mmol) was then added dropwise to the TMPLi solution. The reaction mixture was stirred at          
0 °C for 30 min, warmed to 25 °C and stirred for 1 h. The solvents were then removed in vacuo without 
heating, affording a yellowish solid. Freshly distilled THF was then slowly added under vigorous          
stirring, until a complete dissolution of the salts was observed.  
 
Preparation of TMPZnCl·LiCl (5):57  
A dry and argon flushed 250 mL Schlenk-flask, equipped with a magnetic stirrer and a septum, was 
charged with freshly distilled TMPH (10.22 mL, 60 mmol) dissolved in dry THF (60 mL). This solution 
was cooled to –40 °C and nBuLi (2.4 M in hexane, 25 mL, 60 mmol) was added dropwise. After the 
addition was complete, the reaction mixture was allowed to warm up slowly to –10 °C for 1 h.  
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ZnCl2 (1.0 M in THF, 66 mL, 66 mmol) was added dropwise and the resulting solution was stirred for 
30 min at –10 °C and then for 30 min at rt. The solvents were then removed under vacuum affording a 
yellowish solid. Freshly distilled THF was then slowly added under vigorous stirring until the salts were 
completely dissolved. 
 
Preparation of TMP2Zn·2MgCl2·2LiCl (6):58 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with a solution of TMPMgCl·LiCl (3; 1.16 M in THF, 30 mL, 34.8 mmol). Then, a solution of dry ZnCl2 
(1.0 M in THF, 18.44 mL, 18.4 mmol, 0.53 equiv) was added dropwise and the mixture was stirred for 
12 h at rt before being titrated. 
 
 
1.3 Content Determination of Organometallic Reagents 
 
Organozinc and organomagnesium reagents were titrated with I2 in THF.168 
nBuLi was titrated with dry 2-propanol and 1,10-phenanthroline as indicator in THF.169 
TMPLi was titrated using N-benzylbenzamide as titrating agent and indicator in THF.170 
TMPMgCl·LiCl (3), TMP2Mg·2LiCl (4), TMPZnCl·LiCl (5) and TMP2Zn·2MgCl2·2LiCl (6) were 
titrated with benzoic acid and 4-(phenylazo)diphenylamine as indicator in THF. 
 
 
1.4 Chromatography 
 
Flash column chromatography was performed using silica gel 60 (0.040-0.063 mm) from MERCK. 
Thin layer chromatography was performed using aluminium plates coated with SiO2 (Merck 60,                        
F-254). The spots were visualized by UV-light or staining of the TLC plate with the solution below 
followed by heating if necessary: 
 
- Iodine absorbed on silica gel. 
- KMnO4 (3.0 g), 5 drops of conc. H2SO4 in water (300 mL). 
- Phosphomolybdic acid (5.0 g), Ce(SO4)2 (2.0 g) and conc. H2SO4 (12 mL) in water (230 mL). 
- Ninhydrin (0.3 g) and AcOH (3.0 mL) in butanol (100 mL). 
 
 
 
 
                                                 
168 A. Krasovskiy, P. Knochel, Synthesis 2006, 890. 
169 H.-S. Lin, A Paquette, Synth. Commun. 1994, 24, 2503. 
170 A. F. Burchat, J. M. Chong, N. Nielsen, J. Organomet. Chem.1997, 542, 281. 
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1.5 Analytical Data 
 
NMR spectra were recorded on Varian Mercury 200, Bruker AC 300, WH 400 or AMX 600 
instruments. Chemical shifts are reported as δ-values in ppm relative to the solvent peak, i.e. chloroform-
d (δ = 7.26 ppm for 1H-NMR and δ = 77.0 ppm for 13C-NMR), DMSO-d6 (δ = 2.50 ppm for 1H-NMR 
and δ = 39.5 ppm for 13C-NMR). For the characterization of the observed signal multiplicities the 
following abbreviations were used: s (singlet), d (doublet), t (triplet), m (multiplet), q (quartet), quint 
(quintet), sxt (sextet), sept (septet) as well as br (broad). 
 
Mass spectroscopy: High resolution (HRMS) and low resolution (MS) spectra were recorded on a 
FINNIGAN MAT 95Q instrument. Electron impact ionization (EI) was conducted with an ionization 
energy of 70 eV. For coupled gas chromatography/mass spectrometry (GC/MS), a HEWLETT-
PACKARD HP 6890/MSD 5973 GC/MS system was used. 
 
Infrared spectra were recorded from 4000-400 cm-1 on a Perkin 281 IR spectrometer. Samples were 
measured neat (ATR, Smiths Detection Dura Sample IR II Diamond ATR). The 10-20 most dominant 
absorption bands are reported (in wave numbers cm-1). 
 
Melting points were measured on a Büchi B540 apparatus and are uncorrected. 
 
UV/VIS-spectra were recorded on a Varian Cary 5000. 
 
Photoluminescence spectra were recorded on a Varian Cary Eclipse. 
 
Time-correlated single photon counting (TCSPC): The samples are excited by a 375 nm picosecond 
pulsed laser (PicoQuant, LDH-375), and emitted photoluminescence is collected and detected by a 
highly sensitive photo-multiplier tube (PMT, PicoQuant PMA 192), which allows detection of single 
photons through internal amplification. The time difference between triggering the laser and registering 
the photon on the PMT is measured by an internal clock (PicoQuant TimeHarp 260 P) and then collected 
in a histogram (bin width 25 ps) which yields the TCSPC data points shown in the main text. 
 
Photo Luminescence Quantum Efficiency (PLQE) measurements were performed with an Edinburgh 
Instruments FLS980 fluorescence spectrometer equipped with a 120 mm BenFlect-coated integrating 
sphere. Measurements were performed with 10 µM solutions of compound 62b (5 µM in the case of 
cyclohexane due to low solubility) and 40 µM solutions of 64i in dry and Ar-saturated solvents (OD ~ 
0.15).  
Absolute quantum efficiencies were determined from two measurements per sample. These are (1) the 
sphere loaded with a cuvette containing only the respective solvent and (2) the sphere loaded with the 
cuvette containing the solution of the sample. Assuming isotropic emission, the PLQE is calculated from 
the attenuation of the excitation light and the corresponding PL emission. 
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2. ORGANOMETALLIC FUNCTIONALIZATION OF THE 2,7-NAPHTHYRIDINE SCAFFOLD 
 
2.1 Typical Procedures 
 
Typical Procedure for the Metalation of 2,7-Naphthyridines 9 with TMPLi (TP 1): 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirring bar and a rubber septum, was 
charged with the corresponding 2,7-naphthyridine (1.0 equiv) in dry THF. After cooling to the indicated 
temperature, a solution of TMPLi (2, 1 M in THF, 1.2 equiv) was slowly added. The reaction mixture 
was stirred for 30 min at the same temperature. Then, the corresponding electrophile (1.2 equiv) was 
added and the solution was stirred at -40 °C until complete conversion of the starting material (detected 
by GC-analysis of reaction aliquots). 
 
Typical Procedure for the Zincation of 2,7-Naphthyridone 13 using TMP2Zn·2MgCl2·2LiCl 
(TP2): 
In a dry and argon flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 
naphthyridone 13 (1.0 equiv) was dissolved in dry THF (3 mL). After the solution was cooled down to 
−10 °C, TMP2Zn·2MgCl2·2LiCl (6, 1.2 equiv) was added and the mixture was stirred at the same 
temperature. The completion of the metalation was achieved after 72 h, stated by GC-analysis of reaction 
aliquots quenched with a solution of I2 in dry THF. 
 
Typical Procedure for the Magnesiation of 2,7-Naphthyridone 15 via Iodine-Magnesium 
Exchange (TP3): 
In a dry and argon flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 3-iodo-
2,7-naphthyridone 15 (1.0 equiv) was dissolved in dry THF. At 0 °C a solution of iPrMgCl·LiCl (1) in 
dry THF (1.0 equiv) was added dropwise and the mixture was stirred at the same temperature. The 
completion of the exchange reaction was checked by TLC-analysis of reaction aliquots quenched with 
sat. aq. NH4Cl solution. 
 
 
2.2 Preparation of Starting Materials 
2.2.1 Preparation of 2,7-Naphthyridines 9a-d 
 
1,3,6,8-Tetrahydroxy-2,7-naphthyridine120 
 
A round bottom flask, equipped with a magnetic stirring bar, was charged with diethyl-1,3-
acetonedicarboxylate (36 mL, 200 mmol, 1.0 equiv) and diethylamine (10 mol%, 20 mmol, 2.0 mL) in 
ethanol (350 mL). Malonitrile (10 g, 153 mmol, 1.2 equiv) was added in portions and the resulting dark 
yellow solution was stirred at rt overnight. Then, the solvent was removed under reduced pressure. The 
remaining oil was treated with sulfuric acid (70%, 300 mL) whereupon complete dissolution occurred. 
Then, the solution was heated until light ebullition occurred. After cooling to rt, the reaction mixture 
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was poured into water (350 mL) giving a yellow precipitate, which was filtered, washed with water and 
finally dried to afford the pure product (32.9 g, 85 %) as a yellow powder. 
 
m.p.: 248–250 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 3162, 2827, 2679, 1631, 1589, 1557, 1486, 1408, 1370, 1152. 
MS (DEI+, 70 eV): m/z (%) = 194 (100), 177 (15), 149 (10), 123 (7), 95 (6), 44 (5), 18 (13). 
HRMS (DEI+) calcd. for [C8H6N2O4]: 194.0328; found: 194.0334. 
 
1,3,6,8-Tetrachloro-2,7-naphthyridine120a 
 
A pressure tube, equipped with a magnetic stirring bar, was charged with 1,3,6,8-tetrahydroxy-2,7-
naphthyridine (1.0 g, 5.2 mmol), followed by POCl3 (10 mL). The reaction was heated at 180 °C for      
24 h. Then, the reaction was poured on ice (150 g) and was made alkaline with potassium carbonate. 
The mixture was extracted extensively several times with EtOAc. The combined organic layers were 
dried over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (isohexane/EtOAc = 9:1) to afford the desired product (730 mg, 53%) as a yellow solid. 
 
m.p.: 157 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1583, 1505, 1343, 1258, 1122, 1102, 977, 965, 889, 816. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.57 (s, 2 H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 150.7, 148.4, 147.1, 118.8, 118.0. 
MS (EI, 70 eV): m/z (%) = 272 (26), 270 (37), 268 (100), 266 (81), 233 (26), 231 (46), 219 (34), 197 
(22), 111 (31), 97 (43), 95 (34), 83 (42), 81 (30), 71 (28), 69 (30), 61 (21), 57 (46), 56 (20), 55 (31), 42 
(47), 40 (20). 
HRMS (EI) calcd. for [C8H2Cl4N2]: 265.8972; found: 265.8960. 
 
3,6-Dichloro-1,8-dimethoxy-2,7-naphthyridine (9a)120a 
 
A round flask, equipped with a magnetic stirring bar, was charged with 1,3,6,8-tetrachloro-2,7-
naphthyridine (267 mg, 1 mmol, 1.0 equiv) in methanol (13 mL). Then, potassium carbonate (267 mg, 
2 mmol, 2 equiv) was added at rt. The solution was stirred for 2 h at the same temperature. The solvent 
was evaporated under reduced pressure and the crude residue was purified by flash column chromato-
graphy (isohexane/EtOAc = 9:1) to afford the pure product (206 mg, 80%) as a white solid. 
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m.p.: 155-157 °C. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.03 (s, 2H), 4.13 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 161.8, 148.9, 148.3, 111.1, 102.7, 55.3. 
MS (EI, 70 eV): m/z (%) = 271 (41), 560 (40), 258 (54), 229 (57), 163 (44), 57 (100), 44 (27), 41 (29). 
HRMS (EI) calcd. for [C10H8Cl2N2O2]: 257.9953; found 257.9972. 
 
1-Butoxy-3,6,8-trichloro-2,7-naphthyridine (9c) 
 
A round flask, equipped with a magnetic stirring bar, was charged with 1,3,6,8-tetrachloro-2,7-
naphthyridine (364 mg, 1.36 mmol, 1.0 equiv) in butanol (15 mL). Then, potassium carbonate (377 mg, 
2.72 mmol, 2.0 equiv) was added at 25 °C. The solution was warmed to 40 °C and stirred for 24 h at the 
same temperature. The solvent was evaporated under reduced pressure and the crude residue was 
purified by flash column chromatography (isohexane/EtOAc = 9:1) to afford pure product (339 mg,       
82 %) as a white solid. 
 
m.p.: 88-90 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1588, 1579, 1531, 1339, 1332, 1297, 1193, 1128, 983, 931, 867. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.39 (s, 1H), 7.10 (s, 1H), 4.54 (t, J = 6.4 Hz, 2H), 1.95-1.83 
(m, 2H), 1.66-1.51 (m, 2H), 1.01 (t, J = 7.3 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 160.6, 150.7, 149.0, 148.4, 117.3, 111.6, 111.1, 68.9, 30.7, 19.6, 
13.9. 
MS (EI, 70 eV): m/z (%) = 269 (10), 252 (32), 251 (15), 250 (100), 249 (18), 248 (97), 215 (31), 214 
(15), 212 (50), 211 (17), 158 (12), 149 (12). 
HRMS (EI) cacld. for [C12H11Cl3N2O]: 303.9937; found 303.9941. 
 
1,8-Bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar, was charged with 1-
butanethiol (1.24 mL, 11.6 mmol, 3.0 equiv) in THF (10 mL). The solution was cooled to 0 °C, 
whereupon a solution of nBuLi (4.70 mL, 11.7 mmol, 2.48 M in hexane, 3.05 equiv) was slowly added. 
The solution was stirred at 0 °C for 30 min. Another dry and argon-flushed Schlenk-flask, equipped with 
a magnetic stirring bar, was charged with 1,3,6,8-tetrachloro-2,7-naphthyridine (1.03 g, 3.8 mmol, 1.0 
equiv) in THF (10 mL). The solution was cooled to -78 °C and the freshly prepared thiobutyllithium 
(13.3 mL, 9.6 mmol, 0.72 M in THF, 2.5 equiv) was slowly added. The reaction mixture was stirred at 
the same temperature for 2 h. After the total disappearance of the starting material, the mixture was 
quenched with sat. aq. NH4Cl solution (50 mL). The layers were separated and the aqueous phase 
84 
 
extracted with EtOAc (3 × 50 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated in vacuo. The crude residue was purified by flash column chromatography (isohexane/ 
EtOAc = 100:1) to afford the pure product (1.24 g, 86%) as an off-white solid. 
 
m.p.: 67-69 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2955, 2931, 2871, 1569, 1492, 1323, 1260, 1118, 1098, 986, 873, 
857. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.05 (s, 2H), 3.32 (t, J = 7.3 Hz, 4H), 1.78 (quint, J = 7.3 Hz, 
4H), 1.53 (sxt, J = 7.4 Hz, 4H), 0.99 (t, J = 7.3 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 163.8, 148.2, 145.9, 120.4, 113.3, 33.3, 30.4, 22.5, 13.9. 
MS (EI, 70 eV): m/z (%) = 321 (20), 319 (70), 317 (100), 265 (17), 263 (73), 262 (20), 261 (98), 225 
(29), 41 (24). 
HRMS (EI) calcd. for [C16H20Cl2N2S2]: 374.0445; found: 374.0438. 
 
4,7-Dichloro-[1,2]dithiolo[3,4,5-ij][2,7]naphthyridine (9d)171 
 
A suspension of 1,3,6,8-tetrachloro-2,7-naphthyridine (0.10 g, 0.37 mmol) and sulfur (0.05 g, 1.48 
mmol, 4.0 equiv) in dry NMP (14 mL) was stirred at 190 °C for 3 h. After cooling to rt, the reaction 
mixture was poured into water. The precipitate was filtered, washed with water and dried. The crude 
product was purified by flash column chromatography (isohexane/DCM = 1:1) to furnish pure product 
(40 mg, 42%) as a yellow solid. 
 
m.p.: 208-210 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1584, 1571, 1490, 1343, 1327, 1282, 1092, 999, 870, 808, 681. 
1H-NMR (400 MHz, DMSO-d6): δ/ ppm = 7.46 (s, 2H). 
13C-NMR (100 MHz, DMSO-d6): δ/ ppm = 169.7, 151.7, 143.9, 121.5, 111.2. 
MS (EI, 70 eV): m/z (%) = 262 (72), 261 (12), 260 (100), 227 (11), 225 (29), 180 (15). 
HRMS (EI) calcd. for [C8H2Cl2N2S2]: 259.9036; found: 259.9032. 
 
 
 
 
 
                                                 
171 (a) Y. Zagranyarski, L. Chen, D. Jänsch, T. Gessner, C. Li, K. Müllen, Org. Lett. 2014, 16, 2814. (b) R. Sato, Science of 
Synthesis 2004, 16, 57. (c) S. A. Gamage, R. A. J. Smith, Tetrahedron 1990, 46, 2111.  
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2.2.2 Preparation of MEM-protected 2,7-Naphthyridone (13) 
 
2,6-Dihydroxy-4-methylnicotinonitrile118a 
 
Ethyl acetoacetate (26.0 g, 200 mmol) and cyanoacetamide (16.8 g, 200 mmol, 1.0 equiv) were dissolved 
in methanol (150 mL). A solution of potassium hydroxide (12.4 g, 200 mmol, 1.0 equiv) in methanol 
(100 mL) was added and the resulting mixture was heated to 65 °C and was stirred under reflux for 4 h. 
The white precipitate was filtered off, washed with methanol and dissolved in hot water (100 mL). After 
cooling to rt, the solution was carefully acidified with hydrochloric acid (2 M), until the white solid 
precipitated again. The product was filtered off, washed with water and methanol and then dried to 
furnish the pure compound (23.9 g, 80%) as a colorless powder.  
 
m.p.: 298-300 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2883, 2219, 1595, 1502, 1359, 1291, 1219, 1180, 833, 742. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 12.11 (br, 2H), 5.59 (s, 1H), 2.23 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 162.3, 161.5, 160.7, 117.7, 93.2, 89.4, 21.1. 
MS (EI, 70 eV): m/z (%) = 151 (16), 150 (100), 122 (57), 121 (19), 107 (48), 94 (12), 79 (12). 
HRMS (EI): calcd. for [C7H6N2O2]: 150.0429; found: 150.0417. 
 
2,6-Dichloro-4-methylnicotinonitrile118a 
 
A pressure tube, equipped with a magnetic stirring bar, was charged with 2,6-dihydroxy-4-methyl-
nicotinonitrile (10 g, 67 mmol) and POCl3 (24 mL, 268 mmol, 4.0 equiv). The mixture was heated to 
160 °C and was stirred at that temperature for 14 h. After cooling to rt, the mixture was carefully poured 
onto ice (500 g). The brown precipitate was filtered off and washed with water.  Recrystallization from 
EtOAc and washing with isohexane gave the pure compound (12 g, 95%) as light yellow crystals.  
 
m.p.: 110-113 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3367, 3056, 2231, 1776, 1568, 1337, 1261, 1190, 1115, 1101, 922, 
889, 850. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.27 (q, J = 0.8 Hz, 1H), 2.57 (d, J = 0.8 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 156.5, 153.7, 152.6, 124.0, 113.3, 110.3, 20.6. 
MS (EI, 70 eV): m/z (%) = 186 (100), 168 (15), 153 (13), 151 (42), 150 (38), 133 (13), 124 (16), 115 
(21). 
HRMS (EI): calcd. for [C7H4Cl2N2]: 185.9752; found: 185.9752. 
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4-Methylnicotinonitrile118a 
 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 2,6-
dichloro-4-methylnicotinonitrile (32.5 g, 174 mmol), sodium acetate trihydrate (29.2 g, 348 mmol, 2.0 
equiv) and palladium(II) chloride (0.5 g, 3 mmol, 2 mol%) were suspended in methanol (400 mL). The 
argon was removed in vacuo and the reaction vessel was backflushed with hydrogen. This step was 
repeated three times, until the reaction mixture clearly turned black. After stirring at rt for 18 h under 
hydrogen atmosphere, the reaction mixture was filtered and washed with methanol. The solvent was 
removed under reduced pressure and the residue was diluted in sat. aq. NH4Cl solution (200 mL). The 
mixture was extracted with EtOAc (3 × 50 mL) and dried over anhydrous MgSO4. After filtration, the 
solvent was evaporated in vacuo. The crude product was purified by column chromatography (iso-
hexane/EtOAc = 1:1) to give the pure compound (12.9 g, 63%) as colorless crystals. 
 
m.p.: 46-48 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3020, 2223, 1884, 1592, 1388, 1195, 845, 837, 745, 723. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 8.77 (s, 1H), 8.62 (d, J = 5.3 Hz, 1H), 7.27 - 7.25 (m, 1H), 2.54 
(s, 3H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 152.7, 152.6, 150.8, 124.8, 115.8, 110.9, 20.1. 
MS (EI, 70 eV): m/z (%) = 118 (100), 91 (22). 
HRMS (EI): calcd. for [C7H6N2]: 118.0531; found: 118.0511. 
 
(E)-4-(2-(dimethylamino)vinyl)nicotinonitrile118a 
 
In an oven-dried flask, equipped with a magnetic stirring bar and a reflux condenser, 4-methyl-
nicotinonitrile (13.8 g, 117 mmol) and N,N-dimethylformamide dimethyl acetal (13.9 g, 15.5 mL, 
117 mmol, 1.0 equiv) were dissolved in dry DMF (100 mL). The mixture was heated to reflux at 160 °C 
and was stirred for 5 h at that temperature. After cooling to rt, the solvent was removed in vacuo and the 
residue was diluted in water (100 mL). The suspension was extracted with EtOAc (6 × 50 mL) and the 
combined organic phases were washed with water (6 × 100 mL) and brine (4 × 100 mL). After drying 
over MgSO4 and filtration, the solvent was evaporated in vacuo to give the desired compound (18.5 g,  
91%) as dark red crystals.  
 
m.p.: 88-90 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2905, 2213, 1635, 1582, 1383, 1286, 1199, 1102, 843, 781. 
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1H-NMR (300 MHz, CDCl3): δ/ ppm = 8.47 (s, 1H), 8.22 (d, J = 5.9 Hz, 1H), 7.28 (d, J = 13.2 Hz, 
1H), 7.08 (d, J = 5.9 Hz, 1H), 5.22 (d, J = 13.2 Hz, 1H), 2.97 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 153.7, 150.7, 146.4, 124.8, 117.7, 114.4, 103.3, 90.4, 40.7. 
MS (EI, 70 eV): m/z (%) = 173 (100), 158 (22), 145 (18), 131 (43), 117 (10), 104 (13), 78 (11), 70 (15), 
56 (10). 
HRMS (EI): calcd. for [C10H11N3]: 173.0953; found: 173.0949. 
 
2,7-Naphthyridin-1(2H)-one (8)118a 
 
(E)-4-(2-(dimethylamino)vinyl)nicotinonitrile (18.5 g, 107 mmol) was dissolved in a mixture of con-
centrated acetic acid (135 mL) and concentrated sulfuric acid (135 mL). The mixture was heated to 
reflux at 165 °C and was stirred for 60 h at that temperature. After cooling to rt, the resulting solution 
was diluted with water (CAUTION!) and neutralized with aq. NH3 solution. The brown precipitate was 
filtered off. The remaining solution was extracted with chloroform (5 × 200 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated in vacuo. The crude product was purified 
by column chromatography (EtOAc/MeOH = 9:1) to give the desired compound (6.82 g, 44%) as a light 
brown powder. 
 
m.p.: 260-263 °C.  
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3152, 3000, 2919, 2856, 1659, 1627, 1593, 858, 813, 795. 
1H-NMR (400 MHz, DMSO-d6): δ/ ppm = 11.55 (br, 1H), 9.26 (s, 1H), 8.65 (d, J = 5.5 Hz, 1H), 7.54 
(dd, J = 5.5 Hz, 1H), 7.39 (dd, J = 7.1 Hz, 1H), 6.51 (d, J = 7.1 Hz, 1H).  
13C-NMR (100 MHz, DMSO-d6): δ/ ppm = 161.8, 151.1, 150.3, 143.6, 134.8, 121.4, 119.8, 103.2. 
MS (EI, 70 eV): m/z (%) = 146 (100), 119 (39), 91 (68), 77 (10), 65 (14), 63 (87), 53 (13), 50 (27), 43 
(14), 41 (20), 39 (23), 38 (22), 28 (54). 
HRMS (EI): calcd. for [C8H6N2O]: 146.0480; found: 146.0488. 
 
2-((2-Methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (13) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 2,7-naphthyridone (8, 260 mg, 1.78 mmol) in dry DCM (50 mL). DIPEA (483 mg, 3.74 mmol) and 
2-methoxyethoxymethylchloride (443 mg, 3.56 mmol) were added at rt and the mixture was stirred for 
12 h. Then, the reaction mixture was poured into sat. aq. NaHCO3 solution (100 mL) and the aq. phase 
was extracted with DCM (3 × 50 mL). The combined organic phases were washed with brine and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated in vacuo. The crude product was 
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purified by column chromatography (EtOAc/MeOH = 9.5:0.5) to give 13 (142 mg, 34%) as a light-
brown powder. 
 
m.p.: 85.2 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3070, 3045, 2926, 2885, 1667, 1625, 1082, 1050, 844, 757. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.55 (s, 1H), 8.69 (d, J = 5.4 Hz, 1H), 7.40 (d, J = 7.4 Hz, 1H), 
7.32 (d, J = 5.4 Hz, 1H), 6.45 (d, J = 7.4 Hz, 1H), 5.45 (s, 2H), 3.84 – 3.69 (m, 2H), 3.56 – 3.45 (m, 
2H), 3.32 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 162.0, 151.4, 151.2, 142.8, 135.6, 121.1, 119.2, 104.7, 77.0, 
71.6, 69.0, 59.1. 
MS (EI, 70 eV): m/z (%) = 234 (7), 176 (61), 175 (28), 160 (22), 159 (84), 147 (36), 146 (100), 
129 (11), 128 (53), 84 (20), 77 (12), 59 (77), 57 (12), 46 (12), 45 (19). 
HRMS (EI): m/z calcd. for [C12H14N2O3]: 234.1004; found: 234.1011. 
 
 
2.3 Metalation of 2,7-Naphthyridines 9a-c Using TMPLi (2)  
 
3,6-Dichloro-4-iodo-1,8-dimethoxy-2,7-naphthyridine (11a) 
 
According to TP1, 3,6-dichloro-1,8-dimethoxy-2,7-naphthyridine (9a, 108 mg, 0.41 mmol in 2 mL dry 
THF) was metalated within 30 min at -78 °C. Then, iodine (155 mg, 0.62 mmol, 1.5 equiv) was added 
and the mixture was continuously stirred at -78 °C for 1 h. The reaction mixture was quenched with sat. 
aq. NH4Cl solution (5 mL), extracted with EtOAc (3 × 5 mL) and dried over MgSO4. After filtration, 
the solvents were evaporated in vacuo. The crude product was purified by flash column chromatography 
(isohexane/EtOAc = 9:1) to afford 11a (106 mg, 67%) as a brown solid. 
 
m.p.: 196-198 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1587, 1560, 1526, 1377, 1338, 1283, 1136, 901, 780. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.48 (s, 1H), 4.15 (s, 3H), 4.11 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 162.2, 161.7, 153.0, 150.8, 150.1, 117.4, 103.4, 83.3, 55.7, 55.5. 
MS (EI, 70 eV): m/z (%) = 388 (12), 386 (63), 385 (24), 384 (100), 383 (18), 357 (35), 355 (56), 241 
(15), 197 (18). 
HRMS (EI) calcd. for [C10H7Cl2IN2O2]: 383.8929; found: 383.8930. 
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8-Butoxy-1,3,6-trichloro-4-iodo-2,7-naphthyridine (11b) 
 
According to TP1, 1-butoxy-3,6,8-trichloro-2,7-naphthyridine (9b, 100 mg, 0.33 mmol in 2 mL dry 
THF) was metalated within 30 min at -78 °C. The mixture was stirred for 30 min at the same temperature. 
Then, iodine (125 mg, 0.50 mmol, 1.5 equiv) was added and the solution was continuously stirred at        
- 78 °C for 1 h. The reaction mixture was quenched with sat. aq. NH4Cl solution (5 mL), extracted with 
EtOAc (3 × 5 mL) and dried over MgSO4. After filtration, the solvents were evaporated in vacuo. The 
crude product was purified by flash column chromatography (isohexane/EtOAc =100:1) to afford 11b 
(118 mg, 83%) as a white solid. 
 
m.p.: 88-90 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2952, 2870, 1577, 1545, 1506, 1352, 1297, 1252, 1186, 1084, 977. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.54 (s, 1H), 4.57 (t, J = 6.4 Hz, 2H), 1.97-1.82 (m, 2H), 1.67-
1.50 (m, 2H), 1.01 (t, J = 7.3 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 161.5, 153.8, 151.4, 151.1, 150.8, 118.0, 112.0, 93.7, 69.8, 31.1, 
20.0, 14.3. 
MS (EI, 70 eV): m/z (%) = 378 (30), 376 (98), 375 (14), 374 (100), 339 (19), 338 (15). 
HRMS (EI) calcd. for [C12H10Cl3IN2O]: 429.8903; found: 429.8902. 
 
1,8-Bis(butylthio)-3,6-dichloro-4-iodo-2,7-naphthyridine (11c) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 616 mg, 1.64 mmol in 2 mL 
dry THF) was metalated within 30 min at -40 °C. Subsequently, iodine (830 mg, 3.28 mmol, 2.0 equiv) 
in dry THF (2.0 mL) was added at -40 °C and the mixture was continuously stirred for 2 h. Then, the 
reaction mixture was quenched with sat. aq. NH4Cl solution (5 mL), extracted with EtOAc (3 × 10 mL) 
and dried over MgSO4. After filtration, the solvents were evaporated in vacuo. The crude product was 
purified by flash column chromatography (isohexane/EtOAc = 100:1) to give 11c (744 mg, 90%) as 
slightly yellow solid. 
 
m.p.: 107-109 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2954, 2927, 1561, 1528, 1477, 1460, 1231, 1115, 1001, 835, 821. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.55 (s, 1H), 3.39-3.24 (m, 4H), 1.84-1.71 (m, 4H), 1.60-1.45 
(m, 4H), 0.99 (t, J = 7.3 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 164.5, 163.5, 153.2, 150.1, 147.8, 120.9, 119.8, 88.2, 33.7, 33.5, 
30.4, 30.3, 22.5, 13.9. 
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MS (EI, 70 eV): m/z (%) = 446 (76), 444 (100), 389 (64), 387 (88), 57 (23), 41 (33). 
HRMS (EI) calcd. for [C16H19Cl2IN2S2]: 499.9411; found: 499.9406. 
 
8-Butoxy-1,3,6-trichloro-4-(trimethylsilyl)-2,7-naphthyridine (11d) 
 
According to TP1, 1-butoxy-3,6,8-trichloro-2,7-naphthyridine (9b, 100 mg, 0.33 mmol in 2 mL dry 
THF) was metalated within 30 min at -78 °C. Then, TMSCl (0.062 mL, 0.49 mmol, 1.5 equiv) was 
added and the solution was continuously stirred at -78 °C for 1 h. The reaction mixture was quenched 
with sat. aq. NH4Cl solution (5 mL), extracted with EtOAc (3 × 5 mL) and dried over MgSO4. After 
filtration, the solvents were evaporated in vacuo. The crude product was purified by flash column 
chromatography (isohexane/EtOAc = 99:1) to afford 11d (85 mg, 69%) as a white solid. 
 
m.p.: 114-116 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2962, 2931, 2868, 1578, 1535, 1497, 1298, 1222, 1189, 1084, 883, 
838, 737. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.50 (s, 1H), 4.53 (t, J = 6.4 Hz, 2H), 1.95-1.81 (m, 2H), 1.67-
1.48 (m, 2H), 1.00 (t, J = 7.2 Hz, 3H), 0.57 (s, 9H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 161.4, 154.4, 153.0, 151.4, 148.6, 125.8, 112.3, 111.1, 68.7, 
30.8, 19.6, 13.9, 2.6 (3 x C). 
MS (EI, 70 eV): m/z (%) = 378 (14), 376 (14), 343 (14), 341 (22), 322 (59), 320 (59), 309 (36), 307 
(89), 273 (21), 271 (100). 
HRMS (EI): calcd. for [C15H19Cl3N2OSi]: 376.0332; found: 376.0328. 
 
4-Bromo-1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (12a) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 188 mg, 0.5 mmol in 2 mL 
dry THF) was metalated within 30 min at -40 °C. Bromine (0.03 ml, 0.6 mmol, 1.2 equiv) was added at           
-40 °C and the reaction mixture was stirred further 2 h at this temperature. Then, the reaction mixture 
was quenched with sat. aq. NH4Cl solution (5 mL), extracted with EtOAc (3 × 10 mL) and dried over 
MgSO4. After filtration, the solvents were removed in vacuo. Purification by flash column chromato-
graphy (isohexane/EtOAc = 80:1) gave the desired product 12a (144 mg, 63%) as beige crystals. 
 
m.p.: 80-82 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2957, 2928, 1562, 1537, 1482, 1235, 1115, 1010, 836, 825, 662. 
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1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.59 (s, 1H), 3.34 (t, J = 7.2 Hz, 2H), 3.30 (t, J = 7.2 Hz, 2H), 
1.84-1.71 (m, 4H), 1.61-1.45 (m, 4H), 0.99 (t, J = 7.3 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 164.5, 162.2, 149.8, 148.4, 144.9, 121.1, 114.3, 110.3, 33.6, 
33.5, 30.3, 30.3, 22.5, 13.9. 
MS (EI, 70 eV): m/z (%) = 399 (53), 395 (56), 343 (50), 342 (21), 341 (100), 340 (21), 339 (60), 305 
(19), 41 (19). 
HRMS (EI) calcd. for [C16H19BrCl2N2S2]: 451.9550; found 451.9531. 
 
1,8-Bis(butylthio)-3,6-dichloro-2,7-naphthyridine-4-carbonitrile (12b) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 375 mg, 1 mmol in 4 mL dry 
THF) was metalated within 30 min at - 40 °C. Subsequently, tosyl cyanide (218 mg, 1.2 mmol, 1.2 
equiv) was added at -40 °C and the reaction mixture was continuously stirred for 2 h. Then, the mixture 
was quenched with sat. aq. NH4Cl solution (10 mL), extracted with EtOAc (3 × 20 mL) and dried over 
MgSO4. After filtration, the solvents were removed in vacuo. The crude product was purified by flash 
column chromatography (isohexane/EtOAc = 80:2) to give 12b (251 mg, 63%) as a white solid. 
 
m.p.: 73-75 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2957, 2927, 1566, 1546, 1478, 1329, 1276, 1133, 1082, 923, 838, 
717. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.35 (s, 1H), 3.40-3.29 (m, 4H), 1.84-1.70 (m, 4H), 1.59-1.45 
(m, 4H), 0.99 (t, J = 7.5 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 167.1, 164.7, 162.4, 150.3, 144.3, 118.0, 115.1, 110.7, 94.4, 
33.5, 33.3, 30.4, 30.2, 22.4, 22.2, 13.9, 13.8. 
MS (EI, 70 eV): m/z (%) = 399 (6), 346 (19), 344 (73), 342 (100), 310 (14), 290 (15), 288 (71), 286 
(92), 252 (12), 250 (22), 57 (25), 55 (10), 41 (42). 
HRMS (EI) calcd. for [C17H19Cl2N3S2]: 399.0397; found: 399.0396. 
 
1,8-Bis(butylthio)-3,6-dichloro-4-(trimethylsilyl)-2,7-naphthyridine (12c) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 250 mg, 0.66 mmol in 2.5 mL 
dry THF) was metalated within 30 min at -40 °C. Subsequently, TMSCl (0.10 mL, 0.79 mmol, 1.2 equiv) 
was added at -40 °C and the reaction mixture was continuously stirred for 2 h. Then, the mixture was 
quenched with sat. aq. NH4Cl solution (5 mL), extracted with EtOAc (3 × 10 mL) and dried over MgSO4. 
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After filtration, the solvents were removed in vacuo. The crude product was purified by flash column 
chromatography (isohexane/EtOAc = 100:0.5) to give 12c (207 mg, 73%) as a brown solid. 
 
m.p.: 42-44 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2955, 2928, 1563, 1514, 1470, 1263, 1216, 1119, 1023, 892, 845, 
822. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.49 (s, 1H), 3.36-3.26 (m, 4H), 1.85-1.71 (m, 4H), 1.60-1.45 
(m, 4H), 0.99 (t, J = 7.3 Hz, 6H), 0.54 (s, 9H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 164.2, 164.1, 154.6, 150.6, 147.8, 120.2, 120.1, 114.5, 33.3, 
33.2, 30.5, 22.4, 13.9, 2.8. 
MS (EI, 70 eV): m/z (%) = 393 (22), 392 (21), 391 (82), 390 (28), 389 (100), 357 (20), 335 (62), 333 
(80), 41 (23). 
HRMS (EI) calcd. for [C19H28Cl2N2S2Si]: 446.0840; found: 446.0844. 
 
1,8-Bis(butylthio)-3,6-dichloro-4-(phenylthio)-2,7-naphthyridine (12d) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 187 mg, 0.5 mmol in 2 mL 
dry THF) was metalated within 30 min at -40 °C. Subsequently, S-phenyl benzenethiosulfonate            
(150 mg, 0.6 mmol, 1.2 equiv) was added at -40 °C and the reaction mixture was continuously stirred 
for 2 h. Then, the mixture was quenched with sat. aq. NH4Cl solution (10 mL), extracted with EtOAc    
(3 × 10 mL) and dried over MgSO4. After filtration, the solvents were removed in vacuo. Purification 
by flash column chromatography (isohexane/EtOAc = 200:1) gave the desired product 12d (192 mg, 
80%) as a slightly yellow solid. 
 
m.p.: 115-117 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2958, 2926, 1588, 1525, 1473, 1261, 1233, 1113, 1029, 898, 739, 
687. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.90 (s, 1H), 7.23 (t, J = 7.6 Hz, 2H), 7.15 (t, J = 7.6 Hz, 1H), 
7.07 (d, J = 7.6 Hz, 2H), 3.36-3.33 (m, 4H), 1.83-1.76 (m, 4H), 1.57-1.50 (m, 4H), 0.99 (t, J = 7.2 Hz, 
3H), 0.98 (t, J = 7.2 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 165.2, 164.4, 154.8, 149.8, 149.8, 135.4, 129.4, 127.3, 126.4, 
121.0, 115.9, 113.5, 33.6, 33.5, 30.4, 30.3, 22.4, 22.4, 13.6. 
MS (EI, 70 eV): m/z (%) = 484 (15), 482 (19), 428 (18), 427 (14), 426 (76), 425 (23), 424 (100), 395 
(11), 373 (20), 371 (68), 333 (11), 298 (17), 109 (11), 77 (15), 57 (38), 55 (11), 41 (48). 
HRMS (EI) calcd. for [C22H24Cl2N2S3]: 482.0479; found: 482.0467. 
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1-(1,8-Bis(butylthio)-3,6-dichloro-2,7-naphthyridin-4-yl)-N,N-dimethylmethanamine (12e) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 250 mg, 0.66 mmol in 2 mL 
dry THF) was metalated within 30 min at -40 °C. Subsequently, N,N-dimethylmethyleneiminium iodide 
(147 mg, 0.79 mmol, 1.2 equiv) was added at -40 °C and the reaction mixture was continuously stirred 
for 2 h. Then, the mixture was quenched with sat. aq. NH4Cl solution (5 mL), extracted with EtOAc       
(3 × 10 mL) and dried over MgSO4. After filtration, the solvents were removed in vacuo. The crude 
product was purified by flash column chromatography (isohexane/EtOAc = 95:5) to give 12e (230 mg, 
81%) as a yellow solid. 
 
m.p.: 68-70 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2959, 2926, 1573, 1552, 1486, 1458, 1272, 1241, 1128, 1094, 
1019, 996, 840, 829. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.59 (s, 1H), 3.72 (s, 2H), 3.37-3.28 (m, 4H), 2.30 (s, 6H), 1.84-
1.72 (m, 4H), 1.61-1.45 (m, 4H), 0.98 (t, J = 7.2 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 163.8, 162.2, 148.8, 148.6, 146.0, 120.8, 119.0, 112.2, 58.0, 
45.3, 33.3, 33.2, 30.5, 22.5, 22.4, 13.9. 
MS (EI, 70 eV): m/z (%) = 389 (70), 388 (43), 274 (42), 72 (40), 69 (43), 58 (83), 57 (100), 55 (57), 43 
(60), 41 (81). 
HRMS (EI) calcd. for [C19H27Cl2N3S2]: 431.1023; found: 431.1014. 
 
Ethyl 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine-4-carboxylate (12f) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 207 mg, 0.55 mmol in 2.5 mL 
dry THF) was metalated within 30 min at -40 °C. Then, a 0.4 M solution of MgCl2 (1.5 mL, 0.61 mmol, 
1.1 equiv) was added to the mixture at -40 °C. After further 30 min, ethyl chloroformate (0.06 mL, 0.61 
mmol, 1.1 equiv) was added. The reaction mixture was warmed up to -30 °C and stirred for 5 h at this 
temperature until complete conversion of the starting material. Then, the mixture was quenched with 
sat. aq. NH4Cl (20 mL) solution and extracted with EtOAc (3 × 20 mL). The combined organic layers 
were dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by flash 
column chromatography (isohexane/EtOAc = 80:1) to afford 12f (206 mg, 84%) as a yellow solid. 
 
m.p.: 72-74°C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2956, 2928, 1729, 1552, 1487, 1218, 1208, 1153, 1122, 1061, 867. 
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1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.18 (s, 1H), 4.51 (q, J = 7.1 Hz, 2H), 3.33 (t, J = 7.2 Hz, 4H), 
1.85-1.72 (m, 4H), 1.59-1.48 (m, 4H), 1.45 (t, J = 7.1 Hz, 3H), 0.99 (t, J = 7.3 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 165.2, 165.1, 164.2, 149.1, 145.1, 142.8, 119.5, 117.6, 110.9, 
62.4, 33.3, 33.2, 30.2, 30.1, 22.2, 14.0, 13.7. 
MS (EI, 70 eV): m/z (%) = 446 (5), 401 (7), 391 (74), 389 (100), 359 (9), 357 (13), 337 (11); 335 (46), 
334 (11), 333 (65), 307 (18), 305 (24), 287 (15), 57 (10), 41 (14). 
HRMS (EI) calcd. for [C19H24Cl2N2O2S2]: 446.0656; found: 446.0645. 
 
4-Allyl-1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (12g) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 187 mg, 0.5 mmol in 2 mL 
dry THF) was metalated within 30 min at -40 °C. Then, a solution of CuCN·2LiCl (0.1 mL, 0.1 mmol, 
1.0 M in THF, 0.2 equiv) was added dropwise at -40 °C, followed by the addition of allyl bromide (72 
mg, 0.6 mmol, 1.2 equiv). The reaction mixture was slowly warmed up to rt within 1 h. Then, the mixture 
was quenched with sat. aq. NH4Cl/NH3 (10:1 v/v, 10 mL) solution and extracted with EtOAc (3 × 10 
mL). The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. The 
crude product was purified by flash column chromatography (isohexane/EtOAc = 100:0.5) to afford 12g 
(192 mg, 93%) as a white solid. 
 
m.p.: 61-63 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2957, 2930, 1573, 1551, 1484, 1454, 1255, 1125, 1081, 908, 889, 
830. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.24 (s, 1H), 5.99-5.85 (m, 1H), 5.10 (d, J = 10.0 Hz, 1H), 4.98 
(d, J = 17.1 Hz, 1H), 3.69 (d, J = 5.3 Hz, 2H), 3.38-3.26 (m, 4H), 1.78 (quint, J = 7.3 Hz, 4H), 1.52 (sxt, 
J = 7.3 Hz, 4H), 0.99 (t, J = 7.3 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 164.4, 161.2, 148.6, 148.4, 145.0, 133.5, 120.6, 119.9, 117.1, 
111.2, 33.4, 33.2, 33.0, 30.5, 30.4, 22.5, 13.9. 
MS (EI, 70 eV): m/z (%) = 359 (70), 303 (62), 301 (85), 97 (34), 71 (30), 57 (57). 
HRMS (EI) calcd. for [C19H24Cl2N2S2]: 414.0758; found 414.0742. 
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1,8-Bis(butylthio)-3,6-dichloro-4-(cyclohex-2-en-1-yl)-2,7-naphthyridine (12h) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 187 mg, 0.5 mmol in 2 mL 
dry THF) was metalated within 30 min at -40 °C. Then, a solution of CuCN·2LiCl (0.1 mL, 0.1 mmol, 
1.0 M in THF, 0.2 equiv) was added dropwise at -40 °C, followed by the addition of 3-bromocyclohexene          
(96 mg, 0.6 mmol, 1.2 equiv). The reaction mixture was slowly warmed up to rt within 1 h. Then, the 
mixture was quenched with sat. aq. NH4Cl/NH3 (10:1 v/v, 10 mL) solution and extracted with EtOAc   
(3 × 10 mL). The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. 
The crude product was purified by flash column chromatography (isohexane/EtOAc = 100:0.5) to afford 
12h (216 mg, 95%) as brown oil. 
 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2955, 2927, 2859, 1568, 1541, 1484, 1279, 1229, 1126, 1101, 983, 
658. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 7.79 (s, 1H), 5.99-5.89 (m, 1H), 5.75-5.66 (m, 1H), 4.30 (s, 
1H), 3.36-3.25 (m, 4H), 2.24 (s, 2H), 2.04-1.93 (m, 2H), 1.85-1.70 (m, 4H), 1.59-1.46 (m, 6H), 0.98 (t, 
J = 7.2 Hz, 6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 164.1, 160.7, 148.2, 147.4, 144.7, 130.5, 128.0, 124.8, 121.2, 
112.1, 39.2, 33.3, 33.2, 30.6, 30.5, 28.1, 24.8, 23.1, 22.5, 22.5, 22.4, 13.9. 
MS (EI, 70 eV): m/z (%) = 401 (17), 400 (18), 399 (74), 398 (22), 397 (100), 365 (18), 57 (18). 
HRMS (EI) calcd. for [C22H28Cl2N2S2]: 454.1071; found 454.1068. 
 
Ethyl 3-(1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridin-4-yl)propiolate (12i) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 187 mg, 0.5 mmol in 2 mL 
dry THF) was metalated within 30 min at -40 °C. Then, a solution of ZnCl2 (0.55 mL, 0.55 mmol, 1.0 M 
in THF, 1.1 equiv) was added to the mixture at -40 °C. After 30 min, a solution of CuCN·2LiCl (0.1 mL, 
0.1 mmol, 1.0 M in THF, 0.2 equiv) was added, followed by the addition of ethyl 3-bromopropiolate 
(106 mg, 0.6 mmol, 1.2 equiv). The reaction mixture was continuously stirred overnight, letting it slowly 
warm up to rt. Then, the mixture was quenched with sat. aq. NH4Cl/NH3 (10:1 v/v, 10 mL) solution and 
extracted with EtOAc (3 × 10 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated in vacuo. The crude product was purified by flash column chromatography (isohexane/ 
EtOAc = 140:1) to afford 12i (198 mg, 84%) as an orange solid. 
 
96 
 
m.p: 61-63 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2961, 2924, 2213, 1713, 1538, 1476, 1288, 1229, 1136, 1090, 799 
741. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.55 (s, 1H), 4.36 (q, J = 7.1 Hz, 2H), 3.34 (t, J = 7.1 Hz, 4H), 
1.78 (quint, J = 7.3 Hz, 4H), 1.53 (sxt, J = 7.4 Hz, 4H), 1.40 (t, J = 7.1 Hz, 3H), 0.99 (t, J = 7.3 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 166.0, 164.6, 153.7, 151.9, 150.0, 146.1, 119.5, 112.3, 105.0, 
91.4, 78.9, 62.6, 33.7, 33.6, 30.3, 30.2, 22.5, 22.4, 14.3, 13.8, 13.8. 
MS (EI, 70 eV): m/z (%) = 470 (7), 417.0 (18), 416 (15), 415 (66), 413 (100), 381 (16), 360 (10), 358 
(52), 357 (11), 356 (68), 331 (14), 286 (11), 249 (12), 57 (16), 41.2 (12). 
HRMS (EI) calcd. for [C21H24Cl2N2O2S2]: 470.0656; found: 470.0655. 
 
1,8-Bis(butylthio)-3,6-dichloro-4-((4-methoxy-3,5-dimethylphenyl)sulfinyl)-2,7-naphthyridine 
(12j) 
 
According to TP1, 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 260 mg, 0.69 mmol in 3 mL 
dry THF) was metalated within 30 min at -40 °C. Subsequently, a solution of MgCl2 (2.08 mL, 0.83 
mmol, 0.40 M in THF, 1.2 equiv) was added to the reaction mixture at -40 °C. After further 30 min,         
4-methoxy-3,5-dimethylbenzene-1-sulfinic chloride (225 mg, 1.03 mmol, 1.5 equiv) was added and the 
solution was stirred at -40 °C for 2 h. Then, the reaction mixture was quenched with sat. aq. NH4Cl 
solution (10 mL), extracted with EtOAc (3 × 10 mL) and dried over MgSO4. After filtration, the solvents 
were removed in vacuo. The crude product was purified by flash column chromatography (isohexane/ 
EtOAc = 19:1) to afford 12j (276 mg, 72%) as a yellow solid. 
 
m.p.: 140-142 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2958, 2931, 1559, 1535, 1478, 1271, 1220, 1123, 1056, 1017, 970, 
893. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 8.25 (s, 1H), 7.30 (s, 2H), 3.71 (s, 3H), 3.41-3.21 (m, 4H), 2.30 
(s, 6H), 1.88-1.65 (m, 4H), 1.63-1.39 (m, 4H), 1.00 (t, J = 7.4 Hz, 3H), 0.96 (t, J = 7.4 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ/ ppm = 168.3, 164.5, 159.2, 149.6, 147.9, 143.4, 137.0, 132.8, 124.7, 
123.4, 121.1, 110.2, 59.9, 33.8, 33.4, 30.3, 30.2, 22.5, 22.4, 16.5, 13.9, 13.8. 
MS (EI, 70 eV): m/z (%) = 501 (33), 453 (33), 451 (46), 183 (49), 91 (42), 57 (56), 55 (30), 41 (100). 
HRMS (EI) calcd. for [C25H30Cl2N2O2S3]: 556.0846; found: 556.0848. 
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2.4 Metalation of 2,7-Naphthyridone 13 using TMP2Zn·2MgCl2·2LiCl (6)   
 
3-Iodo-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (15) 
 
According to TP2, 2,7-naphthyridone (13, 60 mg, 0.26 mmol) was metalated within 72 h, using 
TMP2Zn·2MgCl2·2LiCl (6, 1.1 mL, 0.31 mmol, 0.28 M in THF, 1.2 equiv). Iodine (132 mg, 0.52 mmol)             
dissolved in dry THF (2 mL) was then added dropwise at −10 °C. The resulting mixture was            
allowed to warm up to rt and was further stirred for 30 min. Then, the reaction mixture was quenched 
with sat. aq. Na2S2O3 solution (5 mL), extracted with EtOAc (3 × 20 mL) and dried over MgSO4. After 
filtration, the solvent was evaporated in vacuo. The crude product was purified by column chromato-
graphy (EtOAc/MeOH = 9.5:0.5) to give 15 (86 mg, 92%) as a brown crystalline solid. 
 
dec.: 120 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3080, 2953, 2921, 1662, 1597, 1197, 1088, 1036, 871, 789. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.52 (s, 1H), 8.73 (d, J = 5.4 Hz, 1H), 7.18 (dd, J = 5.4 Hz, 
1H), 7.15 (s, 1H), 5.79 (s, 2H), 3.81–3.78 (m, 2H), 3.57 –3.53 (m, 2H), 3.35 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 161.7, 152.1, 152.0, 142.8, 120.2, 118.5, 117.5, 99.7, 80.7, 
71.7, 69.1, 59.2. 
MS (EI, 70 eV): m/z (%) = 360 (3), 302 (14), 285 (16), 272 (39), 232 (13), 159 (11), 158 (17), 24 (145), 
89 (88), 59 (100). 
HRMS (EI) calcd. for [C12H13IN2O3]: 359.9971; found: 359.9983. 
 
2-((2-Methoxyethoxy)methyl)-3-(4-methoxyphenyl)-2,7-naphthyridin-1(2H)-one (16a) 
 
According to TP2, 2,7-naphthyridone (13, 60 mg, 0.26 mmol) was metalated within 72 h using  
TMP2Zn·2MgCl2·2LiCl (6, 1.1 mL, 0.31 mmol, 0.28 M in THF, 1.2 equiv). A solution of Pd(dba)2 (6 
mg, 4 mol %), tfp (5 mg, 8 mol %) and 1-iodo-4-methoxybenzene (72 mg, 0.31 mmol) in dry THF (1 
mL) was added at −10 °C. The resulting mixture was allowed to warm up to rt and was further stirred 
for      12 h. Then, the reaction mixture was quenched with sat. aq. NH4Cl solution (10 mL), extracted 
with EtOAc (3 × 20 mL) and dried over MgSO4. After filtration, the solvent was evaporated in vacuo. 
The crude product was purified by column chromatography (EtOAc/isohexane = 8:2) to give 16a (72 
mg, 81%) as a yellow solid. 
 
m.p.: 84 -86 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3077, 2913, 2854, 1660, 1606, 1510, 1299, 1091, 947, 786.  
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1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.56 (s, 1H), 8.68 (d, J = 5.1 Hz, 1H), 7.48 (d, J = 8.5 Hz, 2H), 
7.29 (d, J = 5.1 Hz, 1H), 6.96 (d, J = 8.5 Hz, 2H), 6.33 (s, 1H), 5.32 (s, 2H), 3.85 (s, 3H), 3.80 –3.76 
(m, 2H), 3.53 –3.49 (m, 2H), 3.32 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 163.2, 160.7, 151.3, 150.7, 150.0, 142.5, 130.7, 127.1, 120.1, 
119.1, 113.9, 106.1, 74.3, 71.9, 69.1, 59.1, 55.5. 
MS (EI, 70 eV): m/z (%) = 340 (10), 265 (55), 253 (38), 252 (100), 89 (12), 59 (43). 
HRMS (EI) calcd. for [C19H20N2O4]: 340.1423; found: 340.1416. 
 
2-((2-Methoxyethoxy)methyl)-3-(p-tolyl)-2,7-naphthyridin-1(2H)-one (16b) 
 
According to TP2, 2,7-naphthyridone (13, 117 mg, 0.50 mmol) was metalated within 72 h, using 
TMP2Zn·2MgCl2·2LiCl (6, 2.86 mL, 0.60 mmol, 0.21 M in THF, 1.2 equiv). A solution of Pd(dba)2 (12 
mg, 4 mol%), tfp (9 mg, 8 mol%) and 1-iodo-4-methylbenzene (131 mg, 0.60 mmol) in dry THF (1 mL) 
was added at −10 °C. The resulting mixture was allowed to warm up to rt and was further stirred for     
12 h. Then, the reaction mixture was quenched with sat. aq. NH4Cl solution (10 mL), extracted with 
EtOAc (3 × 20 mL) and dried over MgSO4. After filtration, the solvent was evaporated in vacuo. The 
crude product was purified by column chromatography (EtOAc/MeOH= 9.5:0.5) to give 16b (135 mg, 
84%) as a yellow solid. 
 
m.p.: 56-58 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3077, 2912, 2867, 1662, 1618, 1544, 1093, 1008, 882, 813.  
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.55 (s, 1H), 8.66 (d, J = 5.4 Hz, 1H), 7.40 (d, J = 7.9 Hz, 2H), 
7.28 –7.20 (m, 3H), 6.30 (s, 1H), 5.29 (s, 2H), 3.87–3.62 (m, 2H), 3.60–3.39 (m, 2H), 3.29 (s, 3H), 2.38 
(s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 163.1, 151.5, 151.1, 149.7, 142.1, 139.7, 131.8, 129.1, 129.1, 
120.0, 118.9, 106.0, 74.1, 71.8, 68.9, 58.9, 21.4. 
MS (EI, 70 eV): m/z (%) = 324 (4), 266 (13), 249 (59), 236(100), 89 (10), 59 (39). 
HRMS (EI): calcd. for [C19H20N2O3]: 324.1474; found: 324.1473. 
 
3-(4-Chlorophenyl)-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (16c) 
 
According to TP2, 2,7-naphthyridone (13, 117 mg, 0.5 mmol) was metalated within 72 h, using 
TMP2Zn·2MgCl2·2LiCl (6, 2.86 mL, 0.6 mmol, 0.21 M in THF, 1.2 equiv). A solution of Pd(dba)2             
(12 mg, 4 mol %), tfp (9 mg, 8 mol %) and 1-chloro-4-iodobenzene (143 mg, 0.60 mmol) in dry THF               
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(1 mL) was added at −10 °C. The resulting mixture was allowed to warm up to rt and was further stirred 
for 12 h. The reaction mixture was quenched with sat. aq. NH4Cl solution (10 mL), extracted with EtOAc 
(3 × 20 mL) and dried over MgSO4. After filtration, the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography (EtOAc/MeOH= 9.5:0.5) to give 16c (148 mg, 86%) 
as a yellow crystalline solid. 
 
m.p.: 102 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3078, 2917, 2871, 1657, 1618, 1092, 1008, 946, 881, 820. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.58 (s, 1H), 8.71 (d, J = 5.5 Hz, 1H), 7.56–7.47 (m, 2H), 7.47 
–7.39 (m, 2H), 7.31 (d, J = 5.5 Hz, 1H), 6.33 (s, 1H), 5.29 (s, 2H), 3.79–3.75 (m, 2H), 3.52–3.47 (m, 
2H), 3.32 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 163.0, 151.4, 151.1, 148.6, 142.2, 136.1, 133.1, 130.7, 128.8, 
120.2, 119.1, 106.4, 74.2, 71.9, 69.1, 59.0. 
MS (EI, 70 eV): m/z (%) = 344 (4), 286 (22), 269 (35), 256 (87), 234 (35), 89 (39), 59 (100). 
HRMS (EI) calcd. for [C18H17ClN2O3]: 344.0928; found: 344.0924. 
 
4-(2-((2-Methoxyethoxy)methyl)-1-oxo-1,2-dihydro-2,7-naphthyridin-3-yl)benzonitrile (16d) 
 
According to TP2, 2,7-naphthyridone (13, 117 mg, 0.5 mmol) was metalated within 72 h, using 
TMP2Zn·2MgCl2·2LiCl (6, 2.86 mL, 0.6 mmol, 0.21 M in THF, 1.2 equiv). A solution of Pd(dba)2 (12 
mg, 4 mol%), tfp (9 mg, 8 mol%) and 4-iodobenzonitrile (137 mg, 0.60 mmol) in dry THF (1 mL) was 
added at −10 °C. The resulting mixture was allowed to warm up to rt and was further stirred for 12 h. 
The reaction mixture was quenched with sat. aq. NH4Cl solution (10 mL), extracted with EtOAc (3 × 
20 mL) and dried over MgSO4. After filtration, the solvent was evaporated in vacuo. The crude product 
was purified by column chromatography (EtOAc/MeOH= 9.5:0.5) to give 16d (124 mg, 74%) as a 
yellow crystalline solid. 
 
m.p.: 106-108 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 3080, 3046, 2926, 2361, 2231, 1650, 1622, 1103, 1082, 850, 792. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.59 (s, 1H), 8.74 (s, 1H), 7.76 (d, J = 8.6 Hz, 2H), 7.71 (d,        
J = 8.6 Hz, 2H), 7.34 (d, J = 5.2 Hz, 1H), 6.34 (s, 1H), 5.26 (s, 2H), 3.78-3.74 (m, 2H), 3.50–3.46 (m, 
2H), 3.30 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 162.7, 151.3, 151.2, 147.8, 142.0, 138.9, 132.3, 130.2, 120.3, 
119.3, 118.2, 113.8, 106.7, 74.2, 71.8, 69.1, 59.1. 
MS (EI, 70 eV): m/z (%) = 335 (2), 277 (20), 260 (39), 247 (61), 230 (13), 89 (55), 59 (100). 
HRMS (EI) calcd. for [C19H17N3O3]: 335.1270; found: 335.1261. 
 
100 
 
2-((2-Methoxyethoxy)methyl)-3-(4-(trifluoromethyl)phenyl)-2,7-naphthyridin-1(2H)-one (16e) 
 
According to TP2, 2,7-naphthyridone (13, 117 mg, 0.5 mmol) was metalated within 72 h, using 
TMP2Zn·2MgCl2·2LiCl (6, 2.86 mL, 0.6 mmol, 0.21 M in THF, 1.2 equiv). A solution of Pd(dba)2 (12 
mg, 4 mol%), tfp (9 mg, 8 mol%) and 4-iodobenzotrifluoride (163 mg, 0.6 mmol) in dry THF (1 mL) 
was added at −10 °C. The resulting mixture was allowed to warm up to rt and was further stirred for 12 
h. The reaction mixture was quenched with sat. aq. NH4Cl solution (10 mL), extracted with EtOAc (3 × 
20 mL) and dried over MgSO4. After filtration, the solvent was evaporated in vacuo. The crude product 
was purified by column chromatography (EtOAc/MeOH= 9.5:0.5) to give 16e (88 mg, 46%) as a yellow 
solid. 
 
m.p.: 97-99 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 3080, 2926, 2891, 2824, 2361, 2340, 1660, 1611, 1126, 1107, 
1065, 1007, 848. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.60 (s, 1H), 8.74 (d, J = 5.5 Hz, 1H), 7.80–7.67 (m, 4H), 7.34 
(d, J = 5.5 Hz, 1H), 6.36 (s, 1H), 5.30 (s, 2H), 3.83–3.75 (m, 2H), 3.55–3.47 (m, 2H), 3.31 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 162.8, 151.3, 151.0, 148.4, 142.2, 138.1 (q, JCF = 1.1 Hz), 
131.9 (q, JCF = 32.9 Hz), 129.9, 125.6 (q, JCF = 3.7 Hz), 123.9 (q, JCF = 272.8 Hz), 120.3, 119.3, 106.6, 
74.2, 71.9, 69.1, 59.0. 
MS (EI, 70 eV): m/z (%) = 378 (2), 320 (21), 303 (50), 290 (81), 89 (43), 59 (100). 
HRMS (EI) calcd. for [C19H17F3N2O3]: 378.1191; found: 378.1187. 
 
3-(Benzo[d][1,3]dioxol-5-yl)-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (16f) 
 
According to TP2, 2,7-naphthyridone (13, 117mg, 0.5 mmol) was metalated within 72 h, using 
TMP2Zn·2MgCl2·2LiCl (6, 1.71 mL, 0.6 mmol, 0.35 M in THF, 1.2 equiv). A solution of PEPPSI-iPr        
(14 mg, 4 mol%) and 5-bromobenzo[d][1,3]dioxole (121 mg, 0.60 mmol) in dry THF (1 mL) was added 
at  −10 °C. The resulting mixture was allowed to warm up to rt and was further stirred for 12 h at 60 °C. 
The reaction mixture was quenched with sat. aq. NH4Cl solution (10 mL), extracted with EtOAc                 
(3 × 20 mL) and dried over MgSO4. After filtration, the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography (EtOAc/MeOH= 9.5:0.5) to give 16f (141 mg, 80%) 
as a colorless solid. 
 
m.p.: 107 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3071, 2932, 2820, 1657, 1615, 1482, 1234, 1086, 1036, 821.  
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1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.57 (s, 1H), 8.69 (d, J = 5.6 Hz, 1H), 7.39 (d, J = 5.6 Hz, 1H), 
7.09 (d, J = 1.6 Hz, 1H), 7.03 (dd, J = 8.0, 1.6 Hz, 1H), 6.89 (d, J = 8.0 Hz, 1H), 6.38 (s, 1H), 6.06 (s, 
2H), 5.36 (s, 2H), 3.85 –3.76 (m, 2H), 3.56 –3.50 (m, 2H), 3.34 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 162.8, 151.0, 150.0, 149.2, 148.7, 147.8, 143.5, 128.1, 123.5, 
120.4, 119.7, 109.9, 108.5, 106.0, 101.8, 74.5, 71.9, 69.3, 59.1. 
MS (EI, 70 eV): m/z (%) = 354 (14), 279 (20), 278 (12), 267 (34), 266 (100), 249 (23), 89 (10), 59 (41). 
HRMS (EI) calcd. for [C19H18N2O5]: 354.1216; found: 354.1215. 
 
3-(4-Aminophenyl)-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (16g) 
 
According to TP2, 2,7-naphthyridone (13, 117 mg, 0.50 mmol) was metalated within 72 h, using 
TMP2Zn·2MgCl2·2LiCl (6, 2.86 mL, 0.6 mmol, 0.21 M in THF, 1.2 equiv). Using a syringe-pump, the 
zinc-species was then added dropwise to a solution of Pd(OAc)2 (5 mg, 4 mol%), tfp (16 mg, 8 mol%) 
and 4-iodoaniline (131 mg, 0.60 mmol) in dry THF (1 mL) over 1 h at rt. The resulting mixture was 
further stirred for 12 h. Then, the reaction mixture was quenched with sat. aq. NH4Cl solution (10 mL), 
extracted with EtOAc (3 × 20 mL) and dried over MgSO4. After filtration, the solvent was evaporated 
in vacuo. The crude product was purified by column chromatography (EtOAc/MeOH = 9.5:0.5) to give 
16g (124 mg, 76%) as a yellow solid. 
 
m.p.: 109 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3326, 3193, 2926, 1665, 1602, 1511, 1294, 1088, 1044, 832. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.51 (s, 1H), 8.71–8.55 (m, 1H), 7.32–7.27 (m, 1H), 7.24–7.20 
(m, 1H), 6.72–6.64 (m, 2H), 6.27 (s, 1H), 5.30 (s, 2H), 4.04 (br, 2H, NH2), 3.78–3.71 (m, 2H), 3.55–
3.45 (m, 2H), 3.29 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 163.3, 151.4, 150.9, 150.2, 148.0, 142.3, 130.4, 124.2, 119.7, 
118.8, 114.3, 105.7, 74.4, 71.8, 68.9, 58.9. 
MS (EI, 70 eV): m/z (%) = 325 (31), 250 (52), 237 (100), 59 (39). 
HRMS (EI) calcd. for [C18H19N3O3]: 325.1426; found: 325.1422. 
 
2-((2-Methoxyethoxy)methyl)-3-(thiophene-2-carbonyl)-2,7-naphthyridin-1(2H)-one (17a) 
 
According to TP2, 2-7-naphthyridone (13, 117 mg, 0.5 mmol) was metalated within 72 h, using 
TMP2Zn·2MgCl2·2LiCl (6, 2.86 mL, 0.6 mmol, 0.21 M in THF, 1.2 equiv). A solution of CuCN·2LiCl 
(0.55 mmol, 0.55 mL, 1.0 M in THF, 1.1 equiv) was added and the reaction mixture was stirred for        
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10 min at −10 °C before thiophene-2-carbonyl chloride (95 mg, 0.07 mL 0.65 mmol) was added. The 
resulting mixture was allowed to warm up to rt and was further stirred for 12 h. The reaction mixture 
was quenched with sat. aq. NH4Cl/NH3 (10:1 v/v, 10 mL) solution, extracted with EtOAc (3 × 20 mL) 
and dried over MgSO4. After filtration, the solvent was evaporated in vacuo. The crude product was 
purified by column chromatography (EtOAc/isohexane = gradient 2:8–10:0, then EtOAc/MeOH = 
9.5:0.5) to give 17a (88 mg, 52%) as an orange crystalline solid. 
 
m.p.: 79-81°C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3077, 2922, 2855, 1643, 1616, 1407, 1100, 855, 755, 724. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.66 (s, 1H), 8.83 (s, 1H), 7.85 (d, J = 4.7 Hz, 1H), 7.77 (d,         
J = 3.3 Hz, 1H), 7.46 (s, 1H), 7.23–7.19 (m, 1H), 6.73 (s, 1H), 5.92–5.66 (m, 2H), 3.62–3.46 (m, 2H), 
3.30–3.15 (m, 2H), 3.12 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 181.4, 161.5, 150.9, 143.0, 142.4, 141.4, 136.8, 136.4, 135.4, 
134.3, 132.6, 128.6, 107.8, 72.5, 71.2, 68.6, 58.9. 
MS (EI, 70 eV): m/z (%) = 344 (2), 268 (100), 256 (36), 228 (17),111 (35), 97 (18), 89 (25), 59 (84), 
43 (16). 
HRMS (EI) calcd. for [C17H16N2O4S]: 344.0831; found: 344.0830. 
 
3-Benzoyl-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (17b) 
 
According to TP2, 2,7-naphthyridone (13, 117 mg, 0.5 mmol) was metalated within 72 h, using  
TMP2Zn·2MgCl2·2LiCl (6, 1.67 mL, 0.6 mmol, 0.36 M in THF, 1.2 equiv). A solution of CuCN·2LiCl 
(0.55 mmol, 0.55 mL, 1.0 M in THF, 1.1 equiv) was added and the reaction mixture was stirred for          
10 min at −10 °C before benzoyl chloride (91 mg, 0.08 mL, 0.65 mmol, 1.3 equiv) was added. The 
resulting mixture was allowed to warm up to rt and was further stirred for 12 h. The reaction mixture 
was quenched with sat. aq. NH4Cl/NH3 (10:1 v/v, 10 mL) solution, extracted with EtOAc (3 × 20 mL) 
and dried over MgSO4. After filtration, the solvent was evaporated in vacuo. The crude product was 
purified by column chromatography (EtOAc/isohexane = gradient 2:8–10:0, then EtOAc/MeOH = 
9.5:0.5) to give 17b (51 mg, 30%) as a yellow solid. 
 
m.p.: 108 –109 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3063, 2926, 2875, 2361, 2340, 1666, 1618, 1254, 1099, 721. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.64 (s, 1H), 8.79 (d, J = 4.7 Hz, 1H), 7.97 (dd, J = 8.0, 1.3 Hz, 
2H), 7.68 (tt, J = 7.4, 1.3 Hz, 1H), 7.52 (t, J = 7.7 Hz, 2H), 7.40 (d, J = 5.3 Hz, 1H), 6.53 (s, 1H), 5.77 
(s, 2H), 3.56–3.51 (m, 2H), 3.25–3.20 (m, 2H), 3.11 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 189.6, 161.5, 150.8, 150.6, 143.7, 141.5, 135.4, 134.6, 130.6, 
128.8, 120.2, 107.8, 77.4, 72.5, 71.1, 68.7, 58.9. 
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MS (EI, 70 eV): m/z (%) = 338 (2), 264 (10), 263 (54), 262 (100), 251 (13), 250 (29), 221 (11), 105 
(32), 91 (14), 89 (18), 77 (28), 59 (70), 45 (15), 43 (20). 
HRMS (EI) calcd. for [C19H18N2O4]: 338.1267; found: 338.1257. 
 
2-((2-Methoxyethoxy)methyl)-3-(phenylthio)-2,7-naphthyridin-1(2H)-one (19a) 
 
According to TP3, the I/Mg-exchange of 3-iodo-2,7-naphthyridone (15, 144 mg, 0.4 mmol) was 
finished within 20 min, using a solution of iPrMgCl·LiCl (1) in dry THF (0.32 mL, 0.4 mmol, 1.26 M, 
1.0 equiv). The corresponding magnesium derivative was then added dropwise to a solution of S-phenyl 
benzene-thiosulfonate (300 mg, 1.2 mmol) in dry THF (5 mL) at 0 °C via syringe. The resulting mixture 
was allowed to warm up to rt and was further stirred for 12 h. The reaction mixture was quenched with 
sat. aq. NaHCO3 solution (10 mL), extracted with EtOAc (3 × 20 mL) and dried over anhydrous MgSO4. 
After filtration, the solvent was evaporated in vacuo. The crude product was purified by column 
chromatography (EtOAc/MeOH = 9.5:0.5) to give the title compound 23a (98 mg, 0.29 mmol, 72%) as 
a brown solid. 
 
m.p.: 69-70 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3070, 2924, 2883, 2815, 1660, 1596, 1523, 1102, 1080, 740.  
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.44 (s, 1H), 8.55 (d, J = 5.4 Hz, 1H), 7.55–7.48 (m, 2H), 7.47–
7.39 (m, 3H), 6.99 (d, J = 5.4 Hz, 1H), 5.96 (s, 1H), 5.82 (s, 2H), 3.87–3.73 (m, 2H), 3.56–3.45 (m, 2H), 
3.33 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 162.9, 151.5, 151.1, 148.4, 141.6, 134.2, 130.2, 130.1, 129.9, 
118.5, 118.1, 105.5, 74.0, 71.6, 69.1, 59.1. 
MS (EI, 70 eV): m/z (%) = 342 (31), 267 (29), 254 (81), 195 (11), 165 (11), 145 (10), 89 (31), 59 (100). 
HRMS (EI) calcd. for [C18H18N2O3S]: 342.1038; found: 342.1034. 
 
2-((2-Methoxyethoxy)methyl)-1-oxo-1,2-dihydro-2,7-naphthyridine-3-carbonitrile (19b) 
 
According to TP3, the I/Mg-exchange of 3-iodo-2,7-naphthyridone (15, 72 mg, 0.2 mmol) was finished 
within 20 min using a solution of iPrMgCl·LiCl (1) in dry THF (0.16 mL, 0.2 mmol, 1.26 M, 1.0 equiv). 
The corresponding magnesium derivative was then added dropwise to a solution of p-toluenesulfonyl 
cyanide (54 mg, 0.3 mmol) in dry THF (3 mL) at 0 °C via syringe. The resulting mixture was allowed 
to warm up to rt and was further stirred for 12 h. The reaction mixture was quenched with sat. aq. 
NaHCO3 solution (10 mL), extracted with EtOAc (3 × 20 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated in vacuo. The crude product was purified by column chromato-
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graphy (EtOAc/MeOH = 9:1) to give the title compound 19b (32 mg, 0.12 mmol, 60%) as a light brown 
solid. 
 
m.p.: 75 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3064, 2925, 2854, 2236, 1665, 1616, 1126, 1071, 978, 791.  
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.64 (s, 1H), 8.89 (s, 1H), 7.44 (d, J = 5.2 Hz, 1H), 7.08 (s, 
1H), 5.68 (s, 2H), 3.97–3.72 (m, 2H), 3.63–3.45 (m, 2H), 3.30 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 160.8, 152.5, 151.8, 140.1, 122.0, 120.4, 119.7, 115.7, 112.6, 
75.5, 71.7, 69.8, 59.2. 
MS (EI, 70 eV): m/z (%) = 259 (1), 200 (14), 184 (33), 172 (14), 171 (159), 154 (25), 89 (55), 59 (100), 
58 (21), 45 (21). 
HRMS (EI) calcd. for [C13H13N3O3]: 259.0957; found: 259.0961. 
 
3-Bromo-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (19c) 
 
According to TP3, the I/Mg-exchange of 3-iodo-2,7-naphthyridone (15, 144 mg, 0.4 mmol) was 
finished within 20 min using a solution of iPrMgCl·LiCl (1) in dry THF (0.32 mL, 0.4 mmol, 1.26 M, 
1.0 equiv). The corresponding magnesium derivative was then added dropwise to a solution of 1,2-
dibromo-tetrachloroethane (260 mg, 0.80 mmol) in dry THF (5 mL) at 0 °C via syringe. The resulting 
mixture was allowed to warm up to rt and was further stirred for 12 h. The reaction mixture was 
quenched with sat. aq. NaHCO3 solution (10 mL), extracted with EtOAc (3 × 20 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated in vacuo. The crude product was purified 
by column chromatography (EtOAc/MeOH = 9.5:0.5) to give the title compound 19c (74 mg, 
0.24 mmol, 60%) as a black crystalline solid. 
 
dec.: 345 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3044, 2924, 2854, 1738, 1689, 1634, 1574, 1531, 1175, 1076. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.48 (s, 1H), 8.71 (d, J = 5.5 Hz, 1H), 7.24 (d, J = 5.5 Hz, 1H), 
6.79 (s, 1H), 5.77 (s, 2H), 3.97–3.72 (m, 2H), 3.64–3.46 (m, 2H), 3.31 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 162.3, 151.7, 151.6, 142.3, 127.1, 119.6, 118.2, 109.7, 76.9, 
71.7, 69.4, 59.1. 
MS (EI, 70 eV): m/z (%) = 312 (1), 226 (16), 224 (17), 145 (17), 89 (72), 59 (100), 45 (19).  
HRMS (EI) calcd. for [C12H13BrN2O3]: 312.0110; found: 312.0104. 
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2.5 Further Functionalization of 2,7-Naphthyridines and Synthesis of Natural 
Products Lophocladine A & B 
 
1,8-Bis(butylthio)-3,6-dichloro-4-(chloromethyl)-2,7-naphthyridine (21)129 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was      
charged with (1,8-bis-(butylthio)-3,6-dichloro-2,7-naphthyridin-4-yl)methyl)-N,N-dimethyl-methane-
amine (12e, 593 mg, 1.29 mmol, 1.0 equiv) in dry CHCl3 (2 mL). The solution was cooled to 0 °C and 
ethyl chloroformate (278 mg, 2.58 mmol, 2.0 equiv) was added dropwise. After stirring the reaction for 
18 h at 0 °C, the mixture was then quenched with H2O (10 mL) and extracted with EtOAc (3 × 10 mL). 
The combined organic layers were washed with a sat. aq. NaCl solution (10 mL), dried over MgSO4, 
filtered and concentrated in vacuo. The crude product was purified by flash column chromatography 
(isohexane/EtOAc = 100:1) to afford 21 (452 mg, 82%) as a slightly yellow solid. 
 
m.p.: 80-82 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2955, 2929, 1588, 1554, 1535, 1480, 1455, 1422, 1131, 1089, 892, 
832. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.36 (s, 1H), 4.92 (s, 2H), 3.37-3.29 (m, 4H), 1.82-1.73 (m, 
4H), 1.58-1.47 (m, 4H), 0.99 (t, J = 7.4 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 164.8, 164.5, 149.4, 140.5, 144.3, 120.6, 114.6, 110.5, 40.0, 
33.5, 30.4, 22.5, 13.9. 
MS (EI, 70 eV): m/z (%) = 369 (39), 367 (100), 365 (94), 330 (30), 311 (92), 309 (80), 277 (33), 273 
(51), 57 (65), 41 (94). 
HRMS (EI) calcd. for [C17H21Cl3N2S2]: 422.0212; found: 422.0207. 
 
3,6-Dichloro-1,8-dimethyl-2,7-naphthyridine (22) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with copper iodide (16.56 g, 87 mmol, 3.0 equiv) and dried for 10 min at 450 °C under high vacuum. 
The flask was refilled with argon, followed by dry THF (500 mL). Then, the flask was cooled to -40 °C 
and a solution of MeLi (115 mL, 174 mmol, 1.51 M in THF, 6.0 equiv) was slowly added. The mixture 
was stirred at -40 °C for approximately 30 min until the solution was completely clear. Another dry, 
argon-flushed round-bottom Schlenk-flask, equipped with a magnetic stirring bar, was charged with 1,8-
bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 10.85 g, 29 mmol, 1.0 equiv) in dry THF (270 mL). 
The solution was cooled to -40 °C and then slowly added via cannula to the Me2CuLi solution.  
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After the complete addition, the reaction mixture was stirred at -40 °C for 2 h. Then, the mixture was 
quenched with sat. aq. NH4Cl/NH3 solution (10:1 v/v, 10 mL, extracted with EtOAc (3 × 100 mL) and 
dried over MgSO4. After filtration, the crude product was purified by flash column chromatography 
(isohexane/EtOAc = 8:2) to afford 22 (5.5 g, 84%) as an off-white solid. 
 
m.p.: 143-145 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2960, 2932, 1588, 1534, 1454, 1421, 1388, 1323, 1184, 1131, 
1048, 891. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.43 (s, 2H), 3.13 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 162.0, 148.3, 145.0, 121.7, 116.9, 29.2. 
MS (EI, 70 eV): m/z (%) = 228 (64), 227 (19), 226 (100), 191 (13), 189 (11), 164 (14), 156 (11), 155 
(16), 128 (12), 123 (10), 114 (8), 63 (11). 
HRMS (EI) calcd. for [C10H8Cl2N2]: 226.0065; found: 226.0071. 
 
1,8-Di(but-3-en-1-yl)-3,6-dichloro-2,7-naphthyridine (23) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 113 mg, 0.5 mmol, 1.0 equiv) in dry THF (1 mL). 
The solution was cooled to 0 °C and TMPZnCl·LiCl (5, 1.83 mL, 1.5 mmol, 0.82 M in THF 3.0 equiv) 
was slowly added. Then, the reaction mixture was allowed to warm to 25 °C and stirred for 2 h. After 
cooling back to 0 °C, a 1.0 M solution of CuCN·2LiCl (0.1 mL, 0.1 mmol, 0.2 equiv) and allyl bromide 
(0.26 mL, 3.0 mmol, 6.0 equiv) was added. The reaction mixture was allowed to slowly warm up to rt 
and was further stirred for 2 h. Then, the mixture was quenched with sat. aq. NH4Cl/NH3 solution (10:1 
v/v, 10 mL), extracted with EtOAc (3 × 10 mL) and dried over MgSO4. After filtration, the crude product 
was purified by flash column chromatography (isohexane/EtOAc = 100:0.4) to afford 23 (92 mg, 60%) 
as a brown oil. 
 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3076, 2977, 2908, 1580, 1526, 1332, 1129, 901, 894, 875. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.43 (s, 2H), 5.97-5.90 (m, 2H), 5.12 (d, J = 17.1 Hz, 2H), 5.04 
(d, J = 10.1 Hz, 2H), 3.47 (t, J = 8.2 Hz, 4H), 2.62 (m, 4H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 164.2, 148.2, 145.4, 137.0, 120.6, 117.0, 115.9, 39.0, 33.8. 
MS (EI, 70 eV): m/z (%) = 306 (15), 293 (39), 291 (64), 279 (50), 277 (68), 267 (26), 265 (54), 263 
(31), 253 (56), 251 (100), 239 (42), 237 (58), 229 (20), 201 (25). 
HRMS (EI) calcd. for [C16H16Cl2N2]: 306.0691; found: 306.0672. 
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1-(Butylthio)-3,6-dichloro-8-((trimethylsilyl)ethynyl)-2,7-naphthyridine (24)131 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was    
charged with 1,8-bis(butylthio)-3,6-dichloro-2,7-naphthyridine (9c, 100 mg, 0.27 mmol, 1.0 equiv), 
Pd(PPh3)2Cl2 (19 mg, 0.027 mmol, 0.1 equiv), triphenylphosphine (3.5 mg, 0.013 mmol, 0.05 equiv), 
(trimethylsilyl)acetylene (0.11 mL, 0.80 mmol, 3.0 equiv) and triethylamine (0.11 mL, 0.80 mmol, 3.0 
equiv) in dry THF (1 mL). The mixture was stirred at 25 °C for 20 min, followed by the addition of 
copper iodide (1 mg, 0.005 mmol, 0.02 equiv). After stirring the reaction at 25 °C for 24 h, the solvent 
was removed on a rotary evaporator. The residue was redissolved in DCM (5 mL) and filtered through 
Celite. The filtrate was concentrated in vacuo and finally purified by flash column chromato-graphy 
(isohexane/EtOAc = 100:2) to afford 24 (49 mg, 48%) as yellow crystals. 
 
m.p.: 160-162 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2954, 2899, 1590, 1501, 1321, 1244, 1121, 892, 839, 756, 700.  
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.42 (s, 1H), 7.14 (s, 1H), 3.27 (t, J = 7.4 Hz, 2H), 1.76 (quint, 
J = 7.4 Hz, 2H), 1.55 (sxt, J = 7.4 Hz, 2H), 0.99 (t, J = 7.1 Hz, 3H), 0.35 (s, 9H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 165.3, 149.3, 148.7, 144.6, 142.5, 121.7, 118.6, 112.8, 109.1, 
103.6, 32.3, 30.1, 22.5, 13.9, -0.8. 
HRMS (EI) calcd. for [C17H20Cl2N2SSi]: 382.0494; found: 382.0488. 
 
3-(Bis(trimethylsilyl)methyl)-6-chloro-1,8-dimethyl-2,7-naphthyridine (25)172 
 
A dry and argon flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 113 mg, 0.5 mmol, 1.0 equiv) and Pd(PPh3)4          
(58 mg, 0.05 mmol, 0.1 equiv) in dry toluene (2.5 mL). Then, (TMS)2CHMgBr·LiCl (2.2 mL, 1.5 mmol, 
0.68 M in THF, 3.0 equiv) was added dropwise and the reaction mixture was stirred for 8 h at 50 °C. 
After a full conversion was monitored by GC analysis of reaction aliquots, sat. aq. NH4Cl solution (10 
mL) was added, followed by extraction with EtOAc (3 × 5 mL). The combined organic layers were dried 
over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (isohexane/EtOAc = 19:1) to afford 25 (102 mg, 58%) as a white solid. 
 
 
 
                                                 
172 (a) T. Klatt, V. Werner, M. G. Maximova, D. Didier, Y. Apeloig, P. Knochel, Chem. Eur. J. 2015, 21, 7830. (b) V. Werner, T. 
Klatt, M. Fujii, J. Markiewicz, Y. Apeloig, P. Knochel, Chem. Eur. J. 2014, 20, 8338. 
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m.p.: 136-137 °C. 
IR (Diamond ATR): 𝜈/ cm-1 = 2952, 1591, 1535, 1245, 1199, 1135, 1038, 889, 824, 776, 683, 665.  
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.30 (s, 1 H), 6.86 (s, 1 H), 3.07 (s, 3 H), 3.04 (s, 3 H), 1.88 (s, 
1H), 0.04 (s, 18 H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 161.6, 161.1, 158.6, 146.5, 143.8, 119.7, 116.6, 113.9, 33.2, 
29.1, 28.8, 0.18. 
MS (EI, 70 eV): m/z (%) = 350 (10), 338 (12), 337 (45), 336 (30), 335 (100), 262 (15), 241 (12), 73 
(55). 
HRMS (EI) calcd. for [C17H27ClN2Si2]: 350.1401; found: 350.1395. 
 
3-(Bis(trimethylsilyl)methyl)-4-bromo-6-chloro-1,8-dimethyl-2,7-naphthyridine (26) 
 
3-(Bis(trimethylsilyl)methyl)-6-chloro-1,8-dimethyl-2,7-naphthyridine (25, 70 mg, 0.2 mmol) was 
dissolved in dry MeCN (8 mL). Then NBS (178 mg, 1.0 mmol, 5.0 equiv) was added and the reaction 
mixture was stirred at 30 °C overnight.  Subsequently, the solvent was removed in vacuo and the residue 
dissolved in a small amount of EtOAc. Purification via column chromatography (100% EtOAc) afforded 
pure 26 (69 mg, 98%) as a brown solid. 
 
dec.: 102 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1577, 1532, 1420, 1378, 1337, 1284, 1248, 1181, 1142, 1072, 
1035, 965, 901, 840, 826, 779, 685. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 7.87 (s, 1H), 3.10 (s, 3H), 3.02 (s, 3H), 2.73 (s, 1H), 0.07 (s, 
18H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 161.8, 161.7, 148.9, 143.1, 121.3, 117.8, 113.8, 33.4, 29.4, 
29.1. 
MS (EI, 70 eV): m/z (%) = 428 (5), 417 (32), 415 (100), 413 (69), 349 (15), 342 (18), 340 (12), 321 
(10), 139 (15), 137 (12), 73 (47). 
HRMS (EI) calcd. for [C17H26BrClN2Si2]: 428.0506; found: 428.0508. 
 
2-(Bis(trimethylsilyl)methyl)-3-bromo-6-methylpyridine (29) 
 
2-(Bis(trimethylsilyl)methyl)-6-methylpyridine (28, 753 mg, 3.3 mmol) was dissolved in dry MeCN        
(10 mL). Then, NBS (578 mg, 3.3 mmol, 1.1 equiv) was added in portions and the reaction mixture was 
stirred at 30 °C overnight.  Subsequently, the solvent was removed in vacuo and the residue dissolved 
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in a small amount of EtOAc. Purification via column chromatography (100% isohexane) afforded pure 
29 (706 mg, 72%) as a colorless oil. 
 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2953, 2914, 2849, 1735, 1560, 1471, 1427, 1269, 1247, 1176, 
1028, 861, 836, 772, 716, 686. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 7.51 (d, J = 8.2 Hz, 1H), 6.56 (d, J = 8.7 Hz, 1H), 2.55 (s, 3H), 
1.77 (s, 1H), 0.02 (s, 18H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 162.5, 155.7, 139.1, 121.5, 115.5, 32.6, 24.8, 0.3. 
MS (EI, 70 eV): m/z (%) = 329 (5), 317 (19), 316 (100), 314 (93), 241 (14), 73 (50), 43 (69). 
HRMS (EI) calcd. for [C13H24BrNSi2]: 329.0631; found: 329.0636. 
 
1-Chloro-2,7-naphthyridine (30) 
 
2,7-Naphthyridin-1-one (8, 3.02 g, 20.7 mmol) and POCl3 (21 mL, 0.22 mol) were sealed in a pressure 
tube, equipped with a magnetic stirring bar, and heated to 130 °C for 18 h. The resulting solution was 
then poured on ice and neutralized with K2CO3. The brown suspension was extracted with DCM (5 × 
200 mL), the organic phase washed with brine and dried over MgSO4. After removing the solvent in 
vacuo, the crude compound was purified by flash column chromatography (DCM/Methanol = 10:0.3) 
to afford 30 (1.51 g, 44%) as a yellow solid. 
 
m.p.: 117 – 119 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1615, 1536, 1329, 1263, 1229, 978, 860, 854, 796, 697. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.74 (s, 1H), 8.81 (d, J = 5.7 Hz, 1H), 8.46 (d, J = 5.8 Hz, 1H), 
7.65 (dd, J = 5.8 Hz, 1H), 7.59 (d, J = 5.8 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 152.2, 151.5, 147.9, 145.7, 140.7, 122.0, 119.3, 118.9. 
MS (EI, 70 eV): m/z (%) = 166 (32), 165 (10), 164 (100), 129 (48), 102 (11). 
HRMS (EI) calcd. for [C8H5ClN2]: 164.0141; found: 164.0151. 
 
1-(Butylthio)-2,7-naphthyridine (31) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 1-chloro-2,7-naphthyridine (30, 436 mg, 2.65 mmol, 1.0 equiv) and dry THF (6 mL). Lithium               
nbuthylthiolate (4 mL, 3.97 mmol, 1.0 M in THF 1.5 equiv) was added dropwise to the solution at                  
-40 °C. After stirring the mixture for 30 min at this temperature, the reaction was quenched with sat. aq. 
NH4Cl solution and extracted with EtOAc (450 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo. The crude residue was purified by flash column chromato-
graphy (isohexane/EtOAc = 8:2) to afford 31 (531 mg, 92%) as a yellow oil.  
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IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2957, 2929, 1610, 1580, 1531, 1464, 1324, 1266, 1222, 1202, 
1047, 987, 846, 700. 
1H-NMR (400 MHz, CDCl3): δ/ ppm= 9.62 (s, 1H), 8.68 (d, J = 5.8 Hz, 1H), 8.43 (d, J = 5.8 Hz, 1H), 
7.52 (d, J = 5.5 Hz, 1H), 7.24 (d, J = 5.5 Hz, 1H), 3.38 (t, J = 7.2 Hz, 2H), 1.77 (quint, J = 7.2 Hz, 2H), 
1.52 (sxt, J = 7.2 Hz, 2H), 0.96 (t, J = 7.2 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 161.9, 149.6, 147.2, 145.8, 138.8, 122.4, 119.4, 115.1, 31.2, 
29.3, 22.1, 13.7. 
MS (EI, 70 eV): m/z (%) = 218 (15), 189 (29), 185 (11), 176 (68), 175 (43), 163 (17), 162 (100), 130 
(16), 129 (31).  
HRMS (EI) calcd. for [C12H14N2S]: 218.0878; found: 218.0877. 
 
4-(2,7-Naphthyridin-1-yl)butanenitrile (32) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 1-(nbutylthio)-2,7-naphthyridine (31, 85 mg, 0.4 mmol), Pd(OAc)2 (5.0 mg, 5 mol%), S-Phos (16 
mg, 10 mol%) and dry THF (1 mL). Then, (3-cyanopropyl)zinc iodide (0.64 mL, 0.6 mmol, 0.94 M in 
THF, 1.5 equiv) was added and the mixture was stirred at rt overnight. The reaction was quenched with 
sat. aq. NH4Cl solution (10 mL), extracted with EtOAc (3 × 10 mL) and dried over MgSO4. After 
filtration, the solvents were removed in vacuo. Purification by flash column chromatography (isohexane/ 
EtOAc = 8:2, gradient to 100% EtOAc) furnished pure 32 (59 mg, 74%) as a brown solid. 
 
m.p.: 85-86 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1616, 1552, 1456, 1430, 1398, 1384, 1275, 1216, 1111, 1076, 
1046, 995, 864, 740. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.61 (s, 1H), 8.73 (d, J = 5.5 Hz ,1H), 8.60 (d, J = 5.8 Hz, 1H), 
7.63 (d, J = 5.5 Hz, 1H), 7.51 (d, J = 5.8 Hz, 1H), 3.54 (t, J = 7.2 Hz, 2H), 2.58 (t, J = 7.1 Hz, 2H), 2.35 
(quint, J = 7.3 Hz, 2H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 160.6, 150.1, 147.0, 145.9, 139.1, 122.3, 119.8, 119.5, 118.3, 
32.4, 23.9, 17.0. 
MS (EI, 70eV): m/z (%) = 197 (3), 196 (3), 157 (24), 145 (10), 144 (100), 130 (6). 
HRMS (EI) calcd. for [C12H11N3]: 197.0953; found: 197.0943. 
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1-(4-Bromo-1-(butylthio)-2,7-naphthyridine (33) 
 
1-(Butylthio)-2,7-naphthyridine (31, 110 mg, 0.50 mmol, 1.0 equiv) was dissolved in dry MeCN (3 mL). 
NBS (223 mg, 1.25 mmol, 2.5 equiv) was added and the reaction mixture was stirred at 35 °C for 17 h. 
Subsequently, the solvent was removed in vacuo and the residue dissolved in a small amount of EtOAc. 
Purification via column chromatography (isohexane/EtOAc = 40:1) afforded pure 33 (75 mg, 51%) as 
a colorless oil. 
 
m.p.: 60 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2954, 2924, 2857, 1597, 1520, 1466, 1375, 1323, 1275, 1229, 
1213, 1048, 993, 915, 828, 822, 721, 705. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.59 (s, 1H), 8.81 (d, J = 5.6 Hz, 1H), 8.61 (s, 1H), 7.84 (d,        
J = 5.8 Hz, 1H), 3.36 (t, J = 7.4 Hz, 2H), 1.76 (quint, J = 7.5 Hz, 2H), 1.52 (sept, J = 7.4 Hz, 2H), 0.97 
(t, J = 7.4 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ/ ppm = 161.7, 149.8, 148.6, 147.1, 138.1, 123.3, 118.7, 113.6, 31.2, 
29.7, 22.3, 13.8.  
MS (EI, 70 eV): m/z (%) = 298 (24), 296 (24), 269 (24), 267 (25), 256 (76), 255 (52), 254 (75), 253 
(42), 242 (100), 230 (100), 161 (34), 160 (22), 129 (27), 128 (20), 41 (25). 
HRMS (EI) calcd. for [C12H13BrN2S]: 295.9983; found: 295.9975. 
 
4-Iodo-2,7-naphthyridin-1(2H)-one (34)134 
 
To a solution of 2,7-naphthyridin-1(2H)-one (8, 0.5 g, 3.42 mmol) in H2O (10 mL) was added a solution 
of NaOH (0.86 g, 21.5 mmol, 6.3 equiv) and NaOAc (4.33 g, 31.8 mmol, 9.3 equiv) in H2O (30 mL). 
The solution was stirred under reflux. Then I2 (3.04 g, 12.0 mmol, 3.5 equiv) was added. The solution 
was acidified with 50% AcOH and subsequently neutralized with 32% NaOH. This acidification-
neutralization procedure was performed under reflux conditions and repeated three more times within 
20 min. In the third acidification step, 50% AcOH was added until free iodine was generated. After 
removal of excess iodine by boiling, the residue was filtered, washed with hot water, and dried to give 
compound 34 (0.56 g, 60%) as a light brown solid. 
 
dec.: 280 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 3033, 2605, 1880, 1681, 1599, 1472, 1194, 837, 807, 650. 
1H-NMR (400 MHz, DMSO-d6): δ/ ppm = 11.87 (s, 1H), 9.21 (s, 1H), 8.81 (s, 1H), 7.83 (s, 1H), 7.45 
(s, 1H). 
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13C-NMR (100 MHz, DMSO-d6): δ/ ppm = 160.6, 152.3, 150.2, 143.6, 140.6, 122.6, 121.7, 67.9. 
MS (EI, 70 eV): m/z (%) = 272 (100), 145 (10), 90 (13), 73 (19), 63 (12), 44 (13). 
HRMS (EI): calcd. for [C8H5IN2O]: 271.9447; found: 271.9437. 
 
4-Phenyl-2,7-naphthyridin-1(2H)-one (Lophocladine A) (35) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 4-iodo-2,7-naphthyridin-1(2H)-one (34, 200 mg, 0.74 mmol, 1.0 equiv), followed by Pd(OAc)2       
(8 mg, 0.04 mmol, 5 mol%) and S-Phos (30 mg, 0.08 mmol, 10 mol%) in dry THF (2 mL). Then, a 
solution of phenylzinc chloride (3.03 mL, 1.09 mmol, 0.36 M in THF, 1.5 equiv) was added via syringe 
pump within 1 h to the reaction mixture. The reaction was stirred for further 3 h at rt. Then, the reaction 
was quenched with sat. aq. NH4Cl solution (5 mL), extracted with chloroform (3 × 10 mL) and dried 
over MgSO4. After filtration, the solvents were removed in vacuo. The crude product was purified via 
HPLC with a gradient of MeCN/H2O. After removal of MeCN, the aq. layer was extracted with chloro-
form (3 × 40 mL). The combined organic layers were dried over MgSO4, filtered and concentrated in 
vacuo to give pure Lophocladine A (35, 67 mg, 41%) as a white solid.  
 
m.p.: 260 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1667, 1590, 1474, 1339, 1244, 1193, 1031, 883, 842, 797, 765, 
705. 
1H-NMR (400 MHz, DMSO-d6): δ/ ppm = 11.84 (br, 1H), 9.40 (d, J = 0.8 Hz, 1H), 8.70 (d, J = 5.7 
Hz, 1H), 7.52-7.42 (m, 5H), 7.40-7.37 (m, 2H). 
13C-NMR (100 MHz, DMSO-d6): δ/ ppm = 160.8, 151.2, 150.3, 141.8, 134.8, 132.9, 129.5, 128.8, 
127.7, 120.6, 117.2, 115.7. 
MS (EI, 70 eV): m/z (%) = 222 (100), 221 (28), 166 (11), 139 (17), 84 (7). 
HRMS (EI) calcd. for [C14H10N2O]: 222.0793; found: 222.0788. 
 
1-Chloro-4-iodo-2,7-naphthyridine (36) 
 
A pressure tube, equipped with a magnetic stirring bar, was charged with 4-iodo-2,7-naphthyridin-
1(2H)-one (34, 0.50 g, 1.84 mmol) and POCl3 (5.0 mL, 54.8 mmol, 30 equiv). The mixture was heated 
up to 140 °C and was stirred at that temperature for 18 h. After cooling to rt, the mixture was carefully 
poured onto ice (50 g) and was made alkaline with potassium carbonate. The mixture was extracted 
extensively several times with CHCl3. The combined organic layers were dried over MgSO4, filtered 
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and concentrated in vacuo. The crude residue was purified by flash column chromatography (isohexane/ 
EtOAc = 9:1) to afford 36 (502 mg, 94%) as a light-yellow solid. 
 
m.p.: 189 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1732, 1602, 1526, 1413, 1385, 1328, 1269, 1220, 1046,  
985, 912, 836, 783, 699. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.65 (s, 1H), 8.92 (d, J = 5.9 Hz, 1H), 8.87 (s, 1H), 7.83 (dd,   
J = 5.9, 0.8 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 153.1, 151.9, 149.5, 142.7, 123.1, 93.7. 
MS (EI, 70 eV): m/z (%) = 289 (50), 232 (18), 189 (19), 163 (21), 107 (28), 61 (20), 44 (26) 43 (100). 
HRMS (EI) calcd. for [C8H4ClIN2]: 289.9108; found: 289.9091 
 
1-Chloro-4-phenyl-2,7-naphthyridine (37) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was    
charged with 1-chloro-4-iodo-2,7-naphthyridine (36, 250 mg, 0.86 mmol), Pd(dba)2 (26 mg, 0.05 mmol,             
5.0 mol%), tfp (21 mg, 0.09 mmol, 10 mol%) and dry THF (1 mL). Then, phenylzinc chloride (2 mL, 
0.90 mmol, 0.45 M in THF, 1.5 equiv) was added and the reaction mixture was stirred at rt overnight. 
The reaction was quenched with sat. aq. NH4Cl solution (10 mL), extracted with EtOAc (3 × 10 mL) 
and dried over MgSO4. After filtration, the solvents were removed in vacuo. Purification by flash column 
chromatography (first isohexane, then isohexane/EtOAc = 7:3) furnished pure 37 (170 mg, 82%) as a 
brown solid. 
 
m.p.: 149 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1601, 1532, 1450, 1426, 1392, 1340, 1308, 1267, 1176, 1044, 985, 
916, 844, 828, 755, 700. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.84 (s, 1H), 8.78 (d, J = 6.0 Hz, 1H), 8.50 (s, 1H), 7.81 (d,        
J = 6.7 Hz, 1H), 7.61–7.52 (m, 3H), 7.50–7.45 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 151.7, 151.0, 146.7, 145.8, 140.1, 134.3, 132.7, 130.0, 129.3, 
129.1, 121.8, 118.4. 
MS (EI, 70 eV): m/z (%) = 242 (33), 241 (27), 240 (100), 239 (38), 205 (12), 177 (10), 151 (7). 
HRMS (EI) calcd. for [C14H9ClN2]: 240.0454; found: 240.0444. 
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4-Phenyl-2,7-naphthyridin-1-amine (Lophocladine B) (38) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Pd2(dba)3 (20 mg, 0.021 mmol, 5 mol%) and 2-dicyclohexylphosphinobiphenyl (18 mg, 0.050 
mmol, 12 mol%). The Schlenk-flask was evacuated and back-filled with argon. 1-chloro-4-phenyl-2,7-
naphthyridine (100 mg, 0.42 mmol) in 2 mL dry THF and LiHMDS (0.50 mL, 0.50 mmol, 1.0 M in 
THF, 1.2 equiv) were added via syringe. The reaction mixture was heated at 65 °C for 12 h. After cooling 
to rt, aq. HCl (5 mL, 1 M) was added and the mixture was stirred for 10 min. Then, the solution was 
neutralized by the addition of aq. NaOH. The crude mixture was extracted with chloroform (3 × 5 mL), 
dried over Na2SO4, filtered, and concentrated in vacuo. The product was purified by flash column 
chromatography (first only EtOAc, then add 1% NEt3) to give pure Lophocladine B (38, 90 mg, 98%) 
as a white solid.  
 
m.p.: 229-232 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 3114, 1678, 1615, 1585, 1545, 1463, 1447, 1353, 1316, 1277, 
1202, 1030, 933, 826, 802, 752, 700. 
1H-NMR (400 MHz, DMSO-d6): δ/ ppm = 9.61 (s, 1H), 8.57 (d, J = 5.9 Hz, 1H), 7.98 (s, 1H), 7.51-
7.36 (m, 6H). 
13C-NMR (100 MHz, DMSO-d6): δ/ ppm = 157.5, 149.2, 147.5, 146.2, 138.2, 136.5, 129.6, 128.7, 
127.1, 120.2, 116.4, 111.8. 
MS (EI, 70 eV): m/z (%) = 222 (16), 221 (100), 220 (68), 192 (8), 84 (40), 46 (10), 44 (29).  
HRMS (EI) calcd. for [C14H11N3]: 221.0953; found: 221.0951. 
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3. ORGANOMETALLIC FUNCTIONALIZATION OF THE 1,5-NAPHTHYRIDINE SCAFFOLD 
 
3.1 Typical Procedures 
 
Typical Procedure for the Metalation of 1,5-naphthyridine (39) in Position 4 (TP1): 
To a solution of 1,5-naphthyridine (39) in THF (0.5 M related to substrate) was added dropwise a solution 
of TMP2Mg·2LiCl (4, 1.1 equiv) at -78 °C. After full metalation (5 min, checked by iodolysis via 
GC/GC-MS), the solution was cannulated dropwise to a solution of the electrophile in THF, which was 
precooled to -78 °C. After warming to rt, the reaction mixture was stirred until completion. The reaction 
mixture was quenched with a sat. aq. NH4Cl solution (10 mL/mmol 1,5-naphthyridine) and extracted 
with EtOAc (3 × 50 mL/mmol 1,5-naphthyridine). The organic phase was then dried over Na2SO4, 
filtered and concentrated in vacuo. The crude product was purified via flash column chromatography on 
silica gel using the appropriate eluent. 
 
Typical Procedure for the Metalation of 3-chloro-1,5-naphthyridines (45a-b) in Position 4 (TP2): 
3-Chloro-1,5-naphthyridine derivative 45a or 45b was dissolved in THF (0.25 M related to substrate) 
and cooled to -40 °C. Then, TMPMgCl·LiCl (3, 1.1 equiv) was added dropwise and the reaction was 
stirred until full metalation was observed (1 h, checked by iodolysis via GC/GC-MS). Then, a solution 
of the electrophile in THF was added dropwise and the reaction was stirred until completion. The 
reaction mixture was quenched with a sat. aq. NH4Cl solution (10 mL/mmol 1,5-naphthyridine) and 
extracted with EtOAc (3 × 50 mL/mmol 1,5-naphthyridine). The organic phase was then dried over 
Na2SO4, filtered and concentrated in vacuo. The crude product was purified via flash column 
chromatography on silica gel using the appropriate eluent. 
 
Typical Procedure for the Metalation of 4-bromo-1,5-naphthyridine (42b) in Position 8 (TP3): 
4-Bromo-1,5-naphthyridine (42b) was dissolved in THF (0.25 M related to substrate) and cooled to              
-40 °C. Then, TMPMgCl·LiCl (3, 1.1 equiv) was added dropwise and the reaction was stirred until full 
metalation was observed (1 h, checked by iodolysis via GC/GC-MS). Then, a solution of the electrophile 
in THF was added dropwise and the reaction was stirred until completion. The reaction mixture was 
quenched with a sat. aq. NH4Cl solution (10 mL/mmol 1,5-naphthyridine) and extracted with EtOAc     
(3 × 50 mL/mmol 1,5-naphthyridine). The organic phase was then dried over Na2SO4, filtered and 
concentrated in vacuo. The crude product was purified via flash column chromatography on silica gel 
using the appropriate eluent. 
 
Typical Procedure for the Metalation of 1,5-naphthyridine derivative 42c in Position 8 (TP4): 
1,5-Naphthyridine derivative 42c was dissolved in THF (0.25 M related to substrate) and TMPZnCl·LiCl 
(5, 1.5 equiv) was added dropwise. The reaction was stirred at rt until full metalation was observed          
(1 h, checked by iodolysis via GC/GC-MS). Then, a solution of the electrophile in THF was added 
dropwise and the reaction was stirred until completion. The reaction mixture was quenched with a sat. 
aq. NH4Cl solution (10 mL/mmol 1,5-naphthyridine) and extracted with EtOAc (3 × 50 mL/mmol 1,5-
naphthyridine). The organic phase was then dried over Na2SO4, filtered and concentrated in vacuo. The 
crude product was purified via flash column chromatography on silica gel using the appropriate eluent. 
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Typical Procedure for the Metalation of 1,5-naphthyridine derivatives 42a and 42g in Position 2 
(TP 5): 
1,5-Naphthyridine derivative 42a or 42g was dissolved in THF (0.25 M related to substrate) and cooled 
to 0 °C. Then, BF3·OEt2 (1.1 equiv) was added dropwise and the reaction mixture was stirred for 10 min. 
After cooling to -40 °C, TMPMgCl·LiCl (3, 1.1 equiv) was added and the reaction was stirred until full 
metalation was observed (1 h, checked by iodolysis via GC/GC-MS). Then, a solution of the electrophile 
in THF was added dropwise and the reaction was stirred until completion. The reaction mixture was 
quenched with a sat. aq. NH4Cl solution (10 mL/mmol 1,5-naphthyridine) and extracted with EtOAc     
(3 × 50 mL/mmol 1,5-naphthyridine). The organic phase was then dried over Na2SO4, filtered and 
concentrated in vacuo. The crude was purified via flash column chromatography on silica gel using the 
appropriate eluent. 
 
 
3.2 Preparation of Starting Material 1,5-Naphthyridine (39)143 
 
3-Aminopyridine (5.0 g, 53.2 mmol) was dissolved in dioxane (30 mL) and water (30 mL). Then, 
glycerine (15.5 mL, 212 mmol) was added, followed by slow addition of conc. H2SO4 (55 mL) at 0 °C. 
After addition of iodine (4.04 g, 15.9 mmol), the reaction mixture was stirred at 150 °C for 15 h. After 
cooling to rt, the mixture was basified using aq. NaOH solution (50%, 250 mL). After addition of sat. 
aq. Na2S2O3 solution (150 mL) and filtration over celite, the reaction mixture was diluted with water 
(500 mL), extracted with Et2O (3 × 500 mL) and dried over Na2SO4. After filtration, the solvent was 
removed in vacuo. The crude product was purified via flash column chromatography (isohexane/EtOAc 
= 1:1, 1% NEt3) to give pure 39 (3.8 g, 55%) as an off-white solid. 
 
m.p.: 73 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1586, 1492, 1300, 1216, 1194, 1106, 1017, 834, 819. 
1H-NMR (400 MHz, CDCl3):173 δ/ ppm = 8.97 (dd, J = 4.1, 1.6 Hz, 2H), 8.40 (dd, J = 8.1, 1.6 Hz, 2H), 
7.63 (dd, J = 8.4, 4.1 Hz, 2H). 
13C-NMR (100 MHz, CDCl3):173 δ/ ppm = 151.2, 144.0, 137.6, 124.4. 
MS (EI, 70 eV): m/z (%) = 130 (100), 129 (29), 104 (15), 103 (18), 79 (10), 58 (10), 44 (10), 43 (38). 
HRMS (EI) calcd. for [C8H6N2]: 130.0531; found: 130.0526. 
 
 
 
 
 
 
 
                                                 
173 B. R. Lahue, S.-M. Lo, Z.-K. Wan, G. H. C. Woo, J. K. Snyder, J. Org. Chem. 2004, 69, 7171.   
117 
 
3.3 Metalation of 1,5-Naphthyridine (39) in Position 4 Using TMP2Mg·2LiCl (4)  
 
1,5-Naphthyridine-4-d (41) 
 
According to TP 1, 1,5-Naphthyridine (39, 130 mg, 1 mmol) was metalated using TMP2Mg·2LiCl (4, 
1.72 mL, 1.1 mmol, 0.64 M in THF, 1.1 equiv) followed by the reaction with D2O (0.1 mL, 5.5 mmol, 
5.5 equiv) in dry THF (2 mL). After workup, the crude product was purified by flash column 
chromatography (isohexane/ EtOAc = 8:2, 1 % NEt3) to give 1,5-naphthyridine-4-d (41) as a beige solid 
(60 mg, 43 %). NMR-spectroscopy revealed an incorporation of deuterium at position 4 with a 2H:1H 
ratio of 89:11. 
 
m.p.: 59-61 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1586, 1488, 1402, 1300, 1246, 1217, 1194, 1106, 1018, 905, 884, 
834, 821, 797, 746, 695. 
1H-NMR (400 MHz, CDCl3): / ppm = 8.98 (d, J = 4.2 Hz, 2H), 8.40 (dd, J = 8.5, 1.7 Hz, 1H), 7.67-
7.61 (m, 2H). 
13C-NMR (100 MHz, CDCl3): / ppm = 151.3, 144.1/144.0 (CH/CD), 137.6, 124.5, 124.4. 
MS (EI, 70 eV): m/z (%) = 132 (12), 131 (52), 130 (100), 129 (19), 104 (18), 103 (15), 76 (8). 
HRMS (EI) calcd for [C8H5DN2]: 131.0594; found: 131.0576. 
 
4-Iodo-1,5-naphthyridine (42a) 
 
According to TP 1, 1,5-Naphthyridine (39, 130 mg, 1 mmol) was metalated using TMP2Mg·2LiCl (4,  
1.72 mL, 1.1 mmol, 0.64 M in THF, 1.1 equiv) followed by the reaction with I2 (395 mg, 1.6 mmol, 1.6 
equiv) in dry THF (3 mL). After workup, the crude product was purified by flash column chromato-
graphy (isohexane/EtOAc = 8:2, 1 % NEt3) to give 42a (158 mg, 62 %) as a white solid. 
 
m.p.: 91-93 °C.          
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1565, 1548, 1481, 1459, 1393, 1376, 1279, 1181, 1028, 961, 841, 
782.  
1H-NMR (300 MHz, CDCl3): / ppm = 9.05 (dd, J = 4.2, 1.6 Hz, 1H), 8.52 (d, J = 4.5 Hz, 1H), 8.36 
(dd, J = 8.5, 1.6 Hz, 1H), 8.28 (d, J = 4.5 Hz, 1H), 7.70 (dd, J = 8.5 Hz, 4.2 Hz, 1H). 
13C-NMR (75 MHz, CDCl3): / ppm = 152.2, 150.8, 143.9 (2C), 138.3, 135.4, 125.5, 116.4. 
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MS (EI, 70 eV): m/z (%) = 257 (9), 256 (100), 129 (73), 102 (57), 76 (16), 75 (21), 74 (14), 64 (10), 50 
(18). 
HRMS (EI) calcd. for [C8H5IN2]: 255.9497; found: 255.9492. 
 
4-Bromo-1,5-naphthyridine (42b) 
 
According to TP 1, 1,5-Naphthyridine (39, 130 mg, 1 mmol) was metalated using TMP2Mg·2LiCl (4, 
1.72 mL, 1.1 mmol, 0.64 M in THF, 1.1 equiv) followed by the reaction with 1,2-dibromotetra-
chloroethane (651 mg, 2 mmol) in dry THF (2 mL). After workup, the crude product was purified by 
flash column chromatography (isohexane/EtOAc = 7:2, 1 % NEt3) to give 42b (102 mg, 49 %) as an 
off-white solid. 
 
m.p.: 94 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1579, 1547, 1475, 1462, 1376, 1282, 1187, 1066, 1027, 965, 855, 
821, 807, 786. 
1H-NMR (300 MHz, CDCl3): / ppm = 9.10 (dd, J = 4.2, 1.6 Hz, 1H), 8.75 (d, J = 4.6 Hz, 1H), 8.43 
(d, J = 8.5, 1.6 Hz, 1H), 7.99 (d, J = 4.6 Hz, 1H), 7.72 (dd, J = 8.5, 4.2 Hz, 1H). 
13C-NMR (75 MHz, CDCl3): / ppm = 151.9, 150.8, 144.9, 142.1, 138.3, 136.4, 128.4, 125.5.  
MS (EI, 70 eV): m/z (%) = 210 (98), 208 (100), 129 (75), 126 (86), 102 (50), 86 (19), 75 (20), 70 (41), 
58 (21), 55 (17), 41 (24). 
HRMS (EI) calcd. for [C8H5BrN2]: 207.9636; found: 207.9616.  
 
2,2-Dimethyl-1-(1,5-naphthyridin-4-yl)propan-1-one (42c) 
 
According to TP 1, 1,5-Naphthyridine (39, 130 mg, 1 mmol) was metalated using TMP2Mg·2LiCl (4, 
1.72 mL, 1.1 mmol, 0.64 M in THF, 1.1 equiv) followed by transmetalation with ZnCl2 (1.1 mL, 1.1 
mmol, 1.0 M in THF, 1.1 equiv). The reaction mixture was stirred for further 10 min before warming up 
to rt. Subsequently, a solution of pivaloyl chloride (1.5 mmol, 180 mg) and Pd(PPh3)4 (0.02 mmol, 23 
mg, 2 mol%) in dry THF (1 mL) was added dropwise. After workup, the crude product was purified by 
flash column chromatography (EtOAc) to give 42c (135 mg, 63 %) as a white solid. 
 
m.p.: 86-88 °C.                         
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2969, 1693, 1494, 1477, 1268, 1220, 1132, 1094, 1019, 946, 877, 
803, 781. 
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1H-NMR (300 MHz, CDCl3): / ppm = 8.98 (d, J = 4.3 Hz, 1H), 8.95 (dd, J = 4.2, 1.7 Hz, 1H), 8.40 
(dd, J = 8.6, 1.7 Hz, 1H), 7.65 (dd, J = 8.6, 4.2 Hz, 1H), 7.37 (d, J = 4.3 Hz, 1H), 1.30 (s, 9H). 
 13C-NMR (75 MHz, CDCl3): / ppm = 212.5, 151.3, 150.5, 148.8, 143.9, 141.1, 137.4, 124.9, 119.8, 
45.2, 26.8. 
MS (EI, 70 eV): m/z (%) = 214 (38), 157 (36), 130 (100), 102 (13), 57 (23), 41 (11). 
HRMS (EI) calcd. for [C13H14N2O]: 214.1106: found: 214.1099. 
 
4-(Phenylthio)-1,5-naphthyridine (42d) 
 
According to TP 1, 1,5-Naphthyridine (39, 130 mg, 1 mmol) was metalated using TMP2Mg·2LiCl (4, 
1.72 mL, 1.1 mmol, 0.64 M in THF, 1.1 equiv) followed by the reaction with S-phenyl benzene-
thiosulfonate (500 mg, 2 mmol, 2.0 equiv) in dry THF (1 mL). After workup, the crude product was 
purified by flash column chromatography (isohexane/EtOAc = 6:2, 1% NEt3) to give 42d (90 mg, 38 %) 
as a white oil. 
 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1555, 1481, 1459, 1439, 1439, 1371, 1355, 1278, 988, 838, 818, 
784, 750, 691. 
1H-NMR (300 MHz, CDCl3): / ppm = 8.99 (dd, J = 4.2, 1.7 Hz, 1H), 8.57 (d, J = 4.8 Hz, 1H), 8.37 
(dd, J = 8.5, 1.7 Hz, 1H), 7.73-7.64 (m, 3H), 7.57-7.50 (m, 3H), 6.79 (d, J = 4.8 Hz, 1H).  
13C-NMR (75 MHz, CDCl3): / ppm = 152.7, 150.0, 149.3, 142.5, 140.7, 137.4, 135.9, 129.9, 129.8, 
128.9, 124.8, 118.4. 
MS (EI, 70 eV): m/z (%) = 238 (50), 237 (100), 205 (20), 103 (10), 51 (18). 
HRMS (EI) calcd. for [C14H10N2S]: 238.0565; found: 238.0549. 
 
4-(Cyclohex-2-en-1-yl)-1,5-naphthyridine (42e) 
 
According to TP 1, 1,5-Naphthyridine (39, 130 mg, 1 mmol) was metalated using TMP2Mg·2LiCl (4, 
1.72 mL, 1.1 mmol, 0.64 M in THF, 1.1 equiv) followed by the addition of CuCN·2LiCl (1.1 mL, 1.1 
mmol, 1.0 M in THF, 1.1 equiv). The reaction mixture was stirred for further 20 min before 3-
bromocyclohex-1-ene (0.17 mL, 1.5 mmol, 1.5 equiv) was added dropwise. Then, the reaction was 
slowly warmed to rt overnight. After workup, the crude product was purified by flash column 
chromatography (isohexane/EtOAc = 7:2, 1% NEt3) to give 42e (125 mg, 60 %) as a colorless oil. 
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IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2925, 1673, 1587, 1493, 1303, 854, 790, 723, 675, 658. 
1H-NMR (300 MHz, CDCl3): / ppm = 8.91 (dd, J = 4.1, 1.7 Hz, 1H), 8.83 (d, J = 4.5 Hz, 1H), 8.33 
(dd, J = 8.5, 1.7 Hz, 1H), 7.55 (dd, J = 8.5, 4.1 Hz, 1H), 7.43 (d, J = 4.4 Hz, 1H), 6.02-5.94 (m, 1H), 
5.74-5.66 (m, 1H), 4.83-4.75 (m, 1H), 2.25-2.13 (m, 1H), 2.12-2.03 (m, 2H), 1.72-1.50 (m, 3H). 
13C-NMR (75 MHz, CDCl3): / ppm = 154.3, 151.1, 149.8, 143.6, 142.6, 137.8, 129.9, 128.7, 124.0, 
122.6, 34.8, 30.7, 25.2, 20.9. 
MS (EI, 70 eV): m/z (%) = 210 (100), 209 (79), 207 (30), 195 (31), 181 (85), 169 (44), 155 (46), 130 
(14), 77 (15), 57 (20), 43 (22). 
HRMS (EI) calcd. for [C14H14N2]: 210.1157; found: 210.1148. 
 
Ethyl 2-((1,5-naphthyridin-4-yl)methyl)acrylate (42f) 
 
According to TP 1, 1,5-Naphthyridine (39, 130 mg, 1 mmol) was metalated using TMP2Mg·2LiCl (4, 
1.72 mL, 1.1 mmol, 0.64 M in THF, 1.1 equiv) followed by the addition of CuCN·2LiCl (1.1 mL, 1.1 
mmol, 1.0 M in THF, 1.1 equiv). The reaction mixture was stirred for further 20 min before ethyl 2-
(bromomethyl)acrylate (288 mg, 1.5 mmol, 1.5 equiv) was added dropwise. Then, the reaction was 
slowly warmed to rt overnight. After workup, the crude product was purified by flash column chromato-
graphy (isohexane/EtOAc = 1:1, 1% NEt3) to give 42f (128 mg, 53 %) as a yellow oil. 
 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1711, 1496, 1368, 1292, 1231, 1191, 1126, 1070, 1024, 954, 848, 
801, 764, 736, 675. 
1H-NMR (300 MHz, CDCl3): / ppm = 8.93 (dd, J = 4.1 Hz, 1.7 Hz, 1 H), 8.83 (d, J = 4.4 Hz, 1 H), 
8.35 (dd, J = 8.5 Hz, 1.7 Hz, 1 H), 7.58 (dd, J = 8.5 Hz, 4.1 Hz, 1 H), 7.42 (d, J = 4.4 Hz, 1 H), 6.30 (s, 
1 H), 5.55 (q, J = 1.3 Hz, 1 H), 4.32 (s, 2 H), 4.14 (q, J = 7.1 Hz, 2 H), 1.17 (t, J = 7.1 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3): /ppm = 166.7, 150.9, 150.1, 147.8, 143.6, 142.9, 138.5, 137.6, 127.7, 
124.3, 123.9, 60.9, 32.2, 14.1. 
MS (EI, 70 eV): m/z (%) = 242 (11), 213 (33), 207 (14), 197 (12), 167 (100), 140 (12). 
HRMS (EI) calcd. for [C14H14N2O2]: 242.1055; found: 242.1081. 
 
4-(4-Methoxyphenyl)-1,5-naphthyridine (42g) 
 
According to TP 1, 1,5-Naphthyridine (39, 260 mg, 2 mmol) was metalated using TMP2Mg·2LiCl (4, 
3.44 mL, 2.2 mmol, 0.64 M in THF, 1.1 equiv) followed by transmetalation with ZnCl2 (2.2 mL, 2.2 
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mmol, 1.0 M in THF, 1.1 equiv). The reaction mixture was stirred for further 20 min before a solution 
of Pd(dba)2 (34 mg, 0.06 mmol, 3 mol%), tfp (28 mg, 0.12 mmol, 6 mol%) and 4-iodoanisole (374 mg, 
1.6 mmol) in dry THF (1 mL) was added dropwise. The reaction mixture was allowed to warm to rt 
overnight. After workup, the crude product was purified by flash column chromatography (isohexane/ 
EtOAc = 7:1, 1% NEt3) to give 42g (285 mg, 75 %) as a white solid.  
 
m.p.: 107 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1603, 1492, 1466, 1382, 1307, 1284, 1235, 1180, 1126, 1027, 835, 
818, 800, 783. 
1H-NMR (300 MHz, CDCl3): / ppm = 9.01 (dd, J = 4.1, 1.7 Hz, 1 H), 8.98 (d, J = 4.5 Hz, 1 H), 8.44 
(dd, J = 8.5, 1.8 Hz, 1 H), 7.78 (d, J = 8.9 Hz, 2 H), 7.64 (dd, J = 8.5, 4.1 Hz, 1 H), 7.62 (d, J = 4.5 Hz, 
1 H), 7.07 (d, J = 8.9 Hz, 2 H), 3.89 (s, 3 H). 
13C-NMR (75 MHz, CDCl3): / ppm = 160.4, 151.1, 150.7, 148.1, 144.7, 142.2, 137.8, 132.0, 129.1, 
124.2, 123.8, 114.0, 55.5. 
MS (EI, 70 eV): m/z (%) = 236 (90), 235 (100), 221 (46), 205 (35), 192 (52).  
HRMS (EI) for calcd. for [C15H12N2O]: 236.0950; found: 236.0937. 
 
4-(1,5-Naphthyridin-4-yl)benzonitrile (42h) 
 
According to TP 1, 1,5-Naphthyridine (39, 130 mg, 1 mmol) was metalated using TMP2Mg·2LiCl (4, 
1.72 mL, 1.1 mmol, 0.64 M in THF, 1.1 equiv) followed by transmetalation with ZnCl2 (1.1 mL, 1.1 
mmol, 1.0 M in THF, 1.1 equiv). The reaction mixture was stirred for further 20 min before a solution 
of Pd(PPh3)4 (58 mg, 0.05 mmol, 5 mol%) and 4-bromobenzonitrile (146 mg, 0.8 mmol) in dry THF     
(1 mL) was added dropwise. The reaction mixture was allowed to warm to rt and stirred at 50 °C 
overnight. After workup, the crude product was purified by flash column chromatography (isohexane/ 
EtOAc = 8:2, 1% NEt3) to give 42h (89 mg, 48 %) as a white solid.  
 
m.p.: 160 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2227, 1584, 1492, 1408, 1261, 1118, 1026, 876, 841, 836, 826, 
791, 655. 
1H-NMR (300 MHz, CDCl3): / ppm = 9.07 (d, J = 4.4 Hz, 1H), 9.01 (dd, J = 4.1, 1.7 Hz, 1H), 8.50 
(dd, J = 8.5, 1.7 Hz, 1H), 7.90 (d, J = 8.6 Hz, 2H), 7.82 (d, J = 8.6 Hz, 2H), 7.71 (dd, J = 8.5, 4.2 Hz, 
1H), 7.64 (dd, J = 8.5, 4.4 Hz, 1H). 
13C-NMR (75 MHz, CDCl3): / ppm = 151.4, 151.2, 146.5, 144.7, 141.5, 141.4, 138.1, 132.1, 131.4, 
124.8, 124.1, 118.8, 112.7. 
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MS (EI, 70 eV): m/z (%) = 231 (47), 230 (100), 203 (5), 176 (5), 116 (5), 102 (4). 
HRMS (EI) for calcd. for [C15H9N3]: 231.0796; found: 231.0767. 
 
Ethyl 4-(1,5-naphthyridin-4-yl)benzoate (42i) 
 
According to TP 1, 1,5-Naphthyridine (39, 130 mg, 1 mmol) was metalated using TMP2Mg·2LiCl (4, 
1.72 mL, 1.1 mmol, 0.64 M in THF, 1.1 equiv) followed by transmetalation with ZnCl2 (1.1 mL, 1.1 
mmol, 1.0 M in THF, 1.1 equiv). The reaction mixture was stirred for further 20 min before a solution 
of Pd(PPh3)4 (58 mg, 0.05 mmol, 5 mol%) and ethyl 4-bromobenzoate (183 mg, 0.8 mmol) in dry THF 
(1.0 mL) was added dropwise. The reaction mixture was allowed to warm to rt and stirred at 50 °C 
overnight. After workup, the crude product was purified by flash column chromatography (isohexane/ 
EtOAc = 7:2, 1% NEt3) to give 42i (89 mg, 40 %) as a white solid.  
 
m.p.: 114-117 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1714, 1492, 1407, 1364, 1270, 1102, 1023, 847, 824, 795, 766, 
714, 699, 661. 
1H-NMR (400 MHz, CDCl3): / ppm = 8.91 (d, J = 4.4 Hz, 1H), 8.88 (d, J = 4.0 Hz, 1H), 8.35 (d, J = 
8.5 Hz, 1H), 8.09 (d, J = 8.0 Hz, 2H), 7.72 (d, J = 8.0 Hz, 2H), 7.55 (m, 1H), 7.52 (d, J = 4.2 Hz, 1H), 
4.31 (q, J = 7.1 Hz, 2H), 1.30 (t, J = 7.1 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): / ppm = 166.3, 151.0, 150.9, 147.3, 144.4, 141.6, 141.1, 137.7, 130.5, 
130.4, 129.4, 124.3, 124.0, 61.1, 14.4. 
MS (EI, 70 eV): m/z (%) = 278 (52), 250 (19), 249 (74), 233 (19), 206 (20), 205 (100), 203 (16), 103 
(13). 
HRMS (EI) calcd. for [C17H14N2O2]: 278.1055; found: 278.1049. 
 
(E)-4-(4-(pyrrolidin-1-yldiazenyl)phenyl)-1,5-naphthyridine (42j) 
 
According to TP 1, 1,5-Naphthyridine (39, 130 mg, 1 mmol) was metalated using TMP2Mg·2LiCl (4, 
0.64 M in THF, 1.72 mL, 1.1 equiv) followed by transmetalation with ZnCl2 (1.1 mL, 1.1 mmol, 1.0 M 
in THF, 1.1 equiv). The reaction mixture was stirred for further 20 min before a solution of Pd(dba)2    
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(29 mg, 0.05 mmol, 5 mol%), tfp (23 mg, 0.10 mmol, 10 mol%) and (E)-1-((4-iodophenyl)-
diazenyl)pyrrolidine (240 mg, 0.8 mmol) in dry THF (1 mL) was added dropwise. The reaction mixture 
was allowed to warm to rt overnight. After workup, the crude product was purified by flash column 
chromatography (EtOAc) to give 42j (100 mg, 41 %) as a brown solid.  
 
m.p.: 134 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1489, 1421, 1392, 1354, 1342, 1313, 1261, 1146, 841, 821, 801, 
660. 
1H-NMR (400 MHz, CDCl3): / ppm = 9.03 (dd, J = 4.1, 1.7 Hz, 1H), 8.99 (d, J = 4.5 Hz, 1H), 8.49 
(dd, J = 8.5, 1.6 Hz, 1H), 7.81 (d, J = 8.7 Hz, 2H), 7.69 (d, J = 4.6 Hz, 1H), 7.66 (dd, J = 8.5, 4.1 Hz, 
1H), 7.58 (d, J = 8.6 Hz, 2H), 3.98-3.68 (m, 4H), 2.10-2.01 (m, 4H). 
13C-NMR (100 MHz, CDCl3): / ppm = 152.2, 150.9, 150.6, 149.2, 144.2, 142.2, 137.4, 133.1, 131.5, 
124.4, 123.9, 120.5, 24.0  
MS (EI, 70 eV): m/z (%) = 303 (10), 206 (21), 205 (100), 83 (8). 
HRMS (EI) calcd. for [C18H17N5]: 303.1484; found: 303.1478. 
 
 
3.4 Metalation of Chloro-1,5-naphthyridines (45a-b) in Position 4 Using 
TMPMgCl·LiCl (3) 
 
8-(Tert-butyldimethylsilyl)-3-chloro-4-iodo-1,5-naphthyridine (47a) 
 
According to TP2, 3-chloro-1,5-naphthyridine derivative 45b (139 mg, 0.5 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.5 mL, 0.55 mmol, 1.1 M in THF, 1.1 equiv) followed by the reaction with I2 (256 
mg, 1.0 mmol) in dry THF (2 mL). After workup, the crude product was purified by flash column 
chromatography (isohexane/EtOAc = 9:1) to give 47a (165 mg, 82 %) as a brown crystalline solid. 
 
m.p.: 162 °C.     
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2950, 2926, 2852, 1545, 1460, 1433, 1352, 1247, 1222, 1144, 
1056, 1004, 903, 827, 803, 775, 672. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 8.95 (d, J = 4.1 Hz, 1H), 8.75 (s, 1H), 7.76 (d, J = 4.1 Hz, 1H), 
0.91 (s, 9H), 0.48 (s, 6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 152.1, 151.5, 147.7, 145.6, 144.1, 137.8, 132.3, 119.4, 27.5, 
17.7, -3.8. 
MS (EI, 70 eV): m/z (%) = 404 (0.23), 349 (33), 348 (19), 347 (100), 220 (9). 
HRMS (EI) calcd. for [C14H18ClN2Si]: 403.9977; found: 403.9950. 
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3-Chloro-4-(phenylthio)-8-(trimethylsilyl)-1,5-naphthyridine (47b) 
 
According to TP 2, 3-chloro-1,5-naphthyridine derivative 45a (84 mg, 0.35 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.35 mL, 0.39 mmol, 1.1 M in THF, 1.1 equiv) followed by the reaction with               
S-phenyl benzenethiolsulfonate (114 mg, 0.45 mmol, 1.3 equiv) in dry THF (1 mL). After workup, the 
crude product was purified by flash column chromatography (isohexane/EtOAc = 9:1) to give 47b (111 
mg, 92 %) as a yellow solid. 
 
m.p.: 82 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1478, 1441, 1242, 1203, 1148, 1061, 1034, 1022, 936, 905, 837, 
755, 734, 969, 685. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.88 (d, J = 4.0 Hz, 1H), 8.81 (s, 1H), 7.68 (d, J = 4.1 Hz, 1H), 
7.24-7.11 (m, 5H), 0.39 (s, 9H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 153.1, 150.8, 149.9, 146.5, 143.3, 142.4, 135.3, 134.7, 130.4, 
130.2, 129.1, 127.0, 0.5. 
MS (EI, 70 eV): m/z (%) = 344 (63), 343 (42), 331 (38), 329 (100), 309 (23), 293 (12), 165 (13), 164 
(28). 
HRMS (EI) calcd. for [C17H17ClN2SSi]: 344.0570; found: 344.0560. 
 
Ethyl 3-(3-chloro-8-(trimethylsilyl)-1,5-naphthyridin-4-yl)benzoate (47c) 
 
According to TP 2, 3-chloro-1,5-naphthyridine derivative 45a (90 mg, 0.38 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.38 mL, 0.42 mmol, 1.1 M in THF, 1.1 equiv) followed by transmetalation with 
ZnCl2 (0.42 mL, 0.42 mmol, 1.0 M in THF, 1.1 equiv). The reaction mixture was stirred for further 20 
min before a solution of Pd(dba)2 (9 mg, 0.016 mmol, 4 mol%), tfp (7 mg, 0.032 mmol, 8 mol%) and 
ethyl 3-iodo-benzoate (110 mg, 0.40 mmol, 1.05 equiv) in THF (1.0 mL) was added dropwise. The 
reaction mixture was allowed to warm to rt overnight. After workup, the crude product was purified by 
flash column chromatography (isohexane/EtOAc = 9:1) to give 47c (105 mg, 72 %) as a white solid.  
 
m.p.: 98 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1717, 1471, 1366, 1281, 1234, 1178, 1143, 1106, 1059, 905, 838, 
755, 701. 
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1H-NMR (CDCl3, 600 MHz): δ/ ppm = 9.03 (s, 1H), 8.87 (d, J = 4.0 Hz, 1H), 8.20 (dt, J = 7.2, 1.8 Hz, 
1H), 8.16-8.15 (m, 1H), 7.73 (d, J = 4.0 Hz, 1H), 7.66-7.61 (m, 2H), 7.40 (q, J = 7.1 Hz, 2H), 1.38 (t,  
J = 7.1 Hz, 3H), 0.49 (s, 9H). 
13C-NMR (CDCl3, 150 MHz): δ/ ppm = 166.4, 152.2, 150.9, 149.6, 146.6, 145.4, 141.7, 134.7, 134.7, 
131.5, 130.6, 129.9 (2C), 128.3, 61.2, 14.5, 0.6.  
MS (EI, 70 eV): m/z (%) = 384 (72), 383 (93), 371 (43), 369 (100), 355 (24), 343 (19), 341 (50), 314 
(22), 311 (20), 162 (20), 148 (20). 
HRMS (EI) calcd. for [C20H21ClN2O2Si]: 384.1061; found: 384.1050. 
 
8-(Tert-butyldimethylsilyl)-3-chloro-4-(3,4-dimethylphenyl)-1,5-naphthyridine (47d) 
 
According to TP 2, 3-chloro-1,5-naphthyridine derivative 45b (139 mg, 0.50 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.5 mL, 0.55 mmol, 1.1 M in THF, 1.1 equiv) followed by transmetalation with 
ZnCl2 (0.55 mL, 0.55 mmol, 1.0 M in THF, 1.1 equiv). The reaction mixture was stirred for further           
20 min before a solution of Pd(dba)2 (14 mg, 0.025 mmol, 5 mol%), tfp (11 mg, 0.05 mmol, 10 mol%) 
and 4-iodo-1,2-dimethylbenzene (104 mg, 0.45 mmol) in dry THF (1 mL) was added dropwise. The 
reaction mixture was allowed to warm to rt overnight. After workup, the crude product was purified by 
flash column chromatography (isohexane/EtOAc = 9:1) to give 47d (149 mg, 78 %) as a white solid.  
 
m.p.: 150 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2926, 1467, 1253, 1218, 1142, 1124, 1065, 911, 830, 802, 774,676, 
656. 
1H-NMR (CDCl3, 400 MHz): δ/ ppm = 8.98 (s, 1H), 8.89 (d, J = 4.1 Hz, 1H), 7.71 (d, J = 4.1 Hz, 1H), 
7.31 (d, J = 7.7 Hz, 1H), 7.23-7.16 (m, 2H), 2.36 (s, 3H), 2.35 (s, 3H), 0.96 (s, 9H), 0.50 (s, 6H). 
13C-NMR (CDCl3, 100 MHz): δ/ ppm = 150.9, 150.5, 149.3, 146.8, 146.4, 142.4, 137.3, 136.4, 132.0, 
131.3, 131.2, 129.9, 129.6, 127.7, 27.6, 20.1, 20.0, 17.8, 3.8. 
MS (EI, 70 eV): m/z (%) = 382 (2), 328 (10), 327 (36), 326 (29), 325 (100), 311 (6), 155 (6). 
HRMS (EI) calcd. for [C22H27ClN2Si]: 382.1632; found: 382.1626. 
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(8-(Tert-butyldimethylsilyl)-3-chloro-1,5-naphthyridin-4-yl)(4-chlorophenyl)methanone (47e) 
 
According to TP 2, 3-chloro-1,5-naphthyridine derivative 45b (139 mg, 0.5 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.5 mL, 0.55 mmol, 1.1 M in THF, 1.1 equiv) followed by the addition of 
CuCN·2LiCl (0.55 mL, 0.55 mmol, 1.0 M in THF, 1.1 equiv). The reaction mixture was stirred for further 
20 min before 4-chlorobenzoyl chloride (0.13 mL, 1.0 mmol, 2.0 equiv) was added dropwise. Then, the 
reaction was slowly warmed to rt over 2 h. After workup, the crude product was purified by flash column 
chromatography (isohexane/EtOAc = 9:1) to give 47e (178 mg, 86 %) as a white solid. 
 
m.p.: 138-140 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2925, 2853, 1676, 1589, 1467, 1402, 1314, 1263, 1227, 1177, 
1153, 1088, 1056, 1015, 933, 913, 839, 826, 804, 777, 749, 679, 669. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.97 (s, 1H), 8.80 (d, J = 4.1 Hz, 1H), 7.77 (d, J = 8.8 Hz, 2H), 
7.75 (s, 1H), 7.43 (d, J = 8.6 Hz, 2H), 0.95 (s, 9H), 0.50 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 192.5, 151.3, 151.1, 149.1, 146.4, 143.8, 141.0, 141.0, 134.4, 
132.1, 131.2, 129.4, 126.8, 27.5, 17.7, 4.0. 
MS (EI, 70 eV): m/z (%) = 416 (<1), 363 (31), 361 (79), 360 (63), 359 (100), 333 (17), 331 (28), 221 
(12), 185 (12). 
HRMS (EI) calcd. for [C21H22Cl2N2OSi]: 416.0878; found 416.0869. 
 
(3-Chloro-1,5-naphthyridin-4-yl)(4-chlorophenyl)methanone (48) 
 
TBAF (0.46 mL, 0.46 mmol, 1.0 M in THF, 2.0 equiv) was added dropwise to a solution of 47e (90 mg, 
0.22 mmol) in dry THF (1 mL).  The reaction was stirred for 12 h at rt, before the solvent was removed 
in vacuo and redissolved in a small amount of EtOAc. The crude product was purified by flash column 
chromatography (isohexane/EtOAc = 1:1) to give 48 (52 mg, 82%) as a white solid. 
 
m.p.: 196-198 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1681, 1587, 1572, 1482, 1401, 1259, 1209, 1159, 1115, 1091, 
1032, 1012, 921, 905, 860, 815, 785, 753, 692. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.02 (s, 1H), 8.90 (dd, J = 4.2, 1.7 Hz, 1H), 8.48 (dd, J = 8.6, 
1.7 Hz, 1H), 7.76 (d, J = 8.8 Hz, 2H), 7.68 (dd, J = 8.6, 4.2 Hz, 1H), 7.45 (d, J = 8.8 Hz, 2H). 
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13C-NMR (150 MHz, CDCl3): δ/ ppm = 191.7, 152.5, 150.9, 143.6, 142.0, 141.6, 141.1, 137.5, 134.1, 
131.0, 129.4, 127.5, 124.9. 
MS (EI, 70 eV): m/z (%) = 302 (1), 275 (42), 273 (66), 241 (32), 239 (100), 203 (10). 
HRMS (EI) calcd. for [C15H8Cl2N2O]: 302.0014; found: 302.0013. 
 
 
3.5 Metalation of 1,5-Naphthyridines (42a-c) in Position 8 Using TMPMgCl·LiCl 
(3) and TMPZnCl·LiCl (5) 
 
4-Iodo-1,5-naphthyridine-8-d (50) 
 
According to TP 3, 4-iodo-1,5-naphthyridine (42a, 128 mg, 0.50 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.5 mL, 0. 55 mmol, 1.1 M in THF, 1.1 equiv) followed by the reaction with D2O 
(0.05 mL, 3.0 mmol, 6.0 equiv) in dry THF (2 mL). The reaction mixture was allowed to warm to rt. 
After workup, the crude product was purified by flash column chromatography (isohexane/EtOAc = 9:1, 
1% NEt3) to give 50 (100 mg, 78%) as a beige solid. NMR-spectroscopy revealed an incorporation of 
deuterium at position 8 with a 2H:1H ration of 63:37. 
 
m.p.: 86-88 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1737, 1565, 1543, 1469, 1373, 1276, 1259, 1241, 1181, 1169, 
1032, 962, 840, 782, 705. 
1H-NMR (300 MHz, CDCl3): / ppm = 9.06 (d, J = 4.2 Hz, 1H), 8.53 (d, J = 4.5 Hz, 1H), 8.28 (d, J = 
4.5 Hz, 1H), 7.70 (dd, J = 8.4, 4.2 Hz, 1H). 
13C-NMR (75 MHz, CDCl3): / ppm = 152.2, 150.9, 144.0/143.9 (CH/CD), 138.4, 135.4, 125.5, 125.4, 
116.4. 
MS (EI, 70 eV): m/z (%) = 257 (100), 256 (95), 130 (59), 103 (45), 102 (46), 76 (24), 75 (26), 50 (23). 
HRMS (EI) calcd. for [C8H4DIN2]: 256.9560; found: 256.9564. 
 
4-Bromo-8-(phenylthio)-1,5-naphthyridine (52a) 
 
According to TP 3, 4-bromo-1,5-naphthyridine (42b, 100 mg, 0.48 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.48 mL, 0.53 mmol, 1.1 M in THF, 1.1 equiv) followed by the reaction with               
S-phenyl benzenethiolsulfonate (180 mg, 0.72 mmol, 1.5 equiv) in dry THF (2 mL). After workup, the 
128 
 
crude product was purified by flash column chromatography (isohexane/EtOAc = 8:2) to give 52a (82 
mg, 54%) as a yellow solid. 
 
m.p.: 152-153 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1567, 1470, 1387, 1256, 1185, 1041, 1025, 833, 747, 728, 688. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.72 (d, J = 4.6 Hz, 1H), 8.65 (d, J = 4.8 Hz, 1H), 8.00 (d, J = 
4.6 Hz, 1H), 7.69-7.63 (m, 2H), 7.56-7.50 (m, 3H), 6.82 (d, J = 4.8 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 154.2, 150.9, 149.1, 141.6, 141.0, 136.4, 136.3, 135.5, 130.4, 
130.1, 129.1, 119.7. 
MS (EI, 70 eV): m/z (%) = 318 (63), 317 (99), 316 (55), 315 (100), 283 (16), 236 (22), 235 (14), 210 
(11), 51 (10). 
HRMS (EI) calcd. for [C14H9BrN2S]: 315.9670; found: 315.9671. 
 
4-Bromo-8-chloro-1,5-naphthyridine (52b) 
 
According to TP 3, 4-bromo-1,5-naphthyridine (42b, 129 mg, 0.62 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.62 mL, 0.68 mmol, 1.1 M in THF, 1.1 equiv) followed by the reaction with 1,1,2-
trichloro-1,2,2-trifluoroethane (232 mg, 1.24 mmol, 2.0 equiv) in dry THF (1 mL). After workup, the 
crude product was purified by flash column chromatography (isohexane/EtOAc = 1:1) to give 52b (80 
mg, 53%) as a white solid. 
 
m.p.: 260-262 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2923, 1576, 1457, 1375, 1263, 1185, 1091, 1042, 863, 825, 731, 
709. 
1H-NMR (400 MHz, DMSO-d6): δ/ ppm = 9.02 (d, J = 4.7 Hz, 1H), 8.90 (d, J = 4.6 Hz, 1H), 8.33 (d, 
J = 4.5 Hz, 1H), 8.14 (d, J = 4.7 Hz, 1H). 
13C-NMR (100 MHz, DMSO-d6): δ/ ppm = 151.9, 151.7, 143.3, 142.0, 140.8, 129.6, 129.6, 125.8. 
MS (EI, 70 eV): m/z (%) = 246 (23), 244 (100), 242 (73), 165 (14), 163 (45), 136 (11), 100 (16). 
HRMS (EI) for [C8H4BrClN2]: 241.9246; found: 241.9230. 
 
4-Bromo-8-(4-chlorophenyl)-1,5-naphthyridine (52c) 
 
According to TP 3, 4-bromo-1,5-naphthyridine (42b, 100 mg, 0.48 mmol) was metalated using 
TMPMgCl·LiCl (3, 0. 48 mL, 0.53 mmol, 1.1 M in THF, 1.1 equiv) followed by transmetalation with 
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ZnCl2 (0.53 mL, 0.53 mmol, 1.0 M in THF, 1.1 equiv). The reaction mixture was stirred for further            
20 min before a solution of Pd(dba)2 (14 mg, 0.024 mmol, 5 mol%), tfp (11 mg, 0.048 mmol, 10 mol%) 
and 1-chloro-4-iodobenzene (0.38 mmol, 91 mg, 0.8 equiv) in dry THF (1 mL) was added dropwise. 
The reaction mixture was allowed to warm to rt overnight. After workup, the crude product was purified 
by flash column chromatography (isohexane/EtOAc = 1:1) to give 52c (72 mg, 59%) as a yellow solid.  
 
m.p.: 162 °C.     
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1578, 1471, 1391, 1258, 1094, 1085, 1018, 864, 806, 763, 717, 
685, 665. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.13 (d, J = 4.4 Hz, 1H), 8.76 (d, J = 4.5 Hz, 1H), 8.02 (d, J = 
4.5 Hz, 1H), 7.71-7.68 (m, 3H), 7.52 (d, J = 8.6 Hz, 2H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 151.6, 150.5, 148.3, 142.7, 142.4, 136.6, 135.6, 134.7, 132.0, 
128.8, 128.5, 125.0. 
MS (EI, 70 eV): m/z (%) = 320 (54), 319 (100), 318 (43), 317 (70), 285 (19), 283 (19), 203 (24). 
HRMS (EI) calcd. for [C14H8BrClN2]: 317.9559; found: 317.9525. 
 
1-(8-Iodo-1,5-naphthyridin-4-yl)-2,2-dimethylpropan-1-one (52d) 
 
According to TP 4, 2,2-dimethyl-1-(1,5-naphthyridin-4-yl)propan-1-one (42c, 107 mg, 0.5 mmol) was 
metalated using TMPZnCl·LiCl (5, 0.58 mL, 0.75 mmol, 1.3 M in THF, 1.5 equiv) followed by the 
reaction with I2 (254 mg, 1.0 mmol, 2.0 equiv) in dry THF (3 mL). After workup, the crude product was 
purified by flash column chromatography (isohexane/EtOAc = 9:1) to give 52d (121 mg, 71%) as a 
white solid. 
 
m.p.:  131 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1692, 1476, 1454, 1209, 1104, 1080, 954, 875, 844, 834, 714, 660. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.04 (d, J = 4.3 Hz, 1H), 8.48 (d, J = 4.5 Hz, 1H), 8.28 (d,            
J = 4.5 Hz, 1H), 7.43 (d, J = 4.3 Hz, 1H), 1.29 (s, 9H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 211.9, 151.4, 150.8, 149.6, 143.9, 141.0, 135.8, 120.9, 116.2, 
45.3, 26.9. 
MS (EI, 70 eV): m/z (%) = 340 (13), 283 (27), 256 (100), 129 (10), 101 (10), 74 (11), 57 (31). 
HRMS (EI) calcd. for [C13H13IN2O]: 340.0073; found: 340.0066. 
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2,2-Dimethyl-1-(8-(4-(trifluoromethyl)phenyl)-1,5-naphthyridin-4-yl)propan-1-one (52e) 
 
According to TP 4, 2,2-dimethyl-1-(1,5-naphthyridin-4-yl)propan-1-one (42c, 107 mg, 0.5 mmol) was 
metalated using TMPZnCl·LiCl (5, 0.58 mL, 0.75 mmol, 1.3 M in THF, 1.5 equiv), followed by the 
dropwise addition of a solution of Pd(dba)2 (12 mg, 0.02 mmol, 4 mol%), tfp (9 mg, 0.04 mmol, 8 mol%) 
and 1-iodo-4-(trifluoromethyl)benzene (109 mg, 0.4 mmol, 0.8 equiv) in dry THF (1 mL). After stirring 
the reaction overnight and subsequent workup, the crude product was purified by flash column 
chromatography (isohexane/EtOAc = 8:2) to give 52e (140 mg, 98%) as an off-white solid. 
 
m.p.: 139-141 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2973, 1704, 1478, 1324, 1314, 1194, 1159, 1111, 1083, 1064, 
1067, 960, 860, 850, 829, 731. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.02 (d, J = 4.4 Hz, 1H), 9.00 (d, J = 4.2 Hz, 1H), 7.87 (d, J = 
8.1 Hz, 2H), 7.80 (d, J = 8.1 Hz, 2H), 7.64 (d, J = 4.4 Hz, 1H), 7.42 (d, J = 4.2 Hz, 1H), 1.34 (s, 9H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 212.6, 151.1, 150.5, 149.2, 147.1, 141.7, 140.2, 131.0, 125.4 
(CF3), 124.4, 124.6, 119.9, 45.4, 26.9. 
MS (EI, 70 eV): m/z (%) = 358 (11), 302 (25), 275 (14), 274 (100), 273 (42), 57 (19). 
HRMS (EI) calcd. for [C20H17F3N2O]: 358.1293; found: 358.1280. 
 
1-(8-(3-Isobutyrylphenyl)-1,5-naphthyridin-4-yl)-2,2-dimethylpropan-1-one (52f) 
 
According to TP 4, 2,2-dimethyl-1-(1,5-naphthyridin-4-yl)propan-1-one (42c, 107 mg, 0.5 mmol) was 
metalated using TMPZnCl·LiCl (5, 0.58 mL, 0.75 mmol, 1.3 M in THF, 1.5 equiv), followed by the 
dropwise addition of a solution of Pd(dba)2 (12 mg, 0.02 mmol, 4 mol%), tfp (9 mg, 0.04 mmol, 8 mol%) 
and 1-(3-iodophenyl)-2-methylpropan-1-one (110 mg, 0.4 mmol, 0.8 equiv) in dry THF (1 mL) was 
added dropwise. After stirring the reaction overnight and subsequent workup, the crude product was 
purified by flash column chromatography (isohexane/EtOAc = 8:2) to give 52f (139 mg, 97%) as a red 
oil.  
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IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2971, 1735, 1682, 1581, 1503, 1478, 1462, 1372, 1234, 1187, 
1156, 1082, 1044, 993, 961, 861, 809, 746, 697. 
1H-NMR (CDCl3, 600 MHz): δ/ ppm = 9.00 (d, J = 4.4 Hz, 1H), 8.99 (d, J = 4.2 Hz, 1H), 8.35 (t, J = 
1.6 Hz, 1H), 8.08 (ddd, J = 7.9, 1.7, 1.2 Hz, 1H), 7.96 (ddd, J = 7.6, 1.8, 1.2 Hz, 1H), 7.67 (d, J = 4.4 
Hz, 1H), 7.65–7.61 (m, 1H), 7.40 (d, J = 4.2 Hz, 1H), 3.61 (sept, J = 6.8 Hz, 1H), 1.33 (s, 9H), 1.26 (d, 
J = 6.9 Hz, 6H). 
13C-NMR (CDCl3, 150 MHz): δ/ ppm = 212.7, 204.0, 151.1, 150.3, 149.1, 147.5, 141.8, 141.6, 137.0, 
136.3, 134.9, 130.6, 128.8, 128.7, 124.5, 119.8, 45.3, 35.6, 26.9, 19.3. 
MS (EI, 70 eV): m/z (%) = 360 (53), 317 (49), 303 (46), 277 (50), 276 (100), 43 (66). 
HRMS (EI) calcd. for [C23H24N2O2]: 360.1838; found: 360.1826. 
 
1-(8-Allyl-1,5-naphthyridin-4-yl)-2,2-dimethylpropan-1-one (52g) 
 
According to TP 4, 2,2-dimethyl-1-(1,5-naphthyridin-4-yl)propan-1-one (42c, 107 mg, 0.5 mmol) was 
metalated using TMPZnCl·LiCl (5, 0.58 mL, 0.75 mmol, 1.3 M in THF, 1.5 equiv). Then, the reaction 
mixture was cooled to -20 °C and CuCN∙2LiCl (0.1 mL, 0.1 mmol, 1.0 M in THF, 0.2 equiv) was added.  
After 5 min of stirring at -20 °C, the mixture was cooled down to –50 °C and allylbromide (0.07 mL, 
0.75 mmol, 1.5 equiv) was added. The mixture was allowed to warm up to rt and was further stirred for 
3 h. After workup, the crude product was purified by flash column chromatography (isohexane/EtOAc 
= 8:2) to give 52g (102 mg, 80%) as a brown solid.  
 
m.p.: 72-74 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2970, 1691, 1500, 1478, 1392, 1273, 1228, 1162, 1050, 988, 912, 
873, 736. 
1H-NMR (CDCl3, 600 MHz): δ/ ppm = 8.97 (d, J = 4.2 Hz, 1H), 8.84 (d, J = 4.3 Hz, 1H), 7.48 (d, J = 
4.3 Hz, 1H), 7.36 (d, J = 4.2 Hz, 1H), 6.19 – 6.07 (m, 1H), 5.20 (t, J = 1.3 Hz, 1H), 5.19–5.16 (m, 1H), 
4.09–4.06 (m, 2H), 1.29 (s, 9H). 
13C-NMR (CDCl3, 150 MHz): δ/ ppm = 213.0, 151.2, 149.4, 149.0, 148.7, 143.1, 140.8, 135.3, 124.1, 
119.7, 117.7, 45.3, 34.6, 26.9. 
MS (EI, 70 eV): m/z (%) = 254 (38), 197 (86), 171 (13), 170 (100), 156 (28), 57 (24), 41 (20). 
HRMS (EI) calcd. for [C16H18N2O]: 254.1419; found: 254.1412. 
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3.6 Metalation of 1,5-Naphthyridines (42a and 42g) in Position 2 Using 
TMPMgCl·LiCl (3) in Presence of BF3·OEt2 
 
4-Iodo-1,5-naphthyridine-2-d (54) 
 
According to TP 5, 4-iodo-1,5-naphthyridine (42a, 128 mg, 0.5 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.5 mL, 0.55 mmol, 1.1 M in THF, 1.1 equiv) in the presence of BF3·OEt2 (0.07 
mL, 0.55 mmol, 1.1 equiv), followed by the reaction with D2O (0.05 mL, 2.5 mmol, 5.0 equiv) in dry 
THF (1 mL). After workup, the crude product was purified by flash column chromatography (EtOAc) 
to give 54 (86 mg, 67%) as an off-white solid. NMR-spectroscopy revealed an incorporation of 
deuterium at position 2 with a 2H:1H ration of 76:24. 
 
m.p.: 96-97 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1556, 1547, 1467, 1379, 1030, 964, 893, 847, 821, 786. 
1H-NMR (300 MHz, CDCl3): / ppm = 9.05 (dd, J = 4.2 Hz, 1.6 Hz, 1H), 8.35 (dd, J = 8.5 Hz, 1.6 Hz, 
1H), 8.29-8.24 (m, 1H), 7.69 (dd, J = 8.5 Hz, 4.2 Hz, 1H). 
13C-NMR (75 MHz, CDCl3): / ppm = 152.1, 150.8, 143.9 (CD/CH), 138.4, 135.4, 135.3, 125.5, 116.4. 
MS (EI, 70 eV): m/z (%) = 257 (100), 256 (37), 130 (29), 129 (11), 102 (12). 
HRMS (EI) calcd. for [C8H4DIN2]: 256.9560; found: 256.9555. 
 
2,4-Diiodo-1,5-naphthyridine (56a) 
 
According to TP 5, 4-iodo-1,5-naphthyridine (42a, 100 mg, 0.39 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.39 mL, 0.43 mmol, 1.1 M in THF, 1.1 equiv) in the presence of BF3·OEt2 (0.05 
mL, 0.43 mmol, 1.1 equiv), followed by the reaction with I2 (200 mg, 0.80 mmol, 2.0 equiv) in dry THF 
(2 mL). After workup, the crude product was purified by flash column chromatography (isohexane/ 
EtOAc = 9:1) to give 56a (110 mg, 74%) as an off-white solid.  
 
m.p.: 166 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1536, 1465, 1449, 1364, 1348, 1248, 1230, 1184, 1084, 1035, 960, 
855, 845, 819, 801, 781. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.02 (dd, J = 4.2, 1.6 Hz, 1H), 8.58 (s, 1H), 8.27 (dd, J = 8.5, 
1.6 Hz, 1H), 7.66 (dd, J = 8.5, 4.4 Hz, 1H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 152.2, 144.9, 144.8, 143.4, 137.5, 126.0, 118.9, 117.4. 
MS (EI, 70 eV): m/z (%) = 382 (94), 256 (10), 255 (100), 128 (34), 101 (10), 75 (9). 
HRMS (EI) calcd. for [C8H4I2N2]: 381.8464; found: 381.8464. 
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2-Bromo-4-iodo-1,5-naphthyridine (56b) 
 
According to TP 5, 4-iodo-1,5-naphthyridine (42a, 256 mg, 1.0 mmol) was metalated using 
TMPMgCl·LiCl (3, 1.0 mL, 1.1 mmol, 1.1 M in THF, 1.1 equiv) in the presence of BF3·OEt2 (0.14 mL, 
1.1 mmol, 1.1 equiv), followed by the reaction with 1,2-dibromotetrachlororethane (615 mg, 2.0 mmol, 
2.0 equiv) in dry THF (2 mL). After workup, the crude product was purified by flash column chromato-
graphy (isohexane/ EtOAc = 8:2, 1% NEt3) to give 56b (240 mg, 72%) as an off-white solid. 
 
m.p.: 165 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1544, 1456, 1376, 1249, 1233, 1185, 1086, 1033, 854, 813, 803, 
778, 665. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.04 (dd, J = 4.2, 1.6 Hz, 1H), 8.39 (s, 1H), 8.29 (dd, J = 8.5, 
1.6 Hz, 1H), 7.70 (dd, J = 8.5, 4.2 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 152.2, 143.6, 143.2, 142.0, 139.1, 137.4, 126.2, 118.1. 
MS (EI, 70 eV): m/z (%) = 336 (97), 334 (100), 290 (9), 128 (35), 102 (13), 75 (16). 
HRMS (EI) calcd. for [C8H4BrIN2]: 333.8603; found: 333.8598. 
 
(4-Iodo-1,5-naphthyridin-2-yl)(phenyl)methanone (56c) 
 
According to TP 5, 4-iodo-1,5-naphthyridine (42a, 100 mg, 0.39 mmol) was metalated using 
TMPMgCl·LiCl (3, 0.39 mL, 0.43 mmol, 1.1 M in THF, 1.1 equiv) in the presence of BF3·OEt2 (0.05 
mL, 0.43 mmol, 1.1 equiv), followed by the addition of CuCN·2LiCl (0.43 mL 0.43 mmol, 1.0 M in 
THF, 1.1 equiv) and benzoyl chloride (0.09 mL, 0.78 mmol, 2.0 equiv). After workup, the crude product 
was purified by flash column chromatography (isohexane/ EtOAc = 9:1) to give 56c (74 mg, 53%) as a 
white solid. 
 
m.p.: 159 °C. 
IR (Diamond-ATR, neat): 𝜈/cm-1 = 1654, 1473, 1457, 1322, 1310, 1195, 986, 885, 863, 821, 808, 786, 
739, 699. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.12 (dd, J = 4.2, 1.6 Hz, 1H), 8.90 (s, 1H), 8.42 (dd, J = 8.5, 
1.6 Hz, 1H), 8.21-8.15 (m, 2H), 7.74 (dd, J = 8.5, 4.2 Hz, 1H), 7.66-7.60 (m, 1H), 7.54-7.47 (m, 2H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 191.7, 154.7, 153.7, 144.3, 142.0, 139.1, 135.6, 135.2, 133.6, 
131.4, 128.4, 126.0, 117.3. 
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MS (EI, 70 eV): m/z (%) = 360 (25), 359 (15), 332 (43), 330 (20), 234 (15), 233 (88), 205 (30), 128 
(13), 105 (100), 77 (85). 
HRMS (EI) calcd. for [C15H9IN2O]: 359.9760; found: 359.975. 
 
(4-(4-Methoxyphenyl)-1,5-naphthyridin-2-yl)(thiophen-2-yl)methanone (56d) 
 
According to TP 5, 4-(4-methoxyphenyl)-1,5-naphthyridine (42g, 100 mg, 0.42 mmol) was metalated 
using TMPMgCl·LiCl (3, 0.46 mmol, 0.42 mL, 1.1 M in THF, 1.1 equiv) in the presence of BF3·OEt2 
(0.06 mL, 0.46 mmol, 1.1 equiv). Then a solution of CuCN·2LiCL (0.46 mL, 0.46 mmol, 1.0 M in THF, 
1.1 equiv) and thiophene-2-carbonyl chloride (0.053 mL, 0.50 mmol, 1.2 equiv) was added. The 
resulting mixture was allowed to warm up to rt and stirred overnight. After workup, the crude product 
was purified by flash column chromatography (first EtOAc, then EtOH) to give 56d (102 mg, 70%) as 
a white solid. 
 
m.p.: 176 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1740, 1637, 1605, 1582, 1514, 1488, 1408, 1376, 1358, 1300, 
1255, 1180, 1148, 1031, 940, 917, 826, 799, 715, 668. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.12 (dd, J = 4.1, 1.7 Hz, 1H), 8.63 (dd, J = 8.5 Hz, 1.7 Hz, 
1H), 8.51 (dd, J = 3.9 Hz, 1.2 Hz, 1H), 8.48 (s, 1H), 7.85 (d, J = 8.8 Hz, 2H), 7.83 (dd, J = 5.0, 1.2 Hz, 
1H), 7.75 (dd, J = 8.5, 4.1 Hz, 1H), 7.25-7.23 (m, 1H), 7.10 (d, J = 8.8 Hz, 2H), 3.91 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 183.4, 160.7, 154.0, 152.5, 149.3, 143.3, 142.8, 139.8, 138.8, 
137.2, 137.1, 132.2, 128.7, 127.8, 124.8, 122.7, 114.1, 55.6. 
MS (EI, 70 eV): m/z (%) = 346 (100), 345 (39), 317 (96), 303 (25), 287 (13), 274 (11), 234 (13), 192 
(17), 111 (61). 
HRMS (EI) calcd. for [C20H14N2O2S]: 346.0776; found: 346.0769. 
 
4-(4-Methoxyphenyl)-2-(p-tolyl)-1,5-naphthyridine (56e) 
 
According to TP 5, 4-(4-methoxyphenyl)-1,5-naphthyridine (42g, 118 mg, 0.50 mmol) was metalated 
using TMPMgCl·LiCl (3, 0.5 mL, 0.55 mmol, 1.1 M in THF, 1.1 equiv) in the presence of BF3·OEt2 
(0.07 mL, 0.55 mmol, 1.1 equiv), followed by transmetalation with ZnCl2 (0.6 mL, 0.6 mmol, 1.0 M in 
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THF, 1.2 equiv). After stirring the reaction for further 10 min, a solution of Pd(dba)2 (9 mg, 0.015 mmol, 
3 mol%), tfp (7 mg, 0.030 mmol, 6 mol%) and 1-iodo-4-methylbenzene (98 mg, 0.45 mmol, 0.9 equiv) 
in dry THF (1 mL) was added dropwise. The reaction mixture was allowed to warm to rt overnight. 
After workup, the crude product was purified by flash column chromatography (isohexane/EtOAc = 
9:1) to give 56e (82 mg, 56%) as a yellow solid.  
 
m.p.:  133 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1606, 1588, 1543, 1514, 1486, 1462, 1363, 1290, 1247, 1181, 
1153, 1112, 1020, 834, 820, 786, 718, 679. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.96 (dd, J = 4.1, 1.7 Hz, 1H), 8.48 (dd, J = 8.5, 1.7 Hz, 1H), 
8.12 (d, J = 8.2 Hz, 2H), 8.07 (s, 1H), 7.82 (d, J = 8.8 Hz, 2H), 7.62 (dd, J = 8.5, 4.1 Hz, 1H), 7.35 (d, 
J = 7.9 Hz, 2H), 7.09 (d, J = 8.8 Hz, 2H), 3.09 (s, 3H), 2.45 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 160.3, 157.8, 150.1, 148.4, 144.5, 141.5, 139.9, 137.7, 136.4, 
131.9, 129.7, 129.5, 127.6, 124.2, 121.7, 114.0, 55.5, 21.5. 
MS (EI, 70 eV): m/z (%) = 327 (16), 326 (91), 325 (100), 311 (27), 282 (15), 163 (7). 
HRMS (EI) calcd. for [C22H18N2O]: 326.1419; found: 326.1397. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
136 
 
4. IRON- AND COBALT-CATALYZED CROSS-COUPLING OF NAPHTHYRIDINES 
 
4.1 Typical Procedures 
 
Typical Procedure for Iron-Catalyzed C(sp2)-C(sp3) Cross-Couplings of Naphthyridines with 
Alkylmagnesium reagents (TP 1): 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a rubber septum, was 
charged with 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 113 mg, 0.50 mmol) and Fe(acac)3           
(9 mg, 0.025 mmol, 5 mol%) followed by dry THF (2 mL). After dropwise addition of the alkyl- 
magnesium reagent (2.4 equiv), the reaction mixture was stirred at rt for the indicated time until 
complete conversion of the starting material (detected by GC-analysis of reaction aliquots). Then, the 
mixture was quenched with sat. aq. NH4Cl solution (10 mL), extracted with EtOAc (3 × 10 mL) and 
dried over MgSO4. After filtration, the solvents were removed in vacuo and the residue was subjected 
to column chromatography on silica yielding the respective title compound. 
 
Typical Procedure for Cobalt-Catalyzed C(sp2)-C(sp3) Cross-Couplings of Naphthyridines with 
Alkylmagnesium Reagents (TP2): 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and septum, was charged 
with anhydrous CoCl2 (5 mol%). The flask was evacuated under high vacuum at 400 °C for 5 min, 
cooled to rt and then backfilled with argon. Subsequently, the respective aryl halide (1.0 equiv) was 
added, followed by dry THF (0.5 M). Then, a solution of the appropriate alkylmagnesium reagent (1.1 
equiv) was added dropwise via syringe. The reaction was stirred for 20 min at rt until complete con-
sumption of starting material was detected by GC-analysis. Saturated aqueous NH4Cl solution (10 mL) 
and EtOAc (10 mL) were added, the phases were separated and the aqueous phase was extracted with 
EtOAc (3 × 20 mL). The combined organic layers were dried over Na2SO4. The solvents were 
evaporated and the residue was subjected to column chromatography on silica yielding the respective 
title compound. 
 
Typical Procedure for Cobalt-Catalyzed C(sp2)-C(sp2) Cross-Couplings of Naphthyridine 22 with 
Arylmagnesium reagents (TP3): 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and septum, was charged 
with anhydrous CoCl2 (5 mol%). The flask was evacuated under high vacuum at 400 °C for 5 min, 
cooled to rt and then backfilled with Argon. Subsequently, the respective aryl halide (1.0 equiv) was 
added, followed by dry THF (0.5 M). The solution was cooled to the indicated temperature. Then, a 
solution of the appropriate arylmagnesium reagent (3.0 equiv) was added dropwise via syringe. The 
reaction was stirred at the adjusted temperature until complete consumption of starting material, detected 
by GC-analysis. Saturated aqueous NH4Cl solution (5 mL) and EtOAc (5 mL) were added, the phases 
were separated and the aqueous phase was extracted with EtOAc (3 × 20 mL). The combined organic 
layers were dried over Na2SO4. The solvents were evaporated and the residue was subjected to column 
chromatography on silica yielding the respective title compound. 
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Typical Procedure for Cobalt-Catalyzed C(sp2)-C(sp2) Cross-Couplings of Naphthyridines with 
Arylzinc Reagents (TP4): 
A dry and argon-flushed Schlenk-flask, equipped with a stirring bar and a septum, was charged with a 
solution of CoCl2·2LiCl (1 M in THF, 5 mol%) and dry THF (2 mL). The respective aryl halide (1.0 
equiv) and HCO2Na (50 mol%) were added at rt. Then, a solution of the appropriate zinc reagent (1.2 
equiv) was added dropwise over 15 min via syringe. The reaction was stirred and monitored by GC-
analysis. Upon consumption of the starting material (approx. 12 h), saturated aqueous NH4Cl solution 
(5 mL) and EtOAc (5 mL) were added, the phases were separated and the aqueous phase was extracted 
with EtOAc (3 × 50 mL). The combined organic layers were dried over Na2SO4. The solvents were 
evaporated and the residue was subjected to column chromatography on silica yielding the respective 
title compound. 
 
 
4.2 Iron- and Cobalt-Catalyzed C(sp2)-C(sp3) Cross-Couplings with Alkyl- 
magnesium Reagents 
 
3,6-Diethyl-1,8-dimethyl-2,7-naphthyridine (58a) 
 
According to TP1, 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 0.5 mmol, 113 mg, 1.0 equiv) 
reacted with EtMgCl (0.44 mL, 1.05 mmol, 2.4 M in THF, 2.1 equiv) within 2 h at rt. After workup, the 
crude product was purified by flash column chromatography (isohexane/EtOAc = 9:1) to afford 58a (74 
mg, 69 %) as a redbrown solid. 
 
m.p.: 56-57 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2967, 2925, 1606, 1545, 1456, 1373, 1329, 1062, 963, 915, 895. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.13 (s, 2H), 3.06 (s, 6H), 2.85 (q, J = 7.5 Hz, 4H), 1.32 (t, J = 
7.5 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 158.9, 158.7, 142.7, 120.8, 114.8, 30.9, 29.1, 13.2. 
MS (EI, 70 eV): m/z (%) = 214 (52), 213 (100), 186 (12), 185 (11), 115 (8), 63 (6), 42 (8). 
HRMS (EI) calcd. for [C14H18N2]: 214.1470; found: 214.1470. 
 
3,6-Diisopropyl-1,8-dimethyl-2,7-naphthyridine (58b) 
 
According to TP1, 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 0.5 mmol, 113 mg, 1.0 equiv) 
reacted with iPrMgCl·LiCl (0.91 mL, 1.15 mmol, 1.26 M in THF, 2.3 equiv) within 30 min at rt. After 
workup, the crude product was purified by flash column chromatography (isohexane/EtOAc = 9:1) to 
afford 58b (50 mg, 41%) as a yellow oil. 
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IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2961, 1608, 1549, 1457, 1426, 1379, 1332, 1091, 936, 886. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 7.20 (s, 2H), 3.16-3.05 (m, 2H), 3.03 (s, 6H), 1.35 (s, 6H), 1.34 
(s, 6H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 162.6, 158.7, 142.8, 121.1, 113.4, 35.8, 29.2, 22.4. 
MS (EI, 70 eV): m/z (%) = 242 (46), 241 (38), 228 (18), 227 (100), 225 (14), 215 (11), 214 (66), 211 
(22), 200 (9), 106 (11). 
HRMS (EI) calcd. for [C16H22N2]: 242.1783; found: 242.1776. 
 
3,6-Dicyclohexyl-1,8-dimethyl-2,7-naphthyridine (58c) 
 
According to TP1, 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 0.5 mmol, 113 mg, 1.0 equiv) 
reacted with cHexMgBr·LiCl (2.6 mL, 1.2 mmol, 0.46 M in THF, 2.4 equiv) within 30 min at rt. After 
workup, the crude product was purified by flash column chromatography (isohexane/EtOAc = 9:1) to 
afford 58c (126 mg, 78%) as a white solid. 
 
m.p.: 78-79 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2922, 2850, 1604, 1540, 1447, 1423, 1328, 939, 900, 876, 849. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 7.10 (s, 2H), 3.02 (s, 6H), 2.74-2.63 (m, 2H), 2.04-1.92 (m, 
4H), 1.86-1.76 (m, 4H), 1.74-1.66 (m, 2H), 1.51-1.32 (m, 8H), 1.30-1.17 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 161.8, 158.6, 142.7, 121.2, 113.8, 45.9, 32.9, 29.3, 26.6, 26.2. 
MS (EI, 70 eV): m/z (%) = 322 (38), 321 (20), 293 (15), 281 (16), 268 (25), 267 (100), 254 (29). 
HRMS (EI) calcd. for [C22H30N2]: 322.2409; found: 322.2402. 
 
3-Chloro-6-cyclopropyl-1,8-dimethyl-2,7-naphthyridine (58d) 
 
According to TP1, 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 0.5 mmol, 113 mg, 1.0 equiv) 
reacted with cyclopropylmagnesium bromide (1.2 mmol, 1.2 mL, 1.0 M in THF, 2.4 equiv) within 30 
min at rt. After workup, the crude product was purified by flash column chromatography (isohexane/ 
EtOAc = 7:1) to afford 58d (72 mg, 62%) as an off-white solid. 
 
m.p.: 93-94 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1601, 1583, 1536, 1424, 1216, 1131, 892, 865. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 7.29 (s, 1H), 7.07 (s, 1H), 3.03 (s, 3H), 3.00 (s, 3H), 2.11-1.99 
(m, 1H), 1.13-1.06 (m, 2H), 1.04-0.95 (m, 2H). 
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13C-NMR (75 MHz, CDCl3): δ/ ppm = 161.0, 159.6, 159.1, 146.7, 143.4, 120.9, 116.7, 113.2, 29.3, 
28.8, 16.9, 9.7. 
MS (EI, 70 eV): m/z (%) = 234 (18), 233 (36), 232 (51), 231 (100), 206 (9), 197 (10), 84 (9). 
HRMS (EI) calcd. for [C13H13ClN2]: 232.0767; found: 232.0750. 
 
1,8-Dimethyl-3,6-diphenethyl-2,7-naphthyridine (58e) 
 
According to TP1, 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 0.5 mmol, 113 mg, 1.0 equiv) 
reacted with Ph(CH2)2MgBr·LiCl (1.35 mL, 1.15 mmol, 0.85 M in THF, 2.4 equiv) within 30 min at       
rt. After workup, the crude product was purified by flash column chromatography (isohexane/EtOAc = 
9:1) to afford 58e (152 mg, 83 %) as a white solid. 
 
m.p.: 102-103 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2924, 2858, 1607, 1546, 1493, 1452, 1328, 893, 750, 713, 696. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 7.24-7.08 (m, 10H), 7.00 (s, 2H), 3.10-3.00 (m, 8H), 3.07 (s, 
6H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 159.3, 156.5, 142.5, 141.7, 128.6, 128.5, 126.1, 121.2, 116.3, 
39.7, 35.7, 29.4. 
MS (EI, 70 eV): m/z (%) = 367 (27), 366 (100), 365 (49), 289 (27), 275 (15), 274 (17), 262 (12), 198 
(12), 91 (48), 43 (27). 
HRMS (EI) calcd. for [C26H26N2]: 366.2096; found: 366.2098. 
 
3-Chloro-1,8-dimethyl-6-phenethyl-2,7-naphthyridine (58f) 
 
According to TP2, 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 0.5 mmol, 113 mg, 1.0 equiv) 
reacted with Ph(CH2)2MgBr·LiCl (0.65 mL, 0.55 mmol, 0.85 M in THF, 1.1 equiv) within 20 min at rt. 
After workup, the crude product was purified by flash column chromatography (isohexane/EtOAc = 
9:1) to afford 58f (119 mg, 80%) as a white solid. 
 
m.p.: 90 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1605, 1580, 1536, 1497, 1454, 1420, 1380, 1328, 1135, 887, 750, 
729, 688. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 7.35 (s, 1H), 7.30-7.15 (m, 5H), 7.07 (s, 1H), 3.22-3.03 (m, 
10H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 161.3, 159.9, 157.7, 147.1, 143.8, 141.4, 128.6, 128.5, 126.2, 
121.3, 117.4, 115.7, 39.7, 35.5, 29.4, 29.1. 
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MS (EI, 70 eV): m/z (%) = 298 (30), 297 (41), 296 (100), 295 (83), 281 (9), 221 (17), 191 (17), 91 (31). 
HRMS (EI) calcd. for [C18H17N2Cl]: 296.1080; found: 296.1076. 
 
1-Phenethyl-2,7-naphthyridine (58g) 
 
According to TP2, 1-chloro-2,7-naphthyridine (30, 0.5 mmol, 82 mg, 1.0 equiv) reacted with 
Ph(CH2)2MgBr·LiCl (0.65 mL, 0.55 mmol, 0.85 M in THF, 1.1 equiv) within 20 min at rt. After workup, 
the crude product was purified by flash column chromatography (isohexane/EtOAc = 1:1) to afford 58g 
(94 mg, 82%) as a yellow solid. 
 
m.p.: 76 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1617, 1550, 1496, 1452, 1376, 1311, 1282, 1238, 1214, 1056, 
1017, 973, 915, 896, 868, 795, 753, 738. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.58 (s, 1H), 8.70 (d, J = 5.7 Hz, 1H), 8.66 (d, J = 5.8 Hz, 1H), 
7.63 (dd, J = 5.7, 1.0 Hz, 1H), 7.51 (d, J = 5.8 Hz, 1H), 7.34-7.17 (m, 5H), 3.73-3.64 (m, 2H), 3.35-3.12 
(m, 2H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 162.8, 150.6, 146.7, 146.2, 141.3, 139.2, 128.7, 128.6, 126.4, 
122.4, 119.8, 117.9, 36.8, 35.9. 
MS (EI, 70 eV): m/z (%) = 235 (16), 234 (95), 233 (100), 219 (15), 218 (19), 157 (33), 130 (22), 116 
(10), 91 (34), 65 (10). 
HRMS (EI) calcd. for [C16H14N2]: 234.1157; found: 234.1148. 
 
1-Methyl-2,7-naphthyridine (58h) 
 
According to TP2, 1-chloro-2,7-naphthyridine (30, 329 mg, 2.0 mmol, 1.0 equiv) reacted with MeMgCl 
(0.81 mL, 2.2 mmol, 2.72 M in THF, 1.1 equiv) within 20 min at rt. After workup, the crude product 
was purified by flash column chromatography (EtOAc) to afford 58h (286 mg, 98%) as a yellow solid. 
 
m.p.: 45 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1615, 1549, 1435, 1393, 1374, 1356, 1276, 1248, 1215, 1081, 
1019, 964, 885, 851, 800, 728, 578. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.59 (s, 1H), 8.72 (d, J = 5.8 Hz, 1H), 8.57 (d, J = 5.8 Hz, 1H), 
7.61 (dd, J = 5.7, 1.0 Hz, 1H), 7.48 (d, J = 5.8 Hz, 1H), 3.05 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 160.2, 151.1, 146.9, 146.1, 138.9, 122.8, 119.6, 117.8, 21.9. 
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MS (EI, 70 eV): m/z (%) = 145 (13), 144 (100), 118 (15), 117 (9), 116 (8), 75 (7), 63 (8), 50 (7). 
HRMS (EI) calcd. for [C9H8N2]: 144.0687; found: 144.0679. 
 
1-(Secbutyl)-2,7-naphthyridine (58i) 
 
According to TP2, 1-chloro-2,7-naphthyridine (30, 82 mg, 0.5 mmol, 1.0 equiv) reacted with                       
sBuMgCl·LiCl (0.42 mL, 0.55 mmol, 1.3 M in THF, 1.1 equiv) within 20 min at rt. The crude product 
was purified by flash column chromatography (isohexane/EtOAc = 1:1) to afford 58i (50 mg, 54%) as 
a colorless oil. 
 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2963, 2929, 1615, 1548, 1461, 1380, 1332, 1265, 1215, 981, 852. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.66 (s, 1H), 8.67 (d, J = 5.8 Hz, 1H), 8.65 (d, J = 5.8 Hz, 1H), 
7.60 (dd, J = 5.7, 0.8 Hz, 1H), 7.44 (dd, J = 5.7, 0.8 Hz, 1H), 3.80 (sept, J = 6.8 Hz, 1H), 2.08-1.95 (m, 
1H), 1.77 (dquint, J = 14.2, 7.3 Hz, 1H), 1.42 (d, J = 6.8 Hz, 3H), 0.88 (t, J = 7.4 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 167.7, 150.3, 146.4, 146.1, 139.2, 122.2, 119.9, 117.3, 37.9, 
29.9, 20.4, 12.4. 
MS (EI, 70 eV): m/z (%) = 186 (15), 185 (25), 172 (11), 171 (82), 159 (13), 158 (100), 157 (78), 156 
(16), 144 (23), 130 (25), 129 (18), 78 (11). 
HRMS (EI) calcd. for [C12H14N2]: 186.1157; found: 186.1170. 
 
5-Butyl-2-(trifluoromethyl)-1,6-naphthyridine (58j) 
 
According to TP2, 5-chloro-2-(trifluoromethyl)-1,6-naphthyridine (57, 0.43 mmol, 100 mg, 1.0 equiv) 
reacted with nBuMgCl (0.35 mL, 0.47 mmol, 1.37 M in THF, 1.1 equiv) within 20 min at rt. The crude 
product was purified by flash column chromatography (isohexane/EtOAc = 9:1) to afford 58j (76 mg, 
69 %) as a colorless oil. 
 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2959, 1607, 1584, 1571, 1471, 1337, 1189, 1139, 1114, 1097, 837, 
741. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.75 (d, J = 8.7 Hz, 1H), 8.68 (d, J = 8.7 Hz, 1H), 7.87 (d, J = 
6.0 Hz, 1H), 7.83 (d, J = 8.7 Hz, 1H), 3.36-3.30 (m, 2H), 1.89-1.80 (m, 2H), 1.49 (dq, J = 14.7, 7.4 Hz, 
2H), 0.98 (t, J = 7.4 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 164.0, 151.7 (q, J  = 35.1 Hz), 150.2, 147.1, 136.3, 122.6, 
120.8, 119.8, 117.9 (q, J = 2.2 Hz), 35.0, 32.0, 23.0, 14.1. 
MS (EI, 70 eV): m/z (%) = 254 (7), 253 (11), 239 (36), 225 (75), 212 (100), 177 (11). 
HRMS (EI) calcd. for [C13H13F3N2]: 254.1031; found: 254.0986. 
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5-Cyclopropyl-2-(trifluoromethyl)-1,6-naphthyridine (58k) 
 
According to TP2, 5-chloro-2-(trifluoromethyl)-1,6-naphthyridine (57, 0.43 mmol, 100 mg, 1.0 equiv) 
reacted with cPropylMgBr·LiCl (0.45 mL, 0.47 mmol, 1.05 M in THF, 1.1 equiv) within 20 min at rt. 
After workup, the crude product was purified by flash column chromatography (isohexane/EtOAc = 
9:1) to afford 58k (53 mg, 52 %) as a colorless oil. 
 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2950, 2854, 1740, 1606, 1572, 1462, 1378, 1340, 1258, 1192, 
1146, 1110, 1096, 1008, 840.      
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.92 (d, J = 8.7 Hz, 1H), 8.67 (d, J = 6.0 Hz, 1H), 7.86 (d, J = 
8.7 Hz, 1H), 7.80 (d, J = 6.0 Hz, 1H), 2.76-2.66 (m, 1H), 1.37-1.31 (m, 2H), 1.23-1.17 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 163.7, 151.3 (q, J = 35.1 Hz), 149.9, 147.0, 135.9, 123.0 (2C), 
122.5, 119.7, 117.6 (q, J = 2.1 Hz), 13.4, 10.7. 
MS (EI, 70 eV): m/z (%) = 238 (10), 237 (100), 223 (7), 217 (30), 168 (34), 167 (11). 
HRMS (EI) calcd. for [C12H9F3N2]: 238.0718; found: 238.0712. 
 
3-(Bis(trimethylsilyl)methyl)-6-butyl-1,8-dimethyl-2,7-naphthyridine (59) 
 
According to TP1, 3-(bis(trimethylsilyl)methyl)-6-chloro-1,8-dimethyl-2,7-naphthyridine (25, 1.14 
mmol, 113 mg, 1.0 equiv) reacted with nBuMgCl (0.87 mL, 1.25 mmol, 1.4 M in THF, 1.1 equiv) within 
12 h at rt. After workup, the crude residue was purified by flash column chromatography (isohexane/ 
EtOAc = 19:1) to afford 59 (240 mg, 56%) as a yellow oil. 
 
IR (Diamond ATR): 𝜈/ cm-1 = 2954, 1605, 1586, 1543, 1458, 1423, 1379, 1331, 1246, 1207, 1194, 
1302, 1001, 941, 858, 826, 775, 684. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 7.06 (s, 1H), 6.87 (s, 1H), 3.08 (s, 3H), 3.03 (s, 3H), 2.81 (t,      
J = 7.8 Hz, 2 H), 1.87 (s, 1H), 1.75 (quint, J = 7.6 Hz, 2H), 1.43 (sxt, J = 7.4 Hz, 2H), 0.96 (t, J = 7.3 
Hz, 3H), 0.05 (s, 18H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 159.9, 158.9, 158.0, 157.0, 142.5, 119.5, 115.2, 114.5, 37.8, 
32.7, 31.7, 29.1, 22.6, 14.0, 0.2. 
MS (EI, 70 eV): m/z (%) = 372 (8), 358 (28), 357 (100), 331 (9), 330 (34), 73 (14). 
HRMS (EI) calcd.for [C21H36N2Si2]: 372.2417; found: 372.2418. 
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(E)-3-butyl-1,8-dimethyl-6-styryl-2,7-naphthyridine (60) 
 
3-(Bis(trimethylsilyl)methyl)-6-butyl-1,8-dimethyl-2,7-naphthyridine (59, 308 mg, 0.83 mmol, 1.0 
equiv) was dissolved in dry THF (13 mL) and reacted with benzaldehyde (106 mg, 1.0 mmol, 1.2 equiv), 
catalyzed by TBAF (0.08 mL, 0.08 mmol, 1.0 M in THF, 0.1 equiv) at -20 °C within 15 min. Then, the 
reaction mixture was quenched with sat. aq. NH4Cl solution (30 mL), extracted with EtOAc (3 × 30 mL) 
and dried over MgSO4. After filtration, the solvents were evaporated in vacuo. The crude product was 
purified by flash column chromatography (isohexane/EtOAc = 9:1) to give 60 (222 mg, 85%) as a white 
solid. 
 
m.p.: 67-68 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2950, 1599, 1545, 1452, 1424, 1380, 1327, 974, 894, 754, 737, 
703, 688, 556. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 7.77 (d, J = 15.8 Hz, 1H), 7.55 (d, J = 7.4 Hz, 2H), 7.32 (t,        
J = 7.5 Hz, 2H), 7.27-7.21 (m, 2H), 7.17-7.08 (m, 2H), 3.09 (s, 3H), 3.05 (s, 3H), 2.79 (t, J = 7.7 Hz, 
2H), 1.70 (quint, J = 7.7 Hz, 2H), 1.36 (sxt, J = 7.41 Hz, 2H), 0.90 (t, J = 7.3 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 159.6, 159.1, 158.2, 150.5, 142.7, 136.9, 133.5, 128.7, 128.3, 
127.3, 127.2, 121.5, 116.3, 116.1, 37.8, 31.7, 29.6, 29.2, 22.6, 14.0. 
MS (EI, 70 eV): m/z (%) = 316 (5), 301 (7), 287 (11), 275 (20), 274 (100), 137 (8). 
HRMS (EI) calcd. for [C22H24N2]: 316.1939; found: 316.1939. 
 
1,8-Dimethyl-3,6-diphenyl-2,7-naphthyridine (61) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 0.5 mmol, 113 mg, 1.0 equiv) and anhydrous 
FeBr3 (7.4 mg, 0.025 mmol, 5 mol%) in dry THF/tBuOMe (1:1, 4 mL). Upon dropwise addition of 
PhMgCl (1.12 mL, 1.78 M in THF, 2.0 mmol, 4.0 equiv) the reaction was stirred for 15 min at rt. After 
workup, the crude residue was purified by flash column chromatography (isohexane/EtOAc = 9:1) to 
afford 61 (65 mg, 42%) as a white solid. 
 
m.p.: 158-160 °C. 
IR (Diamond ATR): 𝜈/ cm-1 = 3058, 3035, 2994, 2938, 1601, 1547, 1498, 1461, 1418, 1378, 1332, 
1257, 1225, 1177, 1156, 1101, 1073, 1026, 978, 893, 794, 774, 763, 695, 682, 644, 579. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.09 (d, J = 7.3 Hz, 4H), 7.79 (s, 2H), 7.44 (t, J = 7.5 Hz, 4H), 
7.40-7.32 (m, 2H), 3.16 (s, 6H). 
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13C-NMR (100 MHz, CDCl3): δ/ ppm = 159.7, 152.6, 143.2, 138.8, 129.3, 128.9, 127.3, 121.9, 114.8, 
29.6. 
MS (EI, 70 eV): m/z (%) = 311 (24), 310 (100), 309 (15), 268 (4), 165 (3), 155 (6), 77 (4). 
HRMS (EI) calcd. for [C22H18N2]: 310.1470; found: 310.1465. 
 
 
4.3 Cobalt-Catalyzed C(sp2)-C(sp2) Cross-Couplings of Naphthyridines with 
Arylmagnesium and Arylzinc Reagents 
 
1,8-Dimethyl-3,6-bis(4-(trimethylsilyl)phenyl)-2,7-naphthyridine (62a) 
 
According to TP3, 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 113 mg, 0.5 mmol, 1.0 equiv) 
reacted with 4-(trimethylsilyl)phenylmagnesium bromide (1.78 mL, 1.5 mmol, 0.84 M in THF, 3.0 
equiv) within 4 h at -40 °C. After workup, the crude residue was purified by flash column chromato-
graphy (isohexane/EtOAc = 1:1) to afford 62a (140 mg, 62%) as a white solid.  
 
m.p.: 135-137 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 2956, 1602, 1549, 1378, 1332, 1245, 1115, 1092, 824, 752, 722, 
692. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.14 (d, J = 8.2 Hz, 4H), 7.87 (s, 2H), 7.68 (d, J = 8.2 Hz, 4H), 
3.24 (s, 6H), 0.33 (s, 18H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 159.7, 152.7, 143.2, 141.9, 138.9, 133.9, 126.5, 121.9, 114.9, 
29.5, 0.9. 
MS (EI, 70 eV): m/z (%) = 455 (17), 454 (45), 441 (16), 440 (40), 439 (100), 213 (23), 212 (57), 73 
(18). 
HRMS (EI) calcd. for [C28H34N2Si2]: 454.2261; found: 454.2258. 
 
4,4'-(1,8-Dimethyl-2,7-naphthyridine-3,6-diyl)bis(N,N-dimethylaniline) (62b) 
 
According to TP3, 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 113 mg, 0.5 mmol, 1.0 equiv) 
reacted with 4-(dimethylamino)phenylmagnesium bromide (1.36 mL, 1.5 mmol, 1.1 M in THF, 3.0 
equiv) within 4 h at -40 °C. After workup, the crude residue was purified by flash column chromato-
graphy (isohexane/EtOAc = 1:1) to afford 62b (145 mg, 73%) as a yellow solid.  
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m.p.: 240-242 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1591, 1544, 1525, 1428, 1357, 1191, 1166, 1126, 946, 879, 822. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.09 (d, J = 9.0 Hz, 4H), 7.69 (s, 2H), 6.83 (d, J = 9.0 Hz, 4H), 
3.22 (s, 6H), 3.04 (s, 12H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 159.4, 152.5, 151.4, 143.7, 128.3, 120.7, 112.4, 40.5, 29.3. 
MS (EI, 70 eV): m/z (%) = 397 (28), 396 (100), 395 (7), 380 (8), 198 (12), 197 (11). 
HRMS (EI) calcd. for [C26H28N4]: 396.2314; found: 396.2311. 
 
3,6-Bis(4-methoxyphenyl)-1,8-dimethyl-2,7-naphthyridine (62c) 
 
According to TP3, 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 113 mg, 0.5 mmol, 1.0 equiv) 
reacted with (4-methoxyphenyl)magnesium bromide (1.92 mL, 1.5 mmol, 0.78 M in THF, 3.0 equiv) 
within 12 h at -40 °C. After workup, the crude residue was purified by flash column chromatography 
(isohexane/EtOAc = 1:1) to afford 62c (110 mg, 60%) as a white solid. 
 
m.p.: 191-193 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1605, 1543, 1514, 1423, 1399, 1378, 1293, 1248, 1173, 1024, 837, 
827, 810, 791, 659. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.13 (d, J = 8.9 Hz, 4H), 7.77 (s, 2H), 7.04 (d, J = 8.9 Hz, 4H), 
3.89 (s, 6H), 3.22 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 160.8, 159.6, 143.4, 128.6, 121.3, 114.4, 113.5, 55.6, 29.5. 
MS (EI, 70 eV): m/z (%) = 371 (29), 370 (100), 355 (8), 185 (12). 
HRMS (EI) calcd. for [C24H22N2O2]: 370.1681; found: 370.1670. 
 
3,6-Dimesityl-1,8-dimethyl-2,7-naphthyridine (62d) 
 
According to TP3, 3,6-dichloro-1,8-dimethyl-2,7-naphthyridine (22, 113 mg, 0.5 mmol, 1.0 equiv) 
reacted with mesitylmagnesium bromide (1.58 mL, 1.5 mmol, 0.95 M in THF, 3.0 equiv) within 4 h at 
rt. The crude residue was purified by flash column chromatography (isohexane/EtOAc = 9:1) to afford 
62d (183 mg, 93%) as a white crystalline solid. 
 
m.p.: 198 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1604, 1543, 1437, 1377, 1327, 1093, 1031, 878, 848. 
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1H-NMR (400 MHz, CDCl3): δ/ ppm = 7.34 (s, 2H), 6.97 (s, 4H), 3.25 (s, 6H), 2.33 (s, 6H), 2.10 (s, 
12H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 159.8, 142.2, 137.8, 136.0, 128.6, 121.1, 119.0, 21.3, 20.5. 
MS (EI, 70 eV): m/z (%) = 394 (64), 393 (91), 392 (13), 377 (10), 189 (10), 44 (100), 42 (10). 
HRMS (EI) calcd. for [C28H30N2]: 394.2409; found: 394.2356. 
 
3,6-Bis(4-iodophenyl)-1,8-dimethyl-2,7-naphthyridine (63) 
 
1,8-Dimethyl-3,6-bis(4-(trimethylsilyl)phenyl)-2,7-naphthyridine (62a, 174 mg, 0.38 mmol, 1.0 equiv) 
was dissolved in dry DCM (2 mL). ICl (0.06 mL, 1.14 mmol, 3.0 equiv) was added dropwise at 0 °C 
and the reaction mixture was stirred for further 10 min. Then, the reaction was quenched with sat. aq. 
Na2S2O3 solution (5 mL), extracted with DCM (3 × 10 mL) and dried over anhydrous Na2SO4. After 
filtration, the solvents were evaporated in vacuo. The crude product was purified by flash column 
chromatography on silica gel (100% isohexane) to give 63 (209 mg, 98%) as a white solid. 
 
m.p.: 175-178 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2922, 2853, 1603, 1548, 1485, 1459, 1427, 1379, 1330, 1260, 
1099, 1059, 1034, 1000, 980, 888, 822, 715. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 7.91 (d, J = 8.6 Hz, 4H), 7.84 (d, J = 8.6 Hz, 4H), 7.84 (s, 2H), 
3.23 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 160.0, 151.6, 143.1, 138.1, 130.0, 122.1, 114.6, 95.9, 29.9, 
29.5. 
MS (EI, 70 eV): m/z (%) = 563 (24), 562 (100), 435 (14), 308 (9), 146 (10), 128 (19), 127 (11), 57 (13), 
41 (9). 
HRMS (EI) calcd. for [C22H16I2N2]: 561.9403; found: 561.9394. 
 
1-Phenyl-2,7-naphthyridine (63a) 
 
According to TP4, 1-chloro-2,7-naphthyridine (30, 82 mg, 0.5 mmol, 1.0 equiv) reacted with PhZnCl 
(0.69 mL, 0.6 mmol, 0.87 M in THF, 1.2 equiv) within 12 h at rt. After workup, the crude residue was 
purified by flash column chromatography (isohexane/EtOAc = 8:2) to afford 63a (82 mg, 80%) as a 
light-yellow solid. 
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m.p.: 129 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1612, 1543, 1450, 1382, 1351, 1217, 1022, 974, 860, 772, 702. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.53 (s, 1H), 8.80 (d, J = 5.7 Hz, 1H), 8.73 (d, J = 5.7 Hz, 1H), 
7.77-7.73 (m, 2H), 7.70 (dd, J = 5.7, 1.1 Hz, 1H), 7.63 (dd, J = 5.8, 0.9 Hz, 1H), 7.60-7.55 (m, 3H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 162.0, 153.0, 146.7, 146.3, 139.8, 138.1, 130.3, 129.6, 128.8, 
121.9, 119.4, 118.4. 
MS (EI, 70 eV): m/z (%) = 207 (6), 206 (45), 205 (100). 
HRMS (EI) calcd. for [C14H10N2]: 206.0844; found: 206.0833. 
 
1-(4-(Trifluoromethyl)phenyl)-2,7-naphthyridine (63c)  
 
According to TP4, 1-chloro-2,7-naphthyridine (30, 110 mg, 0.67 mmol, 1.0 equiv) reacted with 4-(tri-
fluoromethyl)phenylzinc chloride (1.27 mL, 0.8 mmol, 0.63 M in THF, 1.2 equiv) within 12 h at rt. After 
workup, the crude residue was purified by flash column chromatography (isohexane/EtOAc = 1:1) to 
afford 63c (127 mg, 69%) as a white solid. 
 
m.p.: 126-127 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1615, 1539, 1324, 1246, 1157, 1099, 1067, 1022, 976, 850, 837, 
810, 716, 693, 660.  
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.45 (s, 1H), 8.80 (d, J = 5.7 Hz, 1H), 8.75 (d, J = 5.7 Hz, 1H), 
7.87 (d, J = 8.3 Hz, 2H), 7.83 (d, J = 8.3 Hz, 2H), 7.71 (d, J = 5.7 Hz, 1H), 7.67 (d, J = 5.7 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 160.3, 152.3, 146.9, 146.3, 141.5, 139.7, 131.6 (q, J = 32.7 
Hz), 125.7 (q, J = 3.8 Hz), 121.8, 119.4, 119.1. 
MS (EI, 70 eV): m/z (%) = 275 (12), 274 (77), 273 (100), 253 (10), 248 (10), 206 (22), 204 (11), 58 
(12), 57 (19), 50 (11), 44 (73), 43 (50). 
HRMS (EI) calcd. for [C15H9F3N2]: 274.0718; found: 274.0684. 
 
2-Fluoro-4-(2,7-naphthyridin-1-yl)benzonitrile (63e) 
 
According to TP4, 1-chloro-2,7-naphthyridine (30, 82 mg, 0.5 mmol, 1.0 equiv) reacted with (4-cyano-
3-fluorophenyl)zinc chloride (1.1 mL, 0.6 mmol, 0.54 M in THF, 1.2 equiv) within 12 h at rt. After 
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workup, the crude residue was purified by flash column chromatography (isohexane/EtOAc = 1:1) to 
afford 63e (92 mg, 74%) as a white solid. 
 
m.p.: 186 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2234, 1616, 1562, 1538, 1430, 1406, 1372, 1250, 1221, 1133, 
1109, 1068, 996, 915, 878, 855, 767, 756, 737, 694. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.45 (s, 1H), 8.82 (d, J = 5.7 Hz, 1H), 8.79 (d, J = 5.7 Hz, 1H), 
7.87-7.82 (m, 1H), 7.76 (dd, J = 5.7, 0.9 Hz, 1H), 7.73 (dd, J = 5.7, 0.7 Hz, 1H), 7.68-7.67 (m, 1H), 
7.67-7.64 (m, 1H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 163.2 (d, J = 260.6 Hz), 158.2, 151.5, 147.2, 146.3, 145.0 (d, 
J = 7.5 Hz), 139.7, 133.8, 126.7, 121.5, 119.7 (d, J = 34.0 Hz), 118.4 (d, J = 21.2 Hz), 113.7, 102.5 (d, 
J = 17.1 Hz). 
MS (EI, 70 eV): m/z (%) = 250 (9), 249 (65), 248 (100), 230 (8). 
HRMS (EI) calcd. for [C15H8FN3]: 249.0702; found: 249.0699. 
 
1-(3,5-Dimethoxyphenyl)-2,7-naphthyridine (63f) 
 
According to TP4, 1-chloro-2,7-naphthyridine (30, 82 mg, 0.5 mmol, 1.0 equiv) reacted with (3,5-
dimethoxyphenyl)zinc chloride (0.7 mL, 0.6 mmol, 0.86 M in THF, 1.2 equiv) within 12 h at rt. After 
workup, the crude residue was purified by flash column chromatography (isohexane/EtOAc = 9:1) to 
afford 63f (105 mg, 79%) as a yellow solid. 
 
m.p.: 75 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1600, 1586, 1540, 1450, 1424, 1376, 1299, 1236, 1206, 1157, 
1066, 1034, 995, 929, 830, 826, 708, 687, 675. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.57 (s, 1H), 8.78 (d, J = 5.7 Hz, 1H), 8.73 (d, J = 5.7 Hz, 1H), 
7.69 (dd, J = 5.7, 1.1 Hz, 1H), 7.63 (dd, J = 5.7, 0.9 Hz, 1H), 6.86 (d, J = 2.3 Hz, 2H), 6.65 (t, J = 2.3 
Hz, 1H), 3.87 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 161.8, 161.1, 153.0, 146.8, 146.2, 139.9, 139.7, 122.0, 119.3, 
118.6, 108.4, 102.0, 55.7. 
MS (EI, 70 eV): m/z (%) = 267 (16), 266 (100), 265 (51), 251 (42), 236 (25), 235 (74), 221 (13), 208 
(16), 192 (20) 179 (13). 
HRMS (EI) calcd. for [C16H14N2O2]: 266.1055; found: 266.1050. 
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1-(Thiophen-2-yl)-2,7-naphthyridine (63g) 
 
According to TP4, 1-chloro-2,7-naphthyridine (30, 82 mg, 0.5 mmol, 1.0 equiv) reacted with thiophen-
2-ylzinc chloride (0.71 mL, 0.6 mmol, 0.84 M in THF, 1.2 equiv) within 12 h at rt. After workup, the 
crude residue was purified by flash column chromatography (EtOAc) to afford 63g (64 mg, 60%) as a 
brown solid. 
 
m.p.: 66-67 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1607, 1530, 1429, 1365, 1339, 1284, 1213, 1078, 1022, 944, 864, 
850, 803, 720, 700. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 9.89 (s, 1H), 8.79-8.63 (m, 2H), 7.69 (d, J = 3.7 Hz, 1H), 7.66 
(d, J = 5.7 Hz, 1H), 7.60 (d, J = 5.1 Hz, 1H), 7.53 (d, J = 5.7 Hz, 1H), 7.25 (t, J = 4.4 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 154.7, 152.1, 146.8, 146.2, 141.5, 140.0, 130.1, 129.5, 128.1, 
121.3, 119.4, 118.1. 
MS (EI, 70eV): m/z (%) = 213 (19), 212 (100), 211 (97), 168 (9). 
HRMS (EI) calcd. for [C12H8N2S]: 212.0408; found: 212.0415. 
 
5-(4-Methoxy-3,5-dimethylphenyl)-2-(trifluoromethyl)-1,6-naphthyridine (63h) 
 
According to TP4, 5-chloro-2-(trifluoromethyl)-1,6-naphthyridine (57, 100 mg, 0.43 mmol, 1.0 equiv) 
reacted with (4-methoxy-3,5-dimethylphenyl)zinc chloride (0.63 mL, 0.51 mmol, 0.82 M in THF, 1.2 
equiv) within 12 h at rt. After workup, the crude residue was purified by flash column chromatography 
(isohexane/EtOAc = 8:2) to afford 63h (106 mg, 74%) as a white solid. 
 
m.p.: 131-132 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1604, 1570, 1464, 1337, 1249, 1187, 1122, 1092, 1007, 922, 886, 
852, 838, 741, 727, 707. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.88 (d, J = 5.9 Hz, 1H), 8.69 (d, J = 8.8 Hz, 1H), 7.97 (dd,       
J = 5.9, 0.9 Hz, 1H), 7.79 (d, J = 8.8 Hz, 1H), 7.34 (s, 2H), 3.80 (s, 3H), 2.38 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 161.9, 158.4, 151.7 (q, J = 35.1 Hz), 150.6, 147.2, 138.9, 133.5, 
131.6, 130.6, 125.3, 122.6, 122.3, 121.1, 119.8, 118.0, 118.0 (q, J = 2.1 Hz), 59.9, 16.4. 
MS (EI, 70eV): m/z (%) = 332 (96), 331 (25), 318 (21), 317 (100), 302 (25), 301 (47), 287 (12), 273 
(30) 263 (24). 
HRMS (EI) calcd. for [C18H15F3N2O]: 332.1136; found: 332.1129. 
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5-(4-(Benzyloxy)phenyl)-2-(trifluoromethyl)-1,6-naphthyridine (63i) 
 
According to TP4, 5-chloro-2-(trifluoromethyl)-1,6-naphthyridine (57, 100 mg, 0.43 mmol, 1.0 equiv) 
reacted with (4-(benzyloxy)phenyl)zinc chloride (0.57 mL, 0.51 mmol, 0.9 M in THF, 1.2 equiv) within 
12 h at rt. After workup, the crude residue was purified by flash column chromatography (isohexane/ 
EtOAc = 8:2) to afford 63i (135 mg, 83%) as a yellow oil. 
 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1604, 1567, 1465, 1436, 1336, 1292, 1220, 1191, 1141, 1125, 
1081, 1026, 980, 916, 841, 788, 741, 696. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.95 (d, J = 5.9 Hz, 1H), 8.60 (d, J = 8.8 Hz, 1H), 8.05 (dd,       
J = 5.9, 0.9 Hz, 1H), 7.77 (d, J = 8.8 Hz, 1H), 7.54-7.45 (m, 3H), 7.45-7.34 (m, 3H), 7.33-7.28 (m, 2H), 
7.21 (ddd, J = 8.3, 2.6, 1.0 Hz, 1H), 5.19 (s, 2H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 161.6, 159.0, 151.8 (q, J = 35.1 Hz), 150.6, 147.1, 139.2, 138.6, 
136.8, 130.0, 128.8, 128.2, 127.6, 122.8, 122.5, 122.3, 121.6, 119.79, 118.1 (q, J = 2.0 Hz), 116.5, 116.4, 
70.3. 
MS (EI, 70eV): m/z (%) = 381 (12), 380 (47), 92 (7), 91 (100). 
HRMS (EI) calcd. for [C22H15F3N2O]: 380.1136; found: 380.1124. 
 
2-(Trifluoromethyl)-5-(2-((triisopropylsilyl)oxy)phenyl)-1,6-naphthyridine (63j) 
 
According to TP4, 5-chloro-2-(trifluoromethyl)-1,6-naphthyridine (57, 140 mg, 0.6 mmol, 1.0 equiv) 
reacted with 2-((triisopropylsilyl)oxy)phenylzinc chloride (1.8 mL, 0.72 mmol, 0.4 M in THF, 1.2 equiv) 
within 12 h at 60 °C. After workup, the crude residue was purified by flash column chromatography 
(isohexane/EtOAc = 8:2) to afford 63j (163 mg, 61%) as a clear oil. 
 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2947, 1603, 1570, 1464, 1338, 1276, 1247, 1194, 1145, 1131, 
1084, 1007, 920, 885, 839, 759. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.92 (d, J = 6.0 Hz, 1H), 8.36 (d, J = 8.7 Hz, 1H), 8.01 (d, J = 
6.7 Hz, 1H), 7.74 (d, J = 8.7 Hz, 1H), 7.49 (dd, J = 7.5, 1.8 Hz, 1H), 7.44-7.37 (m, 1H), 7.15 (td, J = 
7.5, 1.0 Hz, 1H), 7.00 (dd, J = 8.2, 0.9 Hz, 1H), 0.97-0.83 (m, 3H), 0.73 (d, J = 7.4 Hz, 9H), 0.69 (d,      
J = 7.4 Hz, 9H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 160.9, 153.5, 151.7 (q, J = 35.0 Hz), 149.7, 147.4, 139.9, 131.4, 
130.9, 129.5, 123.5, 122.6, 121.8, 121.5, 119.9, 119.2, 117.8 (q, J =2.2 Hz), 17.6, 12.7. 
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MS (EI, 70eV): m/z (%) = 446 (3), 404 (26), 403 (100), 318 (7), 317 (22). 
HRMS (EI) calcd. for [C24H29F3N2OSi]: 446.2001; found: 446.1993. 
 
4-(3-(Methylthio)phenyl)-1,5-naphthyridine (64a) 
 
According to TP4, 4-iodo-1,5-naphthyridine (42a, 128 mg, 0.5 mmol, 1.0 equiv) reacted with (3-
(methylthio)phenyl)zinc chloride (0.68 mL, 0.6 mmol, 0.88 M in THF, 1.2 equiv) within 12 h at rt. After 
workup, the crude residue was purified by flash column chromatography (isohexane/EtOAc = 7:1, 1% 
NEt3) to afford 64a (101 mg, 80%) as a white solid. 
 
m.p.: 89-91 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1566, 1496, 1474, 1464, 1436, 1376, 1164, 1082, 1026, 954, 904, 
882, 868, 800, 784, 742, 692, 656. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.02 (dd, J = 4.2, 1.7 Hz, 2H), 8.47 (dd, J = 8.5, 1.8 Hz, 1H), 
7.71–7.61 (m, 3H), 7.57–7.50 (m, 1H), 7.51–7.34 (m, 2H), 2.54 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 151.0, 150.9, 148.2, 144.4, 141.8, 138.7, 137.6, 137.3, 128.7, 
128.5, 127.3, 127.0, 124.3, 124.1, 16.0. 
MS (EI, 70 eV): m/z (%) = 250 (15), 249 (92), 248 (100), 234 (14), 233 (13), 232 (38), 205 (60), 203 
(10), 123 (11). 
HRMS (EI) calcd. for [C15H12N2S]: 252.0721; found: 252.0715. 
 
4-(4-Methoxyphenyl)-1,5-naphthyridine (64b) 
 
According to TP4, 4-iodo-1,5-naphthyridine (42a, 128 mg, 0.5 mmol, 1.0 equiv) reacted with (4-
methoxyphenyl)zinc chloride (0.61 mL, 0.6 mmol, 0.98 M in THF, 1.2 equiv) within 12 h at rt. After 
workup, the crude residue was purified by flash column chromatography (isohexane/EtOAc = 7:1,         
1% NEt3) to afford 64b (92 mg, 78%) as a white solid. For analytics see compound 42g (same). 
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4-(1,5-Naphthyridin-4-yl)benzonitrile (64c) 
 
According to TP4, 4-iodo-1,5-naphthyridine (42a, 128 mg, 0.5 mmol, 1.0 equiv) reacted with (4-
cyanophenyl)zinc chloride (0.6 mL, 0.6 mmol, 1.0 M in THF, 1.2 equiv) within 12 h at rt. After workup, 
the crude residue was purified by flash column chromatography (isohexane/EtOAc = 8:2, 1% NEt3) to 
afford 64c (96 mg, 83%) as a white solid. For analytics see compound 42h (same). 
 
4-(1-Methyl-1H-indol-6-yl)-1,5-naphthyridine (64d) 
 
According to TP4, 4-iodo-1,5-naphthyridine (42a, 128 mg, 0.5 mmol, 1.0 equiv) reacted with (1-methyl-
1H-indol-5-yl)zinc chloride (0.62 mL, 0.6 mmol, 0.97 M in THF, 1.2 equiv) within 12 h at rt. After 
workup, the crude residue was purified by flash column chromatography (isohexane/EtOAc = 7:3, 1% 
NEt3) to afford 64d (94 mg, 73%) as a yellow solid. 
 
m.p.: 178-180 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1576, 1485, 1369, 1335, 1244, 1157, 1081, 865, 809, 796, 766, 
737, 668. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.03 (dd, J = 4.1, 1.8 Hz, 1H), 8.99 (d, J = 4.5 Hz, 1H), 8.48 
(dd, J = 8.5, 1.7 Hz, 1H), 8.06 (dd, J = 1.7, 0.6 Hz, 1H), 7.72 (d, J = 4.5 Hz, 1H), 7.69 (dd, J = 8.5, 1.7 
Hz, 1H), 7.65 (dd, J = 8.5, 4.1 Hz, 1H), 7.47 (d, J = 8.5 Hz, 1H), 7.12 (d, J = 3.1 Hz, 1H), 6.59 (dd, J = 
3.1, 0.8 Hz, 1H), 3.86 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 150.8, 150.7, 150.5, 144.4, 142.6, 137.5, 137.2, 129.7, 128.7, 
127.8, 124.6, 124.4, 124.2, 123.5, 109.1, 102.0, 33.1. 
MS (EI, 70eV): m/z (%) = 259 (31), 258 (100), 243 (21), 207 (7). 
HRMS (EI) calcd. for [C17H13N3]: 259.1109; found: 259.1114. 
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4-(4-Methoxynaphthalen-1-yl)-1,5-naphthyridine (64e) 
 
According to TP4, 4-iodo-1,5-naphthyridine (42a, 128 mg, 0.5 mmol, 1.0 equiv) reacted with (4-
methoxynaphthalen-1-yl)zinc chloride (0.74 mL, 0.6 mmol, 0.81 M in THF, 1.2 equiv) within 12 h at rt. 
After workup, the crude residue was purified by flash column chromatography (isohexane/EtOAc = 7:2, 
1% NEt3) to afford 64e (67 mg, 47%) as a white solid. 
 
m.p.: 220-221 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1582, 1510, 1490, 1457, 1422, 1376, 1325, 1304, 1268, 1238, 
1184, 1160, 1122, 1092, 1070, 1042, 868, 824, 812, 804, 764, 712, 666. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.07 (d, J = 4.3 Hz, 1H), 8.89 (dd, J = 4.0, 1.7 Hz, 1H), 8.50 
(dd, J = 8.6, 1.7 Hz, 1H), 8.37 (dt, J = 8.6, 1.0 Hz, 1H), 7.68 (d, J = 4.2 Hz, 1H), 7.64 (dd, J = 8.5, 4.0 
Hz, 1H), 7.51 – 7.43 (m, 2H), 7.37 – 7.32 (m, 2H), 6.97 (d, J = 7.9 Hz, 1H), 4.08 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 156.0, 151.0, 150.8, 148.7, 144.2, 143.4, 137.6, 132.8, 128.0, 
127.1, 126.6, 126.2, 125.7, 125.6, 125.2, 124.2, 122.3, 103.3, 55.6. 
MS (EI, 70 eV): m/z (%) = 286 (36), 285 (100), 271 (15), 270 (63), 242 (35), 241 (13), 121 (15). 
HRMS (EI) calcd. for [C19H14N2O]: 286.1106; found: 286.1108.  
 
1-(8-(4-(Dimethylamino)phenyl)-1,5-naphthyridin-4-yl)-2,2-dimethylpropan-1-one (64f) 
 
According to TP4, 1-(8-iodo-1,5-naphthyridin-4-yl)-2,2-dimethylpropan-1-one (52d, 170 mg, 0.5 
mmol, 1.0 equiv) reacted with 4-(dimethylamino)phenyl)zinc chloride (0.69 mL, 0.6 mmol, 0.87 M in 
THF, 1.2 equiv) within 12 h at rt. After workup, the crude residue was purified by flash column chro- 
matography (isohexane/EtOAc = 8:2) to afford 64f (143 mg, 86%) as a white solid. 
 
m.p.: 165-167 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1188, 1166, 1130, 1100, 1084, 1060, 1038, 1006, 962, 950, 914, 
880, 864, 838, 820, 812, 782, 752, 724, 682. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.99 (d, J = 4.2 Hz, 1H), 8.89 (d, J = 4.5 Hz, 1H), 7.83–7.72 
(m, 2H), 7.60 (d, J = 4.5 Hz, 1H), 7.34 (d, J = 4.2 Hz, 1H), 6.94–6.81 (m, 2H), 3.05 (s, 6H), 1.33 (s, 
9H). 
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13C-NMR (100 MHz, CDCl3): δ/ ppm = 213.1, 150.9, 150.9, 149.4, 148.8, 148.3, 142.3, 141.6, 131.7, 
123.8, 123.3, 119.2, 112.0, 45.2, 40.4, 26.8. 
MS (EI, 70 eV): m/z (%) = 333 (44), 332 (12), 276 (11), 250 (15), 249 (100), 248 (42), 232 (23). 
HRMS (EI) calcd. for [C21H23N3O]: 333.1841; found: 333.1835. 
 
2,4-Bis(4-methoxyphenyl)-1,5-naphthyridine (64g) 
 
According to TP4, 2,4-diiodo-1,5-naphthyridine (56a, 150 mg, 0.39 mmol, 1.0 equiv) reacted with (4-
methoxyphenyl)zinc chloride (0.95 mL, 0.94 mmol, 0.98 M in THF, 2.4 equiv) within 12 h at rt. After 
workup, the crude residue was purified by flash column chromatography (isohexane/EtOAc = 7:1, 1% 
NEt3) to afford 64g (100 mg, 75%) as a yellow solid. 
 
m.p.: 109 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2927, 1606, 1590, 1578, 1542, 1513, 1483, 1459, 1416, 1365, 
1286, 1237, 1175, 1108, 1022, 822, 800, 729, 680. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.93 (dd, J = 4.1, 1.7 Hz, 1H), 8.45 (dd, J = 8.5, 1.7 Hz, 1H), 
8.18 (d, J = 8.9 Hz, 2H), 8.04 (s, 1H), 7.81 (d, J = 8.8 Hz, 2H), 7.60 (dd, J = 8.5, 1.4 Hz, 1H), 7.09 (d,   
J = 8.8 Hz, 2H), 7.05 (d, J = 8.9 Hz, 2H), 3.89 (s, 3H), 3.88 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 161.2, 160.2, 157.3, 149.9, 148.4, 144.5, 141.4, 137.6, 131.9, 
131.8, 129.6, 129.1, 124.2, 121.4, 114.4, 114.0, 55.5. 
MS (EI, 70 eV): m/z (%) = 343 (17), 342 (94), 341 (100), 327 (24), 298 (10), 255 (9). 
HRMS (EI) calcd. for [C22H18N2O2]: 342.1368; found: 342.1366. 
 
8-(4-Methoxyphenyl)-7-phenyl-1,6-naphthyridine (64h) 
 
According to TP4, 8-iodo-7-phenyl-1,6-naphthyridine (65, 100 mg, 0.3 mmol, 1.0 equiv) reacted with 
(4-methoxyphenyl)zinc chloride (0.92 mL, 0.98 M in THF, 0.9 mmol, 3.0 equiv) within 12 h at rt. After 
workup, the crude residue was purified by flash column chromatography (EtOAc) to afford 64h (45 mg, 
48%) as a white solid. 
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m.p.: 168-170 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1600, 1514, 1466, 1368, 1292, 1244, 1174, 1034, 964, 922, 834, 
814, 770, 708, 694. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.38 (s, 1H), 9.14 (dd, J = 4.2, 1.9 Hz, 1H), 8.37 (dd, J = 8.2, 
1.9 Hz, 1H), 7.54 (dd, J = 8.2, 4.2 Hz, 1H), 7.45-7.41 (m, 2H), 7.28-7.23 (m, 5H), 6.92 (d, J = 8.8 Hz, 
2H), 3.85 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 159.0, 155.0, 154.9, 151.7, 150.2, 140.8, 135.7, 133.0, 131.8, 
130.5, 128.3, 128.0, 127.5, 122.5, 122.1, 113.7, 55.3. 
MS (EI, 70 eV): m/z (%) = 313 (11), 312 (48), 311 (100), 296 (13), 281 (16), 268 (29), 267 (23), 266 
(12), 235 (12), 140 (10), 134 (17). 
HRMS (EI) calcd. for [C21H16N2O]: 312.1263; found: 312.1252. 
 
N,N-Dimethyl-4-(7-phenyl-1,6-naphthyridin-8-yl)aniline (64i) 
 
According to TP4, 8-iodo-7-phenyl-1,6-naphthyridine (65, 100 mg, 0.3 mmol, 1.0 equiv) reacted with 
4-(dimethylamino)phenylzinc chloride (1.0 mL, 0.9 mmol, 0.87 M in THF, 3.0 equiv) within 12 h at rt. 
After workup, the crude residue was purified by flash column chromatography (EtOAc) to afford the 
desired product (63 mg, 65%) as a bright yellow solid. 
 
m.p.: 184-186 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 1610, 1601, 1520, 1466, 1434, 1362, 1334, 1202, 1160, 1130, 
1048, 942, 830, 814, 786, 770, 708, 694.  
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.33 (s, 1H), 9.12 (dd, J = 4.2, 1.9 Hz, 1H), 8.32 (dd, J = 8.2, 
1.9 Hz, 1H), 7.49 (dd, J = 8.2, 4.2 Hz, 1H), 7.47-7.42 (m, 2H), 7.29-7.26 (m, 1H), 7.25-7.22 (m, 2H), 
7.21-7.16 (m, 2H), 6.73 (d, J = 8.4 Hz, 2H), 2.97 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 154.8, 151.1, 150.4, 141.1, 135.6, 132.8, 130.5, 127.9, 127.3, 
122.6, 122.0. 
MS (EI, 70 eV): m/z (%) = 326 (23), 325 (100), 324 (59), 308 (21), 281 (22), 279 (16), 161 (12). 
HRMS (EI) calcd. for [C22H19N3]: 325.1579; found: 325.1573. 
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Ethyl 3-((1,5-naphthyridin-4-yl)methyl)benzoate (66a) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a rubber septum, was 
charged with CoCl2 (3 mg, 0.02 mmol, 5 mol%) and heated up to 450 °C for 5 min under high vacuum. 
After cooling to rt, 4-iodo-1,5-naphthyridine (42a, 100 mg, 0.4 mmol, 1.0 equiv) and dry THF (2 mL) 
were added. Thereupon, 3-(ethoxycarbonyl)benzylzinc chloride (2.1 mL, 0.8 mmol, 0.38 M in THF, 2.0 
equiv) was added dropwise and the reaction mixture was stirred at rt for 4 h until complete consumption 
of 42a was observed by GC. A sat. aq. solution of NH4Cl (5 mL) was added and the aq. layer was 
extracted with EtOAc (3 × 5 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by flash column chromatography 
(isohexane/EtOAc = 9:1 + 1% NEt3) to afford 66a (142 mg, 75%) as a yellow oil (73 mg, 62%) as a 
yellow oil. 
 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2989, 1712, 1588, 1495, 1443, 1366, 1273, 1190, 1104, 1081, 
1023, 754, 726, 691. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.00 (dd, J = 4.1, 1.7 Hz, 1H), 8.83 (d, J = 4.4 Hz, 1H), 8.39 
(dd, J = 8.5, 1.7 Hz, 1H), 8.04-8.02 (m, 1H), 7.92 (dt, J = 7.8, 1.4 Hz, 1H), 7.64 (dd, J = 8.5, 1.4 Hz, 
1H), 7.52-7.48 (m, 1H), 7.36 (t, J = 7.7 Hz, 1H), 7.29 (d, J = 4.4 Hz, 1H), 4.73 (s, 2H), 4.35 (q, J = 7.1 
Hz, 2H), 1.36 (t, J = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 166.6, 151.1, 150.3, 149.2, 143.7, 142.9, 139.7, 137.7, 134.0, 
130.9, 130.5, 128.7, 127.8, 124.5, 124.0, 61.0, 35.9, 14.4. 
MS (EI, 70 eV): m/z (%) = 292 (93), 291 (39), 263 (54), 247 (49), 219 (47), 218 (100), 205 (10), 119 
(20). 
HRMS (EI) calcd. for [C18H16N2O2]: 292.1212; found: 292.1203. 
 
4-(3-Fluorobenzyl)-1,5-naphthyridine (66b) 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a rubber septum, was 
charged with CoCl2 (3 mg, 0.02 mmol, 5 mol%) and heated up to 450 °C for 5 min under high vacuum. 
After cooling to rt, 4-iodo-1,5-naphthyridine (42a, 100 mg, 0.4 mmol, 1.0 equiv) and dry THF (2 mL) 
were added. Thereupon, 3-fluorobenzylzinc chloride (3.8 mL, 0.8 mmol, 0.21 M in THF, 2.0 equiv) was 
added dropwise and the reaction mixture was stirred at rt for 4 h until complete consumption of 42a was 
observed by GC. A sat. aq. solution of NH4Cl (5 mL) was added and the aq. layer was extracted with 
EtOAc (3 × 5 mL). The combined organic layers were dried over MgSO4, filtered and concentrated 
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under reduced pressure. The crude residue was purified by flash column chromatography (isohexane/ 
EtOAc = 9:1 + 1% NEt3) to afford 66b (72 mg, 75%) as a clear oil. 
 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2981, 1713, 1587, 1495, 1443, 1414, 1246, 1177, 1136, 1114, 
1073, 1021, 877, 818, 754, 726. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.02 (dd, J = 4.1, 1.7 Hz, 1H), 8.86 (d, J = 4.4 Hz, 1H), 8.41 
(dd, J = 8.5, 1.7 Hz, 1H), 7.66 (dd, J = 8.5, 4.1 Hz, 1H), 7.32 (d, J = 4.4 Hz, 1H), 7.30-7.23 (m, 1H), 
7.12-7.07 (m, 1H), 7.05-6.99 (m, 1H), 6.96-6.88 (m, 1H), 6.68 (s, 2H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 163.1 (d, 1J(C,F) = 246 Hz), 151.2, 150.4, 149.0, 143.8, 142.9, 
142.0 (d, 3J(C,F) = 7.4 Hz), 137.8, 130.1 (d, 3J(C,F) = 8.3 Hz), 125.1 (d, 4J(C,F) = 2.8 Hz), 124.5, 124.1, 
116.4 (d, 2J(C,F) = 21.3 Hz), 113.5 (d, 2J(C,F) = 21.0 Hz), 35.9. 
MS (EI, 70 eV): m/z (%) = 239 (10), 238 (75), 237 (100), 236 (26). 
HRMS (EI) calcd. for [C15H11FN2]: 238.0906; found: 239.0909. 
 
1-Chloro-4-phenyl-2,7-naphthyridine (68) 
 
A dry and argon-flushed Schlenk-flask was charged with a solution of Pd(dba)2 (26 mg, 0.045 mmol,     
5 mol%), tfp (21 mg, 0.09 mmol, 10 mol%) and 1-chloro-4-iodo-2,7-naphthyridine (67, 250 mg, 0.86 
mmol) in dry THF (2 mL). Phenylzinc chloride (2.73 mL, 0.9 mmol, 0.33 M in THF, 1.05 equiv) was 
added dropwise and the reaction was stirred at rt overnight. Then, the reaction mixture was quenched 
with sat. aq. NH4Cl solution (5 mL), extracted with EtOAc (3 ×15 mL) and dried over MgSO4. After 
filtration, the solvents were evaporated in vacuo. The crude product was purified by flash column 
chromatography (isohexane/EtOAc = 7:3) to give 68 (169 mg, 82%) as a white solid. 
 
m.p.: 149 °C. 
IR (Diamond-ATR, neat): 𝜈 ̃/ cm-1 = 1601, 1532, 1451, 1392, 1340, 1308, 1267, 1176, 1044, 985, 916, 
844, 828, 755, 700. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 9.84 (s, 1H), 8.78 (d, J = 6.0 Hz, 1H), 8.50 (s, 1H), 7.81 (d,         
J = 6.7 Hz, 1H), 7.61-7.51 (m, 3H), 7.49-7.44 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 151.7, 151.0, 146.7, 145.8, 140.9, 134.3, 132.7, 130.0, 129.3, 
129.1, 121.8, 118.4. 
MS (EI, 70 eV): m/z (%) = 242 (33), 241 (27), 240 (100), 239 (38), 205 (12), 177 (10), 151 (7), 150 (5). 
HRMS (EI) calcd. for [C14H9ClN2]: 240.0454; found: 240.0444. 
 
 
 
158 
 
4-Phenyl-1-(3,4,5-trimethoxyphenyl)-2,7-naphthyridine (69) 
 
According to TP4, 1-chloro-4-phenyl-2,7-naphthyridine (68, 90 mg, 0.38 mmol, 1.0 equiv) reacted with 
(3,4,5-trimethoxyphenyl)zinc chloride (0.54 mL, 0.45 mmol, 0.84 M in THF, 1.2 equiv) within 12 h at 
rt. After workup, the crude residue was purified by flash column chromatography (EtOAc) to afford the 
desired product (127 mg, 91%) as a white solid. 
 
m.p.: 178-181 °C. 
IR (Diamond-ATR, neat): ?̃?/ cm-1 = 2922, 2850, 1601, 1582, 1505, 1464, 1413, 1384, 1237, 1123, 
1102, 951, 932, 830, 767, 711. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 9.65 (s, 1H), 8.76 (s, 1H), 8.73-8.67 (m, 1H), 7.80 (d, J = 5.8 
Hz, 1H), 7.60-7.56 (m, 2H), 7.56-7.51 (m, 3H), 7.01 (s, 2H), 3.97 (s, 3H), 3.95 (s, 6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 160.9, 153.6, 153.1, 146.9, 145.5, 139.4, 138.3, 135.7, 133.5, 
131.3, 130.1, 129.1, 128.6, 121.6, 117.6, 107.7, 61.2, 56.5, 29.9. 
MS (EI, 70 eV): m/z (%) = 373 (20), 372 (100), 357 (18), 342 (10), 341 (40), 299 (12), 57 (11). 
HRMS (EI) calcd. for [C23H20N2O3]: 372.1474; found: 372.1475. 
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5. FLUORESCENT ARYL NAPHTHALENE DICARBOXIMIDES 
5.1 Preparation of Starting Materials 
 
Aryl dioxaborolanes 
4-(Trimethylsilyl)phenylboronic acid and the pinacol esters of phenylboronic acid, 4-methoxy-
phenylboronic acid, 4-(N,N-dimethylamino)-phenylboronic acid and 4-cyanophenylboronic acid have 
been purchased from commercial sources. 2-(4-Methoxynaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane, 4,4,5,5-tetramethyl-2-(3,4,5-trimethoxy-phenyl)-1,3,2-dioxa-borolane and 2-(4- 
methoxy-8-methylnaphthalen-1-yl)-4,4,5,5-tetra-methyl-1,3,2-dioxaborolane174 have been prepared by 
reacting the corresponding aryl bromides with bis(pinacolato)diboron according to standard 
procedures.175 
 
6-Bromo-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (72)176 
 
A mixture of 1-hexylheptylamine (33 mmol, 6.6 g, 1.5 equiv) and 4-bromo-1,8-naphthalic anhydride 
(71, 22 mmol, 6.0 g, 1.0 equiv) in ethylene glycol (50 mL) was heated at 160 °C. After 12 h, hydrochloric 
acid (2 M, 50 mL) was added to the reaction mixture, which was subsequently extracted with CHCl3         
(3 × 50 mL). The combined organic phases were dried over MgSO4 and concentrated in vacuo. Column 
chromatography (100% CHCl3) gave 72 (9.05 g, 90%) as a yellow oil. For analytics see ref. 175. 
 
2-Allyl-6-bromo-1H-benzo[de]isoquinoline-1,3(2H)-dione (76)167 
 
4-bromo-1,8-naphthalic anhydride (1.0 g, 3.4 mmol, 1.0 equiv) was suspended in 25 mL of absolute 
EtOH and heated up to 70 °C. Upon addition of allyl amine (0.33 mL, 4.4 mmol, 1.3 equiv) the reaction 
mixture turned brown. Afterwards the mixture was heated under reflux until the starting compound was 
completely dissolved. After 30 minutes of stirring the product precipitated and the reaction was refluxed 
for further 2 hours. The reaction was cooled to rt and the solid product was filtered, washed with ethanol 
and dried in vacuo. The product was purified by recrystallization from EtOH to yield 76 (0.98g, 92%) 
as pale brown needles. For analytics see ref. 167. 
 
                                                 
174 A. K. Banerjee, P. S. Poon, M. S. Laya, J. A. Azocar, Russ. J. Gen. Chem. 2003, 73, 1815. 
175 (a) Y. Avlasevich, K. Müllen, J. Org. Chem. 2007, 72, 10243. (b) K. Mutoh, Y. Kobayashi, Y. Hirao, T. Kubo, J. Abe, Chem. 
Commun. 2016, 52, 6797. (c) P. B. Dzhevakov, M. A. Topchiy, D. A. Zharkova, O. S. Morozov, A. F. Asachenko, M. S. Nechaev, 
Adv. Synth. Catal. 2016, 358, 977. 
176 A. Hofer, dissertation 2012, LMU Munich. 
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5.2 Preparation of Aryl Naphthalene Dicarboximides 73, 77, 78 
 
6-Phenyl-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (73a) 
 
A Schlenk-flask was charged with 6-bromo-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(72, 480 mg, 1.05 mmol, 1.0 equiv) and 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (265 mg, 
1.30 mmol, 1.2 equiv). Both compounds were dissolved in toluene (20 mL) under a light argon-stream. 
K2CO3 (2.76 g, 20 mmol) was dissolved in a mixture of water (10 mL) and EtOH (4 mL) and added to 
the Schlenk-flask followed by tetrakis(triphenylphosphine)palladium(0) (116 mg, 0.10 mmol, 10 mol%). 
The mixture was purged with argon for 30 min and then heated to 80 °C. The reaction mixture was 
stirred for further 17 h at this temperature. After cooling to rt, the organic phase was separated and the 
aqueous phase was extracted with toluene (3 × 10 mL). Purification by column chromatography 
(isohexane/CHCl3 = 1:1) gave compound 73a (450 mg, 94%) as a bright yellow solid. 
 
m.p.: 97 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2919, 2852, 1696, 1653, 1587, 1396, 1348, 1237, 1176, 1100, 784, 
768, 702. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 8.69-8.56 (m, 2H), 8.25 (dd, J = 8.5, 1.1 Hz, 1H), 7.74-7.66 
(m, 1H), 7.58-7.53 (m, 2H), 7.53-7.48 (m, 3H), 5.23-5.16 (m, 1H, NCH), 2.31-2.20 (m, 2H, ß-CH2), 
1.89-1.80 (m, 2H, ß-CH2), 1.40-1.16 (m, 16H, 8 × CH2), 0.83 (t, J = 7.1 Hz, 6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 165.7, 165.5, 164.6, 164.4, 146.6, 139.0, 132.4, 131.7, 131.3, 
130.9, 130.6, 130.1, 130.0, 129.0, 128.8, 128.6, 128.0, 127.0, 123.7, 123.0, 122.6, 121.9, 54.6, 32.6, 
31.9, 29.4, 27.1, 22.7, 14.2. 
MS (EI, 70 eV): m/z (%) = 455 (14), 275 (22), 274 (100), 273 (22), 256 (12), 202 (8). 
HRMS (EI) calcd. for [C31H37NO2]: 455.2824; found: 455.2820. 
EA for [C31H37NO2]: calculated: C 81.72 N 3.07  H 8.19 
                                             found: C 81.52     N 3.10  H 8.31 
UV/Vis (CHCl3): lmax () = 355.4 nm (17100).  
Fluorescence (CHCl3, lexc = 355.4 nm): lmax = 420.0 nm. 
Fluorescence quantum yield (CHCl3, lexc = 355.4 nm, E355.4 nm = 0.1341 cm-1, reference: N,N’-
bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide with   = 1.00):   = 0.78. 
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6-(4-Methoxyphenyl)-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (73b) 
 
A Schlenk-flask was charged with 6-bromo-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(72, 215 mg, 0.47 mmol, 1.04 equiv) and 2-(4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(100 mg, 0.45 mmol, 1.0 equiv). Both compounds were dissolved in toluene (10 mL) under a light argon-
stream. K2CO3 (1.40 g, 10 mmol) was dissolved in a mixture of water (5 mL) and EtOH (1 mL) and 
added to the Schlenk-flask followed by tetrakis(triphenylphosphine)-palladium(0) (20 mg, 0.018 mmol, 
5 mol%). The mixture was purged with argon for 30 min and then heated to 80 °C. The reaction mixture 
was stirred for further 17 h at this temperature. After cooling to rt, the organic phase was separated and 
the aqueous phase was extracted with toluene (3 × 10 mL). Purification by column chromatography 
(isohexane/CHCl3 = 1:1) gave compound 73b (176 mg, 78%) as an off-white solid.  
 
m.p.: 63 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2922, 2852, 1698, 1656, 1608, 1588, 1518, 1506, 1463, 1397, 
1348, 1288, 1239, 1176, 1096, 1078, 1036, 963, 867, 838, 785, 760, 724. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 8.66-8.52 (br, 2H), 8.29 (dd, J = 8.5 Hz, 1.1 Hz, 1H), 7.72-7.63 
(m, 2H), 7.44 (d, J = 8.8 Hz, 2H), 7.07 (d, J = 8.8 Hz, 2H), 5.26-5.13 (m, 1 H, NCH), 3.90 (s, 3H, 
OCH3), 2.33-2.17 (m, 2H, ß-CH2), 1.91-1.77 (m, 2H, ß-CH2), 1.42-1.11 (m, 16H, 8 × CH2), 0.82 (t, J = 
9.0 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 165.5, 164.5, 160.0, 146.4, 132.5, 131.3, 131.2, 130.2, 129.1, 
127.9, 126.8, 123.7, 123.1, 122.2, 121.6, 114.3, 55.5, 54.6, 32.6, 31.9, 29.4, 27.0, 22.7, 14.2. 
MS (EI, 70 eV): m/z (%) = 485 (23), 316 (10), 304 (100), 303 (54), 286 (13), 198 (34), 180 (12). 
HRMS (EI) calcd. for [C32H39NO3]: 485.2930; found: 485.2924. 
EA for [C32H39NO3]:    calculated: C 79.14 N 2.88  H 8.09 
                                            found: C 79.18 N 2.69  H 8.22 
UV/Vis (CHCl3): lmax () = 364.8 nm (16900). 
Fluorescence (CHCl3, lexc = 364.8 nm): lmax = 459.6 nm. 
Fluorescence quantum yield (CHCl3, lexc = 364.8 nm, E364.8nm = 0.2522 cm-1, reference: N,N’-
bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide with   = 1.00):  = 0.83. 
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6-(4-(Dimethylamino)phenyl)-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (73c) 
 
A Schlenk-flask was charged with 6-bromo-2-(tridecan-7-yl)-1H-benzo[de]iso-quinoline-1,3(2H)-dione 
(72, 480 mg, 1.05 mmol, 1.05 equiv) and N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)aniline (247 mg, 1.0 mmol, 1.0 equiv). Both compounds were dissolved in toluene (20 mL) under a 
light argon stream. K2CO3 (2.80 g, 20 mmol) was dissolved in a mixture of water (10 mL) and EtOH (3 
mL) and added to the Schlenk-flask followed by tetrakis(triphenylphosphine)-palladium(0) (115 mg, 
0.10 mmol, 10 mol%). The mixture was purged with argon for 30 min and then heated to 80 °C. The 
reaction mixture was stirred for further 17 h at this temperature. After cooling to rt, the organic phase 
was separated and the aqueous phase was extracted with toluene (3 × 10 mL). Purification by column 
chromatography (isohexane/CHCl3 = 5:2) gave compound 73c (70 mg, 14 %) as a bright yellow solid. 
 
m.p.: 125 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2921, 2852, 1694, 1654, 1609, 1587, 1524, 1465, 1397, 1349, 
1237, 1199, 1101, 943, 872, 818, 785, 761. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 8.64-8.54 (m, 2H), 8.40 (d, J = 8.5 Hz, 1H), 7.70-7.65 (m, 2H), 
7.43 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 5.22-5.15 (m, 1H), 3.07 (s, 6H, NMe2), 2.29-2.20 (m, 
2H, ß-CH2), 1.88-1.80 (m, 2H, ß-CH2), 1.35-1.18 (m, 16H, 8 × CH2), 0.82 (t, J = 7.0 Hz, 6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 165.9, 165.6, 164.8, 164.6, 150.7, 147.3, 132.9, 131.6, 131.1, 
130.8, 130.2, 129.3, 127.6, 126.6, 126.5, 112.2, 123.7, 123.0, 121.5, 120.8, 54.5, 40.6, 32.6, 31.9, 29.41, 
27.1, 22.6, 14.2.  
MS (EI, 70 eV): m/z (%) = 499 (22), 498 (59), 318 (10), 317 (43), 316 (100), 315 (19). 
HRMS (EI) calcd. for [C33H42N2O2]: 498.3246; found: 498.3227. 
EA for [C33H42N2O2]:     calculated: C 79.48 N 5.62  H 8.49 
                                              found: C 79.42 N 5.64  H 8.36 
UV/Vis (CHCl3): lmax () = 426.2 nm (17100). 
Fluorescence (CHCl3, lexc = 426.2 nm): lmax = 578.4 nm. 
Fluorescence quantum yield (CHCl3, lexc = 426.2 nm, E426.2 nm = 0.1138 cm-1, reference: N,N’-
bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide with  = 1.00):  = 0.64. 
 
 
 
 
 
163 
 
6-(3,4,5-Trimethoxyphenyl)-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (73d) 
 
A Schlenk-flask was charged with 6-bromo-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(72, 361 mg, 0.79 mmol, 1.05 equiv) and 4,4,5,5-tetramethyl-2-(3,4,5-trimethoxy-phenyl)-1,3,2-
dioxaborolane (220 mg, 0.75 mmol, 1.0 equiv). Both compounds were dissolved in toluene (20 mL) 
under a light argon-stream. K2CO3 (2.80 g, 20 mmol) was dissolved in a mixture of water (10 mL) and 
EtOH (2 mL) and added to the Schlenk-flask followed by tetrakis(triphenylphosphine)palladium(0) 
(0.038 mmol, 43 mg, 5 mol%). The mixture was purged with argon for 30 min and then heated to 80 °C. 
The reaction mixture was stirred for further 17 h at this temperature. After cooling to rt, the organic 
phase was separated and the aqueous phase was extracted with toluene (3 × 20 mL). Purification by 
column chromatography (100% CHCl3) gave compound 73d (350 mg, 86 %) as a yellow oil. 
 
IR (Diamond-ATR, neat): / cm-1 = 2924, 2855, 1698, 1656, 1616, 1586, 1503, 1454, 1415, 1397, 1350, 
1322, 1237, 1180, 1126, 1104, 1060, 1006, 928, 912, 860, 842, 831, 785, 760, 725, 702, 678. 
1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.69 (br, 2H), 8.31 (dd, J = 8.5, 1.1 Hz, 1H), 7.71 (t, J = 7.1 
Hz, 1H), 6.70 (s, 2H), 5.24-5.13 (m, 1H, NCH), 3.95 (s, 3H, OMe), 3.89 (s, 6H, OMe), 2.31-2.18 (m,     
2H, ß-CH2), 1.90-1.77 (m, 2H, ß-CH2), 1.35-1.16 (m, 16H, 8 × CH2), 0.81 (t, J = 6.9 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 165.6, 165.4, 164.5, 164.3, 153.5, 146.6, 138.4, 134.5, 132.4, 
131.7, 131.2, 130.9, 130.4, 130.1, 128.9, 127.7, 127.0, 123.7, 123.0, 122.6, 121.8, 107.3, 61.1, 56.4, 
54.6, 32.5, 31.9, 29.3, 27.0, 22.7, 14.1. 
MS (EI, 70 eV): m/z (%) = 545 (40), 365 (16), 364 (76), 363 (100), 348 (19). 
HRMS (EI) calcd. for [C34H43NO5]: 545.3141; found: 545.3135. 
EA for [C36H41NO3]:     calculated: C 74.83 N 2.57  H 7.94 
                                             found: C 73.47 N 2.58  H 7.75 
UV/Vis (CHCl3): lmax () = 362.2 nm (15900). 
Fluorescence (CHCl3, lexc = 362.2 nm): lmax = 525.1 nm. 
Fluorescence quantum yield (CHCl3, lexc = 362.2 nm, E362.2 nm = 0.2207 cm-1, reference: N,N’-
bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide with  = 1.00):  = 0.65. 
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6-(2,6-Dibromo-3,4,5-trimethoxyphenyl)-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-
dione (73e)  
 
2-(Tridecan-7-yl)-6-(3,4,5-trimethoxyphenyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (73d, 175 mg, 
0.32 mmol) was dissolved in MeCN (10 mL). NBS (120 mg, 0.67 mmol, 2.1 equiv) was added at once 
to the solution and the reaction mixture was stirred for 12 h at 30 °C. The crude mixture was treated 
with brine solution and extracted with CHCl3 (3 × 10 mL). The organic phase was dried over MgSO4 
and concentrated in vacuo. Column chromatography (100% CHCl3) gave 73e (155 mg, 69%) as a 
colorless oil.  
 
IR (Diamond-ATR, neat): ν̃/ cm-1 = 2925, 2855, 1699, 1658, 1590, 1461, 1397, 1352, 1321, 1237, 
1179, 1087, 1008, 986, 935, 909, 861, 784, 763, 729. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 8.68-8.54 (m, 2H), 7.72-7.65 (m, 2H), 7.56 (d, J = 7.5 Hz, 1H), 
5.22-5.15 (m, 1H, NCH), 4.06 (s, 3H, OMe), 3.98 (s, 6H, OMe), 2.28-2.20 (m, 2H, ß-CH2), 1.88-1.82 
(m, 2H, ß-CH2), 1.36-1.20 (m, 16H, 8 × CH2), 0.82 (t, J = 7.0 Hz, 6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 165.4, 165.2, 164.5, 164.1, 151.2, 147.9, 144.8, 135.5, 131.8, 
131.3, 131.1, 130.5, 129.6, 128.6, 128.6, 127.4, 123.9, 123.9, 123.5, 123.2, 122.8, 114.6, 61.5, 61.3, 
54.6, 32.6, 31.9, 29.4, 27.1, 22.7, 14.2. 
MS (EI, 70 eV): m/z (%) = 703 (25), 701 (13), 525 (12), 524 (48), 523 (31), 522 (100), 521 (31), 520 
(50), 399 (9), 397 (9), 361 (25). 
HRMS (EI) calcd. for [C34H41Br2NO5]: 701.1351; found: 701.1357. 
 
2-(Tridecan-7-yl)-6-(3,4,5-trimethoxy-2,6-dimethylphenyl)-1H-benzo[de]isoquinoline-1,3(2H)-
dione (73f) 
 
A dry and argon-flushed Schlenk-flask was charged with a solution of ZnCl2 (0.43 mL, 0.43 mmol,        
1.0 M in THF, 2.1 equiv). MeMgCl (0.14 mL, 0.43 mmol, 3.0 M in THF, 2.1 equiv) was added dropwise 
at 0 °C to the solution. Another dry, argon-flushed Schlenk-flask was charged with 6-(2,6-dibromo-3,4,5-
trimethoxyphenyl)-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (73e, 145 mg, 0.2 mmol,  
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1.0 equiv), Pd(OAc)2 (3 mg, 0.01 mmol, 5 mol%,) and S-Phos (9 mg, 0.02 mmol, 10 mol%) in dry THF 
(1 mL). After stirring for 10 min, this solution was added dropwise to the freshly prepared MeZnCl 
solution. The reaction mixture was stirred overnight at 60 °C and then quenched with sat. aq. NH4Cl 
solution. The crude mixture was extracted with CHCl3 and concentrated in vacuo. Column chromato-
graphy (100% CHCl3) gave 73f (85.0 mg, 74%) as a colorless oil.  
 
IR (Diamond-ATR, neat): ν̃/ cm-1 = 2925, 2856, 1700, 1658, 1589, 1456, 1399, 1349, 1320, 1237, 
1110, 1081, 862, 785, 764. 
1H-NMR (100 MHz, CDCl3): δ/ ppm = 8.67-8.52 (br, 2H), 7.71 (dd, J = 8.4, 1.2 Hz, 1H), 7.65-7.59 
(m, 1H), 7.51 (d, J = 7.4 Hz, 1H), 5.25-5.13 (m, 1H, NCH), 4.02 (s, 3H, OMe), 3.89 (s, 6H, OMe), 2.30-
2.20 (m, 2H, ß-CH2), 1.90-1.80 (m, 2H, ß-CH2), 1.75 (s, 6H, 2 × CH3), 1.35-1.19 (m, 16H, 8 × CH2), 
0.81 (t, J = 6.9 Hz, 6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 165.6, 164.5, 150.1, 146.2, 145.4, 133.8, 131.7, 131.6, 131.0, 
130.8, 130.5, 128.8, 128.2, 127.2, 125.9, 123.9, 123.1, 122.6, 121.9, 60.9, 60.9, 54.6, 32.6, 31.9, 29.4, 
27.1, 22.7, 14.2, 13.5. 
MS (EI, 70 eV): m/z (%) = 574 (18), 573 (43), 393 (24), 392 (100), 391 (92), 348 (7), 55 (8). 
HRMS (EI) calcd. for [C36H47NO5]: 573.3454; found: 573.3448. 
UV/Vis (CHCl3): lmax () = 358.2 (14300), 344.0 nm (16000). 
Fluorescence (CHCl3, lexc = 344.0 nm): lmax = 541.6 nm. 
Fluorescence quantum yield (CHCl3, lexc = 344.0 nm, E344.0 nm = 0.0938 cm-1, reference: N,N’-
bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide with  = 1.00):  = 0.046. 
 
6-(4-Methoxynaphthalen-1-yl)-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (73g) 
 
A Schlenk-flask was charged with 6-bromo-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(72, 348 mg, 0.76 mmol, 1.1 equiv) and 2-(4-methoxynaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (200 mg, 0.70 mmol, 1.0 equiv). Both compounds were dissolved in toluene (10 mL) 
under a light argon-stream. K2CO3 (1.4 g, 10 mmol) was dissolved in a mixture of water (5 mL) and 
EtOH (1 mL) and added to the Schlenk-flask followed by tetrakis(triphenylphosphine)-palladium(0)     
(20 mg, 0.018 mmol, 5 mol%). The mixture was purged with argon for 30 min and then heated to 80 °C. 
The reaction mixture was stirred further 17 h at this temperature. After cooling to rt, the organic phase 
was separated and the aqueous phase was extracted with toluene (3 × 20 mL). Purification by column 
chromatography (isohexane/CHCl3 = 1:1) gave compound 73g (260 mg, 69 %) as a bright yellow solid. 
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m.p.: 98 °C. 
IR (Diamond-ATR, neat): 𝜈/cm-1 = 2920, 2853, 1697, 1655, 1615, 1586, 1511, 1459, 1421, 1398, 
1348, 1311, 1235, 1177, 1157, 1106, 1084, 1025, 881, 817, 784, 759, 735, 712, 667. 
1H-NMR (300 MHz, CDCl3): δ/ ppm = 8.74-8.64 (br, 1H), 8.64–8.52 (br, 1H), 8.41 (d, J = 8.5 Hz, 1H), 
7.82 (d, J = 8.4 Hz, 1H), 7.76 (d, J = 7.5 Hz, 1H), 7.57-7.46 (m, 2H), 7.39 (d, J = 7.9 Hz, 1H), 7.36-7.27 
(m, 2H), 6.97 (d, J = 7.9 Hz, 1H) 5.32-5.17 (m, 1H, NCH), 4.11 (s, 3H, OMe), 2.39-2.22 (m, 2H,  ß-
CH2), 1.96-1.81 (m, 2H,  ß-CH2), 1.47-1.15 (m, 16H, 8 × CH2), 0.85 (t, J = 6.6 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ/ ppm = 165.5, 164.6, 156.1, 145.5, 133.3, 132.9, 131.6, 131.2, 130.9, 
130.5, 129.4, 128.7, 128.7, 128.1, 127.1, 126.8, 125.8, 125.7, 125.6, 122.5, 103.4, 55.8, 54.6, 32.6, 31.9, 
29.4, 27.1, 22.7, 14.2. 
MS (EI, 70 eV): m/z (%) = 535 (32), 355 (16), 354 (69), 353 (100), 239 (8). 
HRMS (EI) calcd. for [C36H41NO3]: 535.3086; found: 535.3080. 
EA for [C36H41NO3]:     calculated: C 80.71 N 2.61  H 7.71 
                                             found: C 80.86 N 2.49  H 7.84 
UV/Vis (CHCl3): lmax () = 325.0 nm (15300). 
Fluorescence (CHCl3, lexc = 325.0 nm): lmax = 509.7 nm. 
Fluorescence quantum yield (CHCl3, lexc = 325.0 nm, E325.0 nm = 0.1386 cm-1, reference: N,N’-
bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide with  = 1.00):  = 0.39. 
 
6-(4-Methoxy-8-methylnaphthalen-1-yl)-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-
dione (73h) 
 
A Schlenk-flask was charged with 6-bromo-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(72, 124 mg, 0.27 mmol, 1.05 equiv) and 2-(4-methoxy-8-methylnaphthalen-1-yl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (77 mg, 0.26 mmol, 1.0 equiv). Both compounds were dissolved in toluene (5 mL) 
under a light argon-stream. K2CO3 (0.70 g, 5 mmol) was dissolved in a mixture of water (3 mL) and 
EtOH (0.5 mL) and added to the Schlenk-flask followed by tetrakis(triphenylphosphine)palladium(0) 
(15 mg, 0.013 mmol, 5 mol%). The mixture was purged with argon for 30 min and then heated to 80 °C. 
The reaction mixture was stirred further 17 h at this temperature. After cooling to rt, the organic phase 
was separated and the aqueous phase was extracted with toluene (3 × 5 mL). Purification by column 
chromatography (isohexane/CHCl3 = 1:1) gave compound 73h (36 mg, 25 %) as a bright yellow solid.  
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m.p.: 164 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2920, 2853, 1697, 1656, 1587, 1513, 1450, 1397, 1344, 1314, 
1233, 1153, 1099, 1045, 815, 784, 765, 726, 677.  
1H-NMR (600 MHz, CDCl3): δ/ ppm = 8.66-8.50 (br, 2H), 8.38 (d, J = 7.9 Hz, 1H), 7.76 (dd, J = 8.4, 
1.1 Hz, 1H), 7.70 (d, J = 7.4 Hz, 1H), 7.57-7.53 (m, 1H), 7.45-7.41 (m, 1H), 7.24 (d, J = 7.8 Hz, 2H), 
6.91 (d, J = 8.0 Hz, 1H), 5.24-5.17 (m, 1H, NCH), 4.09 (s, 3H, OMe), 2.30-2.21 (m, 2H, ß-CH2), 1.92-
1.82 (m, 2H, ß-CH2), 1.74 (s, 3H, CH3), 1.36-1.20 (m, 16H, 8 × CH2), 0.84 (t, J = 6.5 Hz, 6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm =165.6, 164.7, 156.4, 149.9, 134.5, 132.9, 132.5, 132.2, 131.6, 
130.9, 130.1, 128.7, 128.3, 127.0, 126.8, 125.5, 123.6, 122.9, 122.4, 121.6, 121.2, 102.9, 55.9, 54.7, 
32.6, 31.9, 29.4, 27.1, 24.6, 22.8, 14.2. 
MS (EI, 70 eV): m/z (%) = 550 (22), 549 (50), 380 (6), 369 (13), 368 (62), 367 (100), 352 (8), 309 (5).  
HRMS (EI) calcd. for [C37H43NO3]: 549.3243; found: 549.3238. 
EA for [C37H43NO3]:      calculated: C 80.84 N 2.55  H 7.88 
                                               found: C 80.32 N 2.54  H 8.00 
UV/Vis (CHCl3): lmax () = 329.0 nm (17100). 
Fluorescence (CHCl3, lexc = 329.0 nm): lmax = 522.7 nm. 
Fluorescence quantum yield (CHCl3, lexc = 329.0 nm, E329.0 nm = 0.0630 cm-1, reference: N,N’-
bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide with  = 1.00):  = 0.40. 
 
2-(Tridecan-7-yl)-6-(4-(trimethylsilyl)phenyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (73i) 
 
A Schlenk-flask was charged with 6-bromo-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(72, 1.33 g, 2.92 mmol, 1.05 equiv) and (4-(trimethylsilyl)phenyl)boronic acid (540 mg, 2.78 mmol, 1.0 
equiv). Both compounds were dissolved in toluene (40 mL) under a light argon-stream. K2CO3 (8.40 g, 
60 mmol) was dissolved in a mixture of water (30 mL) and EtOH (5 mL) and added to the Schlenk-flask 
followed by tetrakis(triphenylphosphine)palladium(0) (160 mg, 0.14 mmol, 5 mol%). The mixture was 
purged with argon for 30 min and then heated to 80 °C. The reaction mixture was stirred further 17 h at 
this temperature. After cooling to rt, the organic phase was separated and the aqueous phase was 
extracted with toluene (3 × 30 mL). Purification by column chromatography (isohexane/CHCl3 = 1:1) 
gave compound 73i (1.19 g, 81 %) as a green fluorescent oil. 
 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2923, 2855, 1698, 1656, 1587, 1455, 1398, 1349, 1237, 1179, 
1111, 838, 820, 784, 761, 726, 695. 
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1H-NMR (400 MHz, CDCl3): δ/ ppm = 8.71-8.56 (br, 2H), 8.30 (dd, J = 8.5, 1.1 Hz, 1H), 7.71 (dd, J = 
7.9, 2.6 Hz, 3H), 7.51 (d, J = 8.1 Hz, 1 H), 5.28-5.16 (m, 1H, NCH), 2.35-2.22 (m, 2H, ß-CH2), 1.93-
1.79 (m, 2H, ß-CH2), 1.46-1.14 (m, 16H, 8 × CH2), 0.83 (t, J = 6.9 Hz, 6H), 0.36 (s, 9H, TMS). 
13C-NMR (100 MHz, CDCl3): δ/ ppm = 165.6, 165.5, 164.6, 164.4, 146.7, 141.1, 139.3, 133.7, 132.4, 
131.7, 131.3, 130.9, 130.6, 130.0, 129.3, 129.0, 127.9, 126.9, 123.7, 123.0, 122.6, 121.8, 54.6, 32.6, 
31.9, 29.4, 27.0, 22.7, 14.2, -1.0. 
MS (EI, 70 eV): m/z (%) = 527 (20), 348 (8), 347 (29), 346 (100), 345 (26), 331 (11), 330 (33). 
HRMS (EI) calcd. for [C34H45NO2Si]: 527.3220; found: 535.3216. 
EA for [C36H41NO3]:      calculated: C 77.37 N 2.65  H 8.59 
                                              found: C 77.02 N 2.73  H 8.63 
UV/Vis (CHCl3): lmax () = 356.0 nm (18600). 
Fluorescence (CHCl3, lexc = 356.0 nm): lmax = 425.4 nm. 
Fluorescence quantum yield (CHCl3, lexc = 356.0 nm, E356.0 nm = 0.0676 cm-1, reference: N,N’-
bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide with  = 1.00):  = 0.79. 
 
6-(4-Iodophenyl)-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (73k) 
 
A dry and argon-flushed Schlenk-flask was charged with 2-(tridecan-7-yl)-6-(4-(trimethyl-silyl)-       
phenyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (73i, 840 mg, 1.6 mmol, 1.0 equiv) and dry DCM    
(3.5 mL). The flask was cooled to 0 °C and ICl (260 mg, 1.6 mmol, 1.0 equiv) was added dropwise to 
the mixture. After stirring for 10 min at 0 °C, the reaction mixture was quenched with sat. aq. Na2S2O3 
solution (5 mL), extracted with DCM (3 × 10 mL) and dried over MgSO4. After filtration, the solvents 
were evaporated in vacuo. The crude product was purified by flash column chromatography (100% 
CHCl3) to give 73k (770 mg, 83 %) as a yellow oil. 
 
IR (Diamond-ATR, neat): 𝜈/cm-1 = 2922, 2854, 1698, 1656, 1588, 1487, 1463, 1398, 1349, 1324, 
1238, 1178, 1101, 1005, 821, 784, 758. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 8.65-8.56 (m, 2H), 8.18 (d, J = 8.4 Hz, 1H), 7.85 (d, J = 8.4 
Hz, 2 H), 7.70-7.66 (m, 1H), 7.64 (d, J = 7.5 Hz, 1H), 7.23 (d, J = 8.3 Hz, 2 H), 5.22-5.15 (m, 1H, NCH), 
2.27-2.20 (m, 2H, ß-CH2), 1.86-1.79 (m, 2H, ß-CH2), 1.32-1.15 (m, 16H, ß-CH2), 0.79 (t, J = 7.1 Hz, 
6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 165.4, 165.2, 164.4, 164.1, 145.2, 138.4, 137.9, 133.5, 131.8, 
131.7, 131.2, 131.0, 130.4, 129.7, 128.9, 127.8, 127.1, 127.0, 123.7, 123.0, 122.9, 122.2, 94.6, 54.6, 
32.5, 31.8, 29.3, 27.0, 22.7, 14.1. 
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MS (EI, 70 eV): m/z (%) = 581 (11), 401 (12), 400 (68), 399 (16), 199 (12), 198 (100). 
HRMS (EI) calcd. for [C31H36INO2]: 581.1791; found: 581.1781. 
EA for [C31H36INO2]:     calculated: C 64.03 N 2.41  H 6.24 
                                              found: C 63.88 N 2.49  H 6.32 
 
6-(4'-Methoxy-[1,1'-biphenyl]-4-yl)-2-(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(73l) 
 
A dry and argon-flushed Schlenk-flask was charged with 4-iodoanisole (40 mg, 0.16 mmol, 1.0 equiv) 
and dry THF (1 mL). An iodine/magnesium exchange was performed using iPrMgCl.LiCl (0.13 mL, 
0.16 mmol, 1.26 M in THF, 1.0 equiv) within 20 min at 0 °C, followed by transmetalation with ZnCl2 
(0.18 mL, 0.18 mmol, 1.0 M in THF, 1.1 equiv). The freshly prepared zinc species was transferred via 
syringe to another argon-flushed Schlenk-flask which was previously charged with 6-(4-iodophenyl)-2-
(tridecan-7-yl)-1H-benzo[de]isoquinoline-1,3-(2H)-dione (73k, 96 mg, 0.16 mmol, 1.0 equiv), 
palladium(0)bis-(dibenzylideneacetone) (5 mg, 0.008 mmol, 5 mol%), tfp (4 mg, 0.016 mmol, 10 mol%) 
and dry THF (3 mL). The reaction mixture was stirred for 12 h at 50 °C. Then, the reaction was quenched 
with sat. aq. NH4Cl solution, extracted with DCM (3 × 5 mL) and dried over MgSO4. After filtration, 
the solvents were evaporated in vacuo. The crude product was purified by flash column chromatography 
(isohexane/DCM= 1:1) to give 73l (80 mg, 89 %) as a yellow solid. 
 
m.p.: 104 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2924, 2854, 1697, 1652, 1604, 1587, 1497, 1464, 1396, 1349, 
1288, 1238, 1177, 1106, 1039, 823, 784, 760. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 8.70-8.56 (m, 2H), 8.35 (dd, J = 8.5, 1.1 Hz, 1H), 7.76-7.73 
(m, 3H), 7.73-7.69 (m, 1H), 7.64 (d, J = 8.9 Hz, 2H), 7.57 (d, J = 8.4 Hz, 2H), 7.04 (d, J = 8.8 Hz, 2H), 
5.23 (m, 1H, NCH), 7.04 (s, 3H, OMe), 2.31-2.21 (m, 2H, ß-CH2), 1.89-1.80 (m, 2H, ß-CH2), 1.36-1.20 
(m, 16H, 8 × CH2), 0.83 (t, J = 7.1 Hz, 6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 165.7, 164.5, 159.7, 146.4, 141.1, 137.3, 132.9, 132.5, 131.7, 
131.4, 131.0, 130.6, 130.5, 130.1, 129.1, 128.3, 128.0, 127.0, 127.0, 123.8, 123.0, 122.5, 121.8, 114.6, 
55.6, 54.7, 32.6, 31.9, 29.4, 27.1, 22.8, 14.2. 
MS (EI, 70 eV): m/z (%) = 562 (11), 561 (25), 392 (7), 381 (20), 380 (76), 379 (100), 364 (7), 336 (7). 
HRMS (EI) calcd. for [C38H43NO3]: 561.3243; found: 561.3229. 
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EA for [C38H43NO3]:     calculated: C 81.25 N 2.49  H 7.72 
                                             found: C 81.37 N 2.49  H 7.76. 
UV/Vis (CHCl3): lmax () = 364.4 nm (27500). 
Fluorescence (CHCl3, lexc = 364.4 nm): lmax = 492.2 nm. 
Fluorescence quantum yield (CHCl3, lexc = 364.4 nm, E364.4 nm = 0.0528 cm-1, reference: N,N’-
bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide with  = 1.00):  = 0.67. 
 
6-(4-Cyanophenyl)-2-(tridecan-7-yl)-1-benzo[de]isoquinoline-1,3(2H)-dione (73j)   
 
Procedure A: Suzuki-Coupling: 
A Schlenk-flask was charged with 6-bromo-2-(tridecan-7-yl)-1H-benzo[de]iso-quinoline-1,3(2H)-dione 
(72, 980 mg, 2.1 mmol, 1.0 equiv) and 4-Cyanophenylboronic acid (370 mg, 2.52 mmol, 1.2 equiv). 
Both compounds were dissolved in toluene (40 mL) under a light argon stream. K2CO3 (5.0 g, 36.2 
mmol) was dissolved in a mixture of water (20 mL) and EtOH (8 mL) and added to the Schlenk-flask 
followed by tetrakis(triphenylphosphine)-palladium(0) (115 mg, 0.11 mmol, 5 mol%). The mixture was 
purged with argon for 30 min and then heated to 80 °C. The reaction mixture was stirred for further       
17 h at this temperature. After cooling to rt, the organic phase was separated and the aqueous phase was 
extracted with toluene (3 × 20 mL). Purification by column chromatography (isohexane/CHCl3 = 1:1) 
gave compound 73j (416 mg, 41 %) as a bright yellow oil.   
 
Procedure B: Cyanation with K4Fe(CN)6:177 
A dry, argon-flushed schlenk-flask was charged with K4Fe(CN)6 (128 mg, 0.35 mmol, 2.0 equiv), K2CO3 
(72 mg, 0.52 mmol, 3.0 equiv) and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) 
(13 mg, 0.017 mmol, 10 mol%). A solution of 6-(4-iodophenyl)-2-(tridecan-7-yl)-1H-benzo[de]iso-
quinoline-1,3(2H)-dione (73k, 101 mg, 0.174 mmol) in dry DMF (2 mL) was added at rt under argon. 
The reaction mixture was stirred at 100 °C for 4 h, allowed to cool down and the solvent was removed 
under reduced pressure. The crude residue was treated with sat. aq. NH4Cl solution (15 mL) and 
extracted with CHCl3 (3 × 15 mL). Purification by column chromatography (isohexane/CHCl3 = 1:1) 
gave compound 73j (55 mg, 66 %) as a bright yellow oil.  
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IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2923, 2855, 1699, 1656, 1588, 1465, 1397, 1349, 1327, 1238, 
1179, 1103, 844, 784, 759. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 8.71-8.60 (br, 2H), 8.36 (dd, J = 8.5 Hz, 1.0 Hz, 1H), 7.89 (d, 
J = 8.4 Hz, 2H), 7.78 (d, J = 7.5 Hz, 1H), 7.77-7.73 (m, 1H), 7.67 (d, J = 8.4 Hz, 2H), 5.23-5.18 (m, 1H, 
NCH), 2.30-2.23 (m, 2H, ß-CH2), 1.89-1.82 (m, 2H, ß-CH2), 1.37-1.20 (m, 16H, 8×CH2), 0.84 (t,                
J = 7.1 Hz, 6H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 165.7, 165.5, 164.6, 164.4, 146.1, 140.6, 138.5, 132.3, 131.8, 
131.4, 131.0, 130.7, 130.1, 129.1, 128.0, 127.6, 127.1, 123.8, 123.1, 122.8, 122.1, 54.7, 32.6, 31.9, 29.4, 
27.1, 22.8, 14.2. 
MS (EI, 70 eV): m/z (%) = 480 (11), 300 (25), 299 (100), 298 (10), 97 (9), 85 (10), 57 (14). 
HRMS (EI) calcd. for [C32H39NO3]: 480.2777; found: 480.2773. 
UV/Vis (CHCl3): lmax () = 366.4 nm (23700). 
Fluorescence (CHCl3, lexc = 366.4 nm): lmax = 447.4 nm. 
Fluorescence quantum yield (CHCl3, lexc = 366.4 nm, E366.4nm = 0.0732 cm-1, Reference N,N’-
bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide  = 1.00):  = 0.54. 
 
2-Allyl-6-(4-methoxynaphthalen-1-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (77) 
 
A Schlenk-flask was charged with 2-allyl-6-bromo-1H-benzo[de]isoquinoline-1,3(2H)-dione (76, 205 
mg, 0.65 mmol, 1.0 equiv) and 2-(4-methoxynaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(200 mg, 0.70 mmol, 1.1 equiv). Both compounds were dissolved in toluene (10 mL) under a light argon-
stream. K2CO3 (1.40 g, 10 mmol) was dissolved in a mixture of water (5 mL) and EtOH (1 mL) and 
added to the Schlenk-flask followed by tetrakis(triphenylphosphine)palladium(0) (37 mg, 0.03 mmol,   
5 mol%). The mixture was purged with argon for 30 min and then heated to 80 °C. The reaction mixture 
was stirred further 17 h at this temperature. After cooling to rt, the organic phase was separated and the 
aqueous phase was extracted with toluene (3 × 30 mL). Purification by column chromatography 
(isohexane/CHCl3 = 1:1) gave compound 77 (225 mg, 88 %) as a bright yellow solid. 
 
m.p.: 178 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 1696, 1656, 1580, 1510, 1372, 1328, 1232, 1085, 810, 780,759. 
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1H-NMR (600 MHz, CDCl3): δ/ ppm = 8.71 (d, J = 7.4 Hz, 1H), 8.62 (dd, J = 7.2, 1.1 Hz, 1H), 8.40 
(d, J = 8.0 Hz, 1H), 7.84 (dd, J  = 8.5, 1.1 Hz, 1H), 7.77 (d, J = 7.4 Hz, 1H), 7.58-7.54 (m, 1H), 7.53-
7.48 (m, 1H), 7.40 (d, J = 7.8 Hz, 1H), 7.37-7.32 (m, 1H), 7.26 (d, J = 8.5 Hz, 1H), 6.97 (d, J = 7.8 Hz, 
1H), 6.10-6.00 (m, 1H), 5.37 (dd, J = 17.2, 1.4 Hz), 5.24 (dd, J = 10.2, 1.3 Hz, 2H), 4.87 (d, J = 5.7 Hz, 
2H), 4.11 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 164.2, 164.1, 156.2, 146.1, 133.4, 133.3, 132.4, 131.8, 131.5, 
131.1, 129.4, 128.6, 128.6, 128.2, 127.2, 126.9, 125.7, 125.7, 122.9, 122.5, 122.0, 117.7, 103.4, 55.9, 
42.6. 
MS (EI, 70 eV): m/z (%) = 394 (26), 293 (100), 381 (19), 380 (69), 267 (13), 264 (13), 239 (41), 238 
(10), 237 (12), 119 (12). 
HRMS (EI) calcd. for [C26H19NO3]: 393.1365; found: 393.1359. 
 
6-(4-methoxynaphthalen-1-yl)-2-(3-(triethoxysilyl)propyl)-1H-benzo[de]isoquinoline-1,3(2H)-
dione (78) 
 
2-Allyl-6-(4-methoxynaphthalen-1-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (77, 145 mg, 0.37 
mmol) was dissolved in anhydrous DCM (10 mL) under argon. Then, a solution of triethoxysilane (0.34 
mL, 1.85 mmol, 5.0 equiv) and Karstedt’s catalyst (4 mg, 0.011 mmol, 3 mol%, ~2% Pt in xylene: 212 
mg, 0.25 mL) in dry DCM (1 mL) was added slowly. The reaction mixture was stirred for 12 h, then 
purified by flash column chromatography (Florisil 60-100 mesh, CHCl3/EtOH = 80:1) to give the title 
compound (138 mg, 67%) as a yellow solid. 
 
m. p.: 129-131 °C. 
IR (Diamond-ATR, neat): 𝜈/ cm-1 = 2971, 2924, 1702, 1663, 1588, 1509, 1460, 1439, 1380, 1349, 
1287, 1241, 1164, 1075, 1014, 956, 820, 784, 767, 756. 
1H-NMR (600 MHz, CDCl3): δ/ ppm = 8.69 (d, J = 7.4 Hz, 1H), 8.60 (dd, J = 7.2, 1.0 Hz, 1H), 8.40 
(d, J = 8.4 Hz, 1H), 7.82 (dd, J = 8.5, 0.9 Hz, 1H), 7.76 (d, J = 7.4 Hz, 1H), 7.56-7.52 (m, 1H), 7.52-
7.47 (m, 1H), 7.40 (d, J = 7.8 Hz, 1H), 7.36-7.32 (m, 1H), 7.25 (d, J = 7.3 Hz, 1H), 6.97 (d, J = 7.9 Hz, 
1H), 4.26-4.20 (m, 2H), 4.11 (s, 3H), 3.84 (q, J = 7.0 Hz, 6H), 1.94-1.86 (m, 2H), 1.23 (t, J = 7.0 Hz, 
9H), 0.82-0.77 (m, 2H). 
13C-NMR (150 MHz, CDCl3): δ/ ppm = 164.4, 164.3, 156.1, 145.9, 133.3, 133.2, 131.8, 131.3, 130.9, 
129.4, 128.7, 128.6, 128.2, 127.2, 126.8, 125.8, 125.7, 123.1, 122.5, 122.2, 103.4, 60.5, 58.6, 55.9, 43.1, 
29.9, 21.7, 18.5, 14.4, 8.2. 
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MS (EI, 70 eV): m/z (%) = 557 (50), 512 (32), 470 (26), 431 (15), 395 (30), 366 (11), 359 (45), 358 
(100), 355 (11), 276 (11), 241 (21), 163 (36).  
HRMS (EI) calcd. for [C32H35NO6Si]: 557.2234; found 557.2220. 
 
General procedure for grafting silica with 78: 
HDK T40 silica nanoparticles were heated under medium vacuum at 80 °C for 1 h to remove any water 
attached to the surface, then the particles (100 mg) were put in dry CHCl3 (8 mL) with stirring for 16 h 
reaching fine dipersion. The resulting suspension was treated with dissolved 78 (20 mg, 36 μmol in          
1 mL dry CHCl3), then typically allowed to react for 5 h at 50 °C and separated 3-4 times by centri-
fugation (15 min at 19000 rpm) until the supernatant is completely clear. The grafted nanoparticles can 
be applied in the final solvent by redispersion (5 days). 
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D. APPENDIX 
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1. X-RAY DATA 
 
Single Crystal X-Ray Diffraction Studies 
Single crystals, suitable for X-ray diffraction, were obtained by slow evaporation of DCM or CHCl3 
solutions. The crystals were introduced into perfluorinated oil and a suitable single crystal was 
carefully mounted on the top of a thin glass wire. Data collection was performed with an Oxford 
Xcalibur 3 diffractometer equipped with a Spellman generator (50 kV, 40 mA) and a Kappa CCD 
detector, operating with Mo-Kα radiation (λ = 0.71071 Ǻ).  
Data collection was performed with the CrysAlis CCD software;178 CrysAlis RED software179 was 
used for data reduction. Absorption correction using the SCALE3 ABSPACK multiscan method180 
was applied. The structures were solved with SHELXS-97,181 refined with SHELXL-97182 and 
finally checked using PLATON.183 Details for data collection and structure refinement are 
summarized in Tables below. Supplementary crystallographic data can be obtained free of charge 
from the Cambridge Crystallographic Data Center via www.ccdc.cam.ac.uk/data_request/cif. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
178 CrysAlis CCD, Oxford Diffraction Ltd., Version 1.171.27p5 beta (release 01-04-2005 CrysAlis171.NET) (compiled Apr 1  
2005, 17:53:34). 
179 CrysAlis RED, Oxford Diffraction Ltd., Version 1.171.27p5 beta (release 01-04-2005 CrysAlis171.NET) (compiled Apr 1 
2005, 17:53:34) 
180 SCALE3 ABSPACK – An Oxford Diffraction Program (1.0.4, gui:1.0.3) (C), Oxford Diffraction, Ltd., 2005. 
181 Sheldrick, G. M. (1997) SHELXS-97: Program for Crystal Structure Solution, University of Göttingen, Germany. 
182 Sheldrick, G. M. (1997) SHELXL-97: Program for the Refinement of Crystal Structures, University of Göttingen, Germany. 
183 Spek, A. L. (1999) PLATON: A Multipurpose Crystallographic Tool, Utrecht University, Utrecht, The Netherlands. 
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Table 12: Details for X-ray data collection and structure refinement for compounds 9c and 11d. 
                                   
 9c 11d 
Empirical formula C16H20Cl2N2S2 C15H19Cl3N2OSi 
Formula mass 375.36 377.76 
T[K] 253(2) 173(2) 
Crystal size [mm] 0.45 × 0.12 × 0.03 0.41 × 0.08 × 0.03 
Crystal description colorless platelet colorless platelet 
Crystal system monoclinic monoclinic 
Space group C2/c P21/c 
a [Ǻ] 24.1939(15) 9.2449(8) 
b [Ǻ] 8.5126(4) 26.6605(18) 
c [Ǻ] 9.0802(7) 7.1883(6) 
α [°] 90 90 
β [°] 99.150(7) 92.108(8) 
γ [°] 90 90 
V [Ǻ3] 1846.3(2) 1770.5(2) 
Z 4 4 
ρcalcd. [g cm-3] 1.350 1.417 
μ [mm-1] 0.575 0.587 
F(000) 784 784 
Θ range [°] 4.39 – 26.37 4.17 – 26.37 
Index ranges -24 ≤ h ≤ 30 -11 ≤ h ≤ 11 
 -10 ≤ k ≤ 10 -28 ≤ k ≤ 33 
 -11 ≤ l ≤ 11 -8 ≤ l ≤ 8 
Reflns. collected 5984 12200 
Reflns. obsd. 1187 2358 
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Reflns. unique 1881  
(Rint = 0.0461) 
3596  
(Rint = 0.0628) 
R1, wR2 (2σ data) 0.0503, 0.0992 0.0594, 0.1307 
R1, wR2 (all data) 0.0922, 0.1140 0.0995, 0.1467 
GOOF on F2 1.026 0.993 
Peak/hole [e Ǻ-3] 0.327 / -0.259 0.672 / -0.269 
 
 
Table 13: Selected bond lengths (Å) of compound 9c. 
Cl1—C3 1.729(3) C5—C6 1.512(4) 
S1—C1 1.758(2) C6—C7 1.505(4) 
S1—C5 1.807(3) C7—C8 1.509(5) 
C4—C3 1.344(4) N2—C3 1.345(3) 
C4—C10 1.400(3) C9—C10 1.430(4) 
C1—N2 1.325(3) C9—C1i 1.434(3) 
C1—C9 1.434(3) C10—C4i 1.400(3) 
                                                              (i) -x, y, 0.5-z. 
 
Table 14: Selected bond angles (°) of compound 9c. 
C1—S1—C5 102.3(1) C7—C6—C5 113.2(2) 
C3—C4—C10 118.5(2) C6—C7—C8 113.2(3) 
N2—C1—C9 122.8(2) C10—C9—C1 116.0(2) 
N2—C1—S1 115.2(2) C10—C9—C1i 116.0(2) 
C9—C1—S1 121.9(2) C1—C9—C1i 128.1(3) 
C1—N2—C3 118.4(2) C4i—C10—C4 121.4(3) 
C4—C3—N2 124.9(3) C4i—C10—C9 119.3(2) 
C4—C3—Cl1 121.0(2) C4—C10—C9 119.3(2) 
N2—C3—Cl1 114.1(2) C6—C5—S1 112.9(2) 
                                                    (i) -x, y, 0.5-z. 
 
Table 15: Selected torsion angles (°) of compound 9c. 
C5—S1—C1—N2 5.9(2) S1—C1—C9—C1i 7.9(1) 
C5—S1—C1—C9 -177.6(2) C3—C4—C10—C4i -178.1(3) 
C9—C1—N2—C3 -1.9(3) C3—C4—C10—C9 1.9(3) 
S1—C1—N2—C3 174.5(2) C1—C9—C10—C4i 176.1(2) 
C10—C4—C3—N2 0.5(4) C1—C9—C10—C4i -3.9(2) 
C10—C4—C3—Cl1 179.5(2) C1—C9—C10—C4 -4.0(2) 
C1—N2—C3—C4 -0.5(4) C1—C9—C10—C4 176.1(2) 
C1—N2—C3—Cl1 -179.6(2) C1—S1—C5—C6 83.7(2) 
N2—C1—C9—C10 4.1(3) S1—C5—C6—C7 177.8(2) 
S1—C1—C9—C10 -172.1(1) C5—C6—C7—C8 -179.7(3) 
N2—C1—C9—C1i -175.9(3)   
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Table 16: Selected bond lengths (Å) of compound 11d. 
Cl6—C6 1.731(4) C11—C12 1.488(5) 
Cl1—C1 1.728(3) C12—C13 1.515(5) 
Cl3—C3 1.745(3) C13—C14 1.501(5) 
Si1—C17 1.848(4) N2—C1 1.303(4) 
Si1—C16 1.855(4) N2—C3 1.353(4) 
Si1—C15 1.862(4) C8—C9 1.435(4) 
Si1—C4 1.927(4) C9—C1 1.413(5) 
O1—C8 1.335(4) C9—C10 1.428(4) 
O1—C11 1.441(4) C10—C5 1.417(5) 
N7—C8 1.308(4) C10—C4 1.437(4) 
N7—C6 1.346(4) C4—C3 1.372(5) 
C6—C5 1.344(4)   
 
 
Table 17: Selected bond angles (°) of compound 11d. 
C17—Si1—C16 105.1(2) O1—C11—C12 107.9(3) 
C17—Si1—C15 106.5(2) C11—C12—C13 112.1(3) 
C16—Si1—C15 113.4(2) C14—C13—C12 114.1(4) 
C17—Si1—C4 115.9(2) C9—C10—C4 120.7(3) 
C16—Si1—C4 109.2(2) C3—C4—C10 113.7(3) 
C15—Si1—C4 106.9(2) C3—C4—Si1 118.8(2) 
C8—O1—C11 118.1(3) C10—C4—Si1 127.5(3) 
C8—N7—C6 116.5(3) N2—C3—C4 127.5(3) 
C1—N2—C3 117.3(3) N2—C3—Cl3 110.7(3) 
N7—C8—O1 118.3(3) C4—C3—Cl3 121.8(3) 
N7—C8—C9 124.2(3) N2—C1—C9 124.2(3) 
O1—C8—C9 117.5(3) N2—C1—Cl1 112.8(3) 
C1—C9—C10 116.3(3) C9—C1—Cl1 122.9(3) 
C1—C9—C8 126.5(3) C5—C6—N7 126.3(3) 
C10—C9—C8 117.2(3) C5—C6—Cl6 119.7(3) 
C5—C10—C9 116.9(3) N7—C6—Cl6 114.1(3) 
C5—C10—C4 122.3(3) C6—C5—C10 118.9(3) 
 
 
Table 18: Selected torsion angles (°) of compound 11d. 
C6—N7—C8—O1 177.8(3) C1—N2—C3—C4 -2.9(5) 
C6—N7—C8—C9 -1.1(5) C1—N2—C3—Cl3 177.9(2) 
C11—O1—C8—N7 -3.4(4) C10—C4—C3—N2 4.9(5) 
C11—O1—C8—C9 175.6(3) Si1—C4—C3—N2 -173.5(3) 
N7—C8—C9—C1 -178.6(3) C10—C4—C3—Cl3 -176.0(2) 
O1—C8—C9—C1 2.5(5) Si1—C4—C3—Cl3 5.6(4) 
N7—C8—C9—C10 2.8(5) C3—N2—C1—C9 -1.4(5) 
O1—C8—C9—C10 -176.0(3) C3—N2—C1—Cl1 175.5(2) 
C1—C9—C10—C5 178.9(3) C10—C9—C1—N2 3.1(5) 
C8—C9—C10—C5 -2.4(4) C8—C9—C1—N2 -175.5(3) 
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C1—C9—C10—C4 -0.7(5) C10—C9—C1—Cl1 -173.6(2) 
C8—C9—C10—C4 178.0(3) C8—C9—C1—Cl1 7.9(5) 
C5—C10—C4—C3 177.6(3) C8—N7—C6—C5 -1.1(5) 
C9—C10—C4—C3 -2.8(4) C8—N7—C6—Cl6 178.7(2) 
C5—C10—C4—Si1 -4.1(5) N7—C6—C5—C10 1.4(6) 
C9—C10—C4—Si1 175.5(2) Cl6—C6—C5—C10 -178.5(2) 
C17—Si1—C4—C3 175.0(3) C9—C10—C5—C6 0.5(5) 
C16—Si1—C4—C3 -66.5(3) C4—C10—C5—C6 -179.9(3) 
C15—Si1—C4—C3 56.5(3) C8—O1—C11—C12 -173.0(3) 
C17—Si1—C4—C10 -3.2(4) O1—C11—C12—C13 178.3(3) 
C16—Si1—C4—C10 115.3(3) C11—C12—C13—C14 178.4(4) 
C15—Si1—C4—C10 -121.7(3)   
 
 
Table 19: Details for X-ray data collection and structure refinement for compound 15. 
 
 15 
Empirical formula C12H13IN2O3 
Formula mass 360.14 
T[K] 100(2) 
Crystal size [mm] 0.42 × 0.17 × 0.11 
Crystal description colorless block 
Crystal system triclinic 
Space group P-1 
a [Ǻ] 8.5985(2) 
b [Ǻ] 8.9813(2) 
c [Ǻ] 10.1508(2) 
α [°] 113.998(2) 
β [°] 91.780(2) 
γ [°] 111.582(2) 
V [Ǻ3] 650.70(3) 
Z 2 
ρcalcd. [g cm-3] 1.838 
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μ [mm-1] 2.463 
F(000) 352 
Θ range [°] 4.15 – 30.50 
Index ranges -12 ≤ h ≤ 12 
 -12 ≤ k ≤ 12 
 -14 ≤ l ≤ 14 
Reflns. collected 12980 
Reflns. obsd. 3629 
Reflns. unique 3946  
(Rint = 0.0320) 
R1, wR2 (2σ data) 0.0214, 0.0480 
R1, wR2 (all data) 0.0253, 0.0499 
GOOF on F2 1.041 
Peak/hole [e Ǻ-3] 0.526 / -0.759 
 
Table 20: Selected bond lengths (Å) of compound 15. 
I1 – C1 2.114(2) N2 – C5 1.356(3) 
C1 – C2 1.339(2) C11 – C10 1.501(3) 
C1 – N1 1.394(2) C4 – C5 1.370(3) 
O2 – C9 1.402(2) C7 – C3 1.403(2) 
O2 – C10 1.435(2) C7 – C8 1.460(3) 
N1 – C8 1.405(2) C3 – C4 1.403(3) 
N1 – C9 1.468(2) C3 – C2 1.426(2) 
O3 – C12 1.411(3) O1 – C8 1.228(2) 
O3 – C11 1.413(3) N2 – C6 1.324(3) 
C7 – C6 1.402(3)   
 
Table 21: Selected bond angles (°) of compound 15. 
C2 – C1 – N1 122.6(2) C5 – C4 – C3 119.3(2) 
C2 – C1 – I1 117.0(1) O1 – C8 – N1 120.7(2) 
N1 – C1 – I1 120.4(1) O1 – C8 – C7 123.6(2) 
C9 – O2 – C10 114.1(2) N1 – C8 – C7 115.7(2) 
C1 – N1 – C8 121.5(2) O2 – C9 – N1 113.6(2) 
C1 – N1 – C9 121.5(2) N2 – C5 – C4 123.9(2) 
C8 – N1 – C9 116.9(2) O2 – C10 – C11 109.0(2) 
C12 – O3 – C11 113.1(2) C4 – C3 – C2 124.0(2) 
C6 – C7 – C3 118.8(2) C6 – N2 – C5 117.0(2) 
C6 – C7 – C8 119.8(2) O3 – C11 – C10 109.6(2) 
C3 – C7 – C8 121.4(2) N2 – C6 – C7 123.7(2) 
C7 – C3 – C4 117.2(2) C1 – C2 – C3 119.9(2) 
C7 – C3 – C2 118.8(2)   
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Table 22: Selected torsion angles (°) of compound 15. 
C2 – C1 – N1 – C8 -0.5(3) C2 – C3 – C4 – C5 -179.5(2) 
I1 – C1 – N1 – C8 -178.4(1) C1 – N1 – C8 – O1 178.9(2) 
C2 – C1 – N1 – C9 -177.3(2) C9 – N1 – C8 – O1 -4.2(3) 
I1 – C1 – N1 – C9 4.9(2) C1 – N1 – C8 – C7 -0.7(2) 
C6 – C7 – C3 – C4 -3.0(3) C9 – N1 – C8 – C7 176.2(2) 
C8 – C7 – C3 – C4 176.1(2) C6 – C7 – C8 – O1 1.8(3) 
C6 – C7 – C3 – C2 178.2(2) C3 – C7 – C8 – O1 -177.3(2) 
C8 – C7 – C3 – C2 -2.7(3) C6 – C7 – C8 – N1 -178.6(2) 
C12 – O3 – C11 – C10 -171.8(2) C3 – C7 – C8 – N1 2.4(3) 
C5 – N2 – C6 – C7 0.6(3) C10 – O2 – C9 – N1 -76.2(2) 
C3 – C7 – C6 – N2 1.8(3) C1 – N1 – C9 – O2 -83.2(2) 
C8 – C7 – C6 – N2 -177.2(2) C8 – N1 – C9 – O2 99.9(2) 
N1 – C1 – C2 – C3 0.2(3) C6 – N2 – C5 – C4 -1.9(3) 
I1 – C1 – C2 – C3 178.1(1) C3 – C4 – C5 – N2 0.6(3) 
C7 – C3 – C2 – C1 1.4(3) C9 – O2 – C10 – C11 -167.4(2) 
C4 – C3 – C2 – C1 -177.3(2) O3 – C11 – C10 – O2 -69.2(2) 
C7 – C3 – C4 – C5 1.8(3)   
 
 
Table 23: Details for X-ray data collection and structure refinement for compound 42j. 
 
 42j 
Empirical formula C18H17N5 
Formula mass 303.36 
T[K] 123(2) 
Crystal size [mm] 0.15 × 0.03 × 0.03 
Crystal description pale yellow needle 
Crystal system monoclinic 
Space group P21/c 
a [Ǻ] 11.7463(8) 
b [Ǻ] 11.2886(6) 
c [Ǻ] 11.8659(7) 
α [°] 90.0 
β [°] 104.554(6) 
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γ [°] 90.0 
V [Ǻ3] 1522.92(16) 
Z 4 
ρcalcd. [g cm-3] 1.323 
μ [mm-1] 0.083 
F(000) 640 
Θ range [°] 4.22 – 25.24 
Index ranges -14 ≤ h ≤ 14 
 -13 ≤ k ≤ 13 
 -13 ≤ l ≤ 14 
Reflns. collected 10831 
Reflns. obsd. 1975 
Reflns. unique 2986 
(Rint = 0.0586) 
R1, wR2 (2σ data) 0.0567, 0.1160 
R1, wR2 (all data) 0.0947, 0.1362 
GOOF on F2 1.010 
Peak/hole [e Ǻ-3] 0.585 / -0.274 
 
Table 24: Selected bond lengths (Å) of compound 42j. 
N5 – N4 1.316(2) C7 – C8 1.403(3) 
N5 – C15 1.455(3) C5 – N1 1.370(3) 
N5 – C18 1.462(3) C9 – C10 1.402(3) 
C12 – C11 1.397(3) C1 – N1 1.321(3) 
C12 – C13 1.397(3) C1 – C2 1.399(4) 
C12 – N3 1.420(3) C18 – C17 1.526(3) 
N3 – N4 1.282(2) C15 – C16 1.527(4) 
C6 – C7 1.373(3) C17 – C16 1.489(4) 
C6 – C5 1.427(3) C3 – C4 1.408(3) 
C6 – C9 1.484(3) N2 – C8 1.316(3) 
C13 – C14 1.381(3) N2 – C4 1.371(3) 
C14 – C9 1.399(3) C11 – C10 1.372(3) 
C3 – C2 1.362(4) C4 – C5 1.417(3) 
 
Table 25: Selected bond angles (°) of compound 42j. 
N4 – N5 – C15 119.9(2) C14 – C9 – C6 122.0(2) 
N4 – N5 – C18 125.2(2) C10 – C9 – C6 120.7(2) 
C15 – N5 – C18 114.0(2) C11 – C10 – C9 121.5(2) 
C11 – C12 – C13 118.4(2) N1 – C1 – C2 124.9(3) 
C11 – C12 – N3 116.4(2) N5 – C18 – C17 102.0(2) 
C13 – C12 – N3 125.2(2) C1 – N1 – C5 117.4(2) 
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N4 – N3 – C12 111.9(2) C3 – C2 – C1 118.2(2) 
N3 – N4 – N5 113.2(2) N5 – C15 – C16 101.5(2) 
C7 – C6 – C5 116.2(2) C16 – C17 – C18 105.6(2) 
C7 – C6 – C9 120.9(2) C17 – C16 – C15 104.1(2) 
C5 – C6 – C9 122.9(2) C3 – C4 – C5 118.2(2) 
C14 – C13 – C12 120.4(2) C6 – C7 – C8 121.2(2) 
C13 – C14 – C9 121.6(2) N2 – C8 – C7 124.3(2) 
C2 – C3 – C4 119.6(2) N1 – C5 – C4 121.5(2) 
C8 – N2 – C4 116.2(2) N1 – C5 – C6 119.7(2) 
C10 – C11 – C12 120.8(2) C4 – C5 – C6 118.7(2) 
N2 – C4 – C3 118.4(2) C14 – C9 – C10 117.3(2) 
N2 – C4 – C5 123.3(2)   
 
Table 26: Selected torsion angles (°) of compound 42j. 
C11 – C12 – N3 – N4 -173.5(2) C7 – C6 – C5 – C4 -2.2(3) 
C13 – C12 – N3 – N4 5.4(3) C9 – C6 – C5 – C4 178.0(2) 
C12 – N3 – N4 – N5 178.4(2) C13 – C14 – C9 – C10 -1.4(3) 
C15 – N5 – N4 – N3 -175.4(2) C13 – C14 – C9 – C6 179.6(2) 
C18 – N5 – N4 – N3 -6.9(3) C7 – C6 – C9 – C14 139.6(2) 
C11 – C12 – C13 – C14 2.3(3) C5 – C6 – C9 – C14 -40.5(3) 
N3 – C12 – C13 – C14 -176.5(2) C7 – C6 – C9 – C10 -39.3(3) 
C12 – C13 – C14 – C9 -0.7(4) C5 – C6 – C9 – C10 140.5(2) 
C13 – C12 – C11 – C10 -1.8(3) C12 – C11 – C10 – C9 -0.3(4) 
N3 – C12 – C11 – C10 177.1(2) C14 – C9 – C10 – C11 1.9(3) 
C8 – N2 – C4 – C3 179.8(2) C6 – C9 – C10 – C11 -179.0(2) 
C8 – N2 – C4 – C5 0.3(3) N4 – N5 – C18 – C17 -172.5(2) 
C2 – C3 – C4 – N2 176.9(2) C15 – N5 – C18 – C17 -3.4(3) 
C2 – C3 – C4 – C5 -3.5(4) C2 – C1 – N1 – C5 -1.4(4) 
C5 – C6 – C7 – C8 0.4(3) C4 – C5 – N1 – C1 -1.9(3) 
C9 – C6 – C7 – C8 -179.7(2) C6 – C5 – N1 – C1 -180.0(2) 
C4 – N2 – C8 – C7 -2.3(4) C4 – C3 – C2 – C1 0.6(4) 
C6 – C7 – C8 – N2 2.0(4) N1 – C1 – C2 – C3 2.0(4) 
N2 – C4 – C5 – N1 -176.2(2) N4 – N5 – C15 – C16 151.7(2) 
C3 – C4 – C5 – N1 4.3(3) C18 – N5 – C15 – C16 -18.0(3) 
N2 – C4 – C5 – C6 1.9(3) N5 – C18 – C17 – C16 24.4(3) 
C3 – C4 – C5 – C6 -177.6(2) C18 – C17 – C16 – C15 -36.0(3) 
C7 – C6 – C5 – N1 176.0(2) N5 – C15 – C16 – C17 32.4(3) 
C9 – C6 – C5 – N1 -3.9(3)   
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Table 27: Details for X-ray data collection and structure refinement for compound 45a. 
 
 45a 
Empirical formula C11H13ClN2Si 
Formula mass 236.77 
T[K] 173(2) 
Crystal size [mm] 0.47 × 0.19 × 0.08 
Crystal description colorless block 
Crystal system triclinic 
Space group P21/m 
a [Ǻ] 8.7215(4) 
b [Ǻ] 7.0286(4) 
c [Ǻ] 10.0617(4) 
α [°] 90.0 
β [°] 101.810(4) 
γ [°] 90.0 
V [Ǻ3] 603.73(5) 
Z 2 
ρcalcd. [g cm-3] 1.302 
μ [mm-1] 0.385 
F(000) 248 
Θ range [°] 4.14 – 25.24 
Index ranges -12 ≤ h ≤ 12 
 -10 ≤ k ≤ 10 
 -14 ≤ l ≤ 14 
Reflns. collected 11994 
Reflns. obsd. 1602 
Reflns. unique 1954 
(Rint = 0.0366) 
R1, wR2 (2σ data) 0.0357, 0.0866 
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R1, wR2 (all data) 0.0468, 0.0939 
GOOF on F2 1.039 
Peak/hole [e Ǻ-3] 0.296 / -0.265 
 
Table 28: Selected bond lengths (Å) of compound 45a. 
Cl1 – C2 1.732(2) C3 – C4 1.410(2) 
Si1 – C10i 1.854(1) C4 – N2 1.369(2) 
Si1 – C10 1.854(1) C7 – C8 1.413(3) 
Si1 – C9 1.862(2) N2 – C8 1.310(3) 
Si1 – C6 1.896(2) C2 – C1 1.412(3) 
N1 – C1 1.314(2) C5 – C4 1.419(2) 
N1 – C5 1.367(2) C5 – C6 1.423(2) 
C2 – C3 1.356(2) C6 – C7 1.371(2) 
 
Table 29: Selected bond angles (°) of compound 45a. 
C10i – Si1 – C10 112.1(1) N2 – C4 – C3 118.7(2) 
C10i – Si1 – C9 109.3(1) N2 – C4 – C5 122.8(2) 
C10 – Si1 – C9 109.3(1) C3 – C4 – C5 118.5(2) 
C10i – Si1 – C6 109.4(1) C6 – C7 – C8 121.1(2) 
C10 – Si1 – C6 109.4(1) C8 – N2 – C4 116.3(2) 
C9 – Si1 – C6 107.3(1) N2 – C8 – C7 124.6(2) 
C1 – N1 – C5 118.3(2) C4 – C5 – C6 119.7(2) 
C3 – C2 – C1 120.7(2) C7 – C6 – C5 115.6(2) 
C3 – C2 – Cl1 121.0(1) C7 – C6 – Si1 122.4(1) 
C1 – C2 – Cl1 118.3(1) C5 – C6 – Si1 122.0(1) 
N1 – C5 – C4 121.9(2) N1 – C1 – C2 122.7(2) 
N1 – C5 – C6 118.5(1) C2 – C3 – C4 118.0(2) 
 
Table 30: Selected torsion angles (°) of compound 45a. 
C1 – N1 – C5 – C4 0.0 (1) C1 – C2 – C3 – C4 0.0 (1) 
C1 – N1 – C5 – C6 180.0(1) Cl1 – C2 – C3 – C4 180.0(1) 
N1 – C5 – C6 – C7 180.0 (1) C2 – C3 – C4 – N2 180.0(1) 
C4 – C5 – C6 – C7 0.0(1) C2 – C3 – C4 – C5 0.0(1) 
N1 – C5 – C6 – Si1 0.0(1) N1 – C5 – C4 – N2 180.0(1) 
C4 – C5 – C6 – Si1 180.0(1) C6 – C5 – C4 – N2 0.0(1) 
C10 – Si1 – C6 – C7 118.4(1) N1 – C5 – C4 – C3 0.0 (1) 
C10 – Si1 – C6 – C7 -118.4(1) C6 – C5 – C4 – C3 180.0 (1) 
C9 – Si1 – C6 – C7 0.0(1) C5 – C6 – C7 – C8 0.0 (1) 
C10 – Si1 – C6 – C5 -61.6(1) Si1 – C6 – C7 – C8 180.0 (1) 
C10 – Si1 – C6 – C5 61.6(1) C3 – C4 – N2 – C8 180.0 (1) 
C9 – Si1 – C6 – C5 180.0(1) C5 – C4 – N2 – C8 0.0(1) 
C5 – N1 – C1 – C2 0.0(1) C4 – N2 – C8 – C7 0.0(1) 
C3 – C2 – C1 – N1 0.0(1) C6 – C7 – C8 – N2 0.0(1) 
Cl1 – C2 – C1 – N1 180.0(1)   
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Table 31: Details for X-ray data collection and structure refinement for compound 52a. 
 
 52a 
Empirical formula C14H9BrN2S 
Formula mass 317.20 
T[K] 123(2) 
Crystal size [mm] 0.40 × 0.10 × 0.05 
Crystal description colorless block 
Crystal system triclinic 
Space group P1 
a [Ǻ] 4.4749(2) 
b [Ǻ] 5.3850(2) 
c [Ǻ] 12.9818(5) 
α [°] 100.622(4) 
β [°] 93.295(4) 
γ [°] 95.666(4) 
V [Ǻ3] 305.05(2) 
Z 1 
ρcalcd. [g cm-3] 1.727 
μ [mm-1] 3.520 
F(000) 158 
Θ range [°] 4.47 – 25.24 
Index ranges -6 ≤ h ≤ 6 
 -7 ≤ k ≤ 7 
 -18 ≤ l ≤ 18 
Reflns. collected 5948 
Reflns. obsd. 3506 
Reflns. unique 3725 
(Rint = 0.0307) 
R1, wR2 (2σ data) 0.0362, 0.0784 
R1, wR2 (all data) 0.0404, 0.0826 
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GOOF on F2 1.074 
Peak/hole [e Ǻ-3] 0.459 / -0.803 
 
Table 32: Selected bond lengths (Å) of compound 52a. 
Br1 – C3 1.885(5) C4 – C5 1.421(6) 
C1 – N2 1.325(6) C9 – C14 1.357(8) 
C1 – C2 1.401(7) C9 – C10 1.388(8) 
S1 – C6 1.757(7) C11 – C12 1.349(8) 
S1 – C9 1.780(6) C11 – C10 1.376(8) 
N1 – C8 1.329(6) C14 – C13 1.381(8) 
N1 – C4 1.356(6) C13 – C12 1.370(9) 
N2 – C5 1.365(6) C6 – C5 1.430(7) 
C2 – C3 1.365(7) C3 – C4 1.420(7) 
C6 – C7 1.378(8) C8 – C7 1.404(7) 
 
Table 33: Selected bond angles (°) of compound 52a. 
N2 – C1 – C2 123.8(5) N2 – C5 – C4 124.4(4) 
C6 – S1 – C9 102.7(3) N2 – C5 – C6 117.7(5) 
C8 – N1 – C4 116.6(4) C4 – C5 – C6 117.9(4) 
C1 – N2 – C5 116.8(4) C14 – C9 – C10 118.4(6) 
C3 – C2 – C1 119.3(4) C14 – C9 – S1 120.2(5) 
C7 – C6 – C5 117.5(6) C10 – C9 – S1 121.2(5) 
C7 – C6 – S1 126.6(5) C12 – C11 – C10 121.2(6) 
C5 – C6 – S1 115.9(5) C11 – C10 – C9 120.3(6) 
C2 – C3 – C4 120.2(5) C9 – C14 – C13 120.4(6) 
C2 – C3 – Br1 120.5(4) C12 – C13 – C14 121.2(5) 
C4 – C3 – Br1 119.3(4) C11 – C12 – C13 118.5(5) 
N1 – C8 – C7 124.5(4) C3 – C4 – C5 115.5(4) 
N1 – C4 – C3 120.9(4) C6 – C7 – C8 119.8(4) 
N1 – C4 – C5 123.7(4)   
 
Table 34: Selected torsion angles (°) of compound 52a. 
C2 – C1 – N2 – C5 -0.4(7) N1 – C4 – C5 – N2 -178.9(5) 
N2 – C1 – C2 – C3 -0.1(7) C3 – C4 – C5 – N2 0.6(6) 
C9 – S1 – C6 – C7 3.3(7) N1 – C4 – C5 – C6 -0.4(6) 
C9 – S1 – C6 – C5 -175.8(3) C3 – C4 – C5 – C6 179.2(5) 
C1 – C2 – C3 – C4 0.9(7) C7 – C6 – C5 – N2 -179.3(4) 
C1 – C2 – C3 – Br1 -178.4(3) S1 – C6 – C5 – N2 -0.1(6) 
C4 – N1 – C8 – C7 0.6(7) C7 – C6 – C5 – C4 2.0(7) 
C8 – N1 – C4 – C3 179.6(4) S1 – C6 – C5 – C4 -178.8(3) 
C8 – N1 – C4 – C5 -0.9(6) C6 – S1 – C9 – C14 -108.7(5) 
C2 – C3 – C4 – N1 178.4(5) C6 – S1 – C9 – C10 76.5(7) 
Br1 – C3 – C4 – N1 -2.2(6) C12 – C11 – C10 – C9 0.0(13) 
C2 – C3 – C4 – C5 -1.1(6) C14 – C9 – C10 – C11 -0.5(12) 
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Br1 – C3 – C4 – C5 178.2(3) S1 – C9 – C10 – C11 174.4(7) 
C5 – C6 – C7 – C8 -2.4(8) C10 – C9 – C14 – C13 1.1(11) 
S1 – C6 – C7 – C8 178.5(4) S1 – C9 – C14 – C13 -173.9(6) 
N1 – C8 – C7 – C6 1.1(8) C9 – C14 – C13 – C12 -1.1(12) 
C1 – N2 – C5 – C4 0.2(6) C10 – C11 – C12 – C13 0.1(12) 
C1 – N2 – C5 – C6 -178.4(5) C14 – C13 – C12 – C11 0.5(12) 
 
 
Table 35: Details for X-ray data collection and structure refinement for compound 52c. 
 
 52c 
Empirical formula C14H8BrClN2 
Formula mass 319.58 
T[K] 123(2) 
Crystal size [mm] 0.20 × 0.10 × 0.04 
Crystal description colorless block 
Crystal system orthorhombic 
Space group Pca21 
a [Ǻ] 27.5991(11) 
b [Ǻ] 3.8124(2) 
c [Ǻ] 11.2078(5) 
α [°] 90.0 
β [°] 90.0 
γ [°] 90.0 
V [Ǻ3] 1179.27(9) 
Z 4 
ρcalcd. [g cm-3] 1.800 
μ [mm-1] 3.691 
F(000) 632 
Θ range [°] 4.43 – 25.24 
Index ranges -38 ≤ h ≤ 38 
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 -5 ≤ k ≤ 5 
 -11 ≤ l ≤ 15 
Reflns. collected 10713 
Reflns. obsd. 2662 
Reflns. unique 2791 
(Rint = 0.0317) 
R1, wR2 (2σ data) 0.0233, 0.0497 
R1, wR2 (all data) 0.0254, 0.0507 
GOOF on F2 1.054 
Peak/hole [e Ǻ-3] 0.294 / -0.255 
 
Table 36: Selected bond lengths (Å) of compound 52c. 
Br1 – C3 1.885(2) C9 – C10 1.384(4) 
Cl1 – C12 1.743(3) C9 – C14 1.399(4) 
C5 – N1 1.362(4) C2 – C3 1.364(4) 
C5 – C4 1.427(3) C2 – C1 1.415(4) 
C5 – C6 1.435(4) C11 – C10 1.393(3) 
C7 – C6 1.368(4) C13 – C14 1.387(3) 
C7 – C8 1.405(4) C3 – C4 1.417(4) 
C6 – C9 1.491(4) N2 – C8 1.315(4) 
C12 – C13 1.384(4) N2 – C4 1.359(3) 
C12 – C11 1.384(4) N1 – C1 1.323(3) 
 
Table 37: Selected bond angles (°) of compound 52c. 
N1 – C5 – C4 123.2(2) C12 – C11 – C10 119.3(3) 
N1 – C5 – C6 119.8(2) C9 – C10 – C11 120.4(2) 
C4 – C5 – C6 116.9(3) C12 – C13 – C14 118.1(3) 
C6 – C7 – C8 120.8(3) C2 – C3 – C4 120.9(2) 
C7 – C6 – C5 117.4(2) C2 – C3 – Br1 120.2(2) 
C7 – C6 – C9 119.7(2) C4 – C3 – Br1 118.9(2) 
C5 – C6 – C9 122.9(2) N2 – C8 – C7 124.0(3) 
C13 – C12 – C11 121.8(3) C13 – C14 – C9 121.5(3) 
C13 – C12 – Cl1 119.3(2) N2 – C4 – C3 119.7(2) 
C11 – C12 – Cl1 118.9(2) N2 – C4 – C5 124.0(2) 
C8 – N2 – C4 116.7(2) C3 – C4 – C5 116.3(2) 
C1 – N1 – C5 117.2(2) C14 – C9 – C6 117.9(2) 
C10 – C9 – C14 119.0(2) C3 – C2 – C1 117.6(3) 
C10 – C9 – C6 123.0(2) N1 – C1 – C2 124.7(3) 
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Table 38: Selected torsion angles (°) of compound 52c. 
C8 – C7 – C6 – C5 -2.1(4) C11 – C12 – C13 – C14 0.3(4) 
C8 – C7 – C6 – C9 176.5(2) Cl1 – C12 – C13 – C14 -179.0(2) 
N1 – C5 – C6 – C7 -177.5(2) C1 – C2 – C3 – C4 -1.6(4) 
C4 – C5 – C6 – C7 4.3(3) C1 – C2 – C3 – Br1 177.2(2) 
N1 – C5 – C6 – C9 4.0(4) C4 – N2 – C8 – C7 2.5(4) 
C4 – C5 – C6 – C9 -174.2(2) C6 – C7 – C8 – N2 -1.5(4) 
C4 – C5 – N1 – C1 -0.3(4) C12 – C13 – C14 – C9 -1.0(4) 
C6 – C5 – N1 – C1 -178.3(2) C10 – C9 – C14 – C13 1.0(4) 
C7 – C6 – C9 – C10 131.9(3) C6 – C9 – C14 – C13 177.4(3) 
C5 – C6 – C9 – C10 -49.6(4) C8 – N2 – C4 – C3 -179.6(2) 
C7 – C6 – C9 – C14 -44.4(3) C8 – N2 – C4 – C5 0.1(4) 
C5 – C6 – C9 – C14 134.1(3) C2 – C3 – C4 – N2 -177.5(2) 
C5 – N1 – C1 – C2 1.8(4) Br1 – C3 – C4 – N2 3.8(3) 
C3 – C2 – C1 – N1 -0.9(4) C2 – C3 – C4 – C5 2.9(4) 
C13 – C12 – C11 – C10 0.5(4) Br1 – C3 – C4 – C5 -175.9(2) 
Cl1 – C12 – C11 – C10 179.8(2) N1 – C5 – C4 – N2 178.4(2) 
C14 – C9 – C10 – C11 -0.2(4) C6 – C5 – C4 – N2 -3.5(4) 
C6 – C9 – C10 – C11 -176.4(2) N1 – C5 – C4 – C3 -2.0(3) 
C12 – C11 – C10 – C9 -0.6(4) C6 – C5 – C4 – C3 176.1(2) 
 
Table 39: Details for X-ray data collection and structure refinement for compound 52e. 
 
 52e 
Empirical formula C20H17F3N2O 
Formula mass 358.35 
T[K] 173(2) 
Crystal size [mm] 0.20 × 0.15 × 0.05 
Crystal description colorless block 
Crystal system triclinic 
Space group P-1 
a [Ǻ] 7.4440(3) 
b [Ǻ] 8.4203(4) 
c [Ǻ] 14.3590(6) 
α [°] 76.844(4) 
β [°] 86.589(4) 
191 
 
γ [°] 75.684(4) 
V [Ǻ3] 849.19(7) 
Z 2 
ρcalcd. [g cm-3] 1.401 
μ [mm-1] 0.110 
F(000) 372 
Θ range [°] 4.25 – 25.24 
Index ranges -10 ≤ h ≤ 10 
 -12 ≤ k ≤ 12 
 -20 ≤ l ≤ 20 
Reflns. collected 16413 
Reflns. obsd. 3772 
Reflns. unique 5159  
(Rint = 0.0337) 
R1, wR2 (2σ data) 0.0496, 0.1185 
R1, wR2 (all data) 0.0721, 0.1329 
GOOF on F2 1.030 
Peak/hole [e Ǻ-3] 0.425 / -0.397 
 
Table 40: Selected bond lengths (Å) of compound 52e. 
N1 – C1 1.316(2) C6 – C7 1.369(2) 
N1 – C5 1.369(2) C18 – C19 1.387(2) 
C5 – C6 1.418(2) C18 – C17 1.391(2) 
C5 – C4 1.419(2) C17 – C20 1.497(2) 
N2 – C8 1.319(2) F3 – C20 1.331(2) 
N2 – C4 1.369(2) C10 – C11 1.518(2) 
F2 – C20 1.325(2) C10 – C12 1.523(2) 
C16 – C17 1.386(2) C10 – C13 1.535(2) 
C16 – C15 1.389(2) C2 – C3 1.375(2) 
O1 – C9 1.209(2) C2 – C1 1.410(2) 
C9 – C6 1.513(2) C14 – C15 1.396(2) 
C9 – C10 1.525(2) C14 – C19 1.399(2) 
C8 – C7 1.413(2) C14 – C3 1.484(2) 
F1 – C20 1.326(2) C3 – C4 1.429(2) 
 
 
 
 
 
192 
 
Table 41: Selected bond angles (°) of compound 52e. 
C1 – N1 – C5 116.6(1) N1 – C1 – C2 124.1(1) 
N1 – C5 – C6 118.0(1) N2 – C4 – C5 122.4(1) 
N1 – C5 – C4 123.7(1) N2 – C4 – C3 119.6(1) 
C6 – C5 – C4 118.3(1) C5 – C4 – C3 118.0(1) 
C8 – N2 – C4 117.3(1) C11 – C10 – C12 110.4(1) 
C17 – C16 – C15 119.3(1) C11 – C10 – C9 111.3(1) 
O1 – C9 – C6 118.4(1) C12 – C10 – C9 109.5(1) 
O1 – C9 – C10 122.3(1) C11 – C10 – C13 109.3(1) 
C6 – C9 – C10 119.2(1) C12 – C10 – C13 109.7(1) 
N2 – C8 – C7 124.2(1) C9 – C10 – C13 106.5(1) 
C3 – C2 – C1 120.7(1) F2 – C20 – F1 105.9(1) 
C15 – C14 – C19 118.9(1) F2 – C20 – F3 106.5(1) 
C15 – C14 – C3 118.3(1) F1 – C20 – F3 105.5(1) 
C19 – C14 – C3 122.8(1) F2 – C20 – C17 113.2(1) 
C2 – C3 – C4 117.0(1) F1 – C20 – C17 112.2(1) 
C2 – C3 – C14 120.1(1) F3 – C20 – C17 113.0(1) 
C4 – C3 – C14 122.7(1) C16 – C17 – C18 120.5(1) 
C7 – C6 – C5 118.4(1) C16 – C17 – C20 120.0(1) 
C7 – C6 – C9 121.8(1) C18 – C17 – C20 119.4(1) 
C5 – C6 – C9 119.6(1) C6 – C7 – C8 119.3(1) 
C19 – C18 – C17 119.9(1) C16 – C15 – C14 121.0(1) 
C18 – C19 – C14 120.3(1)   
 
Table 42: Selected torsion angles (°) of compound 52e. 
C1 – N1 – C5 – C6 -178.3(1) C17 – C16 – C15 – C14 -0.8(2) 
C1 – N1 – C5 – C4 0.1(2) C19 – C14 – C15 – C16 2.2(2) 
C4 – N2 – C8 – C7 -0.1(2) C3 – C14 – C15 – C16 -177.8(1) 
C1 – C2 – C3 – C4 -0.8(2) C5 – N1 – C1 – C2 0.8(2) 
C1 – C2 – C3 – C14 174.0(1) C3 – C2 – C1 – N1 -0.5(2) 
C15 – C14 – C3 – C2 -43.3(2) C8 – N2 – C4 – C5 0.5(2) 
C19 – C14 – C3 – C2 136.8(1) C8 – N2 – C4 – C3 -177.4(1) 
C15 – C14 – C3 – C4 131.3(1) N1 – C5 – C4 – N2 -179.2(1) 
C19 – C14 – C3 – C4 -48.7(2) C6 – C5 – C4 – N2 -0.8(2) 
N1 – C5 – C6 – C7 179.3(1) N1 – C5 – C4 – C3 -1.4(2) 
C4 – C5 – C6 – C7 0.8(2) C6 – C5 – C4 – C3 177.1(1) 
N1 – C5 – C6 – C9 3.2(2) C2 – C3 – C4 – N2 179.6(1) 
C4 – C5 – C6 – C9 -175.3(1) C14 – C3 – C4 – N2 4.9(2) 
O1 – C9 – C6 – C7 -89.1(2) C2 – C3 – C4 – C5 1.7(2) 
C10 – C9 – C6 – C7 86.8(2) C14 – C3 – C4 – C5 -173.0(1) 
O1 – C9 – C6 – C5 86.8(2) O1 – C9 – C10 – C11 -145.3(1) 
C10 – C9 – C6 – C5 -97.3(2) C6 – C9 – C10 – C11 38.9(2) 
C17 – C18 – C19 – C14 -0.8(2) O1 – C9 – C10 – C12 -23.0(2) 
C15 – C14 – C19 – C18 -1.3(2) C6 – C9 – C10 – C12 161.3(1) 
C3 – C14 – C19 – C18 178.6(1) O1 – C9 – C10 – C13 95.6(2) 
C15 – C16 – C17 – C18 -1.4(2) C6 – C9 – C10 – C13 -80.2(2) 
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C15 – C16 – C17 – C20 -178.9(1) C16 – C17 – C20 – F2 -143.3(1) 
C19 – C18 – C17 – C16 2.2(2) C18 – C17 – C20 – F2 39.1(2) 
C19 – C18 – C17 – C20 179.7(1) C16 – C17 – C20 – F1 96.9(2) 
C5 – C6 – C7 – C8 -0.5(2) C18 – C17 – C20 – F1 -80.7(2) 
C9 – C6 – C7 – C8 175.5(1) C16 – C17 – C20 – F3 -22.2(2) 
N2 – C8 – C7 – C6 0.1(2) C18 – C17 – C20 – F3 160.2(1) 
 
Table 43: Details for X-ray data collection and structure refinement for compound 52g. 
 
 52g 
Empirical formula C16H18N2O 
Formula mass 254.32 
T[K] 173(2) 
Crystal size [mm] 0.35 × 0.35 × 0.20 
Crystal description colorless block 
Crystal system monoclinic 
Space group P21/c 
a [Ǻ] 7.3079(2) 
b [Ǻ] 17.9474(6) 
c [Ǻ] 11.0031(4) 
α [°] 90 
β [°] 95.142(3) 
γ [°] 90 
V [Ǻ3] 1437.33(8) 
Z 4 
ρcalcd. [g cm-3] 1.175 
μ [mm-1] 0.074 
F(000) 544 
Θ range [°] 4.17 – 30.51 
Index ranges -10 ≤ h ≤ 10 
 -25 ≤ k ≤ 25 
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 -15 ≤ l ≤ 15 
Reflns. collected 29342 
Reflns. obsd. 3192 
Reflns. unique 4372  
(Rint = 0.0326) 
R1, wR2 (2σ data) 0.0502, 0.1310 
R1, wR2 (all data) 0.0725, 0.1484 
GOOF on F2 1.036 
Peak/hole [e Ǻ-3] 0.305 / -0.144 
 
 
Table 44: Selected bond lengths (Å) of compound 52g. 
N2 – C8 1.316(2) C10 – C11 1.304(2) 
N2 – C4 1.365(1) C13 – C15 1.524(2) 
C5 – N1 1.365(1) C13 – C16 1.524(2) 
C5 – C6 1.419(2) C13 – C14 1.528(2) 
C5 – C4 1.422(2) O1 – C12 1.208(2) 
C7 – C6 1.371(2) C3 – C12 1.513(2) 
C7 – C8 1.413(2) N1 – C1 1.312(2) 
C2 – C3 1.370(2) C12 – C13 1.523(2) 
C2 – C1 1.415(2) C6 – C9 1.511(2) 
C4 – C3 1.415(2) C9 – C10 1.491(2) 
 
Table 45: Selected bond angles (°) of compound 52g. 
C8 – N2 – C4 116.6(1) C11 – C10 – C9 124.9(2) 
N1 – C5 – C6 119.3(1) C12 – C13 – C15 111.5(1) 
N1 – C5 – C4 122.4(1) C12 – C13 – C16 109.2(1) 
C6 – C5 – C4 118.4(1) C15 – C13 – C16 109.8(2) 
C6 – C7 – C8 120.3(1) C12 – C13 – C14 107.0(1) 
C3 – C2 – C1 119.1(1) C15 – C13 – C14 107.7(2) 
N2 – C4 – C3 118.6(1) C16 – C13 – C14 111.6(2) 
N2 – C4 – C5 123.3(1) C3 – C12 – C13 118.7(1) 
C3 – C4 – C5 118.2(1) C7 – C6 – C5 117.2(1) 
C2 – C3 – C4 118.5(1) C7 – C6 – C9 121.9(1) 
C2 – C3 – C12 121.8(1) C5 – C6 – C9 120.9(1) 
C4 – C3 – C12 119.6(1) C10 – C9 – C6 111.0(1) 
C1 – N1 – C5 117.6(1) N1 – C1 – C2 124.3(1) 
O1 – C12 – C3 118.6(1) N2 – C8 – C7 124.2(1) 
O1 – C12 – C13 122.6(1)   
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Table 46: Selected torsion angles (°) of compound 52g. 
C8 – N2 – C4 – C3 178.4(1) C8 – C7 – C6 – C9 177.9(1) 
C8 – N2 – C4 – C5 -0.5(2) N1 – C5 – C6 – C7 -177.0(1) 
N1 – C5 – C4 – N2 177.5(1) C4 – C5 – C6 – C7 1.4(2) 
C6 – C5 – C4 – N2 -0.8(2) N1 – C5 – C6 – C9 4.4(2) 
N1 – C5 – C4 – C3 -1.4(2) C4 – C5 – C6 – C9 -177.2(1) 
C6 – C5 – C4 – C3 -179.7(1) C7 – C6 – C9 – C10 -97.3(1) 
C1 – C2 – C3 – C4 -1.8(2) C5 – C6 – C9 – C10 81.3(2) 
C1 – C2 – C3 – C12 -178.4(1) C5 – N1 – C1 – C2 1.8(2) 
N2 – C4 – C3 – C2 -176.3(1) C3 – C2 – C1 – N1 -0.4(2) 
C5 – C4 – C3 – C2 2.7(2) C4 – N2 – C8 – C7 1.3(2) 
N2 – C4 – C3 – C12 0.4(2) C6 – C7 – C8 – N2 -0.7(2) 
C5 – C4 – C3 – C12 179.4(1) C6 – C9 – C10 – C11 114.9(2) 
C6 – C5 – N1 – C1 177.5(1) O1 – C12 – C13 – C15 138.7(1) 
C4 – C5 – N1 – C1 -0.8(2) C3 – C12 – C13 – C15 -44.3(2) 
C2 – C3 – C12 – O1 86.0(2) O1 – C12 – C13 – C16 17.2(2) 
C4 – C3 – C12 – O1 -90.6(2) C3 – C12 – C13 – C16 -165.8(2) 
C2 – C3 – C12 – C13 -91.1(2) O1 – C12 – C13 – C14 -103.8(2) 
C4 – C3 – C12 – C13 92.3(1) C3 – C12 – C13 – C14 73.2(2) 
C8 – C7 – C6 – C5 -0.7(2)   
 
 
Table 47: Details for X-ray data collection and structure refinement for compound 56c. 
 
 52c 
Empirical formula C15H9IN2O 
Formula mass 360.14 
T[K] 143(2) 
Crystal size [mm] 0.25 × 0.18 × 0.15 
Crystal description colorless block 
Crystal system orthorhombic 
Space group Pbca 
a [Ǻ] 12.3308(2) 
b [Ǻ] 10.3497(2) 
c [Ǻ] 20.1918(3) 
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α [°] 90.0 
β [°] 90.0 
γ [°] 90.0 
V [Ǻ3] 2576.88(8) 
Z 8 
ρcalcd. [g cm-3] 1.857 
μ [mm-1] 2.477 
F(000) 1392 
Θ range [°] 4.35 – 25.24 
Index ranges -17 ≤ h ≤ 17 
 -14 ≤ k ≤ 14 
 -28 ≤ l ≤ 28 
Reflns. collected 49702 
Reflns. obsd. 3406 
Reflns. unique 3872 
(Rint = 0.0343) 
R1, wR2 (2σ data) 0.0269, 0.0513 
R1, wR2 (all data) 0.0330, 0.0534 
GOOF on F2 1.196 
Peak/hole [e Ǻ-3] 0.538 / -0.555 
 
 
Table 48: Selected bond lengths (Å) of compound 56c. 
I1 – C3 2.081(2) N2 – C8 1.318(3) 
C1 – N1 1.319(2) N2 – C4 1.357(3) 
C1 – C2 1.411(3) O1 – C9 1.221(3) 
C1 – C9 1.506(3) C7 – C8 1.410(3) 
C6 – C7 1.362(3) C2 – C3 1.366(3) 
C6 – C5 1.417(3) C15 – C14 1.381(3) 
C11 – C12 1.388(3) C15 – C10 1.393(3) 
C11 – C10 1.394(3) C9 – C10 1.491(3) 
N1 – C5 1.367(3) C3 – C4 1.420(3) 
C5 – C4 1.421(3) C13 – C14 1.392(4) 
C13 – C12 1.377(3)   
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Table 49: Selected bond angles (°) of compound 56c. 
N1 – C1 – C2 124.7(2) C13 – C12 – C11 120.6(2) 
N1 – C1 – C9 118.6(2) O1 – C9 – C10 120.5(2) 
C2 – C1 – C9 116.7(2) O1 – C9 – C1 119.0(2) 
C7 – C6 – C5 118.6(2) C10 – C9 – C1 120.4(2) 
C12 – C11 – C10 119.6(2) N2 – C8 – C7 123.8(2) 
C1 – N1 – C5 116.7(2) C15 – C14 – C13 120.2(2) 
N1 – C5 – C6 119.0(2) C2 – C3 – C4 119.6(2) 
N1 – C5 – C4 123.5(2) C2 – C3 – I1 120.3(2) 
C6 – C5 – C4 117.5(2) C4 – C3 – I1 120.1(2) 
C12 – C13 – C14 119.8(2) N2 – C4 – C3 120.0(2) 
C8 – N2 – C4 117.3(2) N2 – C4 – C5 123.2(2) 
C6 – C7 – C8 119.7(2) C3 – C4 – C5 116.8(2) 
C3 – C2 – C1 118.6(2) C15 – C10 – C11 119.7(2) 
C14 – C15 – C10 120.1(2) C15 – C10 – C9 118.6(2) 
C11 – C10 – C9 121.3(2)   
 
Table 50: Selected torsion angles (°) of compound 56c. 
C2 – C1 – N1 – C5 0.3(3) C1 – C2 – C3 – I1 -175.6(1) 
C9 – C1 – N1 – C5 179.6(2) C8 – N2 – C4 – C3 178.3(2) 
C1 – N1 – C5 – C6 179.1(2) C8 – N2 – C4 – C5 -0.1(3) 
C1 – N1 – C5 – C4 1.3(3) C2 – C3 – C4 – N2 -179.0(2) 
C7 – C6 – C5 – N1 -176.6(2) I1 – C3 – C4 – N2 -1.5(3) 
C7 – C6 – C5 – C4 1.2(3) C2 – C3 – C4 – C5 -0.4(3) 
C5 – C6 – C7 – C8 -1.2(3) I1 – C3 – C4 – C5 177.1(1) 
N1 – C1 – C2 – C3 -1.9(3) N1 – C5 – C4 – N2 177.2(2) 
C9 – C1 – C2 – C3 178.8(2) C6 – C5 – C4 – N2 -0.6(3) 
C14 – C13 – C12 – C11 0.3(3) N1 – C5 – C4 – C3 -1.2(3) 
C10 – C11 – C12 – C13 1.5(3) C6 – C5 – C4 – C3 -179.0(2) 
N1 – C1 – C9 – O1 -154.7(2) C14 – C15 – C10 – C11 0.1(3) 
C2 – C1 – C9 – O1 24.7(3) C14 – C15 – C10 – C9 -172.9(2) 
N1 – C1 – C9 – C10 27.2(3) C12 – C11 – C10 – C15 -1.7(3) 
C2 – C1 – C9 – C10 -153.5(2) C12 – C11 – C10 – C9 171.2(2) 
C4 – N2 – C8 – C7 0.2(3) O1 – C9 – C10 – C15 30.6(3) 
C6 – C7 – C8 – N2 0.5(4) C1 – C9 – C10 – C15 -151.3(2) 
C10 – C15 – C14 – C13 1.6(3) O1 – C9 – C10 – C11 -142.4(2) 
C12 – C13 – C14 – C15 -1.8(3) C1 – C9 – C10 – C11 35.8(3) 
C1 – C2 – C3 – C4 1.9(3)   
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Table 51: Details for X-ray data collection and structure refinement for compound 64h. 
 
 64h 
Empirical formula C21H16N2O 
Formula mass 312.36 
T[K] 173(2) 
Crystal size [mm] 0.39 × 0.12 × 0.09 
Crystal description colorless rod 
Crystal system monoclinic 
Space group P21/c 
a [Ǻ] 11.6198(6) 
b [Ǻ] 5.8801(3) 
c [Ǻ] 22.9235(13) 
α [°] 90.0 
β [°] 92.639(5) 
γ [°] 90.0 
V [Ǻ3] 1564.60(14) 
Z 4 
ρcalcd. [g cm-3] 1.326 
μ [mm-1] 0.083 
F(000) 656 
Θ range [°] 4.24 – 26.37 
Index ranges -14 ≤ h ≤ 12 
 -7 ≤ k ≤ 7 
 -26 ≤ l ≤ 28 
Reflns. collected 10124 
Reflns. obsd. 2309 
Reflns. unique 3198 
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(Rint = 0.0394) 
R1, wR2 (2σ data) 0.0433, 0.0939 
R1, wR2 (all data) 0.0663, 0.1067 
GOOF on F2 1.022 
Peak/hole [e Ǻ-3] 0.225 / -0.209 
 
 
Table 52: Selected bond lengths (Å) of compound 64h. 
N2 – C8 1.315(2) C7 – C6 1.360(2) 
N2 – C4 1.372(2) C21 – C20 1.384(2) 
O1 – C12 1.374(2) C21 – C16 1.400(2) 
O1 – C15 1.420(2) C17 – C18 1.388(2) 
N3 – C1 1.305(2) C17 – C16 1.396(2) 
N3 – C2 1.379(2) C20 – C19 1.381(2) 
C3 – C2 1.391(2) C18 – C19 1.387(2) 
C3 – C4 1.430(2) C11 – C10 1.395(2) 
C3 – C9 1.493(2) C14 – C13 1.380(2) 
C9 – C10 1.384(2) C5 – C4 1.410(2) 
C9 – C14 1.397(2) C5 – C1 1.411(2) 
C2 – C16 1.489(2) C5 – C6 1.414(2) 
C12 – C11 1.380(2) C8 – C7 1.408(2) 
C12 – C13 1.390(2)   
 
Table 53: Selected bond angles (°) of compound 64h. 
C8 – N2 – C4 116.7(1) C5 – C4 – C3 119.0(1) 
C12 – O1 – C15 117.5(1) C9 – C10 – C11 121.5(1) 
C1 – N3 – C2 119.0(1) C20 – C21 – C16 121.2(2) 
C2 – C3 – C4 117.9(1) C7 – C6 – C5 118.5(1) 
C2 – C3 – C9 123.3(1) N3 – C1 – C5 124.1(1) 
C4 – C3 – C9 118.8(1) C18 – C17 – C16 120.9(2) 
C10 – C9 – C14 118.2(1) C19 – C20 – C21 120.2(2) 
C10 – C9 – C3 120.8(1) C19 – C18 – C17 120.2(2) 
C14 – C9 – C3 121.0(1) C20 – C19 – C18 119.6(2) 
N3 – C2 – C3 122.3(1) C17 – C16 – C21 117.8(2) 
N3 – C2 – C16 112.9(1) C17 – C16 – C2 123.3(1) 
C3 – C2 – C16 124.8(1) C21 – C16 – C2 118.8(1) 
O1 – C12 – C11 124.8(1) C1 – C5 – C6 123.5(1) 
O1 – C12 – C13 115.2(1) N2 – C8 – C7 125.3(2) 
C11 – C12 – C13 120.0(1) C6 – C7 – C8 118.6(2) 
C12 – C11 – C10 119.3(1) C14 – C13 – C12 120.1(1) 
C13 – C14 – C9 120.9(1) N2 – C4 – C5 122.0(1) 
C4 – C5 – C1 117.6(1) N2 – C4 – C3 119.1(1) 
C4 – C5 – C6 119.0(1)   
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Table 54: Selected torsion angles (°) of compound 64h. 
C2 – C3 – C9 – C10 63.6(2) C6 – C5 – C4 – C3 179.6(1) 
C4 – C3 – C9 – C10 -116.2(2) C2 – C3 – C4 – N2 176.4(1) 
C2 – C3 – C9 – C14 -116.4(2) C9 – C3 – C4 – N2 -3.8(2) 
C4 – C3 – C9 – C14 63.8(2) C2 – C3 – C4 – C5 -2.8(2) 
C1 – N3 – C2 – C3 -4.1(2) C9 – C3 – C4 – C5 177.1(1) 
C1 – N3 – C2 – C16 174.2(1) C14 – C9 – C10 – C11 1.4(2) 
C4 – C3 – C2 – N3 5.6(2) C3 – C9 – C10 – C11 -178.7(2) 
C9 – C3 – C2 – N3 -174.2(1) C12 – C11 – C10 – C9 0.1(3) 
C4 – C3 – C2 – C16 -172.5(1) C8 – C7 – C6 – C5 0.0(2) 
C9 – C3 – C2 – C16 7.7(2) C4 – C5 – C6 – C7 -0.7(2) 
C15 – O1 – C12 – C11 -2.3(2) C1 – C5 – C6 – C7 -179.7(2) 
C15 – O1 – C12 – C13 178.1(2) C2 – N3 – C1 – C5 -0.4(2) 
O1 – C12 – C11 – C10 179.4(2) C4 – C5 – C1 – N3 3.1(2) 
C13 – C12 – C11 – C10 -0.9(2) C6 – C5 – C1 – N3 -177.9(2) 
C10 – C9 – C14 – C13 -2.1(2) C16 – C21 – C20 – C19 0.5(2) 
C3 – C9 – C14 – C13 177.9(2) C16 – C17 – C18 – C19 -0.4(3) 
C4 – N2 – C8 – C7 -1.2(2) C21 – C20 – C19 – C18 0.5(3) 
N2 – C8 – C7 – C6 1.0(3) C17 – C18 – C19 – C20 -0.5(3) 
C9 – C14 – C13 – C12 1.4(2) C18 – C17 – C16 – C21 1.4(2) 
O1 – C12 – C13 – C14 179.9(2) C18 – C17 – C16 – C2 176.9(2) 
C11 – C12 – C13 – C14 0.2(2) C20 – C21 – C16 – C17 -1.4(2) 
C8 – N2 – C4 – C5 0.4(2) C20 – C21 – C16 – C2 -177.1(1) 
C8 – N2 – C4 – C3 -178.7(1) N3 – C2 – C16 – C17 -146.1(2) 
C1 – C5 – C4 – N2 179.6(1) C3 – C2 – C16 – C17 32.1(2) 
C6 – C5 – C4 – N2 0.5(2) N3 – C2 – C16 – C21 29.4(2) 
C1 – C5 – C4 – C3 -1.3(2) C3 – C2 – C16 – C21 -152.4(2) 
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2. PHOTOLUMINESCENCE QUANTUM EFFICIENCY MEASUREMENTS (PLQE) 
 
 
 
 
Figure 28: PLQE measurements of 62b (top) and 64i (bottom) in various solvents. The y-axis scale is proportional to the 
number of photons collected in each wavelength interval. 
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3. TIME-CORRELATED SINGLE PHOTON COUNTING (TCSPC) 
 
The solutions are excited at 20 MHz and 5.8 MHz for 62b and 64i, respectively, adjusted to their 
respective decay times. The instrument response function (IRF) of the setup is mostly determined by the 
laser pulse length and is measured at around 120 ps. Mono-exponential fits to the data follow the 
equation 
𝐼(𝑡) = 𝐼0 ∙ 𝑒𝑥𝑝 (
𝑡 − 𝑡0
𝜏
) + 𝐼𝑏𝑔 
 
with initial intensity 𝐼0, time offset 𝑡0, background intensity 𝐼𝑏𝑔, and lifetime 𝜏. The latter are given in 
Table S1 including their fitting uncertainties. We note that the uncertainties are one order of magnitude 
smaller than the time resolution of the setup. However, measured lifetimes are considerably larger than 
the IRF.  
 
Table 55: Lifetimes of mono-exponential fits to the TCSPC data including their fitting uncertainties. 
62b (3.80 ± 0.02) ns 
64i (11.95 ± 0.03) ns 
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4. ADDITIONAL OPTICAL SPECTROSCOPIC DATA FOR DYES 73 
 
Table 56: Overview of spectroscopic data. 
 
73a CHCl3 Tetradecane n-Hexane 1-Butanol 1-Undecanol DMF Toluene 
lAbs[a] 355.4 343.4 342.2 355.2 353.4 355.2 346.8 
lFluo[b] 420.0 402.3 402.7 429.1 420.6 427.2 410.6 
e [c] 17100 17600 16800 19000 18500 17700 16900 
 [d] 0.78 0.094 0.076 0.95 0.76 0.74 0.50 
 [e] 3.21 
  
3.85 
 
3.62 
 
73b 
3b 
CHCl3 Tetradecane n-Hexane 1-Butanol 1-Undecanol DMF Toluene 
lAbs[a] 364.8 356.4 354.2 366.2 365.6 368.0 364.2 
lFluo[b] 459.6 427.8 424.0 498.1 476.4 497.2 443.2 
e [c] 16900 15800 15700 17100 16700 16400 16400 
 [d] 0.83 0.79 0.65 0.83 0.83 0.82 0.75 
 [e] 4.11 3.12 2.65 5.18 4.78 5.24 3.50 
73c 
3c 
CHCl3 Tetradecane n-Hexane 1-Butanol 1-Undecanol DMF Toluene 
lAbs[a] 426.2 403.8 401.2 430.2 428.6 433.8 418.2 
lFluo[b] 578.4 469.8 462.7 638.4 610.0  532.4 
e [c] 11200 16500 12300 10300 11800 10700 10800 
d] 0.64 0.73 0.70 0.013 0.14 0.0037 0.65 
 [e] 6.99 3.61 3.47 3.50 5.51  5.12 
73d 
3d 
CHCl3 Tetradecane n-Hexane 1-Butanol 1-Undecanol DMF Toluene 
lAbs[a] 362.2 357.0 354.8 361.4 362.6 365.6 360.8 
lFluo[b] 525.1 442.3 440.2 572.1 526.4 618.8 492.4 
e [c] 15900 17100 16500 16600 16900 16500 17000 
d] 0.65 0.51 0.41 0.022 0.26 0.0065 0.71 
 [e] 6.62 2.78 2.03 0.208 1.75 0.119 5.40 
73g 
3g 
CHCl3 Tetradecane n-Hexane 1-Butanol 1-Undecanol DMF Toluene 
lAbs[a] 325.0 322.6 322.6 323.6 323.8 323.8 324.0 
lFluo[b] 509.7 431.7 427.1 576.8 532.4 581.8 478.0 
e [c] 15300 16200 14900 16200 18800 15200 16000 
d] 0.39 0.34 0.33 0.088 0.23 0.13 0.18 
 [e] 4.07 1.83 1.70 1.80 4.85 3.85 1.53 
73h 
3h 
CHCl3 Tetradecane n-Hexane 1-Butanol 1-Undecanol DMF Toluene 
lAbs[a] 329.0 327.2 326.6 327.8 329.0 328.8 328.8 
lFluo[b] 522.7 440.2 434.8 570.1 537.0 597.8 487.0 
e [c] 17100 16000 16800 18100 15900 17000 16900 
d] 0.40 0.34 0.34 0.047 0.28 0.055 0.19 
 [e] 4.14 1.89 1.88 1.05 3.10 3.01 1.59 
73i 
3i 
CHCl3 Tetradecane n-Hexane 1-Butanol 1-Undecanol DMF Toluene 
lAbs[a] 356.0 344.4 343.4 357.6 355.0 356.0 353.4 
lFluo[b] 425.4 407.0 406.7 434.2 430.6 432.7 416.7 
e [c] 18600 18800 17400 18600 19100 17900 18200 
 [d] 0.79 0.18 0.14 0.89 0.85 0.64 0.51 
 [e] 3.08 5.08  3.63 3.81 3.38 2.03 
73j 
3j 
CHCl3 Tetradecane n-Hexane 1-Butanol 1-Undecanol DMF Toluene 
lAbs[a] 366.4 356.2 355.6 367.8 365.8 367.8 364.6 
lFluo[b] 447.4 410.8 407.4 480.0 457.5 478.3 427.5 
e [c] 23700 26400 22600 24100 24600 22800 22400 
 [d] 0.54 0.54 0.53 0.70 0.71 0.55 0.51 
 [e] 1.34 0.994 1.02 2.21 2.12 2.15 1.16 
73l 
3l 
CHCl3 Tetradecane n-Hexane 1-Butanol 1-Undecanol DMF Toluene 
lAbs[a] 364.4 357.6 354.0 366.0 369.4 369.0 364.8 
lFluo[b] 492.2 436.7 426.8 556.6 518.2 583.4 454.6 
e [c] 27500 29300 28300 27500 26800 28300 27500 
d] 0.67 0.50 0.50 0.16 0.56 0.15 0.40 
 [e] 2.93 1.43 1.35 1.05 3.21 1.91 1.40 
[a] Absorption maxima in nm. [b] Fluorescence maxima in nm. [c] Molar extinction coefficients in Lmol-1cm-1. [d] Fluorescence 
quantum yields, exc = lmax, reference: N,N’-Bis(tridecan-7-yl)perylene-3,4:9,10-tetracarboxylic diimide with  = 1.00; [e] 
Fluorescence lifetimes in ns. 
 
